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Background: Autism spectrum disorder (ASD) affects 20-30% of adults with intellectual 
disability. This group are vulnerable to mental health problems and poor quality of life. They 
usually share a common mental health care pathway with adults who have intellectual 
disability without ASD. However, there is little evidence on whether this is an appropriate 
approach. 
 
Aim: The thesis aimed to explore differences between those with and without ASD among 
specialist mental health service users with intellectual disability. 
 
Method: The needs, mental health, behaviour, social functioning and service use of 50 
participants with ASD from a specialist mental health service for adults with intellectual 
disability in South East London were compared with 48 participants without ASD. ASD 
diagnoses were assessed using the Autism Diagnostic Observation Schedule (ADOS). In 
addition, anonymised case records provided routinely collected, clinical data on 788 
participants. 
 
Results: Participants with ASD consumed fewer services than those without ASD despite 
having more needs. ASD was a significant predictor of poorer mental health and behaviour. 
Participants with ASD had poorer social functioning than those without ASD. However, when 
severe intellectual disability, absence of a psychiatric disorder and needs were taken into 
account, ASD was not a significant predictor of poorer social functioning. 
 
The rate of clinically diagnosed ASD among specialist mental health services users with 
intellectual disability was 33.5%. However, there was evidence that undiagnosed ASD and 
unrecognised ASD behaviours were common. 
 
Conclusion: The mental health, behaviour and social functioning of specialist mental health 
service users with intellectual disability was poorer for those with ASD and significantly 
associated with factors that characterise many of these individuals. There appeared to be high 
levels of undiagnosed ASD and a lack of ASD-specific assessment protocols or care 
pathways. However, these findings may be limited to the specific service user group sampled. 
More research is needed to determine whether increased recognition of ASD and improved 
access to services would lead to better outcomes for adults with intellectual disability who 
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The thesis is about the impact of autism spectrum disorder (ASD) on adults with intellectual 
disability who have mental health problems. The study focuses on individuals who are 
receiving specialist mental health services for adults with intellectual disability. The 
assessment and prevalence of intellectual disability, ASD and mental health problems are 
discussed along with service use and intervention. The thesis is supported by two clinic-
based, cross-sectional studies that compared participants who have intellectual disability with 
and without ASD. 
 
Outline of thesis 
The thesis begins with a review of the literature relevant to the mental health and service use 
of adults with intellectual disability and ASD (Chapters 2 to 5). Existing research is used to 
develop the research questions and hypotheses for the project (Chapter 6). The methods used 
for the research components of the study are described and followed by the results (Chapters 
7 to 12). Finally, the findings are discussed in relation to what was previously known in this 
area, how the study adds to the evidence base and the implications of the findings for future 
research and clinical practice (Chapter 13). 
 
Terminology 
The thesis uses terminology as described below. Definitions and diagnostic criteria for 
intellectual disability and ASD are described in the background section and Chapter 2.  
Throughout the thesis, the term specialist mental health service users with intellectual 
disability is used to describe the users of specialist mental health services that are provided 
specifically for adults with intellectual disability. 
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Intellectual disability 
Intellectual disability is used in the thesis as an equivalent to learning disability (used by 
services in the UK; Simpson, 1995) and mental retardation (currently used in diagnostic 
criteria; APA, 1994; WHO, 1992). Some people also use the term learning difficulty 
(Department of Health, 2001b). The term intellectual disability is widely used in the 
international scientific literature and distinguishes the diagnosis from specific learning 
disorders such as dyslexia. In tables and figures, the abbreviation ID is used. Severity of 
intellectual disability refers to whether an individual has mild, moderate or severe/profound 
intellectual disability. 
 
Autism spectrum disorder 
The abbreviation ASD (Autism Spectrum Disorder) is used to describe a group of conditions 
that current diagnostic criteria call pervasive developmental disorders (PDD; APA, 1994; 
WHO, 1992). In addition to childhood autism and autistic disorder, ASD includes high-
functioning autism, Asperger syndrome, atypical autism and PDD-not otherwise specified 
(PDD-NOS). Different groups and individuals also use autism spectrum conditions, autistic 
spectrum difference or neuro-diversity and often autism is used as an umbrella term for these 
(Department of Health, 2010b). The thesis uses ASD for all individuals with an autism 




Intellectual disability and ASD are distinct but related conditions that can occur separately or 
together. They are not mental health problems but individuals with intellectual disability 
and/or ASD may experience additional psychopathology. 
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Intellectual disability 
Intellectual disability is a developmental disorder characterised by impairments in intelligence 
and social functioning (Department of Health, 2001b). The most common cause is 
‗unknown‘; accounting for around 30-50% of cases (Bhate & Wilkinson, 2006). However, 
there are many known genetic, biological and environmental causes (Matilainen et al., 1995). 
 
As the label suggests, intellectual disability is a lifelong disorder. Although improvements in 
individuals‘ IQ, skills and functioning can occur over time or as a result of intervention, there 
is no ‗cure‘ (Beadle-Brown et al., 2000). Most people with intellectual disability in the UK 
live within the community (Kozma et al., 2009). Current policy focuses on independence, 
choice, citizenship and social inclusion with an emphasis on person-centred and people first 
approaches (Department of Health, 2006b; 2007b). 
 
Depending on the severity of their impairment, individuals with intellectual disability are 
likely to need support throughout or at some point during their lives (Schalock et al., 2010). It 
has been established that as a group, people with intellectual disability require a high level of 
service input and that the amount of resources needed to provide health and social care for 
them is increasing (Emerson & Hatton, 2008; Emerson, 2009; Strydom et al., 2010). 
However, the actual costs of intellectual disability to the economy are not well understood 
(Romeo & Molosankwe, 2010). 
 
In the UK, service development has been heavily influenced by the Mansell Committee report 
(Department of Health, 1993). Developments in policy on health and social care culminated 
in the publication of Valuing People and Valuing People Now (Department of Health, 2001b; 
2009c). There are guidelines specifically about the provision of mental health services for 
people with intellectual disability including the Green Light Toolkit (Foundation for People 
with Learning Disabilities, 2004). Despite a growing culture of inclusion and drive for access 
Chapter 1: Introduction & background 
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to mainstream services, people with intellectual disability are often not mentioned or included 
in important mental health policy documents (e.g. National Service Frameworks and National 
Institute of Health and Clinical Excellence (NICE) Guidance). 
 
Autism spectrum disorder 
ASD is “A lifelong condition that affects how a person communicates with, and relates to, 
other people.” (Department of Health, 2010b; pp. 10). People with ASD often have restricted 
interests and fixed routines, they may also experience sensory under- or over-sensitivity 
(Emerson & Baines, 2010). 
 
Autism is a relatively new concept; it was only added to diagnostic manuals in 1980 (APA, 
1980). The word itself was coined in 1910 and the disorder infantile autism first described in 
the 1940s (Kanner, 1943; Kuhn, 2004). Since then the definition and classification of autism 
has expanded and developed into a group of ‗pervasive developmental disorders‘ (PDD) that 
include Asperger syndrome and atypical ASD (WHO, 1992).  
 
These disorders are said to form a spectrum because although all individuals with ASD have 
difficulties in social communication, interaction and imagination their functioning is affected 
in different ways (Department of Health, 2010b). It is common, for people with ASD to be 
referred to as either low- or high-functioning. This can be seen as equivalent to those with and 
without intellectual disability but is not a diagnostic classification (Knapp et al., 2009; 
National Audit Office, 2009b). 
 
ASD is a neurodevelopmental condition that has no known prevention or cure. A single cause 
has not been identified but there appear to be a number of genetic components to the aetiology 
of ASD (Sokol & Lahiri, 2011). Some chromosomal conditions are associated with a broader 
autistic behavioural phenotype although not all individuals will meet the criteria for ASD 
Chapter 1: Introduction & background 
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(Piven et al., 1997). These  include phenylketonuria, tuberous sclerosis, Fragile X and 
Turner‘s syndrome (Medical Research Council, 2001). 
 
There is evidence that adult outcome for individuals with ASD is generally poor, whilst 
burden on carers is often high (Hare et al., 2004; Howlin et al., 2004). However, despite a 
great deal of interest in children with ASD, until recently there has been relatively little 
research on adults with ASD (Barnard et al., 2001; Brugha et al., 2009b; Lunsky et al, 2009; 
Matson & Boisjoli, 2008; Totsika et al., 2010). 
 
The economic cost of ASD in the UK is estimated to be around £28 billion a year (Knapp et 
al., 2009). The vast majority of this sum (£25 billion) comes from supporting adults with 
ASD. Concern in the UK about service provision for these individuals has been highlighted 
by the Department of Health (2006; 2009a; 2009b) and the National Audit Office (2009). 
Reports from these bodies conclude that current knowledge is lacking with regards to the 
number of people with ASD using services, the needs of people with ASD and the 
effectiveness of service provision. 
 
In the UK, significant changes in policy and legislation have taken place in the last two years 
with the passing of the Autism Act, 2009 and subsequent implementation of the Autism 
Strategy (Department of Health, 2010b). A clinical guideline on the recognition, referral, 
diagnosis and management of ASD in adults undergoing a consultation process and is due to 
be published in June 2012 (NICE, 2012). 
 
People with intellectual disability and ASD 
It is common for intellectual disability and ASD to co-occur. The rate of comorbidity appears 
to increase with the severity of each disorder (Matson & Shoemaker, 2009; Saemundsen et 
al., 2010). There are shared elements in the diagnostic criteria for severe intellectual disability 
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and autism including cognitive impairment and communication difficulties (Matson et al., 
2008a). 
 
Mental health of adults with intellectual disability and ASD 
People with intellectual disability are at increased risk of mental health problems compared to 
the general population (Cooper & van der Speck, 2009). There is evidence that individuals 
with ASD are also at higher risk; although most studies have been on children and adolescents 
(Bradley & Bolton, 2006; Matson et al., 2010). In a survey of psychiatric morbidity in the 
UK, there was no evidence that adults with ASD received more services for mental or 
emotional problems compared with the general population (Brugha et al., 2009b). It is not 
currently clear whether adults with intellectual disability and ASD are at further increased risk 
of mental health problems than those with one condition or the other (Underwood et al, 2010). 
 
A recent review of the literature specifically on the mental health of adults with both 
intellectual disability and ASD identified only 14 reports from eight research groups 
(Underwood et al., 2010). Two were on the development of mental health assessment tools 
for adults with intellectual disability and ASD (Helverschou et al., 2009; Matson & Boisjoli, 
2008). The others focussed on the prevalence of psychopathology in adults with intellectual 
disability and ASD. In all of these studies there were issues concerning the diagnostic 
methods used (for ASD and for psychiatric disorder) (Underwood et al., 2010). They also 
varied according to whether age, severity of intellectual disability and gender were controlled 
for and which other variables – such as place of residence – were taken into account (La 
Malfa et al., 2007). 
 
Few of these studies looked beyond clinical psychiatric diagnoses to see where there were any 
differences in mental health and social functioning of those with and without ASD. Nor was 
service use investigated in any depth although medication did feature. 
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Conclusion of the background to the thesis 
There are similarities between intellectual disability and ASD and a great deal of crossover in 
their prevalence but they present distinct challenges for individuals, carers and service 
providers. There is a lack of research on the provision of services for individuals with 
intellectual disability and ASD who have additional mental health problems. It is important 
that studies include the full range of individuals who form this heterogeneous group; across 
gender, age, ethnicity, severity of intellectual disability and type of ASD. 
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Chapter 2: Recognition and assessment of intellectual disability, ASD and comorbid 
mental health problems 
 
Effective recognition and assessment of intellectual disability, ASD and mental health 
problems is key to successful clinical intervention and service provision (National Audit 
Office, 2009b). It underpins the ability of researchers to accurately estimate prevalence, 
identify patterns of comorbidity, evaluate intervention and measure outcome. It is becoming 
increasingly important to demonstrate that clinical or administrative diagnoses are supported 
by standardised assessment using evidence-based tools (Lord, 2010; Medical Research 
Council, 2001; NICE, 2011). 
 
Diagnosing mental and developmental disorders is a challenging process even for the most 
experienced clinician (Goldberg & Murray, 2006). Central to making an accurate diagnosis is 
determining whether an individual‘s symptoms meet diagnostic criteria and ruling out a 
differential diagnosis (Royal College of Psychiatrists, 2009a). Standardised methods and tools 
have been developed to aid this process. 
 
This chapter covers the assessment of people with intellectual disability, ASD and comorbid 
mental health problems. The availability of standardised instruments is reviewed. Many of the 
diagnoses referred to are based on DSM-IV and ICD-10 criteria (APA, 1994; WHO, 1992). 
New versions of these manuals due to be published in 2013 and 2015 respectively (see pages 
21 and 25). 
 
Recognition and assessment of intellectual disability and ASD 
Intellectual disability and ASD are not single disorders with clear aetiology (Matilainen et al., 
1995; Medical Research Council, 2001). They are ways of describing and categorising 
individuals based on their behaviour and, in the case of intellectual disability, deficits in their 
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cognitive development (Tylender et al., 2007). As such there are no diagnostic tests that can 
determine categorically whether or not a person has intellectual disability or ASD (Lord & 
Bishop, 2009; WHO, 1996). 
 
Recognition and assessment of intellectual disability 
Recognition and diagnosis of intellectual disability usually takes place during childhood. 
Eligibility for adult intellectual disability services is often initially based on whether an 
individual was recognised as having special educational needs or whether they were 
recognised as having intellectual disability by children‘s services (see 
www.improvinghealthandlives.org.uk/about/definition). Psychometric assessment may be 
required to confirm eligibility. 
 
Diagnostic criteria for intellectual disability 
The psychiatric criteria for intellectual disability used in this thesis are clearly defined and 
have remained stable over time. Intellectual disability is classed as a mental and behavioural 
disorder in ICD-10 (WHO, 1992) and a developmental disorder on Axis II of DSM-IV (APA, 
1994). 
 
Intellectual disability is described as: 
“A reduced level of intellectual functioning resulting in diminished ability to adapt to the 
daily demands of the normal social environment.” (WHO, 1992; pp.177). 
 
ICD-10 and DSM-IV state that an individual should have impairment in areas of adaptive 
behaviour skills manifested during the developmental period, which contribute to the overall 
level of intelligence, i.e. cognitive, language, motor, and social abilities. This is generally 
supported by evidence that the individual has an Intelligence Quotient (IQ) score of less than 
70 (APA, 1994; WHO, 1992). However, it is acknowledged that low IQ alone is not sufficient 
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for assessing an individual‘s eligibility for intellectual disability services (Department of 
Health, 2001). 
 
Intellectual disabilities are categorised as mild, moderate, severe and profound; quantified by 
ICD-10 as IQ scores of 50-69, 35-49, 20-34 and below 20 respectively (WHO, 1992). 
Intellectual disability can co-occur with any other diagnosis or diagnoses within ICD-10 
criteria (although it can be an exclusionary criteria for some language disorders; WHO, 1992). 
 
The publication of new diagnostic criteria could see major changes to the classification of 
intellectual disability and development disorders including ASD (Andrews et al., 2009). In 
DSM-5 these will now be grouped together under neurodevelopmental disorders. The term 
mental retardation will be replaced by intellectual disability which will be classed as an 
intellectual developmental disorder. Other changes to intellectual disability severity criteria 
and coding by IQ level are currently unclear (APA website, 2011). The term intellectual 
developmental disorder will also be used by ICD-11 as a replacement for mental retardation. 
This category will be relocated under neurodevelopmental disorders (Salvador-Carull et al., 
2011). 
 
In practice, working or ‗administrative‘ definitions of intellectual disability continue to vary 
within and between countries, disciplines and services (Holland, 2011; Sturmey, 1999). In the 
UK the range of terms that refer intellectual disability include learning disability, learning 
difficulty and mental impairment (Northfield, 2004). These differ between legislation (e.g. 
Mental Health Act 1983, Sexual Offences Act 1956 and Police & Criminal Evidence Act 
1984) and government departments (e.g. Department for Work & Pensions, Local Authorities 
that provide social care for adults with disabilities, Department for Education and Department 
of Health). 
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This heterogeneity in terminology and definition can make it difficult to determine whether 
service users or research participants described as having intellectual disability really belong 
to the same group unless eligibility criteria are explicitly stated.  
 
Assessment of intellectual disability 
The assessment of intellectual disability in adults is relatively uncommon since most 
individuals are expected to have received a diagnosis in childhood. However, there is 
evidence that mild intellectual disability remains under diagnosed particularly among those 
not accessing services (Clarke & Griffiths, 2008; Cooper et al., 2007; Department of Health, 
2001b). Settings where screening for intellectual disability may be particularly useful include 
prisons and mental health services (Hayes, 2002; Søndenaa et al., 2008). 
 
A diagnosis of intellectual disability is usually made by specialist psychologists and 
intellectual disability psychiatrists. The most widely used assessment tool for adults is the 
Wechsler Adult Intelligence Scale (WAIS; Wechsler, 2008). This produces a range of scores 
including full scale IQ, performance IQ and verbal IQ (WAIS III; Wechsler, 1997). Other 
tools that provide evidence on level of functioning and skills include adaptive behaviour 
scales (ABS) such as the Adaptive Behaviour Assessment System–II (ABAS–II; Harrison & 
Oakland, 2003), American Association of Mental Retardation ABS (AAMR, 1992), Scales of 
Independent Behavior (SIB-R; Bruininks et al., 1996) and Vineland-II ABS (Sparrow, 2005). 
These tools can also be used to estimate severity of intellectual disability. They provide a 
greater range of information on behaviour and daily living skills. As such they are more 
widely used in research than standard psychometric tests (Beail, 2003). 
 
Sometimes a measure of need is used as a proxy for an assessment of ability or cognitive 
development. There is an argument that service eligibility and provision should be based on 
need rather than fulfilment of diagnostic criteria (McKenzie & Paxton, 2006). Assessment 
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tools for people with intellectual disability include the Camberwell Assessment of Need for 
adults with Developmental and Intellectual Disability (Xenitidis et al., 2003), Inventory of 
Client and Agency Planning (Bruininks et al., 1984) and Supports Intensity Scale (Thompson 
et al., 2004). 
 
Much research on intellectual disability relies on existing clinical or administrative diagnoses 
(Maulik et al., 2011). This could be because the reliability and validity of clinical diagnoses 
are taken for granted since services for adults with intellectual disability are well established. 
In summary, there is no consensus on the ‗gold standard‘ assessment for intellectual disability 
apart from clinical judgement supported by psychometric tests and a standardised measure of 
adaptive functioning (Schalock et al., 2010; Verri et al., 2004). 
 
Recognition and assessment of ASD 
Signs of ASD may be observed in children as young as 12 months old. However, a formal 
diagnosis is not usually made until at least three years of age (Filipeck et al., 1999; Ozonoff et 
al., 2010; Medical Research Council, 2001). The average age of diagnosis is around 6 years 
old for autism (Andrews et al, 2009) and around 11 years old for Asperger syndrome (Howlin 
& Asgharian, 1999; Levy et al., 2009). 
 
Since ASD is a relatively new concept and wider criteria were not introduced until 1994 (in 
the case of the DSM; APA, 1994) it is common for older individuals to remain undiagnosed 
in adulthood (Brugha et al., 2011; National Audit Office, 2009a). It is recommended that 
diagnoses should always be carried out by multi-disciplinary professionals with specific 
expertise in the assessment of ASD (NICE, 2012).  However there are a lack of clinicians 
with this specialist training (National Audit Office, 2009b). Therefore, few individuals receive 
comprehensive diagnostic assessment and the identification rate of ASD in the general 
population is estimated to be as low as 1-4% (National Audit Office, 2009a). 
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There is debate on the stability of ASD symptoms over time (Matson et al., 2008b; Seltzer et 
al., 2003). It is thought that most individuals who receive a diagnosis in childhood will meet 
the criteria for ASD as adults (Billstedt et al., 2005). However, studies have reported 
improvements in functioning and behaviours, particularly in high-functioning ASD (Esbensen 
et al., 2010; Marriage et al., 2009; Piven et al., 1996). The strongest predictors of adult 
symptoms of ASD appear to be childhood IQ and speech before five years of age (Billstedt et 
al., 2007). If services are to be needs rather than diagnosis driven it may be useful to reassess 
ASD symptoms across the lifespan particularly for those diagnosed early in childhood 
(Bennett et al., 2005). 
 
Diagnosing ASD in adults with severe and profound intellectual disability is known to be 
particularly problematic. There are many overlaps between their characteristics and features 
of ASD, particularly with regards to communication, imagination, restricted behaviours 
(Bhaumik et al., 2010; de Bildt et al., 2003; de Bildt et al., 2004; Matson et al., 2007b). It is 
not clear whether this leads to under- or over-diagnosis of ASD among adults with severe 
intellectual disability. Identifying effective standardised assessments for this group is more 
difficult (NICE, 2012). 
 
Diagnostic criteria for ASD 
The core clinical features identified by Kanner (1971) remain at the cornerstone of the 
characterisation of people with ASD which is currently classed as a disorder of psychological 
development in ICD-10 (WHO, 1992) and a clinical disorder on Axis I of DSM-IV (APA, 
1994). 
 
The psychiatric diagnostic criteria for ASD are still evolving (Filipeck et al., 1999). There are 
discrepancies between different criteria over which disorders are included and what these 
disorders are called (APA, 1994; WHO, 1992). However, the ‗triad of impairments‘ that 
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describe the core characteristics of ASD consistently form the basis of the definition and 
diagnostic criteria for ASD (Bhaumik et al., 2010). 
 
The ICD-10 definition of ASD is: “The presence of abnormal and/or impaired development 
that is manifest before the age of 3 years, and by the characteristic type of abnormal 
functioning in all three areas of social interaction, communication, and restricted, repetitive 
behaviour.” (WHO, 1992; pp.198). 
 
Despite the known overlaps in the prevalence of intellectual disability and ASD there can be a 
degree of diagnostic overshadowing that results in one these conditions being overlooked in 
the presence of an existing diagnosis of the other (Matson & Shoemaker, 2009; Murphy et al., 
2011). The diagnostic criteria for ASD are the same for individuals with and without 
intellectual disability although the diagnosis of a specific ASD may take into account 
evidence of accompanying intellectual impairment (Royal College of Psychiatrists, 2001a; 
Saemundsen et al., 2010).  
 
Unlike intellectual disability, according to ICD-10 and DSM-IV, there are several diagnoses 
that cannot co-occur in an individual with ASD. The most commonly cited example is that 
ASD currently forms part of the exclusionary criteria for attention deficit hyperactivity 
disorder (ADHD). Differential diagnoses that should be considered are other developmental 
language disorders, schizophrenia, schizoid personality disorder, intellectual disability and 
oppositional defiance disorder (Filipeck et al., 1999). 
 
Aligning diagnostic criteria and clarifying issues of exclusionary diagnoses are one of the key 
aims of DSM-5 and ICD-11 (Sartorius, 2010). In DSM-5, autism spectrum disorder will 
replace the term pervasive developmental disorders (PDD). It will include ―autistic disorder, 
Asperger‟s disorder, childhood disintegrative disorder, and pervasive developmental disorder 
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not otherwise specified‖ (APA website, 2011). There will be a single label of ASD with one 
set of diagnostic criteria. In addition, the ‗triad of impairments‘ will be amended to two 
domains: 1) social/communication deficits and 2) fixated interests and repetitive behaviours. 
It appears that levels of ASD severity will be introduced based on the level of support 
required by an individual (APA website, 2011). It is thought that ICD-11 will also replace the 
label PDD with ASD; less is known about changes to the actual diagnostic criteria. 
 
Assessment tools for ASD 
A large number of ASD screening tools have been developed. These include the Autism 
Behavior Checklist (Krug et al., 1980), Autism Spectrum Screening Questionnaire (Posserud 
et al., 2008), CHecklist for Autism in Toddlers (Dumont-Mathieu & Fein, 2005), Child 
Autism Rating Scale (Schopler et al., 1980), Gilliam Autism Rating Scale (Gilliam, 1995) and 
Social Communication Questionnaire (SCQ; Berument et al., 1999). 
 
A smaller number of tools have been developed for adults including the ASD in Adults 
Screening Questionnaire (ASDASQ; Nylander & Gillberg, 2001) and Autism Spectrum 
Quotient (AQ; Baron-Cohen et al., 2001). The Pervasive Developmental Disorder in Mental 
Retardation Scale (PDD-MRS; Kraijer & Bildt, 2005) and ASD Diagnosis for Adults 
Assessment (ASD-DA; Matson et al., 2007a; 2008b) were designed specifically for adults 
with intellectual disability. 
 
The AQ was designed to screen for high-functioning ASD and Asperger syndrome in adults 
(Baron-Cohen et al., 2006) A shortened version – the AQ20 was recently used in a study on 
the prevalence of ASD in the UK (Brugha et al., 2009b). The authors of this study considered 
the AQ to be the most reliable and valid self-report tool available (Brugha et al., 2009a). The 
AQ and AQ20 are self-rated and as such are only suitable for adults with high-functioning 
ASD. 
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Table 2.1 describes selected assessment tools that may be suitable for adults with intellectual 
disability. 
 
Table 2.1: Characteristics of selected ASD assessment tools 
 Type of tool Outcome Diagnostic criteria Population 
ASDASQ Screening questionnaire (clinician 
completed, 10 items rated 0 or 1) 
Total score (0-9) ≥5 
indicates probable  ASD 
Unclear Adults 
ASD-DA Diagnostic scale (informant 
interview, 31 items  rated 0 or  1) 









Screening questionnaire of current 
behaviour (clinician completed,  12 
items) 
Total score (0-19)≥10 
indicates ASD 
DSM-III-R Adults & 
children 
with ID 
SCQ Screening questionnaire  of current  
& lifetime behaviour (informant 
completed, 40 items rated 0 or 1) 
Total score (0-39) ≥15 
indicates ASD, ≥22 
indicates autism 




ADI-R Diagnostic interview with 
informant (93 items , 1.5-2.5 
hours) 
Diagnostic algorithm: 
autism. Current Behavior 
Algorithm 
DSM-IV & ICD-10 Children & 
adults 
ADOS Diagnostic observation assessment 
(28-31 items, 45 minutes) 
ADOS diagnostic 
classification: autism,  ASD 
or no ASD  
DSM-IV & ICD-10 Children & 
adults 
DISCO Diagnostic interview with 
informant 
Specific ASD diagnoses 
according to diagnostic 
criteria 
DSM-IV & ICD-





3Di Computerised diagnostic interview 
with informant (90 minutes) 
ICD-10 criteria for  autism, 





The ASDASQ was designed for use among adult psychiatric outpatients (Nylander & 
Gillberg, 2001). In was a study on the prevalence of ASD in Taiwan, it was found to have 
good validity and test-retest reliability but only fair inter-rater reliability (Chang et al., 2003). 
An older version (the Nylander questionnaire) was found to have good inter-rater reliability, 
no false negatives but a high number of false positives, however the sample size of this study 
was small (Ferriter et al., 2001). The ASDASQ is completed by a clinician, based on their 
observations of an individual‘s behaviour. 
 
The PDD-MRS was developed to cover the full range of ASD, intellectual disability severity 
and ages (Kraijer & Bildt, 2005). It was first tested in a population screening study of Dutch 
children (de Bildt et al., 2003) and compared with the Autism Behavior Checklist (ABC; 
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Krug et al., 1980), Autism Diagnostic Interview (ADI-R; Lord et al., 1994) and Autism 
Diagnostic Observation Schedule (ADOS; Lord et al., 2000). The PDD-MRS had high 
sensitivity but low specificity and only moderate agreement with the ABC (de Bildt et al., 
2003). The PDD-MRS has been used to explore the prevalence of ASD and other psychiatric 
disorders among adults with intellectual disability in Italy (La Malfa et al., 2004; 2007) and 
England (Morgan et al., 2002; 2003). The PDD-MRS is designed to be completed by a 
clinician based on their observation of an individual‘s current behaviour. 
 
The ASD-DA was designed for and tested on adults with severe and profound intellectual 
disability in residential settings. Several studies were published on its development, 
psychometric properties and the relationships between ASD symptoms, IQ and challenging 
behaviours (Matson et al., 2007a; 2007c; 2008a; 2008b; 2008c; Matson & Rivet, 2007; 
Rojahn et al., 2010; Wilkins & Matson, 2008). However it goes not appear to have been used 
outside of this research group. 
 
There are four diagnostic assessments tools for ASD: the ADOS, the ADI-R, the Diagnostic 
Interview for Social and Communication Disorders (DISCO; Billstedt et al., 2007) and the 
Developmental, Dimensional and Diagnostic Interview (3Di; Skuse et al., 2004). All were 
originally designed for diagnosing ASD in children although they have been adapted for use 
with adults and those with intellectual disability (Nebelschwalm & Matson, 2008).  
 
All of these tools were developed to provide item scores that feed into algorithms with cut-off 
scores for a diagnosis of ASD and/or autism based on DSM-IV or ICD-10 criteria (see Table 
2.1). In addition, the DISCO has algorithms that directly relate to Early Infantile Autism 
(Kanner & Eisenberg, 1956), Asperger syndrome according to Gillberg et al. (2001) and 
ASD/social impairment according to Wing & Gould (1979). The 3Di includes algorithms for 
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a number of other ICD-10 psychiatric diagnoses. In addition to these measures, Gillberg et al 
(2001) developed the Asperger Syndrome (and high-functioning autism) Diagnostic Interview 
(ASDI). However, this does not relate to DSM or ICD-10 criteria for Asperger syndrome. 
 
The ADI-R, 3Di and DISCO are structured interviews with an informant whereas an ADOS 
assessment involves observation of and interaction with the person being assessed. The 
ADOS includes a module designed specifically for adults although it requires them to be 
verbally fluent. The modules for those with phrase or no speech were developed for children 
rather than non-verbal adults (Berument et al., 2005). 
 
The ADI-R and 3Di rely on an informant who can provide information on a person‘s 
developmental history to determine whether the behaviours described started before they were 
three years of age as required by diagnostic criteria. This can be difficult to establish when 
assessing adults. Criteria designed specifically for adults with intellectual disability remove 
this requirement (DC-LD; Royal College of Psychiatrists, 2001a & DMID; Fletcher et al., 
2007). However, the diagnostic algorithm for the ADI-R and 3Di are all based on early 
developmental history and it is not clear whether they can be adapted to accurately diagnose 
ASD when there is little or none of this information available. All of these diagnostic 
measures require considerable resources in terms of training, equipment and the time they 
take to administer (de Bildt et al., 2004; Murphy et al., 2011). 
 
Evidence on the best ways to assess adults with intellectual disability for ASD is weak; 
largely because studies tend to focus on autism in children rather than the full range of ASD 
across the lifespan (Stoesz et al., 2011). Many tools were developed for and tested on groups 
that included people with intellectual disability but there are often no specific norms for them 
(Kraijer & Bildt, 2005). 
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The effect of ASD screening tools on treatment and outcome was reviewed recently (Livanis 
& Mouzakitis, 2010). Three instruments were reviewed but no evidence on their treatment 
validity was found. Norris and Lecavalier (2010) reviewed five carer-completed screening 
scales. They identified 20 studies on these tools; most were on the SCQ which the authors 
described as performing well. There was limited research on other measures and little 
evidence on their validity for those with low-functioning ASD. The SCQ appears to be the 
ASD screening tool that has been most tested including studies across a range of ages and 
intellectual functioning (NICE, 2011). 
 
Newer technologies may be able to play a role in the process of diagnosing ASD. These 
include neuro-imaging and genetic testing (Ecker et al., 2010). Research on these techniques 
is at a very early stage and more studies are needed before their effectiveness can be 
confirmed (NICE, 2011; NICE, 2012). 
 
The forthcoming NICE guideline for ASD in adults systematically evaluated screening tools. 
The ABC and SCQ were the only tools appropriate for use across the full range of intellectual 
functioning that met the inclusion criteria (NICE, 2012). The PDD-MRS was also included as 
a tool for use with adults who have intellectual disability but the review recognised that data 
on its accuracy was limited and that it is a clinician-rated rather than carer-rated instrument. 
 
A study comparing the ADI-R, ADOS and DSM-IV criteria found a fair level of agreement 
between the ADI-R and ADOS (de Bildt et al., 2004). This may indicate that a combination of 
these assessments is more effective than the use of either in isolation (de Bildt et al., 2004). It 
not clear whether the ADI-R or ADOS can be used to assess individuals with profound 
intellectual disability (Kraijer & Bildt, 2005). 
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The ADOS is the only standardised diagnostic assessment that requires direct contact and 
observation of the individual being assessed for ASD. Most assessment tools used for adults 
with intellectual disability and ASD (including all the identified screening tools) rely on 
informant-derived data. It is also the only measure able to indicate presence or absence of 
ASD without the need for any information on a person‘s developmental history. Given this it 
would appear to be the most suitable diagnostic assessment for use with adults who have 
intellectual disability. 
 
The NICE Guidelines for ASD in adults were unable to draw any conclusions on the best 
methods of screening for ASD. However, for a standardised diagnostic assessment of ASD in 
adults with intellectual disability, the ADOS was recommended (NICE, 2012). 
 
Conclusion on the recognition and assessment of ASD 
There is great concern about the under recognition of ASD and evidence that increasing 
identification would lead to improved outcomes and lower costs to the economy (National 
Audit Office, 2009a). Although there are a great number of assessment tools available, the 
evidence for their effectiveness is weak. 
 
It is becoming less acceptable for studies on people with ASD to rely on clinical diagnoses 
without confirmation using standardised tools. This is in part because there is a lack of 
qualified experts who are capable of carrying out diagnostic assessment. The ADOS and ADI-
R are considered the ‗gold standard‘ diagnostic methods for both research and clinical 
practice (Berument et al., 1999; Bradley & Bolton, 2006; La Malfa et al., 2007; Medical 
Research Council, 2001; Marriage et al., 2009; Murphy et al., 2011). However, to date few 
studies have used the ADOS and ADI-R for adults (Brugha et al., 2009a; Ecker et al., 2010). 
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Recognition and assessment of mental health problems in adults with intellectual 
disability and ASD 
 
There is evidence that the prevalence and presentation of mental health problems in adults 
with intellectual disability and/or ASD is atypical compared with the general population 
(Einfeld & Aman, 1995; Hutton et al., 2008). This is thought to be due to complex 
relationships between a number of biological, psychological and social factors (Cooper & 
Simpson, 2006; Ghaziuddin, 2005; La Malfa et al., 2007). However, little is known about the 
aetiology and prognosis of mental health problems in these groups (Ruedrich, 2010). As such 
carrying out an assessment and making a valid and reliable diagnosis are considerable 
challenges (Kannabiran & McCarthy, 2009; Reiss et al., 1982). Nonetheless there have been 
significant advances in the classification and recognition of comorbid psychiatric disorders 
and multiple diagnoses are becoming more common (Gillberg, 2011; Rush, 2004). 
 
As neurodevelopmental conditions with implications for functioning and adaptive skills, there 
are a number of characteristics common among people with intellectual disability and those 
with ASD that support the hypothesis that either group is at an increased risk of developing 
mental health problems (see Text box 2.1).  
 
Text box 2.1: Bio-psycho-social-environmental risk factors for mental health problems that are 
common among individuals with intellectual disability and/or ASD 
 Abnormal brain physiology and neurobiology 
 Lower self-esteem, bullying and stigma 
 Lack of protective factors – employment/occupation, social support 
 Living in a restrictive environment 
 Lack of control and independence 
 Less well developed coping skills 
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These include overlaps and similarities in symptoms between disorders (Helverschou et al., 
2011). In addition there are a lack of: a consensus on what constitutes a mental health 
problem for these groups; standardised assessment and diagnostic tools; and specialists with 
expertise in assessing and diagnosing mental health problems (Einfeld & Aman, 1995; 
Mohiuddin et al., 2011; Sturmey, 1999). 
 
Diagnosing mental health problems is hardest when an individual is unable to communicate. 
However even seemingly high functioning adults with intellectual disability and/or ASD may 
not be able to understand and express their emotions. These people can find it difficult to 
interpret and answer questions about their mental health (Leyfer et al., 2006; Kannabiran & 
McCarthy, 2009; Macneil et al., 2009). 
 
Mental health problems in people with intellectual disability 
In the past it was thought that people with intellectual disability did not suffer from mental 
health problems (Harris, 2006). If individuals displayed behavioural symptoms of psychiatric 
disorder it was assumed that these were features of intellectual disability itself (Einfeld & 
Aman, 1995; O‘Brien, 2003). It has now been shown that people with intellectual disability 
can experience a range of mental health problems many of which are treatable (Raghaven, 
2007). In fact, many mental health problems are more prevalent among those with intellectual 
disability than they are in the general population (Cooper et al., 2007; Deb et al., 2001b; 
WHO, 1992). 
 
Experts describe a pathoplastic effect of intellectual disability on the symptoms of mental 
health problems (Cooper & Simpson, 2006; WHO, 1996). As severity of intellectual disability 
increases this effect becomes greater resulting in a more atypical presentation and making it 
harder to make an accurate assessment/diagnosis (Einfeld & Aman, 1995). Examples of 
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pathoplasticity and characteristics of intellectual disability that complicate the diagnostic 
process are shown in Text box 2.2 (see Cooper & Simpson, 2006; Einfeld & Aman, 1995; 
Sturmey, 1999). 
 
Text box 2.2: Proposed effects of developmental level on mental health problems 
 Ability to experience and understand complex and abstract concepts (e.g. guilt) 
 Lower ‗baseline‘ skills and functioning making it difficult to identify and quantify whether 
there has been a loss or decrease 
 Different sleeping and eating patterns compared with adults in the general population 
 Increased likelihood of presenting with symptoms less often seen in the general population 
(e.g. irritability or loss of communication skills) 
 Different forms of symptoms (e.g. unusual delusions compared with those usually found in 
the general population) 
 
 
There remains debate about what constitutes psychopathology in people with intellectual 
disability. Einfeld & Aman (1995) categorised the most prominent approaches as follows: 
 
Educational Challenging behaviours arise as a reaction to environmental stressors. 
As such changing a person‘s environment or helping them to adapt 
should reduce their problem behaviour. 
Behavioural Focuses on learnt maladaptive behaviours with identifiable antecedents 
and consequences. 
Psychiatric Behaviours indicate the presence of a treatable mental disorder. 
 
Three arguments within the psychiatric model are proposed (Einfeld & Aman, 1995): 
 
1) People with intellectual disability experience the same range of psychiatric 
 disorders in the same way as the general population. 
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2) As above but a distinction is made between psychiatric disorder and  behavioural 
problems that are ‗non-psychiatric‘. 
3) Some psychiatric disorders are the same as in the general population but  certain 
behaviours and problems are more common in people with intellectual disability and need 
new ways of categorisation and labelling. 
 
The nature of the relationship between problem behaviours and psychiatric disorder are still 
disputed but there is evidence to support the theory that they are linked (Dudley et al., 1999). 
It has long been known that challenging behaviour is common among people with intellectual 
disability (Holden & Gitlesen, 2003). One view is that challenging behaviour is a behavioural 
equivalent of psychiatric symptoms in people with intellectual disability; therefore 
challenging behaviour may be an important indicator of the presence of psychiatric disorder 
(Beasley, 2000). There is some evidence to support this but studies have varied widely in 
approach, size and validity (Hemmings et al., 2006; Holden & Gitlesen, 2003; Jenkins et al., 
1998; Kishore et al., 2005; Moss et al., 2000; Rojahn et al., 2004). It has been found that 
treating previously undiagnosed psychiatric disorders can lead to a reduction in the severity 
challenging behaviour (Tsiouris et al., 2003a).  
 
Other studies have found mixed results depending on specific diagnoses and behaviours 
(Hemmings et al., 2008a) while others have found no association between psychiatric disorder 
and challenging behaviour (Tsiouris et al., 2003b). One study concluded that although mental 
health problems and challenging behaviour co-exist this does not mean they are related, 
causally or otherwise (Jenkins et al., 1998). Nonetheless, the presence of challenging 
behaviour in adults with intellectual disability increases the difficulty of accurately assessing 
their mental health. 
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Mental health problems in people with ASD 
Research on the co-occurrence of mental health problems and ASD is at a very early stage 
(Kim et al., 2000; Medical Research Council, 2001). As with intellectual disability, it was 
previously thought that people with ASD did not suffer from additional mental health 
problems (Ghaziuddin, 2005). There was an initial reluctance to give individuals multiple 
diagnoses (particularly if they also had intellectual disability) and unease about applying 
notions of psychiatric disorder as described in the general population to those with ASD 
(Gadow et al., 2008).  
 
Many of the issues described above also apply to people with ASD including diagnostic 
overshadowing and pathoplasticity (Helverschou et al., 2011; Barneveld et al., 2011). The 
Medical Research Council (2001) identified additional difficulties when assessing individuals 
with ASD: literal interpretation of questions, concrete thinking, and intense and unusual 
interests/preoccupations that can be confused with obsessions, compulsions and delusions. 
 
Common features of ASD that overlap with indicators of mental health problems include self-
injurious behaviour, aggression, unusual sensory responses, food fads, phobias, laughing or 
crying for no apparent reason and talking to oneself (Sverd, 2003). Identifying the onset and 
precise nature of these behaviours can help to identify whether they indicate the development 
of a mental health problem. This should be a key feature of any diagnostic assessment. 
 
Little is known about the impact on mental health assessment when intellectual disability and 
ASD co-occur as there has been a lack of research on this specific topic (Bradley & Bolton, 
2006; Underwood et al., 2010). There is some evidence that the estimated prevalence of 
mental health problems among adults with intellectual disability and ASD becomes lower 
when more stringent diagnostic criteria are applied compared with clinical assessment 
(Melville et al., 2008). 
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Diagnostic criteria for mental health problems 
Using standard ICD and DSM criteria for adults with intellectual disability or ASD can be 
challenging for the reasons described above (Hassiotis et al., 2009a). Aside from practical 
issues, there have long been concerns that these systems are not applicable to individuals with 
intellectual disability, particularly those with moderate and severe forms (Einfeld & Aman, 
1995; Perez-Achiaga et al., 2009; Rush, 2004).  
 
As a result of this, two sets of criteria specifically for individuals with intellectual disability 
were developed: the Diagnostic Criteria for adults with Learning Disability and Diagnostic 
Manual for Intellectual Disability; based on ICD-10 and DSM-IV respectively (DC-LD; 
Royal College of Psychiatrists, 2001a & DMID; Fletcher et al., 2007). Individuals with low-
functioning ASD are covered by the criteria in DC-LD and DMID but there is no evidence on 
their utility for this group. There are currently no specific diagnostic criteria or guidelines for 
assessing mental health problems in adults with ASD.  
 
Despite the development of specific manuals for intellectual disability, most research and 
clinical practice on the mental health of adults with intellectual disability or ASD relies on the 
original DSM and ICD criteria (Ruedrich, 2010). This allows for standardised classification 
across different types of services and between different disciplines. Using generic criteria 
means that clinicians may be able to more easily assess eligibility for services, implement 
appropriate intervention, adhere to statutory guidelines and justify decisions on an 
individual‘s care. 
 
Mental health assessment tools for people with intellectual disability 
Structured and semi-structured interview tools developed to aid the diagnosis of mental health 
problems in adults with intellectual disability include the Diagnostic Assessment for the 
Chapter 2: Recognition & assessment 
38 
Severely Handicapped-II  (DASH-II; Matson, 1995); Present Psychiatric State for Adults with 
Learning Disability (PPS-LD; Cooper, 1997); Psychiatric Assessment Schedule for Adults 
with Developmental Disorders (PAS-ADD; Prosser et al., 1998); Psychopathology Instrument 
for Mental Retarded Adults (PIMRA; Matson et al., 1984) and Reiss Screen (Reiss, 1988). 
 
There are also scales that assess mental health using a checklist of symptoms. Some provide a 
total score and subscales for specific diagnoses such as the PAS-ADD checklist (Moss et al., 
1998) and Developmental Behaviour Checklist (Mohr et al., 2005). Others are condition 
specific; such as the Glasgow Depression Scale for people with intellectual disability (Cuthill 
et al., 2003). 
 
Mohr & Costello (2007) carried out an updated review of tools that were reported to have 
potential for assessing the mental health of adults with intellectual disability (Aman, 1991). 
Comparison between the measures was limited due to the wide range of methods employed 
by studies and in their sample sizes. There was evidence on criterion and/or concurrent 
validity for the DASH, DBC, PAS-ADD, PIMRA and Reiss Screen. The authors considered 
that the internal consistency of these tools was adequate but found large variations in reports 
of test re-test and inter-rater reliability between different studies on the same instruments 
(Mohr & Costello, 2007). 
 
Unwin & Deb (2008) reviewed the evidence on mental health and behavioural assessment 
scales. Only one purely psychiatric scale was identified (the PAS-ADD) described as a 
diagnostic or screening tool. Other scales – the DASH, Reiss Screen and PIMRA – were 
classified as “Combined behaviour and psychiatric illness scales”. The review stressed the 
difficulties in interpreting the results when using these scales since they include both 
behavioural and mental health symptoms without distinguishing between them. 
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Mental health assessment tools for people with ASD 
A review of psychopathology assessment tools identified six instruments developed 
specifically for people with ASD (Underwood et al., 2011). There was limited evidence on 
the effectiveness of these tools and none were widely used in research or clinical practice. 
Two measures that were designed for adults had only been tested on those with severe and 
profound intellectual disability. The authors concluded that: 
 
“People with ASD do not form a homogenous group for whom one tool will be applicable. 
Instruments need to take into account critical variables such as age, developmental level, 
communication skills and intellectual functioning. The standardized assessment of 
psychopathology in adults and children with ASD is a work in progress as tools need to be 
further developed and tested. There appears to be a particular lack of tools developed 
specifically for adults with higher functioning ASD. Existing and future tools must be 
developed to standards such as those set out by the American Psychiatric Association (1999). 
It is important that the psychometric properties and results of tests carried out on these 
instruments are comprehensively reported.” (pp. 292) 
 
The review recommended the use of tools developed for people with intellectual disability 
although it was acknowledged that there was also a lack of evidence on their effectiveness for 
people with ASD (Underwood et al., 2011; see Appendix I for the full text of this review on 
the assessment of psychopathology in ASD). 
 
The standardised assessment and monitoring of individuals‘ mental health and behaviour is 
strongly recommended by guidelines on intervention and service provision for people with 
intellectual disability (Deb & Unwin, 2006). A range of tools have been developed to help 
services monitor the outcomes of people receiving mental health care. These include the 
HoNOS-LD (Roy et al., 2002), the Clinical Outcomes in Routine Evaluation Outcome 
Measure (CORE-OM; Evans et al., 2000) and a number of quality of life instruments 
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(Townsend-White et al., 2011). Measures used in studies on outcome for adults with 
intellectual disability also include Global Assessment of Functioning (GAF; APA, 1987) and 
Threshold Assessment Grid (TAG; Slade et al., 2000) (Hall et al., 2006). 
 
However, none of these instruments focus on mental health symptoms or measure overall 
levels of psychopathology. A lack of well-evaluated measures is a widely recognised problem 
for clinicians and researchers (Kellett et al., 2004; Underwood et al., 2011). Just five tools 
were identified in a review of the literature on mental health scales for adults with intellectual 
disability.  
 
Two measures have been developed by Matson et al.: the Assessment of Dual Diagnosis for 
those with mild/moderate intellectual disability (Matson & Bamburg, 1998) and the 
Diagnostic Assessment for the Severely Handicapped-II (DASH-II) for those with severe 
intellectual disability (Matson, 1995). Although the DASH-II has been used in several studies 
of those with and without ASD (see Table 4.1) there is no evidence for its use with adults who 
have mild/moderate intellectual disability. 
 
It has been suggested that the Brief Symptom Inventory (BSI) and Symptom Checklist 90-
Revised (SCL-90-R) can be used with individuals with mild intellectual disability (Kellett et 
al., 2004). However, both rely on self-reported symptoms and are therefore not suitable for 
those with moderate or severe intellectual disability. Nor were they specifically designed to 
pick up behaviours and symptoms that may be more common among people with intellectual 
disability than the general population. 
 
The Developmental Behaviour Checklist for Adults (DBC-A) was designed to assess 
behavioural and emotional disturbance among people with intellectual disability (Mohr et al., 
2004). An informant rates 109 items according to whether specific behaviours occurred: 
never, sometimes or often over the last six months. A total score and six subscale scores can 
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be calculated. The scale has validated cut-off points for ‗psychiatric caseness‘ with varying 
degrees of specificity and sensitivity when compared with clinical psychiatric diagnosis. 
Among the tools reviewed by Mohr & Costello (2007) the DBC-A had the highest internal 
consistency, specificity and sensitivity. Many tools such as the PAS-ADD checklist and 
DASH-II were designed to be diagnostic assessments and the use of their total scores is not 
appropriate. 
 
Assessment of problem behaviour 
A review of behavioural assessment scales identified just three tools that had sufficient 
evidence on their development or psychometric properties (Unwin & Deb, 2008). These were 
Aberrant Behaviour Checklist (ABC), AAMR Adaptive Behaviour Scale and Behaviour 
Problems Inventory (BPI). 
 
The ABC is a well-known tool designed especially for people with intellectual disability 
(Aman et al., 1985). The 58 items are scored from zero (no problem) to three (severe 
problem) by an informant on the basis of the person‘s behaviour over the previous four 
weeks. The scale is widely used and has good reported psychometric properties (Rojahn et al., 
2011; Unwin & Deb, 2008). 
 
The AAMR‘s Adaptive Behaviour Scale (1992) features a section on ‗social maladaptation‘ 
that has been found to have limited reliability (Unwin & Deb, 2008). The 52-item BPI-01 
measures the frequency and severity of self-injurious, stereotyped and aggressive/destructive 
behaviours (Rojahn et al., 2001). It has been found to have good internal consistency, 
reliability and clinical criterion validity (Rojahn et al., 2010; Unwin & Deb, 2008). 
 
Studies comparing adults who have intellectual disability with and without ASD have used 
the ABC, BPI-01 and the Disability Assessment Schedule (Rojahn et al., 2010; Totsika et al., 
2010; Tsakanikos et al., 2011). 
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Conclusion on the recognition and assessment of intellectual disability, ASD and 
comorbid mental health problems 
There is good evidence that the challenges of making a diagnosis result in the under 
recognition of intellectual disability, ASD and comorbid mental health problems in adults. 
This can lead to the under treatment of mental health problems in adults with intellectual 
disability and ASD (Xenitidis et al., 2007). Defining and recognising the characteristics of 
groups within intellectual disability/ASD populations is of great importance (Schroeder & 
Reese, 2007). However, it cannot be done with sufficient reliability and validity without 
effective assessment tools. 
 
The assessment of mental health problems in adults with intellectual disability and/or ASD is 
less straightforward than for the rest of the population. Some tools used in the general 
populations are clearly not suitable for adults with intellectual disability or ASD because they 
are unable to understand or answer the questions. Others assume a ‗normal pre-morbid‘ level 
of functioning (Royal College of Psychiatrists, 2009b). Given these difficulties few reviews or 
guidelines recommend any one particular instrument and the gold standard is cited as: 
―clinical diagnosis by a specialist, provided comprehensive assessments and measurements 
have been used‖ (Cooper et al., 2007, pp.32). 
 
Further research is needed to determine the accuracy of clinical diagnoses of ASD and 
comorbid mental health problems in adults with intellectual disability and what effect this 
may have on service provision and outcome (Underwood et al., 2012). Currently the best way 
to explore the mental health of adults with intellectual disability and ASD would appear to be 
using those tools available for screening and diagnosis in adults with intellectual disability.
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Chapter 3: Prevalence of intellectual disability, ASD and comorbid psychiatric disorder 
 
Epidemiological studies of mental health problems have been carried out since the 19
th
 
century (Prince et al., 2003). Research on the prevalence and patterns of disorders is used to 
explore the causes of mental health problems, identify risk factors, develop services and 
interventions, and predict outcome (Prince et al., 2003). A ‗gold standard‘ observational 
epidemiological study would be prospective, longitudinal and comparative (e.g. a cohort 
study). Although, prevalence studies are more likely to be cross-sectional (Ford, 2003). These 
types of study are lacking in the fields of intellectual disability and ASD research with very 
few that were truly designed to study the epidemiology of these conditions particularly with 
respect to comorbid mental health problems (Hove & Havik, 2010; Smiley, 2005; Sverd, 
2003). 
 
Estimated rates of a condition can differ greatly over time, between populations and between 
studies depending on a number of factors. As well as changes in the actual prevalence rate, 
these include the definition of the condition being studied, the methods used to sample the 
population and assess them, sample size, ease of recognition and the rate of identification in 
the general population.  
 
Prevalence of intellectual disability 
Intellectual disability is often described as the most common developmental disorder and 
causes a great deal of burden worldwide (WHO, 2001). Diagnostic criteria include the 
stipulation that individuals with intellectual disability have an IQ lower than 70 (APA, 1994; 
WHO, 1992). This is based on the principal that level of ‗intelligence‘ as measured by IQ is 
normally distributed among the population; with an average score of 100 and one standard 
deviation of 15 points. Given this it would be expected that around 2.5% of the population 
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have intellectual disability (i.e. an IQ lower than two standard deviations from the population 
mean of 100). However, this is an overestimate of prevalence since mortality rates are much 
higher among those with very low IQ (Bhate & Wilkinson, 2006; Emerson, 2009). 
 
Estimates of intellectual disability prevalence worldwide range from 1 to 3% (Harris, 2006). 
A recent meta-analysis of 52 population-based studies estimated a rate of 10.37 per 1000 
people (Maulik et al., 2011). The number of people with intellectual disability is increasing 
across the lifespan (Emerson & Hatton, 2008). As the general population ages, the number of 
adults and older adults with intellectual disability is increasing particularly among 40-59 year 
olds (Department of Health, 2001b). 
 
Characteristics of individuals with intellectual disability 
The proportion of individuals with each severity of intellectual disability is estimated to be 
85% mild, 10% moderate and 5% severe/profound (Bhate & Wilkinson, 2006). The rate of 
mild intellectual disability is said to be higher among males than females but this is not found 
consistently across studies (Harris, 2006; Maulik et al., 2011). There is evidence that rates of 
mild-moderate intellectual disability are higher in deprived and urban areas (Department of 
Health, 2001b; Emerson, 2010). Prevalence of intellectual disability in the UK appears to be 
higher among young people from South Asian communities (Department of Health, 2001b; 
Emerson & Hatton, 2005a). 
 
Prevalence of ASD 
The most commonly quoted prevalence rate of ASD among the general population is 1%. 
However, estimates actually range from between four and 157 cases per 10 000 (Baron-Cohen 
et al., 2009). The exact number of people with ASD in the UK is currently unknown 
(Department of Health, 2006; National Audit Office, 2009b). 
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There is great debate about whether we are experiencing an ‗autism epidemic‘ (Charman, 
2011). Although it does appear that rates of ASD are increasing over time (from 0.04% in 
1978) the reasons for this are complex and manifold (Baron-Cohen et al., 2009). Most older 
studies measured the prevalence of autism rather than the wider spectrum of disorders that are 
included in more recent estimates. In addition, regardless of whether or not the actual rate of 
ASD has increased the number of individuals identified and receiving a diagnosis has. This is 
largely because of improvements in awareness and recognition, greater provision of services 
and wider diagnostic criteria (Barbaresi et al., 2008; Medical Research Council, 2001). 
 
The majority of early studies focussed on children but there is increasing interest in measuring 
prevalence among adults not least to confirm or refute whether ASD is becoming more 
common. If theories of an increasing rate of ASD are correct there should be a negative 
relationship between prevalence of ASD and age with much lower rates among older adults 
(Brugha et al., 2011). However, the few studies that have been carried out on adults found 
similar rates to studies on children (Baron-Cohen et al., 2009; Brugha et al., 2009b; Brugha et 
al., 2011). 
 
There is evidence that measuring prevalence by identifying clinical or administrative cases 
leads to an underestimation of the number of people with ASD compared to  systematic 
screening (Barbaresi et al., 2008; Baron-Cohen et al., 2009; Emerson & Baines, 2010). In a 
review by Fombonne (2003) relationships between prevalence estimates and methodological 
variations were marked. There was a negative correlation between sample size and 
prevalence, and a positive correlation between year of publication and prevalence. Only two 
studies accounted for the reliability of the screening measure they used. 
 
Most prevalence studies use standardised ASD assessment measures. However, many 
(including population-based studies aiming to identify those without an existing diagnosis) 
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rely on reviews of case notes rather than direct assessment of participants. In children, this 
method appears to be associated with somewhat lower estimates of ASD prevalence (e.g. 
Barbaresi et al., 2008; Centers for Disease Control & Prevention, 2009). Limited data on 
whether rates of ASD are higher among adults with mental health problems are available from 
two studies. However, each had different results with one appearing to show an elevated rate 
(Nylander & Gillberg, 2001) but the other a lower rate (Chang et al., 2003). 
 
There is consistent evidence that ASD is more prevalent among males than females with the 
ratio varying between 2.5:1 and 4.5:1 (Barbaresi et al., 2008; Carter et al., 2007; Centers for 
Disease Control & Prevention, 2009). The evidence for differing rates according to ethnicity 
is somewhat mixed. Some studies have found higher rates among white individuals and an 
under representation of people from black and ethnic minorities within ASD samples (Centers 
for Disease Control & Prevention, 2009; Mandell et al., 2008). However, it is likely that 
selection or referral biases and under diagnosis partially account for these differences (Begeer 
et al., 2008). 
 
Adults with intellectual disability and ASD  
Intellectual disability and ASD are known to commonly occur together (Matson & 
Shoemaker, 2009).  As the diagnostic criteria for ASD has widened the proportion of people 
with high-functioning ASD has increased and current estimates of the prevalence of 
intellectual disability among those with ASD are much lower than they were in the past 
(Bhaumik et al., 2010). On the other hand, improvements in recognition and assessment have 
lead to an increase in the proportion of people with intellectual disability who have a 
diagnosis of ASD. 
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Most of the literature indicates that at least 50% of people with ASD have intellectual 
disability with some estimates reaching 70% (Baird et al., 2006; La Malfa et al., 2004; 
Matson & Shoemaker, 2009). However lower rates have been found and are more likely in 
studies that include people with high-functioning ASD. For example a large US study found a 
rate of 41% (Centers for Disease Control & Prevention, 2009). In the hospital statistics 
included in Emerson & Baines‘s (2010) review 32.6% of adults with ASD also had a 
diagnosis of intellectual disability. In the review of the literature on prevalence of intellectual 
disability among children with ASD the author‘s derived estimated rate was 40-67%. A recent 
meta-analysis of studies on children found a rate of 76% in autism and 65% in ASD (NICE, 
2011). The rate referred to most often is 55%; found by Baird et al (2006). 
 
Rates of ASD in people with intellectual disability 
As with studies on the prevalence of ASD in the general population there is great variation in 
the estimated rates of ASD among people with intellectual disability. As Table 3.1 shows the 
estimated prevalence of ASD among people with intellectual disability ranges from around 
8% up to 40%. The only comprehensive population-based screening study found surprising 
low rates of ASD, particularly when stringent DSM-IV criteria were applied (Cooper et al., 
2007). It is not clear why this might be, however the study used a broad-based measure of 
physical and mental health rather than a specific ASD assessment to screen for potential 
cases. This may have resulted in the under-identification of individuals with ASD. 
 
Other studies tended to find rates of 20 to 40% and there was evidence that there was a high 
level of undiagnosed or unconfirmed ASD among adults with intellectual disability (Hare et 
al., 2003; La Malfa et al., 2004; Saemundsen et al., 2010). 
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Table 3.1: Recent studies reporting rates of co-occurring intellectual disability and ASD 
 Method Population Diagnostic assessment Prevalence estimate Additional notes 
de Bildt et al., 
2005 
Assessment of all children with 
ID in a geographical area. 
825 children with ID in 
the Netherlands (aged 4-
18) 
Phase 1: PDD-MRS & ABC 





Rates were higher among those with 
moderate to severe ID compared with mild 
ID 
Bryson et al., 
2008 
Further assessment of those 
identified by population-based 
study on prevalence of ID 
171 adolescents with IQ≤ 
75 in Canada (aged 14-20) 
ADI-R 28.2% (95%CI: 21.2-
35.2%) 
No significant difference in rate of ASD 
between severe (32%) and mild ID (24%) 
Cooper et al., 
2007 
Population-based screen of a 
geographical area 
1023 adults with ID in the 
UK 
Phase 1: C21st Health 
Check. Phase 2: clinical 
diagnosis by ID psychiatrist 
7.5% (clinical 
diagnosis) 
Rate fell to 2% when DSM-IV-TR 
diagnostic criteria were applied. 
La Malfa et al., 
2004 
Assessment of residents in two 
institutions for people with ID 
166 adults with ID in Italy. Phase 1: PDD-MRS. Phase 
2: clinical review using 
DSM-IV & ICD-10 criteria 
39.2% Prevalence of existing ASD diagnoses was 
7.8%. 
Morgan et al., 
2002 
Assessment of those in contact 
with ID services 
571 adults with ID in the 
UK 
Phase 1: PDD-MRS. Phase 
2: clinical diagnosis by ID 
psychiatrist using ICD-10 
30% Severe ID prevalence = 57%, 
moderate=31%, mild=12%. Prevalence of 
ASD decreased with age. 
Saemundsen et 
al., 2010 
Assessment of adults with 
severe ID in one city 
119 adults with severe ID 
in Iceland 
Phase 1: The Bryson scale. 
Phase 2: CARS. Phase 3: 
ADI-R 
21% (95% CI 
14.7–29.2) 
Prevalence of existing ASD diagnoses was 
9% 
Totsika et al., 
2010 
Assessment of participants in 
five studies on staffed group 
homes & a primary care service 
819 adults with ID in the 
UK 
Assessed as having the triad 
of impairments 
characteristic 
of ASD using the DAS-B 
34.3% Assessments were based on case note 
reviews 
Hare et al., 2003 Identification of those with 
confirmed or suspected ASD 
Estimated 1723 adult 
service users with ID in 
the UK 
Clinical diagnosis reported 
by service providers 
10.1% Only 33% of identified cases had a 
confirmed diagnosis of ASD.  
Bhaumik et al., 
2010 
Identification of individuals 
with an existing ASD diagnosis 
from a specialist psychiatric 
service for adults with ID 
1145 adults with ID in the 
UK 
Clinical diagnosis according 
to ICD-10 criteria 
19% No evidence that some clinicians diagnosed 
ASD more than others 
Bouras et al., 
2003 
Assessment of referrals to a 
mental health service for adults 
with ID 
752 adult mental health 
service users with ID 
Clinical diagnosis by ID 
psychiatrists using ICD-10 
19.5% No significant change in proportion of 
service users with ASD over time (1983 to 
2001) 
ABC=Autism Behavior Checklist, CARS=Childhood Autism Rating Scale, DAS-B=Disability Assessment Schedule-Behaviour checklist, PDD-MRS=Pervasive Developmental Disorder in Mental Retardation Scale
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Estimates of ASD among adults with intellectual disability using psychiatric or mental health 
services tended to fall at the lower end of the range, however both studies reporting this relied 
on routine clinical diagnoses (Bhaumik et al., 2010; Bouras et al., 2003). 
 
Emerson & Baines (2010) carried out a systematic review of prevalence studies published 
since 2000. The five studies that met their inclusion criteria reported a wide range of results, 
the authors of the review estimated that the prevalence rate of ASD among adults with 
intellectual disability lies between 20 and 33%. 
 
The accuracy of prevalence rates of ASD in people with intellectual disability are confounded 
by the level of cross-over between the two conditions and difficulties in assessment (Bhaumik 
et al., 1997). A recent study found that of 925 participants with intellectual disability and no 
clinical diagnosis of ASD, 20% were reported to have two or more ASD traits. They were 
more likely to be aged over 50 and have other mental health problems but less likely to have 
mild intellectual disability or behaviour problems (Bhaumik et al., 2010). Unfortunately these 
individuals were not further assessed to determine whether they had undiagnosed ASD. 
 
Patterns of prevalence of co-occurring intellectual disability and ASD 
There is a direct relationship between severity of intellectual disability and ASD; prevalence 
of ASD increases at each level of severity (Matson & Shoemaker, 2009). A number of studies 
have compared the characteristics of adults who have intellectual disability with and without 
ASD. This research has found that adults with intellectual disability and ASD tend to be 
younger, male and have more severe intellectual disability than those with intellectual 
disability alone (Lunsky et al., 2009; Melville et al., 2008; Morgan et al., 2003; Tsakanikos et 
al., 2006). There is evidence that the ratio of males to females with ASD is more even among 
individuals with intellectual disability and becomes more so as severity of intellectual 
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disability increases (Fombonne, 2003). Research has also found differences between 
individuals who have intellectual disability with and without ASD on social skills, language 
ability, adaptive behaviour (Wilkins & Matson, 2008). 
 
Psychiatric disorder among adults with intellectual disability and ASD 
As with research on the prevalence of intellectual disability and/or ASD, the methods used by 
studies on the prevalence of mental health problems in these groups vary a great deal 
(Varghese & Banerjee, 2011). In addition to different ways of diagnosing intellectual 
disability/ASD, there are many variations in the definition and assessment of mental health 
problems. Some studies focus on presence/absence of psychiatric disorder in general where as 
others focus on specific diagnoses such as psychotic disorder or depression. 
 
Rates of psychopathology in people with intellectual disability 
ICD-10 suggests that the prevalence of psychiatric disorder among people with intellectual 
disability is three to four times greater than in the general population (WHO, 1992). Estimated 
rates derived from research studies have ranged greatly from 10% up to 60%. A study by Deb 
et al (2001b) screened for psychiatric disorder among a randomly selected group of 101 adults 
with intellectual disability who lived in the community. The results were compared with 
estimates in the general population. The rates for any psychiatric disorder according to ICD-
10 criteria were similar (14.4% for those with mild and moderate intellectual disability versus 
16% for the general population). However, rates were significantly higher among those with 
mild/moderate intellectual disability for schizophrenia and phobia disorders. A larger study 
(N=1023) found similar results when using strictly applied ICD-10 criteria but a higher 
prevalence of 22.4% when relying on clinical diagnoses by intellectual disability 
psychiatrists. This rate increased to 40.9% when problem behaviours and ASD were included 
as types of psychopathology (Cooper et al., 2007).  
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In a Norwegian study of 593 adults with intellectual disability, 22% of participants had a 
history of psychiatric disorder (Hove & Havik, 2008). Applying the Psychopathology 
Checklists for Adults with Intellectual Disability, the study found that 35% met this measure‘s 
criteria for psychiatric disorder. A study that combined a register of adults with intellectual 
disability and one of people with mental health problems in Australia identified 4221 
individuals with a dual diagnosis (Morgan et al., 2008). This represented 1.7% of the total 
sample; 31.7% of those with intellectual disability had a psychiatric disorder. The prevalence 
of schizophrenia among those with intellectual disability was 3.6% (compared with around 
1% for the general population). 
 
A review of research on the mental health of people with intellectual disabilities found 85 
studies; those on prevalence were categorised into five types (Ruedrich, 2010). Rates of 
psychiatric disorder varied considerably from 10-37% (in population studies) and 15-35% (in 
institutional/community-based studies).  Among individuals referred for psychiatric 
evaluation, the prevalence of psychiatric disorder ranged from 53% up to 90%. Rates reported 
in reviews of specific diagnoses were ADHD: 14-60%; anxiety: 2.8-35%; mood disorders: 9-
20%; personality disorders: 1-22%; and psychotic disorder (1.3%-5.2%). The authors also 
found a number of studies that reviewed comorbidity in those with specific aetiology of 
intellectual disability. 
 
Pattern of diagnoses among people with intellectual disability & psychiatric disorder 
In a study of mental health services users with intellectual disability in Australia the most 
common psychiatric diagnosis was schizophrenia followed by mood disorders (including 
bipolar disorder), personality, anxiety and dementia (Pridding & Tomasoni, 2006). A very 
similar pattern was found in the UK where a third of those with a psychiatric disorder had 
schizophrenia (Bouras et al., 2003). In contrast, a study in the United States found that most 
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mental health service users with intellectual disability had diagnoses of affective disorders 
(Hackerman et al., 2006). Psychotic disorders accounted for only 15% of diagnoses. 
 
Rates of psychopathology in people with ASD 
The risk of additional psychopathology is thought to be higher among people with ASD than 
the general population (Kannabiran & McCarthy, 2009; Kring et al., 2008). This is perhaps to 
be expected since at least 50% of people with ASD also have intellectual disability which is a 
known risk factor for mental health problems. While higher rates of psychotic disorder are 
seen among people with intellectual disability, the disorders that appear to be more prevalent 
in people with ASD are depression/mood disorders and anxiety (Davis et al., 2008; 
Ghaziuddin et al., 2002; Macneil et al., 2009; Mazefsky et al., 2011; Munesue et al., 2008; 
Steensel et al., 2011). This could be due to the difficulties in diagnosing psychosis in people 
with ASD or the type of studies carried out, particularly as most are on children in whom 
psychotic disorders are rare (Bakken et al., 2007; Mattila et al., 2010). 
 
As always, estimated rates of psychiatric disorder among people with ASD vary according to 
study population and methods which can make estimating an overall level of prevalence very 
difficult (Kanne et al., 2009a; Macneil et al., 2009). Many early estimates were based on case 
studies and small sample sizes and there has been a lack of epidemiological studies in this 
area (Howlin, 2000; Lainhart & Folstein, 1994). Many studies do not include a comparison 
group making it difficult to ascertain how the rates found differ between those with and 
without ASD (White et al., 2009). The NICE guideline on ASD in children was only able to 
produce evidence statements on the prevalence of comorbid anxiety (27%), depression (9%) 
and OCD (8%) because there were no studies of sufficient quality on other psychiatric 
diagnoses (NICE, 2011). However, it is thought that people with ASD experience a range of 
other disorders (Sverd, 2003). 
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Table 3.2 shows the range of rates reported by studies reviewed for the thesis. Estimated 
prevalence in the general population is also shown as a comparison. Although there does 
appear to be an increase in prevalence of most disorders among those with intellectual 
disability and/or ASD, the estimates vary a great deal.  
 
Table 3.2: Variation in estimates of prevalence of mental health problems 









ID & ASD 
Any diagnosis 16%  10-59% 9-89% 5-53% 
Anxiety disorder 6.9% 2-41% 7-84%, 3-77% 
Bipolar disorder 1% 13% 9-39% 2-77% 
Depression 2.3% 10-15% 5- 50% 2- 64% 
OCD 1.1% 3-12% 1- 25% 0-13% 
Personality disorder 4.4% 8%   
Psychotic disorder 0.4% 1-18% 0-53%, 1-30% 
(Bakken et al., 2010; Bradley & Bolton, 2006; Ghaziuddin et al., 1998; Green et al., 2000; Gjevik et al., 2010; 
Helverschou & Martinsen, 2011; Hill & Furniss, 2006; Hofvander et al., 2009; Howlin, 2000; Hutton et al., 
2008; Lai et al., 2011; Leyfer et al., 2006; Mattila et al., 2010; Mazefsky et al., 2011; Mehtar & Mukaddes, 
2011; Padgett et al., 2010; Patel et al., 1993; Reid et al., 2011; Strydom et al., 2010; Tantam, 2000; Tsiouris et 
al., 2011; Totsika et al., 2010; Varghese & Banerjee, 2011) 
 
 
Most of the studies reviewed in Table 3.2 were on children. Recent research is providing an 
overall picture of psychopathology among adults with ASD. For example a study of 122 
adults with ASD in Sweden found that 53% had a mood disorder, 50% an anxiety disorder, 
24% had OCD and 12% a psychotic disorder (Hofvander et al., 2009). In a study that 
followed-up 135 children with ASD into adulthood, 16% developed new psychiatric disorders 
mainly anxiety and affective (Hutton et al., 2008). Padgett et al (2010) looked at non-affective 
psychosis in ASD and although the studies identified were too heterogeneous to meta-analyse 
the authors suggested that a rate of 7.8% was the most reliable. A recent review found that 
among adults with ASD, anxiety disorders were most common (5-35% for generalized 
anxiety, 10-64% for phobias and 1-37% for OCD), followed by affective disorders (0-50%) 
and schizophrenia (0-6%) (Skokauskas & Gallagher, 2010). It has been suggested that the 
                                               
1 Sourced from the Adult Psychiatric Morbidity in England survey 2007 (McManus et al., 2009) 
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prevalence of anxiety is lower among individuals with low-functioning ASD than it is among 
those without intellectual disability (Helverschou & Martinsen, 2011). There is some 
evidence that the risk of mental health problems (including ADHD, anxiety and depression) 
increases as the number of ASD traits an individual has increases (Lundström et al., 2011). 
 
Attention deficit hyperactivity disorder (ADHD) 
ASD is an exclusionary diagnosis for ADHD in ICD-10 and DSM-IV because people with 
ASD often exhibit symptoms of hyperactivity (Funabiki et al., 2011). However, in practice, it 
is generally recognised that ASD and ADHD co-occur (Bradley & Isaacs, 2006; Brereton et 
al., 2006; Department of Health, 2010b). A meta-analysis carried out for the NICE guideline 
on ASD in children estimated that 45% of those with ASD also have ADHD (NICE, 2011). 
 
Rates of psychopathology in adults with intellectual disability & ASD 
It appears that individuals with ASD are more likely to experience mental health problems 
than the general population but it is not clear whether this is associated with the fact that a 
significant proportion of people with ASD have intellectual disability. To date few studies 
have focused specifically on mental health problems in individuals with both intellectual 
disability and ASD (Bakken et al., 2010). 
 
Many studies on psychopathology in ASD focussed on high-functioning ASD and few 
differentiate between those with and without intellectual disability (Hill & Furniss, 2006). 
Many found that higher rates or symptoms of psychiatric disorder were associated with lower 
cognitive and functional impairment (Leyfer et al., 2006; Steensel et al., 2011). Others have 
found a relationship between high-functioning ASD and increased psychopathology (Mayes 
et al., 2011a; Vickerstaff et al., 2006). 
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Most of the early studies that compared those with intellectual disability and ASD to those 
with intellectual disability alone were on children and adolescents (Matson & Shoemaker, 
2009). Research appeared to show an increased risk among those with both conditions 
(Bradley et al., 2004; Bradley & Bolton, 2006; Brereton et al., 2006). Participants with ASD 
appeared to have particularly high rates of anxiety, depression and manic disorders compared 
to those without ASD. There have been few studies on the mental health of adults with 
intellectual disability and ASD (Underwood et al., 2010). Table 3.3 details studies that have 
measured the prevalence of psychiatric disorder among adults who have intellectual disability 
with and without ASD. 
 
In one of the first studies, Morgan et al. (2003) found that adults with intellectual disability 
and ASD had significantly increased lifetime prevalence of depression and bipolar disorder; 
but there was no difference in the rate of schizophrenia compared with those who had 
intellectual disability alone. Bakken et al. (2010) found higher rates of anxiety, depression and 
psychotic disorders in those with ASD compared to those without ASD. A study of 
psychiatric in- and out-patients in Canada found that most of those with intellectual disability 
and ASD had a psychiatric disorder but they were less likely to have a psychotic disorder than 
those without ASD or those with neither intellectual disability nor ASD (Lunsky et al., 2009).  
 
By contrast, a study in London found lower rates of psychiatric disorder in adults with ASD 
and intellectual disability attending a specialist mental health service than in those without 
ASD (Tsakanikos et al., 2006). A separate analysis of the data from this sample found that 
most of those with ASD did not have a psychiatric disorder although the rate of comorbidity 
appeared to be increasing over time (Tsakanikos et al., 2007).  
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Results for ASD + ID vs. ID 
Bakken et 
al., 2010 
Adults & adolescents. ASD assessed by 
clinical diagnosis using ICD-10 criteria 
62 132 PAC 
Any psychiatric disorder: 53% vs.17%, psychosis: 25% vs. 9%, depression: 
37% vs. 15%, anxiety: 34% vs. 9%, OCD: 13% vs. 3%, all p<0.05 
Melville et 
al., 2008 
Adults. Matched on gender, age, severity of 
ID. ASD identified using C21st Health Check 




LD, ICD-10 & 
DSM criteria) 
Mental ill-health excluding problem behaviours: 21% vs. 23%, including 
problem behaviours: 48% vs. 40%, both  p>0.05 
Morgan et 
al., 2003 
Adults. ASD identified using PDD-MRS and 





41% had a psychiatric disorder. Rates were higher for depression (20% vs. 3%) 




Adults (aged 50+). Subsample matched on 




Psychiatric caseness in unmatched sample: 32% vs.23%, p=0.09, psychiatric 
caseness in matched sample: 37%(N=65)  vs. 27% (N=65), p=0.11 
Lunsky et 
al., 2009 
Adult mental health patients. Matched on 
gender & inpatient/outpatient status. ASD 





Lower rate of psychosis:26% vs. 78%, p<.01). No significant difference on 
other disorders. Lower rate of psychosis compared with 23 mental health 
patients with no ASD or ID:83%,p<.01 
Tsakanikos 
et al., 2006. 
Adult mental health patients. ASD assessed by 





Any psychiatric disorder: 36% vs. 55%,p <.01. PD: 3% vs. 9%, p<.01. p>.05 
for anxiety: 4% vs. 8%, depression: 6% vs. 9% & psychosis: 16% vs. 19%. 
Charlot et 
al., 2008  
Adult inpatients with depression. Matched on 
age, gender & ID severity. ASD assessed by 
clinical diagnosis using DSM-IV-TR criteria 
13 40 MASS Prevalence of comorbid anxiety: 62% vs. 38%  
ASD-CA=ASD-Comorbidity for Adults scale, DASH-II=Diagnostic Assessment for the Severely Handicapped-II, MASS=Mood & Anxiety Semi-Structured Interview for Patients with ID,  PAS-ADD= Psychiatric 
Assessment Schedule for Adults with Developmental Disorders, PDD-MRS=Pervasive Developmental Disorder in Mental Retardation Scale, PIMRA= Psychopathology Instrument for Mental Retarded Adults, 
SAPPA= Schedule for the Assessment of Psychiatric Problems Associated with Autism (and Other Developmental Disorders)
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More recently, a population study in the UK found some differences in behavioural problems 
but not in psychiatric disorders between adults who had intellectual disability with and 
without ASD (Melville et al., 2008).  Totsika et al., (2010) explored the mental health of older 
adults with intellectual disability. No differences were found in the rates of psychiatric 
disorder, problem behaviours or quality of life between those with and without ASD. 
 
In the study by Morgan et al. (2008) of psychopathology in adults with intellectual disability, 
ASD was significantly more prevalent among those with a psychiatric disorder. A study of 
factors associated with mental health problems in adults with intellectual disability included a 
small number of people with ASD (N=25, 4.4% of the sample) (Hove & Havik, 2010). ASD 
was associated with higher levels of psychotic disorder, anxiety, OCD and problem 
behaviour. However, after controlling for factors included age, gender and presence of ASD, 
severity of intellectual disability was the only variable significantly associated with 
psychopathology. 
 
In summary, the results of these studies were extremely variable. There are two key issues to 
bear in mind when evaluating the evidence on whether there are differences in the prevalence 
of psychopathology between those who have intellectual disability with and without ASD: 
 
 The accuracy of participants‘ allocation to the ASD and no ASD groups 
 Whether the study carried out a comprehensive diagnostic assessment of psychiatric 
disorder or accepted that exceeding the threshold on a checklist or rating scale was 
sufficient for a participant to be given a diagnosis. 
 
Studies that do not carry out standardised ASD assessments may be less likely to find 
differences between those with and without a diagnosis since there could be many individuals 
with ASD among those in the ‗no ASD‘ group. This could be an issue for the Melville et al. 
Chapter 3: Prevalence & comorbidity 
58 
study (2008) in which, as discussed earlier, a particularly low rate of ASD was found (see 
Cooper et al., 2007). Conversely, using cut-off scores on an assessment tool as the sole 
determinant of whether a participant has a psychiatric disorder could lead to an 
overestimation of prevalence among those with ASD. Individuals with ASD are likely to 
present with a range of behaviours that will increase their score on a rating scale of 
psychopathology. In a clinical diagnostic assessment it would be possible to ascertain more 
accurately whether these symptoms are due to their ASD or an additional mental health 
problem (Bradley et al., In press). 
 
A further issue is the lack of studies on non-clinical populations among which there may be 
high levels of referral bias. As such, of the studies described in Table 3.3, only Morgan et al. 
(2003) can be said to be of a high enough standard to provide good quality evidence on 
differences in the prevalence of psychiatric disorder among adults who have intellectual 
disability with and without ASD. However, this study did not attempt to match those with and 
without ASD or take any other factors into account during the analysis of the data even 
though the authors acknowledged there was a high rate of severe intellectual disability among 
those with ASD. 
 
Patterns of prevalence and characteristics associated with psychiatric disorder in adults 
with intellectual disability & ASD 
There is a lack of consensus among studies on the prevalence of mental health problems in 
people with intellectual disability on whether there are differences according to age, gender, 
living situation or severity of intellectual disability (Driessen et al., 1997; Hove & Havik, 
2010). Furthermore, when differences have been found it is not clear whether these could be 
due to measurement or selection biases, particularly if the studies are based on clinic 
populations (Hove & Havik, 2010). 
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Many studies on the patterns mental health problems in ASD are on children and it is 
debateable whether differences found with respect to age, gender, ethnicity or IQ are likely to 
be sustained in to adult life. Research on gender differences is lacking due to the lower 
prevalence of ASD in females. Many studies include mainly or only male participants so 
much of the evidence available on the relationships between ASD and mental health problems 
may only really be relevant to high-functioning male children. 
 
There is some evidence for higher rates of psychiatric disorder among those with mild 
intellectual disability. For example Morgan et al. (2008) found that compared to those with 
intellectual disability alone, participants with additional mental health problems were more 
likely to have mild intellectual disability. Morgan et al. (2003) found that prevalence of 
psychiatric disorder in those with ASD was 65% among those with mild intellectual disability 
compared with 35% among those with moderate and 40% for severe intellectual disability. 
Studies have found a positive correlation between IQ and rates of disorder, particularly 
depression and anxiety (Mayes et al., 2011b). Others have found no such association 
(Munesue et al., 2008).  
 
Since the rate of ASD is known to increase with intellectual disability severity the 
interactional effect of these two factors on psychopathology is unclear. It is often found that 
once severity of intellectual disability or adaptive functioning are accounted for, differences in 
the prevalence of psychiatric disorder between those with and without ASD are less 
pronounced or no longer significant (Hove & Havik, 2010; Totsika et al., 2010). 
 
Factors that appear to predict increased psychopathology among adults with intellectual 
disability and ASD include social problems, fewer daily living skills, low social skills, 
negative life events, health problems and a family history of mental health problems 
Chapter 3: Prevalence & comorbidity 
60 
(Ghaziuddin et al., 1995; Ghaziuddin & Greden, 1998; Horovitz et al., 2011; Hove & Havik, 
2010; Matson et al., 2009; Piven & Palmer, 1999). There is evidence that multiple risk factors 
in an individual are related to greater severity of psychiatric symptoms and that certain factors 
are more clearly associated with specific disorders (e.g. complications in pregnancy and 
phobia; Gadow et al., 2008). It is also thought that there are differences in rates of mental 
health problems according to aetiology of  intellectual disability (Ruedrich, 2010). There is a 
consistent finding that individuals with intellectual disability and ASD who have mental 
health problems are often diagnosed with more than one psychiatric disorder (Bakken et al., 
2010; Ghaziuddin et al., 2002; Melville et al., 2008). 
 
Conclusion on the prevalence of intellectual disability, ASD and comorbid mental health 
problems 
 
The exact number of adults with intellectual disability, ASD and comorbid mental health 
problems remains unclear. There are wide ranges in the estimated rates of these conditions. 
Although there appears to be consistent evidence that rates of ASD are getting higher over 
time, the cause of this apparent increase is not yet established. It is most likely the result of a 
combination of factors including wider diagnostic criteria and better recognition. Improving 
the accuracy of estimates of the prevalence and incidence of intellectual disability, ASD and 
mental health problems should be an important priority for researchers and policy makers. 
More high-quality studies are needed to establish whether adults with intellectual disability 
and ASD are at increased risk of mental health problems compared to those without ASD. 
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Chapter 4: Mental health, behaviour and social functioning of adults with intellectual 
disability and ASD 
 
Previous chapters revealed the extent of comorbidity among adults with intellectual disability 
and ASD and the effect this has on assessing and diagnosing individuals‘ problems. This 
chapter explores the impact this complexity has on people‘s lives. Intellectual disability, ASD 
and mental health problems are often associated with unemployment, lack of independence, 
social exclusion, deprivation, poorer quality of life and lower life expectancy (Balogh et al., 
2008). People with intellectual disability and ASD are known to have poorer physical health 
compared with the general population and more unmet health needs (O‘Hara et al., 2010). 
 
The first part of this chapter looks at the mental health of adults with intellectual disability 
and ASD. That is, studies on mental health and problem behaviour that have looked at 
measures other than prevalence of psychiatric disorder. In addition to this research, a body of 
literature has developed that explores what life is like for people with intellectual disability 
and/or ASD. A range of methods have been used from autobiography; qualitative and 
ethnographic research; case reports and series to quantitative and comparative follow-up 
studies (Howlin, 2000). The second part of this chapter describes studies that have measured 
the social functioning of adults with intellectual disability and ASD. 
 
Mental health of adults with intellectual disability and ASD 
There is little evidence on the prognosis for adults with intellectual disability and ASD who 
have mental health problems (Prasher, 1999; McCarthy & Kannabiran, 2010). There are 
relatively few studies on interventions and even fewer on long-term outcomes (Davis et al., 
2008; Young & Chesson, 2006). In an era when mental health service research is focussed on 
recovery models, little is known about how this approach applies to people with intellectual 
disability and/or ASD (Banks et al., 2008; Care Services Improvement Partnership et al., 
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2007). It is not clear whether mental health service users with intellectual disability and ASD 
have more problems than those without ASD when they are referred to services. It is also not 
known whether their mental health problems are more or less likely to respond to treatment. 
 
In one of the few studies to explore the incidence of mental health problems in adults with 
intellectual disability there was no difference between those with and without ASD on rates of 
recovery from mental health problems (Melville et al., 2008). However, those with ASD were 
significantly less likely to recover from problem behaviours than those without ASD. 
 
Much of the early research on clinical outcomes for adults with intellectual disability and 
mental health problems focussed on inpatient admissions (Hemmings, 2010). These studies 
appeared to show that adults with intellectual disability were admitted to inpatient units more 
often than those without intellectual disability and stayed in them longer, however later 
studies did not find these differences (Chaplin, 2004). Admission rates of adult community 
mental health service users to inpatient care have been found to be as low as 5% over 12 
months (Hackerman et al., 2006). 
 
Studies on the mental health of adults with intellectual disability and ASD tend to measure 
prevalence of psychiatric disorder or specific problems rather than broader constructs of 
mental health or well-being. Many studies have found an association between severity of 
intellectual disability and psychiatric symptoms but the nature of this relationship is unclear 
(Hove & Havik, 2010). Factors found to predict a greater number of problems include severe 
intellectual disability, being female and not living with family (Jones et al., 2008). 
 
There is some evidence that individuals with ASD exhibit a higher number and more severe 
symptoms of psychiatric disorder than those without ASD, particularly for depression and 
anxiety (Gadow et al., 2004; Gjevik et al., 2010; Kim et al., 2000; Matson et al., 2010; Mayes 
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et al., 2011a). Studies have also found a positive association between number of ASD traits 
and symptoms of depression and anxiety (Kanne et al., 2009b). 
 
The most commonly cited studies that have compared the mental health of individuals who 
have intellectual disability and with and without ASD were on children and adolescents 
(Bradley et al., 2004; Bradley & Isaacs, 2006; Brereton et al., 2006; Hill & Furniss, 2006). 
They tended to focus on those with severe intellectual disability and found that participants 
with ASD had higher scores for attention deficit hyperactivity disorder, anxiety, depression 
and mania on standardised measures than those without ASD. 
 
Table 4.1 describes studies that have compared the mental health of adults who have 
intellectual disability with and without ASD. Research on the prevalence of mental health 
problems in individuals with intellectual disability, described in Chapter 3, reported equivocal 
results.  
 










Overall results for those with 
ASD 
La Malfa et 
al., 2007 
Adults with severe ID. ASD group 
assignment made according to cut-offs for 
ASD on PDD-MRS, plus DSM-IV/ICD-
10 criteria review for doubtful cases 
41 49 DASH-II 
Significant correlations between 
PDD-MRS scores & DASH-II 
subscale scores for depression, 




Adults with severe ID. Compared: ASD + 
ID vs. ID vs. ASD + ID + 
psychopathology. Clinical diagnosis of 
ASD/no ASD using DSM-IV/ICD-10 
checklist. 
162 151 ASD-CA 
Significant differences for ASD+ID 
vs. ID on total, anxiety & depression 
scores. No significant differences 





Adults with severe ID. Compared: 
ASD+ID vs. ID vs. ASD+ID+ epilepsy  
vs. ID+epilepsy groups matched on 
age/gender/ethnicity/ID severity. Clinical 
diagnosis of ASD/ no ASD using DSM-
IV/ICD-10 
50 50 ASD-CA 
Higher scores for anxiety subscale 
between ASD + ID + epilepsy & ID 
+ epilepsy and for depressive 
subscale between ASD + ID + 
epilepsy & ID (both p<0.05) 
Charlot et 
al., 2008  
Adult inpatients with depression. 
Matched on age/gender /ID severity. 
Clinical diagnosis of ASD/no ASD 
according to DSM-IV criteria. 
13 40 MASS 
Higher mean number of anxiety 
symptoms: 12 vs. 10, p=.05. No 
differences on individual symptoms 
or clusters, except for decreased sleep 
(p=0.05). 
ASD-CA= ASD-Comorbidity for Adults scale, DASH-II=Diagnostic Assessment for the Severely Handicapped-II, MASS= Mood & Anxiety 
Semi-Structured Interview for Patients with ID, PDD-MRS= Pervasive Developmental Disorder in Mental Retardation Scale 
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By contrast, the studies reported in Table 4.1, which used continuous measures of symptoms 
and symptom severity, were more consistent. They appear to show that adults with 
intellectual disability and ASD have poorer mental health than those without ASD across a 
range of measures. As with the earlier studies on children and adolescents, depression and 
anxiety scores were often significantly higher for participants with ASD. 
 
However, it should be noted that none of these studies on adults used a standardised 
diagnostic assessment to confirm whether those in the ASD group did – and those in the ‗no 
ASD‘ group did not – have ASD. In addition, most only included participants with severe 
intellectual disability. 
 
There is evidence that adults with intellectual disability and ASD tend to score highly on 
scales that measure symptoms of mental health problems. Studies that rely on cut-off scores 
of rating scales to ascertain psychiatric ‗caseness‘ without a comprehensive diagnostic 
assessment may overestimate the rate of psychopathology among adults with ASD and 
intellectual disability. On the other hand, studies that only measure the prevalence of 
psychiatric disorder may not adequately capture differences in the mental distress experienced 
by participants with and without ASD. More studies across the range of intellectual disability 
severities are needed. 
 
Problem behaviours among adults with intellectual disability and ASD 
The estimated prevalence of challenging behaviour among individuals with intellectual 
disability ranges from 1-2% up to 40-50% depending on the definitions applied, population 
studied and type of challenging behaviours recorded (Holden & Gitlesen, 2006; O‘Brien, 
2003). Research has linked variations in the presence of challenging behaviour to severity of 
intellectual disability, language abilities, age (highest in late adolescence), gender (greater 
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prevalence among males), cause of intellectual disability, presence of physical health 
problems including epilepsy, life events and socio-economic status (Hemmings et al., 2008a; 
O‘Brien, 2003; Taggart et al., 2011). Other studies have found no differences in gender, but 
some differences by degree of intellectual disability (Davidson et al, 2003). Bihm et al. (1998) 
found that age was positively correlated with aggression, epilepsy was negatively correlated it 
and that aggression was related to psychosis and depression. 
 
There is evidence that challenging behaviour is also highly prevalent among individuals with 
ASD (Holden & Gitlesen, 2006). Aside from the repetitive and restricted behaviours that are 
characteristic of people with ASD, specific problems associated with ASD include 
aggression, self-injurious behaviour and hyperactivity (Levy et al., 2009; Tsiouris et al., 
2003a).  
 
A number of studies have found higher rates of challenging behaviour among individuals with 
intellectual disability and ASD compared to those with intellectual disability alone (Bradley et 
al., 2004; Holden & Gitlesen, 2006; McCarthy et al., 2010; Rojahn et al., 2010). However, 
other studies found no significant difference in prevalence between those with and without 
ASD when participants were matched on age, gender and severity of intellectual disability 
(Melville et al., 2008). 
 
Relationship between psychiatric disorder and challenging behaviour 
There is conflicting evidence on whether there is an association between problem behaviours 
and psychopathology in people with intellectual disability and ASD (Myrbakk & 
Vontetzchner, 2008; Rojahn et al., 2004). McCarthy et al (2010) found differences between 
psychiatric diagnoses according to presence of ASD in mental health service users with 
intellectual disability and challenging behaviour. However there was no association between 
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psychopathology and challenging behaviour once age, gender and severity of intellectual 
disability were controlled for. 
 
Social functioning of adults with intellectual disability and ASD 
Adults with intellectual disability are said to be among the most vulnerable and socially 
excluded individuals (Department of Health, 2001b). Many are unable to live independently 
or hold down a job. It is thought that round 60% of adults with intellectual disability live with 
their families (Department of Health, 2001b) and only 17% are employed (Foundation for 
People with Learning Disabilities, 2007). It is not clear whether those who intellectual 
disability and ASD have comparatively poorer social functioning than those with intellectual 
disability alone. 
 
Much of the focus of research on the social functioning of people with intellectual disability 
has been on community housing; an important issue given the changes that have occurred in 
providing accommodation for these individuals (Felce et al., 2008; Felce et al., 2011). The 
most commonly used measures are community participation, choice, adaptive behaviour and 
challenging behaviours (Kozma et al., 2009). The social functioning of people with 
intellectual disability appears to be associated with IQ and level of adaptive functioning 
(Felce et al., 2011). 
 
Research on adults with ASD began in the late 1960s when those children who were among 
the first to be diagnosed with autism reached adulthood. Studies were mainly descriptive but 
found indications that adult outcome, in terms of social functioning, for most of those with 
ASD was poor and appeared to be related to IQ and verbal skills (Lockyer & Rutter, 1969; 
Lotter, 1974; Rutter et al., 1967). Kanner (1971) explored the ‗destinies‘ of the original 
sample that defined the clinical criteria for autism and surmised that those who were not 
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admitted to hospital and lived in a supportive environment had a better outcome. Lotter 
(1974) commented that ‗...it remains easier to predict a poor outcome than a good outcome‘ 
(pp. 273). 
 
Research that followed largely confirmed these earlier findings. Although, in general, 
outcomes for adults with ASD appear to improving over time (Howlin, 1997; Howlin & 
Goode, 1998). A review in 2000 of outcome in adult life for those with high-functioning ASD 
identified six studies (Howlin, 2000). Results were ‗extremely variable‘, however most 
studies reported low rates of employment (maximum 44%), independent living (maximum 
50%) and ‗good outcome‘ (maximum 44%). The review found there was a suggestion of 
increased mortality among people with ASD (further increased for those with low IQ) but no 
evidence of an increase in forensic issues (Howlin, 2000). Adult outcomes for those with the 
full spectrum of ASD have not been systematically studied (Levy & Perry, 2011). 
 
Since the review by Howlin (2000), described above, there has been an increasing interest in 
adult outcomes for people with ASD and a number of further studies on the social functioning 
of adults with ASD have been published. These are detailed in Table 4.2; as found previously 
the methods and results have varied widely. 
 
A significant number of these studies concentrated on people with high-functioning ASD. 
Many looked at the impact of IQ on social functioning but few focused on those with 
intellectual disability to explore whether these associations are present among those with low 
IQ (particularly below 50). In addition, many did not include a comparison group so it is not 
clear whether these individuals had poorer social functioning compared to those without any 
other disorder or with intellectual disability alone. Other studies included a comparison group 
of participants with a different disorder or different types of ASD. 
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Table 4.2: Studies on the social functioning of adults with ASD 
Study Participants Comparison 
group 
Measure(s) Source of data Overall results for 
those with ASD 
Engstrom et 
al., 2003 
16 adults with Asperger 
syndrome or high-functioning 
ASD (DSM-IV criteria) 
(IQ>70)  
None Employment, relationships, type of 
residence, needs. Composite score of 
social functioning based on Lotter‘s 
criteria* 
Clinician interview, participant 
interview, Camberwell Assessment 
of Need (CAN) 
Good to fair social 
functioning in majority 
(87%). 
Farley et al., 
2009 
41 adults who had ASD without 
ID (confirmed by ADI-R & 
ADOS) 
None Employment, ability to travel 
independently, type of residence, 
relationships, level of support required 
(see Engstrom‘s definition). Howlin et al. 
2004 criteria* 
Vineland Adaptive Behaviour 
Scales, parent interview 
Fair to very good social 





58 adults who had ASD without 
ID (according to DSM-IV 
criteria) 
None Employment, type of residence, 
relationships, quality of life. 
Quality of Life Questionnaire for 
adults with intellectual disability 
(QoLQ), Interpersonal Support 
Evaluation List, CAN 
Low levels of 
independence & 
employment 
Howlin et al., 
2004 
68 adults with ASD & IQ>50 
(confirmed in adulthood by 
ADI-R) 
None Education, employment, friendships, type 
of residence. Composite score of social 
functioning.* 
ADI-R, parent interview, case 
records. 
Mostly poor social 
functioning (58%). 
Significantly poorer for 
those with IQ of 50-69 
Barnard et 
al., 2001 
450 adults with ASD 
(according to parent-reported 
diagnoses which were not 
assessed) 
None Employment, activities, type of residence Parent interview Low levels of 
employment, activities 
& independence 
Eaves & Ho, 
2007 
48 young adults with ASD 
(according to Rutter criteria) 
(38 with ID) 
None Quality of life, employment, type of 
residence, friendship, independence, 
satisfaction with services. Howlin et al. 
2004 criteria* 
Parent interview Fair to very good social 
functioning for majority 




74 adults with ASD (clinical 
diagnosis) 
None Quality of life, employment, health, social 
network. 
Parent interview, Comprehensive 
Quality of Life Questionnaire, 
social/language DAS items, CARS, 
ICAP 
Poor quality of social 
interaction, low levels of 
structured activity (16%) 
& independence 
Green et al., 
2000 
20 male adolescents with 
Asperger syndrome (IQ>70)  
(according to ICD-10 criteria) 
20 males with 
conduct disorder 
Social & emotional functioning: 
Independence, interpersonal difficulties, 
relationships. Psychiatric functioning 
Isle of Wight Semi-structured 
Informant & Child Interviews, Social 
& Emotional Functioning interview 
Poorer social functioning 
than comparison group, 
no correlation between 
social functioning & IQ 
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Study Participants Comparison 
group 
Measure(s) Source of data Overall results for 
those with ASD 




19 males who had ASD 
(according to Rutter criteria) 
without ID (IQ>70) 





Education, employment, friendships, type 
of residence, language, independence, 
stereotyped behaviours, relationships, 
cognitive functioning. Composite score of 
social functioning.* 
ADI-R, ADOS, Socio-Emotional 
Functioning Interview & Vineland 
Adaptive Behavior Scales 
Poorer social functioning 
(problems with jobs, 
relationships, & 
independence). 74% had 
severe social difficulties 
Marriage et 
al., 2009 
45 adults diagnosed with ASD 
(according to DSM-IV) in 
childhood (12 had ID) 
35 adults diagnosed 
with ASD after age 
of 18 (1 had ID) 
Education, vocation, independence, social, 
intimate relationships 
Case note review, Australian Scale 
for Asperger‘s Disorder, AQ, Child 
Symptom Inventory. ADI-R & 
ADOS 
Poorer social functioning 
for those with ASD & 
ID compared with ID 
alone 
Billstedt et 
al., 2005  
78 adults with autism  (DSM-
IV criteria & DISCO) (62 with 
ID) 
42 adults with 
atypical autism (36 
with ID) 
Type of residence, relationships, Lotter‘s 
criteria of outcome* 
Parent interview, DISCO, Global 
Assessment of Functioning (GAF) 
Poor social functioning 
for majority (89%), no 
difference between groups 
Cederlund et 
al., 2008 
70 adult males with autism or 
atypical autism (according to 
DSM-III & DISCO) (67 had 
ID) 
70 adult males with 
Asperger syndrome 
(IQ>70) 
Type of residence, Outcome rating based 
on Lotter‘s criteria* 
DISCO, GAF, Vineland Adaptive 
Behavior Scales 
Poor social functioning 
for majority. Better for 
those with AS. 
Esbensen et 
al., 2010 
79 adults with ASD & ID 
(confirmed by ADI-R) 
70 adults with 
Down syndrome 
(matched on age) 
Type of residence, social contact with 
friends, employment, health, functioning. 
Howlin et al. 2004 criteria* 
Parent interview, revised Barthel 
Index, Vineland Screener Scale, 
Scales of Independent Behavior-
Revised 
Low levels of 
independence & contact 
with friends. Poorer 
social functioning. 
Totsika et al., 
2010 
Adults with ID & ASD aged 50 
years & over (DAS triad of 
impairments) (65 with matched 
adaptive behaviour skills) 
Adults with ID 
aged over 50 years 
(65 in matched 
group) 
Domestic, social and community activities  Index of Community and Index of 
Participation in Domestic Life, ABC, 
PIMRA or PAS-ADD 
Lower levels of activity 
but no differences 
between matched groups 
Felce et al., 
2011 
158 adults with ID & ASD 
(triad of impairments on DAS) 
in staffed community housing 
269 adults with ID 
in staffed 
community housing 
Challenging behaviour, independence 
variety/frequency of social & community 
activities, constructive activities 




Brown et al., 
2009 
51 adults with severe ID & 
ASD (according to ICD-10 
criteria) 
21 adults with 
severe ID 
Life satisfaction, community satisfaction, 
recreation satisfaction, job satisfaction,  
challenging behaviour,  
Lifestyle Satisfaction Scale, 
Schedule of Handicaps Behaviours 
& Skills, AAMR ABS, Leiter 
International Performance Scales,, 
QoLQ,  Reynell Language 
Development Scales 
ASD was not a 
significant predictor of 
quality of life once 
challenging behaviour & 
IQ were accounted for 
*See Appendix V. AAMR ABS=American Association on Mental Retardation Adaptive Behavior Scale, ABC= Aberrant Behaviour Checklist , ADI=Autism Diagnostic Interview, ADOS=Autism Diagnostic 
Observation Schedule, DAS= Disability Assessment Schedule, DISCO=Diagnostic Interview for Social & Communication disorders, ICAP=Inventory for Client & Agency Planning PAS-ADD= Psychiatric 
Assessment Schedule for Adults with Developmental Disorders, PIMRA= Psychopathology Instrument for Mental Retarded Adults, QoLQ=Quality of Life Questionnaire.
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Rates of unemployment for those with ASD ranged from 24 to 98%. Many left school without 
qualifications and only 8 to 20% were living independently. One study found that 24% of all 
those with ASD were not engaging in any meaningful activity and 31% were not involved in 
any social activities (Barnard et al., 2001). 
 
Some of these studies were able to explore associations between intellectual and social 
functioning for adults with ASD. In Eaves and Ho‘s study  (2007) verbal IQ in childhood was 
the best predictor of social functioning score which also correlated with performance IQ. 
Another study found that low IQ and low verbal skills in childhood predicted social 
functioning but poor and very poor social functioning definitions include these items 
(Billstedt et al., 2005). Renty & Roeyers (2006) found that higher quality of life scores were 
significantly associated with having a job/being a student, higher perceived informal support 
and lower of unmet needs. 
 
In a study that compared adult males with autism to those with Asperger syndrome (AS), 
most participants had poor social functioning (Cederlund et al., 2008). Those with AS had 
significantly better social functioning. Among those with autism, none had good social 
functioning, 5% had fair social functioning and only 8% of those over 23 lived independently. 
The majority of this group had intellectual disability. Participants with autism had 
significantly lower Global Assessment of Functioning (GAF) scores than those with AS; GAF 
score was significantly associated with IQ. 
 
Marriage et al. (2009) compared adults diagnosed with ASD in childhood and those who were 
diagnosed after 18 years of age. Of the participants diagnosed as children, those with 
intellectual disability scored lower than those without intellectual disability on all measures 
except for intimate relationships. 
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In Howlin et al.‘s study (2004) there was not a significant correlation between IQ and social 
functioning. However, a sub-analysis compared participants whose IQ was 50-69 with those 
whose IQ was over 70. Those in the lower IQ group scored significantly higher (indicating a 
poorer social functioning) on residential status, educational level, level of work and total 
rating of social functioning. 
 
Few studies directly compared adults who had intellectual disability with and without ASD. A 
series of studies from Wales has explored the mental health and social functioning of adults 
with intellectual disability. Sub-analyses of those with ASD (as assessed using items on the 
Disability Assessment Schedule (DAS; Holmes et al., 1982) relating to the ASD triad of 
impairments) have been carried out. Totsika et al. (2010) compared quality of life for older 
adults with and without ASD. Participants with ASD were involved in a significantly lower 
number of domestic, social and community activities than those without ASD. They also 
spent a lower proportion of their time engaged in any activity (39% vs. 59%). Those with 
ASD had significantly more behaviour problems (a higher mean score on the Aberrant 
Behavior Checklist) than those without ASD. 
 
However, in a sub-analysis of those with matching adaptive skills there were no significant 
differences between those with and without ASD on any quality of life measure or problem 
behaviours (Totsika et al., 2010). 
 
A recent study from this series looked at adults with intellectual disability who lived in staffed 
community housing (Felce et al., 2011). Participants with ASD were more likely to have 
severe challenging behaviour (36% vs. 15%), had higher levels of problem behaviour and 
lower levels of adaptive behaviour than those without ASD. When participants were matched 
on adaptive behaviour, there remained significant differences in levels of problem behaviour 
and the proportions with challenging behaviour. Measures investigated included 
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variety/frequency of social and community activities, household independence, engagement 
in constructive activities. There were no significant differences between those with and 
without ASD on any measure. The authors of these studies acknowledged limitations with 
regards to the way participants were categorised into those with and without ASD (Felce et 
al., 2011; Totsika et al., 2010). 
 
The ‗Camberwell cohort‘ were a total population sample of children with severe intellectual 
disability and/or ASD in South London, this group was followed up as adults to explore their 
life satisfaction (Beadle-Brown et al., 2009). Participants with ASD had lower levels of 
community satisfaction than those without ASD but there was no difference on any other 
measure. The only childhood predictor of quality of life among the whole sample was 
independent living skills. Of the measures taken when participants were adults the most 
important factors associated with quality of life were challenging behaviour and IQ. 
 
Esbensen et al. (2010) compared individuals with ASD and intellectual disability to those 
with Down syndrome. Few participants had high or very high levels of independence. Most of 
those with ASD had low or very low levels of independence where as those with Down 
syndrome tended to be classed as having moderate or low levels. Predictors of social 
functioning for those with and without ASD were total functional abilities and service receipt. 
Severity of intellectual disability and maladaptive behaviours were not significant predictors 
of social functioning. 
 
This study found that those accessing mental health services had poorer social functioning 
and concluded that: “It will be important for future researchers to examine the best ways to 
assess psychological and psychiatric needs among adults with autism spectrum disorders so 
that appropriate interventions can be put in place” (Esbensen et al., 2010; pp. 287). 
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Although a number of the studies described above included measures of psychopathology, 
none looked at the social functioning of those who have mental health problems or the 
interaction between psychiatric disorder and social functioning. Chaplin et al. (2010b) studied 
750 mental health service users with intellectual disability who had a mean age of 33 years. 
Half lived with their family, 37% in a supported residence and 13% lived independently. The 
vast majority (97%) of those living independently had mild intellectual disability. Age, level 
of intellectual disability and diagnoses of anxiety or personality disorder were significant, 
independent predictors of type of residence. Presence of ASD was not associated with type of 
residence although only 5% of those with ASD lived independently. 
 
It is clear that the mental health and social functioning of people with intellectual disability 
and ASD varies greatly over time, geographical areas and between individuals. The evidence 
on which factors are significantly associated with social functioning is weak. This is because 
the few good quality studies in this area have included diverse populations and used a range 
of methods to define/diagnose ASD, collect data and measure social functioning (Levy & 
Perry, 2011). However, there is some consistent evidence on the characteristics that appear to 
be related social functioning for people with intellectual disability and ASD. 
 
The following factors have been found to have a positive relationship with social functioning: 
 
 IQ 
 Expressive communication 
 Early language skills 
 Adaptive functioning 
 Level of perceived informal support 
Chapter 4: Mental health, behaviour & social functioning 
74 
The following factors have been found to have a negative relationship with social functioning: 
 
 Severity of ASD/ASD symptoms 
 Level of unmet formal support needs 
 
It is important that studies on differences in the social functioning of adults who have 
intellectual disability with and without ASD explore the effect of these variables. That is, 
whether they are better predictors of social functioning than ASD itself or effect moderators 
that have a different impact on individuals with and without ASD. 
 
Measuring the social functioning of adults with intellectual disability and ASD 
Common measures for people with intellectual disability include life expectancy, physical and 
mental health, adaptive functioning, service contact, employment, relationships (O‘Brien, 
2001). Often in the literature there is a blurring of the boundaries between ‗baseline‘ factors, 
‗inputs‘ and ‗outcomes‘. For example, service receipt, needs, daily living skills or cognitive 
functioning are used as measures of social functioning rather than independent variables that 
may predict it. 
 
In Howlin‘s (2000) review of adult outcome for people with ASD, seven types of measure 
were used by the included studies: “1) IQ, academic skills and adaptive behaviours; 2) 
language ability; 3) behavioural problems; 4) education and employment history; 5) 
independence and social relationships; 6) psychiatric history; and 7) stability of IQ over time 
and variables related to outcome” (pp. 67). 
 
The research described in this chapter also used a wide range of methods to define and 
measure social functioning. The most common themes were employment, education and 
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independence. It was standard practice for these studies to use a composite scale based on 
information from a range of instruments rather than any direct data collection or use of an 
existing measure of social functioning. Many of the measures were based on criteria 
developed by Howlin (2004) or Lotter (1974). 
 
There are some limitations to these measures particularly for adults with intellectual 
disability. For example, Lotter‘s definition of poor social functioning included ‗obvious 
severe handicap‘ therefore those with intellectual disability are more likely to fall into these 
categories. Most mental health service users with intellectual disability would score poor or 
very poor on these criteria (Levy & Perry, 2011).  
 
There could also be problems applying the two criteria developed by Howlin to people with 
intellectual disability, ASD and mental health problems. In the earlier criteria (Howlin et al., 
2000), the composite score included measures of autistic behaviours and language therefore 
those with ASD would be more likely to score higher and appear to have poorer social 
functioning if compared to a group without ASD. To date there is little evidence on the 
psychometric properties of these measures (Billstedt et al., 2005; Levy & Perry, 2011). The 
criteria used by Howlin et al. (2004) have been found to have intra-class correlation of 0.97 
(Farley et al., 2009). Marriage et al (2009) acknowledged that such methods “should be 
considered more qualitative than quantitative” (pp. 327).  
 
In addition to social functioning, studies have used quality of life measures. Quality of life 
domains have been identified as social inclusion, physical well-being, interpersonal 
relationships, material well-being, emotional well-being, self-determination, personal 
development and rights (Schalock et al., 2002). The questionnaire used in the Ignored or 
Ineligble? report was reviewed by a panel of parents of adults with ASD (Barnard et al., 
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2001). But on the whole, previous research has not been based on measures developed by 
asking adults with intellectual disability and ASD what they think is important. 
 
Conclusion on the social functioning of adults with intellectual disability and ASD 
In early studies, adults with ASD appeared to have generally poor life outcomes. More recent 
research found that their social functioning was better than expected. IQ and verbal skills 
appear to be the most significant predictors of social functioning and there is evidence that 
those with intellectual disability or more severe ASD do less well in adult life. 
 
There are few recommendations on what might be done to improve the social functioning of 
adults with intellectual disability and ASD. Howlin (2000) suggested that although life for 
people with ASD appears to have improved over time, it is likely this is due to less 
institutionalisation and more opportunities. Stating: “…there is no evidence to suggest that 
long-term outcome can be dramatically improved following the implementation of any 
particular intervention programme” (pp. 78). 
 
Most factors associated with poorer social functioning are those that tend not to change such 
as IQ and severity of ASD symptoms. However it is possible that early recognition and 
intervention could improve individuals‘ adaptive functioning and skills and that this could in 
turn lead to better social functioning. More research is needed on the relationships between 
socio-demographic/clinical characteristics, psychopathology, challenging behaviour and 
social functioning. 
 
It is currently not clear whether adults with intellectual disability and ASD have better or 
poorer social functioning than those with intellectual disability alone. The social functioning 
of people with intellectual disability and ASD who have mental health problems is even more 
poorly understood (Pridding & Tomasoni, 2006). 
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Studies should be prospective, longitudinal and population-based but given the difficulties 
carrying out these types of studies, clinic-based, cross-sectional studies can provide a valuable 
snapshot of individuals‘ lives (Engstrom et al., 2003; Elison et al., 2010). An improved 
understanding of the characteristics that appear to predict social functioning and the course of 
mental health problems would aid the provision of services and interventions for adults with 
intellectual disability and ASD.
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Chapter 5: Services and interventions for people with intellectual disability, ASD and 
mental health problems 
 
People with intellectual disability and ASD access a broad range of largely community-based 
services provided by the public, private and voluntary sectors. The common aim of these 
services is to improve the lives and outcomes of individuals. But, since resources are scarce 
they also strive to be as efficient and cost-effective as possible. This chapter looks at the 
evidence-base for the provision of services and interventions for adults with intellectual 
disability and ASD as well as data on their service use and its impact on mental health and 
outcome. The focus is on policy and health service provision in England. 
 
Policy 
Valuing People: A New Strategy for Learning Disability for the 21st Century  focussed on 
independence, choice, equality and inclusion (Department of Health, 2001b). The White 
Paper maintained that individuals with intellectual disability have the same right to access 
mainstream health services as the rest of the population and should be able to do so whenever 
possible. This would be implemented through the National Service Framework for Mental 
Health, the Care Programme Approach and Health Action Plans. Other issues raised included 
a lack of outcome measures with which to compare the health of people with intellectual 
disability to the rest of the population and the over-use of psychotropic medication for those 
with challenging behaviour. Valuing People acknowledged that people with intellectual 
disability and ASD may have different needs compared with the rest of the intellectual 
disability population but stated that ―the majority will not need autism specific services‖ 
(Department of Health, 2001b, pp. 101). 
 
The explicit exclusion of people with high-functioning ASD from Valuing People led to more 
intense lobbying for better service provision for people with ASD; culminating in the passing 
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of the Autism Act, 2009. A number of accompanying documents were published including 
the National Autism Strategy (Department of Health, 2009a; 2010b), a National Audit Office 
report (National Audit Office, 2009b) and good practice guidance (Department of Health, 
2009b). As with Valuing People, these policies focus on improving access to services, 
independence and reducing inequality. Two clinical guidelines on the recognition and 
diagnosis of ASD in children and adults are in development (NICE, 2011; NICE, 2012). 
Other  significant changes have been made; for example the NHS Standard Contract for 
Mental Health and Learning Disabilities now explicitly states that services must make 
reasonable adjustments for adults with ASD in accordance with the Disability Discrimination 
Act (Department of Health, 2010b). 
 
Although Valuing People recognised the needs of adults with intellectual disability and ASD 
there was little specific mention of how those needs might be met. Meanwhile the recent ASD 
policies and documents have largely focussed on those with high-functioning ASD. Perhaps 
because, as discussed in previous chapters, it is not clear whether people with both intellectual 
disability and ASD are at increased risk of mental health problems or have poorer outcomes, 
therefore they rarely receive specific mention in either intellectual disability or ASD policy. 
Despite evidence that they have increased and more complex needs than the general 
population, people with intellectual disability and/or ASD remain excluded from or 
unmentioned in mainstream documents such as clinical guidelines and National Service 
Frameworks (Care Services Improvement Partnership et al., 2007). 
 
Services and interventions 
People with intellectual disability and ASD are likely to need input from a range of services at 
some point during or throughout their lives (Department of Health, 2001b; Department of 
Health, 2010b). There is recognition that access to services is more limited once individuals 
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reach adulthood (National Audit Office, 2009b). However with low levels of employment and 
many people being unable to live independently, the need for support increases as individuals 
approach 18 (Department of Health, 2009b; Higgins, 2009). 
 
As set out in government policy, adults with intellectual disability and ASD should be able to 
access the same range of health services as the rest of the population. Intellectual disability 
services provide support for people to access mainstream mental health services where 
possible. However, it is acknowledged that mainstream services and community intellectual 
disability services do not always have the expertise or resources to support people with 
additional complex needs and that in some circumstances specialist input is required 
(LeMesurier et al., 2007). As such there are several community and inpatient assessment and 
treatment services specifically for adults with intellectual disability who have mental health 
problems and/or challenging behaviour. 
 
These services are not consistently or comprehensively provided throughout the UK (Chaplin 
et al., 2010a). In areas where there is limited specialist provision, people with intellectual 
disability and mental health problems are often said to ―fall between two stools‖ (Doody, 
2001). This happens when neither intellectual disability services nor mainstream mental 
health services have the necessary expertise to provide for them. This type of situation is even 
more common for adults with ASD (Barnard et al., 2001; Higgins, 2009). Those who are 
eligible should receive the same provision as adults with intellectual disability. However, it is 
not clear whether adults with intellectual disability and ASD are successfully accessing or 
benefitting from these services. Furthermore, specialist ASD services may be reluctant to 
accept individuals with intellectual disability because they consider this group are already 
provided for by intellectual disability services. 
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There is little evidence on the best ways to provide mental health services to adults with 
intellectual disability (Hemmings, 2008). Evaluation studies on service models and 
interventions rarely specifically mention whether they included participants with ASD (e.g. 
Coelho et al., 1993; Dowling et al., 2006; Kerr et al., 2005; Lennox et al., 2007; Martin et al., 
2005; Oliver et al., 2005; Willner et al., 2002). Research does not often consider whether 
there might be differences between those with and without ASD at baseline or with regards to 
outcome. Few studies take into account whether ASD, severity of intellectual disability or 
presence/absence of psychiatric disorder (among other factors) might confound their results. 
Evidence that a range of variables appear to be associated with outcome does not appear to 
have had much influence on the design or analysis of research (Courtemanche et al., 2011). 
 
Service consumption of adults with intellectual disability 
Evidence on the cost of intellectual disability to the economy is weak (Romeo & 
Molosankwe, 2010). At the time of the World Health Report of 2001 there were no estimates 
for the overall disease burden of intellectual disability (WHO, 2001). The Department of 
Health (2001b) has estimated that total UK expenditure on health and social services for 
people  with intellectual disability is around £3 billion a year. 
 
A high proportion of the social care costs associated with intellectual disability are accounted 
for by residential placements (Felce et al., 2008; Hallam et al., 2006; Polder, 2002; Strydom et 
al., 2010). High service use and expenditure on adults with intellectual disability has been 
associated with age, challenging behaviour, mental health problems, more severe intellectual 
disability, higher levels of need and white ethnicity (Harrington & Kang, 2008; Kang & 
Harrington, 2008; Knapp et al., 2005; Strydom et al., 2010). Other factors related to different 
types of service use include type of residence and number of service users per residence 
(Knapp et al., 2005). 
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Mental health service consumption
2
 of adults with intellectual disability 
There has long been evidence that a large amount of mainstream mental health service 
consumption is accounted for by a relatively small number of service users (Lavik, 1983). 
Despite this, exploring the characteristics of those with intellectual disability who get referred 
to services and the level of services they use has not been a priority for mental health research 
(Driessen et al., 1997; Spiller et al., 2007). 
 
As described in Chapter 3, there is evidence that mental health services users are more likely 
to be male and tend to be younger than the rest of the intellectual disability population 
(Bhaumik et al., 2008b; Bouras et al., 2003). It is not clear whether this is due to actual 
differences in the prevalence of mental health problems or referral bias. Other studies have 
not found gender to be associated with increased likelihood of referral and found that older 
people were more likely to referred to specialist mental health services (Driessen et al., 1997).  
 
There appears to be some consensus that users of specialist mental health services are more 
likely to have mild intellectual disability (Spiller et al., 2007). Although this is not found in all 
studies (Bhaumik et al., 2008b). Factors that have been identified as predictors of mental 
health service consumption among adults with intellectual disability include age, type of 
residence, length of service use, severity of behaviour problems, severity of intellectual 
disability and presence of a psychotic disorder (Driessen et al., 1997; Jacobson, 1998; Knapp 
et al., 2005; Spiller et al., 2007).  
 
Services consumption of adults with ASD 
The National Audit Office (2009b) acknowledged that while it is known that adults with ASD 
use a wide range of services, precise data on their service consumption is very limited. Only a 
                                               
2 For the purposes of the thesis mental health services include psychiatry, psychology & behaviour support 
services. 
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few studies that included information on the service use of adults with ASD can be identified 
(Knapp et al., 2007). Many focused on certain types of service (such as employment) and the 
costs of providing them (Cimera & Cowan, 2009). A study in California on service use 
among individuals with developmental disorders found that those with ASD were more likely 
to be receiving support and respite services than those with other types of disability including 
intellectual disability (Kang & Harrington, 2008; Harrington & Kang, 2008). 
 
A more recent study, also from the United States, looked at service use after individuals with 
ASD left school (Shattuck et al., 2011). Of the 410 participants, 35% were receiving mental 
health services but only 23.5% were accessing other medical services. Almost 40% received 
no services and this was associated with Afro-Caribbean ethnicity, low income and higher 
levels of functioning. Although participants were categorised into four levels of ‗functional 
mental skills‘ it was not clear whether or how these related to intellectual disability. Level of 
functioning was not associated with receipt of mental health services. Furthermore, gender, 
age, verbal ability and type of residence were not associated with service use. 
 
Service consumption of adults with intellectual disability and ASD 
Knapp et al. (2009) suggested that while around 55% of people with ASD also have 
intellectual disability, these individuals account for 66% of the annual cost of ASD to the UK 
economy. The estimated lifetime cost for people with ASD and intellectual disability is 50% 
greater than for those without intellectual disability. Presence of ASD has been found to be a 
strong predictor of hospital admission, medication use and problem behaviours in adults with 
intellectual disability (Cowley et al., 2005; Tsakanikos et al., 2007; Underwood et al., 2010). 
 
As with the general intellectual disability population, expenditure for those who also have 
ASD is largely accounted for by residential costs (Knapp et al., 2009). However, published 
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data on adults with intellectual disability and ASD for types of service use other than 
accommodation is difficult to obtain (Knapp et al., 2007). 
 
In Knapp et al. (2009), adults with intellectual disability and ASD living with family were 
estimated to have high levels of day centre, college and respite care use. This study provided 
some evidence that adults with intellectual disability and ASD have higher support costs than 
those without intellectual disability. However, it is still unclear whether this is due to the 
presence of intellectual disability, ASD or the combination of both conditions. 
 
Only one study could be found that directly compared the service use of adults who have 
intellectual disability with and without ASD. Age-matched groups of 70 adults with ASD and 
70 adults with Down syndrome (DS) were compared (Esbensen et al., 2010). Participants with 
ASD were significantly more likely to be receiving mental health and personal care services 
than those with DS. However those with ASD were significantly less likely than those with 
DS to be receiving recreational, transport, employment services or income support. Service 
receipt was significantly associated with social outcomes for both groups (see Chapter 4 for 
more details on this study). 
 
Interventions 
There are a range of interventions that are used for individuals with intellectual disability or 
ASD who have additional mental health or behavioural problems. These are most often the 
same as (or adapted versions of) those developed for the general population. This section 
explores the use of interventions commonly provided for adults by NHS services in the UK. 
 
Medication 
Rates of medication use among those with intellectual disability and/or ASD are high 
compared with the general population; with antipsychotic medication being the most 
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commonly prescribed (De Kuijper et al., 2010; Matson & Neal, 2009). This should  not 
necessarily be taken as an indication that psychotic disorders are the most prevalent mental 
health problems among these individuals since antipsychotics are likely to be prescribed for a 
wide range of other disorders (Paton et al., 2011). 
 
Although antipsychotic, anticonvulsant and mood stabilising medications are not licensed for 
such use, they are often prescribed for behavioural problems in the absence of any psychiatric 
disorder (Deb et al., 2008; De Kuijper et al., 2010). Despite this widespread use the evidence 
base for psychotropic medication to treat behaviour problems is extremely weak (Deb & 
Unwin, 2007; Matson & Neal, 2009). Among antipsychotics, risperidone has been found to be 
effective in some studies (McDougle et al., 1999) with others finding no advantage over 
placebo (Tyrer et al., 2008). There are concerns about the level of benzodiazepine use among 
adults with intellectual disability and/or ASD, particularly when prescribed on a PRN (as 
required) basis (De Kuijper et al., 2010; Robertson et al., 2000). 
 
Psychotropic medication use in individuals with intellectual disability has been found to be 
associated with presence of ASD, communication problems, challenging behaviour, presence 
of a psychiatric disorder, type of residence and severity of intellectual disability (de Bildt et 
al., 2006; Holden & Gitlesen, 2004; Paton et al., 2011; Robertson et al., 2000; Tsakanikos et 
al., 2007). In addition some research has found relationships between medication and gender 
(De Kuijper et al., 2010). 
 
Studies have found that 40-64% of individuals with ASD are prescribed at least one 
psychotropic medication with most individuals receiving more than one and some taking up 
to seven different drugs (Esbensen et al., 2009; Weeden et al., 2011). There is also evidence 
that when people with ASD are prescribed psychotropic medications they end up taking them 
for long periods of time (Esbensen et al., 2009). Studies on the effectiveness of psychotropic 
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medication have found high rates of non-response among those with ASD and challenging 
behaviours (Beherec et al., 2011). 
 
There is evidence to suggest that adults with intellectual disability and ASD are more likely to 
be taking psychotropic medication than those with intellectual disability alone (Tsakanikos et 
al., 2006). LoVullo & Matson (2009) found that 71% of those with intellectual disability, 
ASD and psychopathology were taking medication, this was higher than those with 
intellectual disability only (0%) and those with intellectual disability and ASD (16%) but the 
report did not provide any data on people with intellectual disability and psychopathology. 
 
Morgan et al. (2003) reported that 52% of those with intellectual disability and ASD were 
prescribed psychotropic medication but did not compare this to the rate for those without 
ASD. Melville et al., (2008) found that adults with intellectual disability and ASD were more 
likely to be on antipsychotic medication than those without ASD; although this difference was 
not statistically significant. A randomised controlled trial of antipsychotic medication for 
challenging behaviour in adults with intellectual disability found no evidence that those with 
ASD had a different response to those without ASD (Tyrer et al., 2008). 
 
Behavioural, educational, psychological and social interventions 
Data on the effectiveness of pharmacological treatment continues to throw doubt on the 
appropriateness of medication particularly for behaviour problems in adults with intellectual 
disability and/or ASD (McGillivray & McCabe, 2004; Romeo et al., 2009). As a result, there 
is demand for increased access for these individuals to evidence-based behavioural, 
educational, psychological and social interventions (Hassiotis et al., 2009b; Matson & Neal, 
2009). However, research on the effectiveness of psychosocial interventions is at an even 
earlier stage than that on pharmacological treatment (Gustafsson et al., 2009; Hatton, 2002; 
Seida et al., 2009). 
Chapter 5: Services & intervention 
87 
Interventions most commonly used for adults with intellectual disability and ASD who have 
mental health problems include anger management, behavioural therapies and cognitive 
behavioural therapy (CBT). Naturally, there are concerns about whether adults with 
intellectual disability and/or ASD are able to participate in the processes required for 
psychological interventions like CBT (Hatton, 2002). When mainstream approaches are 
adapted there is additional concern about their fidelity to the original theoretical and evidence-
based models (Hemmings et al., 2008b). 
 
A survey of research on psychosocial interventions for adults with intellectual disability 
and/or ASD who have mental health problems identified only three systematic reviews that 
met the authors‘ inclusion criteria (Gustafsson et al., 2009). There was limited evidence for 
the effectiveness of specialist community services for adults with intellectual disability 
compared with mainstream services (Chaplin, 2004) and the use of CBT to reduce aggression 
(Hassiotis & Hall, 2008). 
 
A review of psychosocial interventions for ASD identified 14 systematic reviews that 
included adults (Seida et al., 2009). The studies included in these reviews did not appear to 
have been designed for those with additional psychopathology but focussed on problem 
behaviours or symptoms of ASD. Very few were high quality randomised controlled trials 
and there was little information on whether they included participants with and/or without 
intellectual disability. 
 
In the UK, most psychosocial interventions for adults with intellectual disability and ASD 
who have mental health problems are delivered by psychologists and behaviour support 
specialists. Few of the studies on mental health service consumption cited in this chapter 
distinguished between psychiatric and psychological/behavioural services. Those that did 
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appeared to show that adults with intellectual disability were more likely to have access to a 
psychiatrist than a psychologist and that psychology service use was associated with age, 
severity of intellectual disability and challenging behaviour (Jacobson, 1998; Knapp et al., 
2005). 
 
Conclusion on service provision for adults with intellectual disability and ASD 
Adults with intellectual disability and ASD remain overlooked in the development and 
evaluation of mainstream policies, services and interventions. Their specific mental health 
needs are often not considered with regards to specialist intellectual disability or ASD 
provision. More evidence is needed on identifying service users at increased risk of mental 
health problems and which factors impact on their outcomes. 
 
Specialist services for adults with intellectual disability and/or ASD in the UK are highly 
varied (Chaplin et al., 2010a; Department of Health, 2007a). Services for adults with high-
functioning ASD remain largely separate from services for adults with intellectual disability 
who are expected to provide for those with low-functioning ASD. However, there is growing 
acknowledgement that even specialist intellectual disability services find it difficult to meet 
the needs of people with ASD who have mental health or behaviour problems (Mills & 
Francis, 2010). 
 
Many studies describe service consumption as being associated with needs-related 
characteristics of individuals (e.g. whether they have additional mental health problems or 
severity intellectual disability) (Kang & Harrington, 2008; Shattuck et al., 2011). However, 
there are few data on whether there is a direct link between standardised measures of need and 
level of service consumption (Knapp et al., 2005). 
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There is little data on the service and intervention use of adults with intellectual disability but 
some evidence that there are differences between those with and without ASD. The evaluation 
of service models and interventions for adults with intellectual disability and/or ASD remains 
challenging. This could be in part because the characteristics of service users, the needs of 
specific groups of service users and the impact of these on outcomes are not well understood. 
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Chapter 6: Aims, objectives and hypotheses 
 
Summary of the literature review 
The accurate assessment of ASD, intellectual disability and mental health problems can lead 
to improvements in estimates of prevalence, provision of services, effective intervention and 
outcome (National Audit Office, 2009b). Using evidence-based, standardised tools increases 
the reliability and validity of diagnoses (NICE, 2010). 
 
The literature suggests that a significant proportion (around 30-40%) of specialist mental 
health service users with intellectual disability also have ASD (Emerson & Baines, 2010; 
Matson & Shoemaker, 2009). There is good evidence that those with and without ASD differ 
on a range of socio-demographic and clinical variables.  
 
Adults with intellectual disability appear to be at higher risk of mental health problems than 
the general population (Cooper et al., 2007) as do adults with ASD (Hutton et al., 2008). 
There is evidence that adults with both intellectual disability and ASD are at further increased 
risk of problem behaviour, However, it is less clear whether there are differences in the 
prevalence and pattern of psychiatric disorder between those with and without ASD (Melville 
et al., 2008; Underwood et al., 2010). 
 
In the UK, there are Government strategies in place to ensure that people with intellectual 
disability, ASD and mental health problems have improved access to assessment and services 
(Department of Health, 2001b; 2010b; 2011). However, the evidence base for service 
provision, specific interventions and the implementation of guidelines for people with 
intellectual disability and ASD is weak (NICE, 2011). 
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Early research reported generally poor life outcomes for adults with ASD (Howlin et al, 
2004). There is evidence that those with intellectual disability and more severe ASD do less 
well in adult life (Cederlund et al., 2008; Marriage et al., 2009). Little is known about whether 
adults with intellectual disability and ASD who are receiving services for mental health 
problems have poorer social functioning compared to those with intellectual disability alone. 
Verbal ability, IQ, support characteristics and level of unmet formal support needs appear to 
affect the social functioning of people with ASD. However, the interaction between these 
factors is unclear. 
 
More research on the mental health of adults with intellectual disability and ASD is needed. 
Understanding which service users appear to have poorer mental health, behaviour and social 
functioning than others despite receiving psychiatric treatment, and the extent to which 
having ASD is a contributing factor, should inform the development of more effective 
services and lead to improved outcomes.  
 
Aims and objectives 
 
The thesis aimed to find out whether: 
 Specialist mental health service users with intellectual disability and ASD have a 
different clinical profile compared to those without ASD. 
 
 Specialist mental health service users with intellectual disability and ASD have poorer 
mental health, behaviour and social functioning compared to those without ASD. 
 
The objectives of the thesis were to: 
 Explore whether the mental health needs of adults with intellectual disability and ASD 
are being adequately provided for by specialist mental health services for adults with 
intellectual disability. 
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 Determine whether there is any evidence (from a clinic-based population) to support 
the hypothesis that adults with intellectual disability and ASD have poorer mental 
health and social functioning compared to those without ASD. 
 
To achieve the aims of the thesis, data were collected from a sample of specialist mental 
health service users who had intellectual disability with and without ASD using evidence-
based, standardised methods. A combination of observation, informant interview and case 
note review were used to explore participants‘ characteristics, needs, service use, medication 
use, mental health, behaviour and social functioning. Crucially, the study was able to validate 
existing clinical diagnoses of ASD using gold standard diagnostic assessment. 
 
In addition, a large survey of specialist mental health service users with intellectual disability 
was carried out using routinely collected clinical data. This study was designed to determine 
the extent to which results from participants in the main study were generalisable to the 
clinical population from which they were sampled. 
 
The hypotheses for study were: 
H1:  Participants with intellectual disability and ASD will have a significantly greater 




H2: Participants with intellectual disability and ASD will have significantly poorer health 
and social functioning than those without ASD (as measured by the HoNOS-LD). 
 
H3: Participants with intellectual disability and ASD will have significantly poorer 
mental health than those without ASD (as measured by the DBC
2
). 
                                               
1 Camberwell Assessment of Need for adults with Developmental & Intellectual Disability (Xenitidis et al., 
2003) 
2 Developmental Behaviour Checklist for Adults (Mohr et al., 2004) 
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H4: Participants with intellectual disability and ASD will have significantly higher levels 
of problem behaviour than those without ASD. 
 
H5: Participants with intellectual disability and ASD will have significantly poorer social 
functioning than those without ASD (as measured by a specially devised Social 
functioning scale). 
 
H6:  Participants with intellectual disability and ASD will have significantly higher levels 
of mental health service use than those without ASD (as measured by a Service 
Consumption Score). 
 
H7:  Participants with intellectual disability and ASD will have significantly higher levels 
of medication use than those without ASD. 
 
H8:  In addition to presence/absence of ASD, the mental health and social functioning of 
participants will be associated with unmet needs, level of service use and severity of 
intellectual disability. 
 
The factors included in hypothesis eight were sourced from the literature review. However a 
range of other – potentially confounding – variables will also be explored. These include age, 
gender, ethnicity and type of residence. 
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Chapter 7: Introduction to the methodology 
 
As previous chapters have described, research on the mental health of adults with intellectual 
disability and ASD is in its infancy. This is in part because this area was not previously 
recognised as important but also because of the challenges that face researchers when carrying 
out research with this complex service user group. The lack of earlier research makes 
designing studies difficult; there is a little evidence on which to base decisions about 
eligibility criteria, sample size, measures and analyses. 
 
This chapter has two sections covering general methodological issues and the specific 
methods used in the research studies for the thesis. The first section looks at the range of 
considerations that should be taken into account when conducting research on the mental 
health of adults with intellectual disability and ASD. A number of these are relevant to health 
services research in general where as others are more specific to the participants in these 
studies. Study design, sources of data, recruitment issues and capacity to consent to take part 
in research are discussed. 
 
The second section of the chapter describes the design of the research studies that form the 
thesis; including the participants and the clinical setting from which they are sampled. The 
specific eligibility criteria, procedures, methods of data collection, measures and analyses of 
each study are reported in Chapters 8 and 10. 
 
Research on the mental health of adults with intellectual disability and ASD  
Methodological issues such as diagnosis and assessment have been discussed in previous 
chapters and individual measures will be described later in chapters 8 and 9. There are a 
number of additional, practical challenges that face researchers when including participants 
with complex needs. People with intellectual disability and/or ASD vary greatly in terms of 
Chapter 7: Introduction to methods 
95 
their characteristics and also their ability to understand research, engage with others, make 
decisions and express their views. 
 
Study design 
The research studies were principally descriptive and designed to find out whether users of a 
specialist mental health service for adults with intellectual disability who have ASD are 
different from other service users with regards to their characteristics, mental health and 
social functioning. The aim was to provide a snap-shot of the lives of specialist mental health 
service users who have intellectual disability with and without ASD. As such, the studies 
employed observational, cross-sectional designs. 
 
Data sources 
Using a range of the best available sources and collecting data in a systematic way can 
increase confidence in the findings of research and reduce measurement bias (Prince, 2003). 
Information about participants can be assembled from existing records (e.g. medical notes), 
the person themselves or someone who knows them personally or in a professional capacity. 
The more structured and standardised the method of data collection the easier it is to compare 
individuals or groups of participants. Where available, it is preferable to use existing 
measures that have been methodically developed and tested (Prince, 2003). 
 
Assessment tools may be participant-, informant- or observation-based. Participants can be 
asked to self-rate items on a questionnaire or they can be interviewed face-to-face by a 
researcher. However, this can be difficult for people with intellectual disability and/or ASD 
who may not be able to describe their feelings and experiences or may be unaware of the 
impact their behaviour has on others. They may also have difficulty understanding the 
questions being asked of them. 
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Many people with intellectual disability and/or ASD have limited verbal skills and some are 
unable to speak at all, though they may communicate using other means such as Makaton or 
pictorial aids. In these situations it seems appropriate to ask someone who knows the person 
well to act as their ‗informant‘ and answer questions on their behalf. Though largely accepted 
in mental health research this method of data collection is not without its biases (Stewart, 
2003). 
 
An informant will often be asked to make judgements about an individual‘s thoughts, feelings 
and behaviour. In some situations informants may have reason to under or overplay a person‘s 
problems; perhaps if they feel they are being judged as a carer or if they hope to improve their 
access to services. Informants may be so accustomed to an individual‘s behaviour that they no 
longer consider it challenging or unusual. 
 
This study sought to include individuals with intellectual disability of all abilities and collect 
data using standardised methods. It was important that each measure was suitable for all 
participants. Since there would be some participants who were unable to communicate with a 
researcher it was necessary to choose instruments that were designed to be administered using 
an informant. In the case of assessing whether participants did or did not have ASD, an 
observation based measure was chosen. This was because many informant-based tools rely on 
information about the person‘s early life and it was anticipated that many participants would 
not have an informant who had known them since childhood. 
 
Accessing difficult to reach populations 
Adults with intellectual disability and/or ASD are often socially excluded and may also have 
limited access to services. This can make it difficult to identify potential participants and also 
causes problems when approaching people to take part in research. Individuals may rely on 
other people to open and read their mail, be unable to access a telephone and have limited 
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direct contact with services. Their approachability is often dependent on the willingness of 
others to facilitate their involvement (such as family or paid support workers). This can 
introduce an element of sampling bias if individuals who agree to take part differ from those 
who refuse; e.g. they are more independent or have fewer problems. To reduce this bias a 
range of methods were used to approach participants including letters and face-to-face 
contact. Steps were taken to ensure that all correspondence and information given to 
participants was accessible for people with intellectual disability and ASD. 
 
A further barrier for research is the relatively small proportion of the population that 
individuals with intellectual disability and ASD who have mental health needs represent. This 
has been estimated to be around 0.05% of the general population (see Chapter 3); impeding 
the ability of single site studies to recruit sufficient sample sizes. Having a small number of 
potential participants is likely to make random sampling unfeasible or even unnecessary since 
it will be more practical to approach and attempt to recruit as many people as possible from 
the sample population. Since little is known already about the mental health of adults with 
intellectual disability and ASD it makes sense to develop the evidence base from easily 
defined, clinic-based populations. This should make it easier to identify potential participants 
and assess their eligibility. It also means that researchers can work with service providers to 
approach and recruit participants. 
 
Capacity and consent 
Research on adults with intellectual disability and/or ASD that only included participants who 
have capacity to consent would be restricted to a relatively small proportion of the group it set 
out to study. The sample would not represent the range of individuals seen in service settings; 
introducing omission bias. It would not be reasonable to generalise the findings of studies that 
only included people with less severe intellectual disability. It was therefore decided that the 
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studies for the thesis would be designed to include participants who lack capacity to consent 
to take part. 
 
The Mental Capacity Act (MCA) Mental Capacity Act (MCA), 2005, its accompanying Code 
of Practice (Department for Constitutional Affairs, 2007) and guidance from the British 
Medical Association (2007), Medical Research Council (2007) and Department of Health 
(2008) give clear definitions of capacity and the requirements for research that seeks to recruit 
participants who lack capacity. 
 
A person is said to have capacity to give informed consent to take part in research if they are 
able to demonstrate that they can: 1) understand the information about the research and what 
taking part will involve, 2) retain that information and use it to make a decision about whether 
to take part and 3) convey their decision 
 
Their consent is only valid if the person is acting voluntarily and has been provided with 
sufficient information to enable them to make a decision (Department of Health, 2001a). 
 
A person's capacity to consent may vary from situation to situation and over time. Someone 
who lacks capacity to consent to complex medical treatment may be able to understand and 
decide whether to answer a short questionnaire for a research study. It should be assumed that 
a person has capacity to consent until it is otherwise indicated. 
 
Individuals who lack capacity to consent for themselves can be included in a research study if 
a consultee agrees that they can take part (Medical Research Council, 2007). A consultee is 
someone who knows the participant well and is not connected to the research. In the first 
instance, a personal consultee should be sought (someone who is not paid to care for the 
participant – usually a relative, friend or advocate). If there are no persons able or willing to 
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act as a personal consultee then a nominated consultee can be approached. This can be a paid 
carer provided they are independent of the research. A consultee is provided with information 
about the study, they are asked to consider the wishes and interests of the person who lacks 
capacity and whether they would be content to take part or whether doing so might upset them 
(Department of Health, 2008). 
 
Summary of methodological issues 
The issues described in this section contribute to the well-established difficulties encountered 
when recruiting participants with intellectual/developmental disability into research projects 
(Martin et al., 2005; Oliver et al., 2002). Chapters 2 to 6 demonstrated the relative lack of 
research on the mental health and service use of adults with intellectual disability/ASD and 
the likely reasons for this. Other challenges to the development of the evidence base include 
the complexity of services and delivery of interventions for this group and unwillingness 
among providers to take part in research or evaluate their services (Oliver et al., 2002). 
 
Introduction to the research components of the thesis 
 
Design 
The thesis is based on cross-sectional data from a clinic-based population. 
 
Participants 
Data were collected from users of a specialist mental health service for adults with intellectual 
disability. 
 
Two groups of participants were compared: 
 
1) Adults with intellectual disability who have ASD (ASD) 
2) Adults with intellectual disability who do not have ASD (no ASD) 
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A third set of participants was identified: adults with intellectual disability who have traits, 
features or behaviours consistent with ASD but no formal clinical diagnosis. 
 
In some cases this group‘s ASD traits had been identified prior to the study and were 
mentioned in their mental health record. In other cases the presence of ASD traits only 
became apparent during the assessments carried out for the study. Data from these 
participants were analysed separately (see Chapter 11). 
  
The two studies for the thesis were: 
 
1) An in-depth comparison of participants with and without ASD using standardised 
measures to collect data from a sample of service users. 
2) A supplementary comparison of those with and without a clinical diagnosis of 
ASD using anonymised data from an entire clinic population. 
 
Clinical setting 
All participants were users of a specialist, multi-disciplinary, community-based mental health 
service for adults with intellectual disability. This Mental Health in Intellectual Disability 
(MHID) service is provided by the South London and Maudsley NHS Foundation Trust 
(SLaM) (Chaplin et al., 2010a). SLaM provides mainstream and specialist mental health 
services to the London boroughs of Croydon, Lambeth, Lewisham and Southwark.  
 
This area has a population of just over 1 million people (Stewart et al., 2009). Lambeth, 
Lewisham and Southwark are among the ten most deprived boroughs in London, while 
Croydon is ranked 20
th
 (Department for Communities & Local Government, 2007). Lambeth, 
Lewisham and Southwark have higher numbers of people from Afro-Caribbean backgrounds 
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than the national average (around 24% compared with 3% for the England and 11% for 
London) where as Croydon is more in line with London-wide statistics (13%) (Office for 
National Statistics, 2001). 
 
The MHID service is made up of specialist community psychiatric nurses (CPNs who have 
received mental health in intellectual disability training) and intellectual disability 
psychiatrists. The service provides community psychiatric assessment, intervention and 
follow-up. This can include referral to local Learning Disability Partnerships who employ 
specialist psychologists, behavioural support workers, occupational therapists and speech & 
language therapists. 
 
Services are provided through psychiatry outpatient appointments/home visits and outreach 
nursing (Chaplin et al., 2006). Medication is prescribed to service users via their general 
practitioners (GPs). Service users who require an enhanced level of input are placed on the 
Care Programme Approach (CPA). 
 
The MHID service accepts referrals from primary care, social services/community services 
for adults with intellectual disability and generic adult mental health services (Bouras et al., 
2003). When a referral is received, the eligibility of the individual is considered and if 
appropriate they are invited for a multi-disciplinary assessment with an intellectual disability 
psychiatrist and a CPN (see eligibility criteria below). At the initial appointment, eligibility 
for the service and any existing diagnoses are reassessed. Information on the person‘s history 
and current mental state is gathered using a structured assessment package (Chaplin et al., 
2006). This is used as the basis for diagnostic formulation according to ICD-10 criteria 
(WHO, 1992). A broad range of elements of a service users‘ presentation are assessed 
including: 
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 Presence and severity of intellectual disability 
 Presence of a psychiatric disorder or challenging behaviour 
 Presence of any additional disorders including ASD 
 Presence of any physical/sensory disabilities or health problems 
 
This information is recorded in the service user‘s mental health record and in follow-up letters 
to the referrer and other relevant parties including the person‘s GP. 
 
Eligibility criteria 
Individuals are eligible for the MHID service if they:  
 
 1)  are over 18 years of age, 
 2) are resident in Croydon, Lambeth, Lewisham or Southwark, 
3)  have a diagnosis of intellectual disability (defined as IQ below 70 and 
significant social impairment; both present from childhood) 
and 4)  have an additional mental health problem and/or significant risk 
behaviour (defined as any mental disorder included in any classification 
system or challenging behaviour that requires psychiatric mental health 
intervention). 
 
The presence of ASD in addition to intellectual disability is not sufficient to meet the fourth 
inclusion criteria; adults with intellectual disability and ASD must have an additional mental 
health problem or challenging behaviour to be eligible for the service. Adults with ASD who 
have mental health problems or challenging behaviour are only eligible if they have 
intellectual disability. 
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Following the initial assessment, patients are accepted on to the service‘s caseload or 
discharged back to their GP. A care plan is devised for people accepted into the service that 
sets out the decisions made about their care. This includes whether they will be placed on 
CPA, how often they will be seen and by whom, whether they will be referred to any other 
services and what treatment they will receive. 
 
Service users are seen by appointment at weekly outpatient clinics or where necessary at 
home. MHID does not operate an emergency service or out-of-hours appointments. Service 
users not on CPA are offered appointments with an intellectual disability psychiatrist or CPN 
from a once yearly review up to around every 3 months or more often if required. Those who 
are on CPA have contact with a CPN by outpatient or home visit once every two weeks. 
Many service users also see their CPN regularly for administration of depot medication. There 
is no limit on the length of time that an individual can remain on the service‘s caseload. 
 
Clinical data 
All SLaM service users' mental health records are managed using the electronic Patient 
Journey System (ePJS). This is a computerised online application which replaced paper 
records in 2006 (Stewart et al., 2009). Information is recorded and stored in defined fields, 
entered as text or uploaded as attachments. Paper records from before 2006 have been 
digitally archived and added to service users‘ ePJS files. 
 
All contacts, events concerning service users, referrals, discharges, correspondence regarding 
service users and the results of clinical assessments are recorded on ePJS as well as socio-
demographic and clinical information (including diagnoses according to ICD-10 categories, 
current medication and care plans). 
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It is MHID policy to routinely measure clinical outcome using the Health of the Nation 
Outcome Scales for People with Learning Disabilities (HoNOS-LD; Roy et al., 2002). The 
HoNOS-LD should be administered at initial assessment, before a review (CPA/6 month 
review or crisis review) or on discharge from the service (Chaplin et al., 2006). Each 
assessment is recorded on ePJS. 
 
Summary of the research components for the thesis 
The MHID service is a good example of a well-developed specialist mental health service for 
adults with intellectual disability (Chaplin et al., 2010a). It may not be typical of services 
within the UK but it offers a number of advantages for research: 
 
 Well-defined eligibility criteria. 
 Access to a large number of service users in a compact geographical area. 
 Multi-disciplinary assessment by specialist clinicians. 
 The use of standardised diagnostic criteria (ICD-10; WHO, 1992). 
 Clear care pathways and protocols (see www.estiacentre.org/workingpapers.html) 
 The use of standardised outcome assessment (HoNOS-LD; Roy et al., 2002). 
 Standardised and electronic recording of clinical mental health records. 
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Chapter 8: Methodology 
 
This chapter describes the method of the main study for the thesis. The study aimed to collect 
a broad range of data on participants‘ characteristics, needs, service use, mental health, 
behaviour and social functioning.  A standardised diagnostic assessment was used to confirm 
whether or not participants had ASD. 
 
Participants 
The study included individuals who were accepted service users on the Mental Health in 
Intellectual Disability (MHID) service caseload between January 2009 and December 2010 
(see chapter 7 for the service‘s eligibility criteria). 
 
Sampling 
The mental health records of service users were reviewed to identify a) those with a 
documented clinical diagnosis of ASD, b) those described as having autistic 
traits/features/behaviours and c) those without any mention of ASD. 
 
The study focussed on Lambeth, Lewisham and Southwark (LLS) service users and did not 
initially seek to recruit participants from Croydon. This was because at the time of the initial 
screen for service users for with ASD, the mental health records for Croydon service users 
were not available on the electronic Patient Journey System (ePJS). 
 
It was thought that there would be sufficient numbers of participants on the LLS caseloads 
(N≈500) to recruit the planned sample size of 50 participants with ASD and 50 without ASD. 
All LLS service users with a documented clinical diagnosis of ASD who were eligible for the 
study were approached to take part. 
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Eligibility criteria 
The inclusion criteria for the study were that a participant was: 
 
 1)  an accepted service user on the MHID caseload between January 2009 
  and December 2010 (see chapter 8 for the service‘s eligibility criteria) 
and  2)  willing to provide informed consent (or a consultee was willing to   
  assent if a participant lacked capacity). 
 
The exclusion criteria for the study were that a participant was: 
 
 1) subsequent to being accepted, deemed ineligible to receive MHID   
  services and was due to be discharged, 
 2) yet to be assessed or had no information in their mental health 
record to determine whether they had a clinical diagnosis of ASD, 
 3)  currently an inpatient in hospital or resident at a secure unit, 
 4)  currently placed ‗out of area‘ (i.e. in a residential or treatment facility  
  outside of Croydon, Lambeth, Lewisham or Southwark), 
or  5)  considered by their care co-ordinator to be unsuitable for the research project. 
 
The study then employed a systematic process of confirming participants‘ eligibility for each 
group with and without ASD. 
 
Eligibility for ASD group 
The inclusion criteria for the ASD group were that a participant: 
 
1) had a clinical diagnosis of ASD documented in their mental health record. 
and  2) exceeded the threshold for ASD on the Autism Diagnostic Observation 
Schedule (ADOS) or there was evidence they met ICD-10 criteria for ASD 
according to a review by an intellectual disability psychiatrist (see Assessment 
of ASD, page 113). 
Chapter 8: Method 
107 
Eligibility for group without ASD 
The inclusion criteria for the group without ASD were that a participant: 
 
1) had no mention of ASD, autistic traits, behaviours or features in their mental 
health record 
and 2) scored below the threshold for ASD on the ADOS or there was evidence  they 
 did not met ICD-10 criteria for ASD according to a  review by an intellectual 
 disability psychiatrist 
 
Ethical approval 
The study was granted ethical approval by the St Thomas‘ Research Ethics Committee in June 
2008 (reference: 08/H0802/52). The study was also approved by the Institute of Psychiatry 
Research and Development Office (reference: R&D2008/024). Substantial amendments to 
include a wider range of measures and recruit participants from a larger sample base were 
granted in November 2008 and November 2009 respectively (see Appendix IV). 
 
Capacity and consent 
It was anticipated that many participants would lack capacity to give informed consent 
because of their intellectual disability, ASD or mental health problem. The study was 
therefore designed to include participants who were unable to consent to take part in research. 
 
The study first sought the opinion of individuals' care coordinators and carers on whether the 
person had capacity to decide whether to take part in the study. This was followed up by the 
completion of a capacity checklist by an experienced researcher when they met the participant 
(see Appendix V). If a participant was unable to meet the criteria for capacity to consent, a 
personal consultee (unpaid carer, family member or friend) was sought. A nominated 
consultee was sought in cases where an individual had no family, unpaid carer or advocate 
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who was willing to act as a consultee. Consultees were asked to discuss the study with the 
service user and/or any other relevant people. If they agreed that the person could take part 
they were asked to sign an assent form. 
 
Procedure 
Recruitment began in January 2009. A list of service users with a clinical diagnosis of ASD 
was obtained from a database used in previous research (Bouras et al., 2003). The ePJS was 
searched to find those on the current caseload and obtain their contact details. From 
November 2009 the sample was extended to include participants on the current caseload who 
had not taken part in the previous research. The list of people on the caseloads was updated 
throughout 2010 to add any new service users. 
 
Identification of service users with and without a clinical diagnosis of ASD 
The ePJS was used to screen the mental health records of potential participants for the study. 
The researcher looked for any mention of ASD, ‗autistic traits‘ ‗autistic behaviours‘ or 
‗autistic features‗ in the diagnosis section of ePJS, in correspondence to the service user's GP, 
in care plans or if, these were not available, in any document written by a health or social 
service professional involved in the person's care. 
 
Following this screen, service users were put into three groups. Service users in groups one 
and two were considered for inclusion in the study. 
1) Individuals with a clinical diagnosis of ASD documented in their mental health record. 
2) Individuals for whom there was no mention of ASD, autistic traits, behaviour or 
features in their mental health record. 
3) Individuals with a provisional diagnosis of ASD that was yet to be assessed and 
service users who were said to have autistic traits, behaviours or features not reaching 
the criteria for a diagnosis of ASD or not formally assessed. 
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Recruitment 
Service users were approached by post or in person when they attended an outpatient 
appointment. Potential participants were given a letter from a consultant psychiatrist from the 
MHID service. Also enclosed were a Service User Participant Information Sheet, reply form 
and stamped addressed envelope. All correspondence and information sheets were designed to 
be accessible for people with intellectual disability. They were developed in consultation with 
Steve Hardy (Estia Centre, King‘s College London) who is a specialist in education and 
training on the mental health of adults with intellectual disability. 
 
Service users who were interested in taking part in the study were asked to contact the 
researcher team by telephone, email or using a reply form given to them with the study 
information. A researcher arranged to meet the participant and their informant to carry out a 
capacity assessment and where appropriate the informant interview and ASD assessment for 
the study. 
 
Informed consent was obtained from all participants who had capacity and agreed to take part 
(see Appendix V for the service user letters, participant information sheet and consent/assent 
form). Where a participant did not demonstrate capacity to consent, a consultee (a person 
well-known to the service user who was not connected to the research programme) was 
appointed to decide and give assent on their behalf. 
 
Matching procedure 
For every individual with ASD attempts were made to recruit a matching participant without 
ASD. Matches were made on a case-by-case basis according the priorities and categories 
listed below. 
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Primary matching criteria in order of priority: 
 
Severity of intellectual disability Exact match (mild/moderate/severe) 
Gender    Exact match (male/female) 
Age     As close as possible (preferably within 5 years  
     but up to 10 years or beyond if necessary) 
 
If several matches were available additional criteria were employed to choose which potential 
participant would be approached. 
 
The secondary matching criteria were: 
 
Psychiatric disorder  Presence/absence of a diagnosis (where present;   
    specific disorder or type of disorder
1
) 
Type of residence  Living independently/with family/in a residential placement 
Ethnic group   Afro-Caribbean//white/other or unclear 
 
When a suitable participant with no clinical diagnosis of ASD was recruited to the study they 
were assessed using the eligibility criteria described above. If a participant did not meet the 
study criteria for ‗no ASD‘ they were excluded and a replacement who was the next best 
match was approached. 
 
Selection, recruitment and assessment of those without a clinical diagnosis of ASD continued 
using this process until it was necessary to approach participants who were not good matches 
to those in the ASD group. This was because there were no suitable matching candidates 
among the remaining sample of potential participants. When there were no further 
                                               
1 psychotic or bipolar disorder/depression or anxiety disorder/dementia/other disorders 
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participants without a clinical diagnosis of ASD left to approach from the Lambeth, 




The selection of measures used in the study took into account whether there was an evidence-
base or precedent for the tool‘s use in research on adults with intellectual disability. The 
instruments employed were selected on the basis that they: 
 
 Were suitable for use with adults 
 Were suitable for all severities of intellectual disability 
 Were designed for or could be used for interviews with lay informants who knew the 
participant and their current behaviour well but did not necessarily have information 
about their earlier life or developmental history 
 Could be completed by a trained and experienced researcher 
 When used together would not take longer than three hours to administer 
 
The measures used in the study are listed below. The method of data collection for each 
measure is denoted by the following superscripts: 1) Informant interview, 2) Case note review 
and 3) Observational assessment. See Data collection  below for more details on these 
methods. 
 
See Appendix V for copies of non-standardised measures: service user profile form, 
informant profile form and review of participants‘ mental health record. 
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Socio-demographic and clinical characteristics 
Socio-demographic characteristics: 
 
Intellectual disability diagnosis: 
Service user profile form
1 
Mental health record (ePJS)
2 
ICD-10 diagnosis according to ePJS record
2
 
ASD assessment: ICD-10 diagnosis according to ePJS record
2
 
Autism Diagnostic Observation Schedule (ADOS; 
Lord et al., 1989)
3 
Social Communication Questionnaire (SCQ; 
Berument et al., 1999)
1 




Needs, service use and interventions 
Needs: CANDID (Xenitidis et al., 2000)
1
 




Mental health service use and 
medication: 
 
Mental health record (ePJS)
2
 
Primary health care, other healthcare, 






Mental health and problem behaviour 
Psychiatric disorder: Mental health record (ePJS)
2
 
Health and social functioning: HoNOS-LD (Roy et al, 2002)
1 
Mental health: Developmental Behaviour Checklist for Adults 
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Social functioning 
Communication, community life, 














Assessment of intellectual disability 
The study relied on the clinical assessment of participants‘ severity of intellectual disability 
by specialist intellectual disability psychiatrists according to ICD-10 criteria. Anyone 
referring an individual to the MHID service must provide evidence that the person has an IQ 
below 70 before they will be considered for an assessment (Chaplin et al., 2006). Where there 
was evidence from a participants‘ mental health record that their level of functioning had been 
assessed using a standardised psychometric test, the results were cross-checked with their 
clinical diagnosis. 
 
Assessment of ASD 
Initial selection and allocation to study group according to presence or absence of ASD was 
made on the basis of routine clinical assessment according to ICD-10 criteria. This was 
sourced from participants‘ mental health records and recorded during the recruitment process 
(see Procedure above). 
 
Diagnostic ASD assessment 
Confirmation of the presence or absence of ASD was established using the ADOS (Lord et 
al., 1989). Four methods of diagnostic assessment were considered: ADI-R, ADOS, DISCO 
and 3Di. The ADOS was chosen as it could be used for all participants; not just those with an 
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informant who knew their developmental history. It is also the only instrument that involves 
direct contact with the person being assessed rather than reliance on an informant. 
 
As reported in Chapter 2, the ADOS is considered one of the ‗gold standard‘ methods of 
carrying out a diagnostic ASD assessment and is recommend by clinical guidelines for adults 
with ASD (NICE, 2012). It comprises four modules; one of which is chosen based on the 
participant‘s verbal ability. An ADOS assessment takes around 45 minutes to complete. A 
trained administrator attempts to engage the participant in a series of ‗presses‘ and rates their 
social communication, interaction and behaviour (Lord et al., 1989). The presses range from 
response to name (module 1) to discussing emotions (module 4). The assessor also uses the 
presses to observe the person‘s use of eye contact or gestures, the quality and frequency of 
their social responses and whether they initiate interaction. All assessors using the ADOS for 
research purposes must have completed an official training course. 
 
Under the following circumstances an ADOS assessment was not carried out: 
 
 1) the participant refused, 
 2) the participant‘s consultee refused,  
 3) the participant‘s level of functioning was below that at which an ADOS can be 
 carried out (e.g. equivalent to under 18 months old) 
or 4) the participant had a physical disability or sensory impairment such that it was 
 not possible for them to complete the tasks that form the ADOS assessment. 
 
Additional ASD assessment 
It was anticipated that it would not be possible to assess all participants using the ADOS 
therefore an ASD assessment was included in the informant interview. Tools identified in the 
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literature review that were suitable for adults with intellectual disability were considered: the 
ASDASQ, ASD-DA, PDD-MRS and SCQ (see Chapter 2). The SCQ was chosen as it is 
suitable for all levels of functioning and was designed to be completed by a lay informant 
rather than an observing clinician. 
 
The SCQ was developed from the Autism Screening Questionnaire as a brief ASD screening 
tool for children (Berument et al., 1999; Rutter et al., 2003). It has two versions; the lifetime 
form covers the individual‘s developmental history and has content parallel to the ADI-R, 
where as the current form looks at behaviour over the last three months. The SCQ is designed 
to be completed by a parent or carer. It has one item on whether the individual is able to talk 
in short phrases then 33 (if the person is non-verbal) or 39 items (if the person is verbal) with 
yes/no responses, which depending on the direction of the question, score either 0 or 1. The 
total SCQ score is calculated by adding the total number of 1s scored. 
 
Review of participants without an ADOS result 
A consultant intellectual disability psychiatrist reviewed participants who could not complete 
an ADOS assessment. A file was compiled for each person comprising the completed 
schedules from the informant interview and case note review (including the SCQ). Additional 
information was sourced from ePJS; such as all available details of the participant‘s clinical 
diagnosis of ASD (for those in the ASD group), outpatient follow-up letters to their GP and 
any other relevant reports or assessments.  
 
ICD-10 Diagnostic Criteria for Research (WHO, 1993) were used to confirm that: 
 
1. participants in the ASD group met the criteria for ASD 
2. participants in the ‗no ASD‘ group did not meet the criteria for ASD 
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Assessment of Needs 
The Camberwell Assessment of Need was developed to measure the needs of people with 
severe mental illness (Slade et al., 1999). Four variants have been developed: CANDID for 
adults with developmental and intellectual disability; CANE for the elderly; CANFOR for 
forensic settings and CAN-M for mothers. Each assessment has three versions: clinical, 
research and short appraisal schedule. The CANDID was designed for people with intellectual 
disability who have mental health problems. It is designed to provide a multi-perspective 
assessment of need from the individual themselves, a member of staff and an informal carer 
(Xenitidis et al., 2003). 
 
The CANDID covers 25 areas of need, each are rated according to whether in the last four 
weeks there was: no need (no serious problem in this area and no help given); met need 
(appropriate help being given for a particular problem) or unmet need (a serious problem and 
no help currently being given or a serious problem despite help being given). For each 
perspective three scores are calculated: 1) total number of met needs, 2) total number of 
unmet needs and 3) total number of needs (total of 1 and 2).  
 
The CANDID has been used to measure the needs of adults mental health service users with 
intellectual disability (Hall et al., 2006; Martin et al., 2005). It has also been used with older 
people with intellectual disability in the UK (Strydom et al., 2005) and Ireland (McCausland 




Data on service use were collected from mental health records and during an informant 
interview using the Client Service Receipt Inventory (CSRI). All contacts with health or 
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social services recorded on ePJS were extracted for the 12 month period prior to the informant 
interview. These included outpatient appointments, home visits and face-to-face meetings 
with the participant and/or their carers. Data were recorded on the profession of the clinician 
and the service they worked for. Visits to non-mental health services (e.g. GP or hospital 
appointment) were also recorded. 
 
Client Service Receipt Inventory (CSRI) 
The CSRI was developed as a method of collecting data on service use and related 
characteristics of people with mental disorders (Chisholm et al., 2000). Although designed to 
be used for mainstream health and social care services the CSRI is adaptable for specific user 
groups. The questionnaire is completed with the participant or an informant and covers socio-
demographics, usual living situation, employment and income, service receipt and medication 
profile. 
 
The CSRI is widely used to evaluate economic costs of service use in both research and 
clinical settings (Beecham & Knapp, 2001). It has been used in several studies on the service 
consumption of adults with intellectual disability or ASD (Felce et al., 2008; Hallam et al., 
2006; Jarbrink & Knapp, 2001; Knapp et al., 2005; Knapp et al., 2009). Studies have found 
good agreement between data collected on number of visits to health professionals using the 
CSRI and case records (Patel et al., 2005). 
 
Service Consumption Score (SCS) 
An adapted version of service consumption score (SCS) was used to look at the relative 
mental health service use of those with and without ASD (Lavik, 1983). Similar methods have 
been used before to investigate mental health service use among adults with intellectual 
disability (Driessen et al., 1997; Spiller et al., 2007). 
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It was anticipated that contact with mental health services would vary widely and involve 
combinations of different clinicians, outpatient appointments, home visits, meetings in the 
community and inpatient stays. Because of this complexity, a crude measure of service use 
was adopted where each contact was assigned one ‗point‘ regardless of where it occurred or 
with whom. SCS included each contact with a MHID psychiatrist, MHID CPN, psychologist, 
behaviour support worker, mainstream mental health service and psychiatric inpatient stays. 
 
Mental health and behaviour problems 
The study explored existing clinical diagnoses of psychiatric disorder as well as standardised 
measures of mental health and behavioural symptoms. 
 
Psychiatric diagnoses 
The study relied on routine clinical assessment of whether participants had an additional 
psychiatric disorder. This was carried out by specialist intellectual disability psychiatrists 
according to ICD-10 criteria. Currently, there is no ‗gold standard‘ diagnostic assessment of 
mental health for adults with intellectual disability (see Chapter 2). The most robust diagnoses 
are likely to be those made through “Comprehensive, specialist psychiatric assessment using 
standardised diagnostic criteria from a longitudinal perspective incorporating life events, 
past abuse and other medical issues.” (Bradley et al., In press). 
 
The analyses focussed on the primary disorder for which the participant was receiving mental 
health services regardless of whether this was in remission at the time of the review. If a 
participant had not received a diagnosis of any additional psychiatric disorder it was assumed 
they were receiving specialist mental health services for impairment of behaviour. 
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Health of the Nation Outcome Scales for people with Learning Disabilities 
The Health of the Nation Outcome Scales (HoNOS) are a set of measures developed by the 
Royal College of Psychiatrists. They were designed for the Department of Health to measure 
the health and social functioning of people with severe mental illness (Royal College of 
Psychiatrists, 2006). A number of adapted scales for specific groups have been derived 
including the HoNOS-LD for people with learning disability (Roy et al., 2002). 
 
The HoNOS-LD has 22 items covering a range of domains. Each item is rated from 0 (no 
problem) to 4 (very severe problem). Items are rated at the current level achieved with 
existing support. Thus a person who is unable to wash or dress themselves may still score 0 
on level of self-care if their appearance and personal hygiene are well maintained albeit with 
help from others. The questionnaire is designed to be completed by a trained administrator in 
an interview with the individual themselves or an informant. Ratings are based on the last four 
weeks. A total score is calculated by adding the scores of all 22 items. A higher total score on 
the HoNOS-LD indicates lower health and social functioning (Roy et al., 2002).  
 
The HoNOS is used widely in clinical practice and research (Pirkis et al., 2005) and forms the 
basis of the clustering and outcome measurement for Payment by Results (Department of 
Health, 2010d). The HoNOS-LD is used by many mental health in intellectual disability 
services and as an outcome measure in research (Baker & Daynes, 2010; Hillier et al., 2010; 
Tenneij et al., 2009; Sakdalan et al., 2010). 
 
The HoNOS-LD is a broad measure; it contains some items that are likely to change over time 
and others which tend to remain more stable (Roy et al., 2002). The magnitude of change in 
mean total score is not thought to be associated with severity of intellectual disability (Roy et 
al., 2002). The HoNOS-LD has been reported to have good reliability and validity (Tenneij et 
al., 2009). It has been recommended as a well-validated measure which should be used by 
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research studies to evaluate outcomes for adults with intellectual disability who have mental 
health problems (Prakash et al., 2007). There is no evidence on whether the HoNOS-LD has 
different properties when used with adults with intellectual disability and ASD. 
 
Two studies have carried out factor analyses of the HoNOS-LD. The first was a study of 155 
community intellectual disability service users that identified four factors (Skelly & 
D'Antonio, 2008). These were: communicative-cognitive competence; behaviour disturbance 
incorporating relationship breakdown; loss of adaptive behaviour incorporating acute physical 
illness and internal dysregulation. These factors accounted for 48% of the variance among 
responses with each factor explaining 9-15% of the variance. No further psychometric 
properties were provided. 
 
A more recent study sourced HoNOS-LD data from 2032 mental health service users 
(Tsakanikos et al., In preparation). In this analysis, three subscales were identified: Neuro-
cognitive functioning, Mental health/behaviour and Health/social functioning. These factors 
accounted for 43% of the variance with each factor explaining 7-26% of the variance.  The 
internal consistency of these factors according to Cronbach‘s alpha ranged from 0.76 to 0.8 
(see Appendix I). 
 
The HoNOS-LD was designed for individuals with mental health problems rather than as a 
generic outcome tool for adults with intellectual disability. Given this and the greater number 
of participants on which the analysis was based, the factors identified by Tsakanikos et al. (In 
preparation) were used for the clinical study data. 
 
Six items within the HONOS-LD focus on problem behaviour: problems directed towards 
others, self-injury, behaviour destructive to property, problems with personal behaviours, 
rocking, stereotyped & ritualistic behaviour and others. These items were used to form a 
HoNOS-LD problem behaviour subscale. 
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Developmental Behaviour Checklist 
The review of assessment tools carried out for Chapter 2 found that there are three types of 
measure: purely psychiatric, purely behavioural and a combination of mental health and 
behaviour problems (Unwin & Deb, 2008). The Developmental Behaviour Checklist for 
adults (DBC) was chosen to measure participants‘ overall psychopathology (Einfeld & Tonge, 
2002). This was based on the strength of the evidence for its psychometric properties and its 
suitability for all ranges of intellectual disability severities (Mohr et al., 2004). Of the mental 
health assessments reviewed in Chapter 2, the DBC was the only measure that provided a 
total score of psychopathology. The PAS-ADD, PIMRA and DASH are screening and 
diagnostic tools that provide subscale scores and dichotomous outcomes of disorder/no 
disorder rather than a continuous measure of current symptomatology. 
 
The DBC contains a number of behavioural items in addition to mental health symptoms. 
Many of these are identical or similar to items in other behavioural measures. For example, 
nearly all of the 58 ABC items are included in the DBC (Mohr et al., 2005). Total scores on 
these two scales are highly correlated (ibid). 
 
The DBC-A has 108 behaviours or problems, listed alphabetically, and one final item on 
whether the person has problems with feelings or behaviour, in addition to problems with 
their development. Each items is rated ―0‖ if it has not been true/has not occurred in the last 
six months, ―1‖ if it has been somewhat true or sometimes occurs and ―2‖ if it is very true or 
often occurs. 
 
The authors have suggested three cut-off scores of the Total Problem Behaviour Score 
(TPBS) on the DBC-A that indicate psychiatric ‗caseness‘ (Mohr et al., 2004). A threshold of 
96 was found to be 100% specific compared with clinical judgement.  Using a cut-off of 51; 
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the scale had a specificity of 50% and sensitivity of 87%. At a cut-off of 31 the specificity 
was 6% and sensitivity was 100%. 
 
Six DBC-A subscales have been identified by factor analysis: Disruptive, Self-absorbed, 
Communication disturbance, Anxiety/anti-social, Social relating and Depressive. There is no 
information on what constitutes a clinically significant difference in DBC-A scores. The 
manual of the 96-item DBC-P suggests that a change of 17 points or more on the TPBS can 
be attributed to an actual change in behaviour (Einfeld & Tonge, 2002). Translated according 
to the number of items in the DBC-A this would suggest that a difference of 19 points is 
clinically significant. 
 
DBC mental health and problem behaviour subscales 
It was recognised that the DBC is a broad measure that includes both mental health and 
behavioural symptoms as well as a number of ASD characteristics. As such, efforts were 
made to separate out the different types of items. A researcher and consultant intellectual 
disability psychiatrist reviewed the DBC items to determine which category each belonged to 
(mental health or behaviour). To aid this review, the items were compared with behaviours 
and symptoms included in other scales. 
 
Comparative mental health measures: depression, psychosis and anxiety subscales of the 
DBC for children, Mini PAS-ADD and DASH-II mental health subscales (Anxiety, 
Depression, Mania and Psychotic disorder). 
 
Comparative problem behaviour measures: Aberrant Behaviour Checklist, Challenging 
Behaviour Checklist, DAS-B, Behaviour Problem Inventory and DASH-II behaviour 
subscales (stereotypes/tics, self-injurious behaviours and impulse control/miscellaneous 
behaviour problems). 
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Following this review, the DBC items were split into two categories – 1) Mental health 
problems (34 items) and 2) Behaviour problems (72 items) (see Appendix VI). 
 
Social functioning scale for adults with developmental disability 
A scale of social functioning for adults with developmental disability was specially devised 
for the study. Items included in the scale were derived from the informant interview including 
the CSRI and HoNOS-LD. The scale was developed following a review of the measures 
described in Chapter 4, particularly those used by Howlin (2000; 2004) and Lotter (1978) (see 
Appendix V).   
 
These measures used information extracted from other measures rather than direct collection 
of data. They have been widely used and were developed specifically to explore adult 
outcome for people with ASD. However they were not designed for people with intellectual 
disability and many of the items relate to functioning in such a way that individuals with more 
severe intellectual disability will always appear to have poor social functioning (Levy & 
Perry, 2011) . 
 
None of the existing measures appeared suitable for comparing specialist mental health 
service users who have intellectual disability with and without ASD. Therefore a new 
measure of social functioning was developed with items that could be extracted from the tools 
used by the study. The criteria for the item ratings of the scale were carefully chosen based on 
the principle it should be achievable for an individual with any severity of intellectual 
disability to have a rating of excellent social functioning. 
 
An expert with intellectual disability advised on the development of the scale. Wendy Perez is 
a self-advocate who runs her own company providing consultation on person-centre planning, 
improving accessibility and citizenship for people with intellectual disability (Holman, 2005). 
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She has advised on a number of service development and policy documents including Valuing 
People and Better Services for People with ASD (Department of Health, 2006a; Dowling et 
al, 2006; Hall et al, 2008; Hollins & Perez, 2000: Royal College of General Practitioners, 
2010). 
 
The Social functioning scale covers five domains: structured activity, independence, social 
life, community life and communication. Each domain has four levels. Table 8.1 and Table 
8.2 (overleaf) show how the items are scored and how they contribute to an overall social 
functioning rating of Excellent, Good, Fair, Poor or Very Poor. 
 
Table 8.1 Items included in the social functioning scale for adults with developmental disability 
Sub-scale Score  




In paid, supported or voluntary work, at college or in training for ≥0.6FTE* 
In paid, supported or voluntary work, at college or in training for ≥0.2 FTE but <0.6 
FTE or other structured activities ≥0.6 FTE 
In paid, supported or voluntary work, at college or in training for <0.2 FTE or other 
structured activities <0.6 FTE 





Lives independently and is able to go out unsupervised 
Does not live independently but is able to go out unsupervised 
Unable to go out unless supervised 
Unable to go out regularly 




Regularly sees friends and does not feel lonely 
Has friends but doesn‘t see them regularly or regularly sees friends but frequently 
feels lonely or isolated 
Has no particular friends but does not feel lonely or isolated 
Has no friends and feels lonely or isolated or has no friends and has minimal social 
interaction 




Regularly accesses a range of amenities in the community 
Limited access to a range of amenities in the community 
Access to only one type of amenity in the community 





No communication needs 
Some communication  problems but able to needs to familiar people 
Difficulties expressing needs but able to understand other people 
No verbal or non-verbal communication and unable to understand other people 
* Full time equivalent=35 hours per week 
 
Table 8.2: Scoring of the social functioning scale for adults with developmental disability 
Rationale for score Score Level of social functioning 
Excellent on at least three items and no rating of poor 13-15 Excellent 
Average score at least equivalent to good 10-12 Good 
Average score more than adequate but less than good 6-9 Fair 
Average scores less than or equivalent to adequate 3-5 Poor 
Poor on three or more items and no rating of excellent 0-2 Very poor 
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Data collection 
The data were collected in three phases: an interview with an informant, observational ADOS 
assessment and a case note review of participants‘ mental health records. On recruitment to 
the study each participant was assigned a unique identification number (study ID). Material 
containing information about participants (included the data collection schedules) was kept 




Most of the data were collected during face-to-face interviews with informants. Participants 
(or where appropriate their carers) were asked to nominate the person who knew them best. 
This was usually a family member - when the participant lived with family; a keyworker or 
support worker - when the participant lived in a residential placement; or a community 
keyworker or support worker - when the person lived independently. At the request of the 
participant, their informant could also be a close friend or a health/social care professional 
who knew them well (e.g. their community psychiatric nurse). 
 
Eligibility criteria for informants were that they had known the participant for at least three 
months and had contact with them at least once a fortnight. Participants were given the 
opportunity to attend the informant interview if they wished to. Informant interviews usually 
took place at the participant‘s home or the York clinic (Guy‘s Hospital) but could be carried 
out elsewhere at the request of the participant or the informant. All informants were given an 
information sheet and asked to sign a consent form. In some cases the informant was the same 
person that had acted as a consultee and given assent for the participant to be included in the 
research. 
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The following measures were administered at the informant interviews: service user profile, 
informant profile, CANDID, CSRI, DBC, HoNOS-LD and SCQ. The informant interviews 
were carried out by an experienced researcher between January 2009 and March 2011. The 
researcher received training on administering the informant interview measures from a 
consultant intellectual disability psychiatrist. 
 
Observational ASD assessment 
All participants were asked to attend an ADOS assessment. Where possible this took place at 
the York clinic, Guy‘s Hospital. In some cases the assessment took place at the participant‘s 
usual outpatient clinic. Where the person was unable to travel to any of these locations, the 
assessment was carried out in a suitable place at their home. Selection of the appropriate 
ADOS module was based on information provided at the informant interview. Modules 1 and 
2 were carried out with a carer present if appropriate, modules 3 and 4 were carried out with 
the participant alone unless they specifically asked for a carer to be present. With the 
participant‘s consent (or where appropriate consultee‘s assent) the ADOS assessments were 
video recorded. 
 
The ADOS assessments were carried out by five examiners between November 2009 and 
April 2011. All had completed official ADOS training including post-course requirements. 
One of the assessors was a researcher, one was a consultant intellectual disability psychiatrist, 
two were senior trainee intellectual disability psychiatrists and one was an assistant 
psychologist. All assessors had experience of working and carrying out research with adults 
with intellectual disability and/or ASD. 
 
Reliability and consensus coding 
The ADOS assessors met to view and code video recordings of the assessments. At these 
meetings a consensus coding and ADOS diagnosis (ASD or no ASD) was achieved. 
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Agreement (Cohen‘s kappa) between the original ADOS diagnosis and the consensus 
diagnosis was calculated and used as a measure of inter-rater reliability. It was not possible 
for all assessments to be recorded or all recordings to be consensus coded. Priority for 
consensus coding was given to assessments that indicated a differential diagnosis to the 
participant‘s clinical status for presence/absence of ASD. 
 
Case note review 
The ePJS was used to carry out a retrospective review of each participant‘s mental health 
records. Data were collected using a specially developed schedule (see Appendix V). The 
case note reviews were the source of all clinical and some demographic data on participants 
(i.e. age, severity of intellectual disability, psychiatric diagnoses, length of MHID service use, 
CPA status and medication). They were also used to measure participants‘ use of health and 
social care services in the 12 months prior to the informant interview.  
 
The primary source of clinical data for the case note review were follow-up letters to 
participants‘ general practitioners (which include a section listing ICD Axis I, II and III 
diagnoses). Information given in most recent items of correspondence was cross-checked with 
previous correspondence and diagnosis data to ensure it was consistent across sources. The 




Data from the informant interviews, ADOS assessments and case note reviews were entered 
into SPSS by an experienced researcher and two MSc students. All data entered by the 
students were double checked by the researcher.  
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Analysis 
Prior to the comparison of the groups with and without ASD, exploratory data analyses were 
carried out to assess the quality of the data and measures. Distribution, missing observations 
and outliers were investigated. For each linear regression analysis a histogram of the 
standardised residuals was examined to check that the data were normally distributed. 
Participants who had outlying standardised residuals were removed from the analysis to 
improve the normality of the data. 
 
Descriptive analyses and hypotheses testing 
For the continuous data, Analyses of Variance (ANOVA) and linear regression were used. 
For categorical measures, Chi-square tests and binary logistic regression analyses were used. 
Fisher‘s exact tests were used when more than 50% of cells had a count less than five. The 
independent variables (other than ASD) entered into the regression analyses were selected on 
the basis that they were significantly associated with the dependent variable according to a 
one-way ANOVA or Chi-square test. 
 
Power calculations 
The required sample size was estimated using data from research on similar populations. 
Analyses were carried out on data from 371 specialist mental health service users with 
intellectual disability (Underwood et al., 2012). Mean HoNOS-LD score was significantly 
higher for participants with a clinical diagnosis of ASD (20.8, SD=12.2) than for those 
without ASD (13.7, SD=9.7, t(220)=-4.7, p<0.01).  
 
Brereton et al. (2006) found a significant difference of 18.2 on the DBC‘s Total Problem 
Behaviour Score between young people with autism or intellectual disability. Knapp et al. 
(2009) estimated that no adults with intellectual disability and ASD would be in employment, 
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whilst the Foundation for People with Learning Disability (2007) reported that around 17% of 
adults with intellectual disability have a job. 
 
Power calculations, carried out by nQuery Advisor software, using a two group t-test or Chi-
square test with 0.05 two-sided significance level, found that a sample size of: 
 
 40 participants in each group would have 80% power to detect a difference in mean 
HoNOS-LD scores of 7.1 
 29 participants in each group would have 80% power to detect a difference in mean 
TBPS scores of 18.2 
 50 participants in each group would have 80% power to detect the difference between 
a proportion of 0.01 and a proportion of 0.17 (odds ratio of 20.277)  
 
Sample size 
Preliminary analysis indicated there would be around 400 potential participants eligible for 
the data study and that around 126 would have a clinical diagnosis of ASD (Underwood et al., 
2012). Given the difficulties often experienced when recruiting participants with intellectual 
disability it was anticipated that it would be possible to recruit around half the number of 
people approached. Allowing for drop-outs and cases where an individual‘s clinical diagnosis 
was not supported by standardised ASD assessment it was decided that all eligible service 
users with a clinical diagnosis of ASD would be approached in order to achieve a sample size 
of 50 participants with ASD who would be matched to 50 participants without ASD. 
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Chapter 9: Results 
 
The study compared the needs, service use, mental health, behaviour and social functioning of 
those with and without ASD (confirmed by standardised diagnostic assessment). The analyses 
were designed to determine the extent to which these dependent variables were significantly 
predicted by presence of ASD and/or other socio-demographic and clinical factors. 
 
Recruitment 
During 2009 and 2010, there were 526 service users on the Lambeth, Lewisham and 
Southwark (LLS) Mental Health in Intellectual Disability (MHID) service caseload. A screen 
of service users‘ records identified 149 individuals with a clinical diagnosis of ASD and 344 
with no clinical diagnosis of ASD or mention of ASD in their mental health records. Eight 
service users were ineligible for the study (they were yet to be assessed and there was 
insufficient information to determine whether they had ASD). In addition, there were 25 
service users with ASD traits/behaviour/features who were excluded from the study. 
 
All LLS service users who appeared eligible for the ASD group were approached to take part 
from January 2009 until December 2010. The response rate was low; 53 (37%) out of 142 
eligible participants with a clinical diagnosis of ASD were eventually recruited. 
 
The aim was to match each participant with ASD to a participant without ASD on severity of 
intellectual disability, gender, age and where possible psychiatric disorder, type of residence 
and ethnicity. A further exclusion criterion was applied when recruiting participants without 
ASD. In addition to the criteria described in Chapter 8, a participant was not recruited if they 
had a diagnosis of or were suspected of having dementia. This was because none of the 
participants in the ASD group had dementia. 
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Recruitment of participants without ASD was carried out on a case-by-case basis by 
identifying the best match or matches for each participant with ASD. If they agreed to take 
part, these service users were assessed to confirm that they did not have ASD. 
 
As recruitment progressed, an increasing number of participants who had no mention of ASD 
in their mental health records exceeded the diagnostic threshold on the ADOS and therefore 
did not meet the study criteria for ‗no ASD‘. It became clear that there was a lack of service 
users without ASD who were good matches for the participants with a clinical diagnosis of 
ASD. Matching on severity of intellectual disability was a particular problem. Only one 
service user with severe intellectual disability recruited into the study scored below the ADOS 
threshold for ASD. 
 
When it was not possible to recruit any further matched participants without ASD (because 
there were no matching service users who had not been approached already) the selection 
criteria were widened. This was primarily in order to find participants with severe intellectual 
disability who did not have ASD. The recruitment process was amended as follows: 
 
 The matching criteria were disregarded, in reverse order of the identified priorities, 
until there were no more eligible service users from Lambeth, Lewisham or Southwark 
left to approach. 
 The sample base was widened to include specialist mental health service users with 
moderate or severe intellectual disability from Croydon. 
 An attempt was made to include participants from other specialist mental health 
services for adults with intellectual disability. However consultant psychiatrists from 
these services were unable to identify anyone with severe intellectual disability who 
did not have ASD or ASD traits. 
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The number of individuals failing to meet the study criteria for ‗no ASD‘ continued to rise. It 
became necessary to approach all eligible service users without a clinical diagnosis of ASD 
who were on the LLS caseload between January 2009 and December 2010 (N=302) and all 
eligible service users with no clinical diagnosis of ASD and moderate or severe intellectual 
disability on the Croydon caseload between August and December 2010 (N=30) regardless of 
whether they were a good match for participants in the ASD group. 
 
In total, 474 specialist mental health service users with intellectual disability were approached 
to take part in the study. The overall recruitment rate was 27%; 56 (12%) of those approached 
refused to take part and there was no response from 289 (61%). 
 
Participants 
The final number of participants recruited into the study was 129 (see Figure 11.2). There 
were 53 participants with a clinical diagnosis of ASD and 76 with no clinical diagnosis of 
ASD. Their characteristics are reported in Appendix VI. 
 
Most participants (59%) were assessed as having capacity to consent to take part in the study. 
Informants for the data collection interview were paid care staff (60%), family members 
(31%) and MHID CPNs (4%). One participant refused to consent to an informant being 
interviewed and answered all items himself. Another participant nominated a friend to be his 
informant and also took part in the interview. 
 
All informants had known participants for at least three months and had contact with them at 
least once every two weeks. Informants who were not family members had known 
participants for an average of 4 years. Eighty-six percent of non-family informants had known 
the participant for at least 12 months. There was no significant difference between those with 
and without ASD on informant contact. 
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ASD assessment 
Assessments were carried out for all 129 participants to determine whether they met the study 
criteria for ASD or ‗no ASD‘.  An Autism Diagnostic Observation Schedule (ADOS; Lord et 
al., 1989) assessment was completed for 113 participants; 88% of the sample. Of the 16 
participants that did not take part in an ADOS assessment: four could not be contacted, their 
consultee refused for four participants, three had sensory impairments, two refused, one was 
too ill due to a psychiatric disorder, one had physical impairments and one had died. 
 
ADOS assessment 
A module 1 (non-verbal) ADOS assessment was used for 27 participants, module 2 (phrase 
speech) for 12 participants, module 3 (fluent speech) for 19 participants and module 4 
(advanced speech) for 55 participants. Table 9.1 shows the proportion of those in each group 
who exceeded the ADOS thresholds for ASD. 
 
Table 9.1: Results of the ADOS assessments 
 Clinical diagnosis 
of ASD 
N = 44 
No clinical 
diagnosis of ASD 
N = 69 
Exceeding Communication cut-off score for ASD 44 36 
Exceeding Social Interaction cut-off score for ASD 44 35 
Exceeding cut-off for ASD (total, communication & 
social interaction scores all exceed cut-offs) 
44 24 
 
The 24 participants with no clinical diagnosis of ASD who exceeded the ADOS threshold 
were excluded. All of the participants with a clinical diagnosis of ASD exceeded the threshold 
ADOS for ASD and were included. 
 
Reliability of the ADOS assessments 
An inter-rater reliability coding was carried out on 35 ADOS assessments (37%). There was 
agreement on whether the participant exceeded the ADOS thresholds for ASD on 83% of 
these assessments and Cohen‘s kappa was 0.59 (p<0.001). 
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Expert review ASD assessment 
An ASD assessment for the 16 participants who did not take part in an ADOS assessment was 
carried out by a consultant intellectual disability psychiatrist. As detailed in Chapter 9, the 
participants‘ informant interview schedule and information from their mental health record 
were reviewed and used to complete a checklist of ICD-10 criteria for ASD. The results are 
shown in Table 9.2. 
 
Table 9.2: Results of the ASD assessment for those who did not complete an ADOS 
 Clinical diagnosis 
of ASD N = 9 
No clinical diagnosis of 
ASD N = 7 
No evidence of ASD or previous 
assessment had ruled out ASD 
3 3 
Met ICD-10 criteria for ASD 6 4 
 
Three participants with a clinical diagnosis of ASD were excluded because they did not 
appear to meet ICD-10 criteria for ASD according to a review of their mental health record. 
Four participants with no clinical diagnosis of ASD were excluded because they appeared to 
meet ICD-10 criteria for ASD. 
 
As Table 9.1 and Table 9.2 showed, 94% of participants with a clinical diagnosis of ASD met 
the study criteria for ASD. The three participants whose diagnosis was not confirmed did not 
take part in ADOS assessments. Two people could not be contacted following the informant 
interview. One participant‘s records revealed they previously had ADOS and ADI-R 
assessments at a specialist ASD clinic and did not meet the criteria for a diagnosis. There was 
evidence from another participant‘s records that they did not meet ICD-10 criteria for ASD. 
One participant could not take part due to a visual impairment. A review of their records 
indicated that while there was evidence that they currently met ICD-10 criteria for ASD they 
did not appear to have had any social or communication impairments as a child. There was 
evidence that these had emerged during adulthood. 
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A high proportion (37%) of the 76 participants with no clinical diagnosis of ASD were 
excluded because they exceeded the ADOS threshold or met ICD-10 criteria for ASD. The 
proportions of excluded participants were 19% of those with mild intellectual disability, 33% 
of those with moderate intellectual disability and 93% of those with severe intellectual 
disability. Only one person with severe intellectual disability met the study criteria for ‗no 
ASD‘. 
 
Without further assessment it was not possible to determine whether the excluded individuals 
had undiagnosed ASD, ASD traits that would not meet the criteria for ASD or whether there 
was some other reason that their behaviour during the ADOS assessment meant they 
exceeded the threshold for ASD. Analyses of data for these excluded participants are reported 
in Chapter 12. Figure 9.1 shows a detailed flow of participants through the recruitment 
process. 
 
Figure 9.1: Flow of participants through the study 
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Following the ASD assessment procedure, 50 participants with ASD and 48 without ASD 
were included in the study. 
 
Participant characteristics 
The remainder of this chapter focuses on the 98 participants who met the study criteria. 
Unless otherwise indicated in the text or tables, the analyses were based on 50 participants 
with ASD and 48 participants without ASD. 
 
ASD symptomatology 
The two groups were compared to explore differences in ASD symptomatology between 
them. There were Social Communication Questionnaire (SCQ) data for 93 participants. Table 
9.3 shows the results of the SCQ assessments. 
 
Table 9.3: SCQ results for participants with & without ASD 
 ASD N = 49 No ASD N = 44 
Mean SCQ score (SD) 16.2 (4.8) 5.5 (3.1) 
Range of SCQ scores 4 to 26 0 to 15 
Exceeding cut-off for ASD (≥15) 32 (65%) 1 (2%) 
 
 
Participants with ASD had a significantly higher mean SCQ score than those without ASD 
(F(1,92)=161.04, p<0.001). Participants with ASD were significantly more likely to score 15 
or higher on the SCQ (X
2
(1)=40.2, p<0.001). However, some participants with ASD (35%) 
scored below the SCQ threshold for ASD. All but one of the participants without ASD scored 
below the ASD threshold
1




                                               
1 NB SCQ item responses were used to confirm ASD diagnosis for those without an ADOS assessment but total 
SCQ score was not. 
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Table 9.4: Psychometric properties of the SCQ 
Cronbach‘s alpha 0.867 
Sensitivity 0.65 
Specificity 0.97 
Positive Predictive Value 0.97 
Negative Predictive Value 0.71 
 
The SCQ had good internal consistency (Cronbach‘s alpha; George & Mallery, 20102). 
Compared with the ASD assessment procedure, the SCQ had high specificity and positive 
predictive value but relatively low sensitivity and negative predictive value. This suggests that 
any individual scoring above 15 on the SCQ is very likely to have ASD. However, a low 
score on the SCQ does not necessarily indicate that the person does not have ASD. 
 
Socio-demographic and clinical characteristics 
Table 9.5 shows the characteristics of the participants with and without ASD.  
 
Table 9.5: Socio-demographic characteristics of the participants with & without ASD 
  ASD No ASD Significance test 
Age Mean years (SD) 
Range 
36.4 (12.4) 
18 to 68 
43.7 (11.6) 
20 to 63 
 F(1,97)=8.92, p=0.004 
Severity 
of ID 
Mild 20 (40%) 35 (73%) 
χ2(2)=17.4, p<0.001 Moderate 14 (28%) 12 (25%) 
Severe 16 (32%) 1 (2%) 
Gender 
Males 40 (80%) 29 (60%) 
χ2(1)=4.51, p=0.034 
Females 10 (20%) 19 (40%) 
Ethnicity 
Afro-Caribbean 19 (38%) 15 (31%) 
χ2(2)=0.731, p=0.694 White  27 (54%) 30 (63%) 
Other or unclear  4 (8%) 3 (6%) 
Type of 
residence 
With family 21 (42%) 11 (23%) 
χ2(2)=12.4, p=0.002 Residential  27 (54%) 23 (48%) 




Present 23 (46%) 41 (85%) 
χ2(1)=16.8, p<0.001 
Absent 27 (54%) 7 (15%) 
 
There were several significant differences between those with and without ASD: 
                                               
2 α≥0.9=excellent, α≥0.8=good, α≥0.7=acceptable, α≥0.6=questionable, α≥0.5=poor, α<0.5=unacceptable. 
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 Participants with ASD were younger.  
 Participants with ASD were more likely to be male. 
 Participants with ASD were more likely to live with family (χ2(1)= 4.1, p=0.044) and 
less likely to live independently (χ2(1)=11.4, p=0.001). 
 Participants with ASD were less likely to have mild intellectual disability (χ2(1)=10.8, 
p=0.001) and more likely to have severe intellectual disability (χ2(1)=15.3, p<0.001). 
 
Individuals are referred to the mental health in intellectual disability (MHID) service if they 
have or are suspected of having a psychiatric disorder but also if they have significant 
impairment of behaviour requiring psychiatric input.  On acceptance onto the caseload, all 
service users are assessed by an intellectual disability psychiatrist for the presence of 
psychiatric disorder according to ICD-10 criteria (WHO, 1992).  
 
Most participants in the clinical study had a diagnosis of psychiatric disorder. 
 Participants with ASD were less likely to have an additional psychiatric disorder than 
those without ASD. 
 
More than half of the participants with ASD appeared to be receiving specialist mental health 
services for challenging behaviour rather than a psychiatric disorder. 
 
These results demonstrated that attempts to match the groups with and without ASD were not 
successful. They also showed that participants with ASD were significantly different from 
those without ASD on a range of socio-demographic and clinical characteristics including the 
reason for them receiving specialist mental health services (i.e. whether or not they had been 
diagnosed with a psychiatric disorder). 
 
Chapter 9: Results 
139 
Exploratory data analysis 
Histograms demonstrating the normal distribution of the standardised residuals for each linear 
regression analyses are shown in Appendix VI. To meet the assumptions for regression 
analysis there should be a minimum of 15 participants per independent variable entered into 
the model (Field, 2000). The study included 98 participants; therefore a maximum of six 
predictors (five plus presence/absence of ASD) were selected for each analysis. 
 
The independent variables that were entered into each analysis were selected by determining 
whether there was a significant association between the dependent variable and any of the 
following: severity of intellectual disability, age, gender, ethnicity, type of residence, 
presence/absence of psychiatric disorder, needs and service consumption score. There were 
no occasions on which there were more than six potential predictors and therefore no further 
analyses were needed in order to choose which independent variables should be entered. 
 
Another assumption of regression analysis is that there is no co-linearity between the 
independent variables. Analyses showed that there were associations between ASD and: age, 
gender, type of residence severity of intellectual disability and presence/absence of 
psychiatric disorder. Although ASD was significantly correlated with these variables the 
relationships were not strong enough (r was not greater than 0.5; Cohen, 1988) to violate the 
assumptions of the regression models. 
 
There was a significant correlation, greater than 0.5, between age and type of residence; there 
was a particularly strong relationship between being younger and living with family. As a 
result, in cases where both age and type of residence were significantly associated with a 
dependent variable, only age was entered into the regression analysis. This was because the 
nature of the relationship is that age would be causal predictor of type of residence rather than 
vice versa. Further diagnostic analyses found no evidence that there were problems with co-
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linearity for any of the regression analyses: tolerance values were greater than 0.6, variance 
inflation factors were less than two and condition indices were less than 15 (Field, 2000). 
 
It was important to ascertain the relative importance of any factors that were found to be 
significant predictors of the dependent variables. For linear regression analyses, this was 
achieved by examining the standardised coefficient (β) of each variable (Field, 2000). For 
binary logistic regression, this was achieved by examining the exponential of the regression 
coefficient – Exp (B) – which represents the change in odds resulting from a unit change in 
the predictor (Field, 2000). 
 
Needs 
Participants‘ needs were measured the Camberwell Assessment of Needs for Adults with 
Intellectual Disability (CANDID; Xenitidis et al., 2003). In addition, during the 
administration of the Client Service Receipt Inventory (CSRI), informants were asked an 
open question about whether the participant had any unmet needs. 
 
CANDID 
There were CANDID data for 93 participants. The internal consistency of the CANDID 
(measured using Cronbach‘s alpha) was low (α=0.49). Cronbach‘s alpha increased when the 
followings items were deleted: Eyesight/hearing, Major mental health problems, Exploitation 
risk and Sexual expression. Removing all four of these items improved the internal 
consistency from unacceptable to questionable (α=0.62). Since the revised scale was more 
reliable than the full 25-item scale it was used in all further analyses. This did not affect the 
findings of the analyses. 
 
It appeared that although participants had a range of needs (between five and 18 in total), on 
average the majority were being met (between 33 and 100% of the time). The most commonly 
Chapter 9: Results 
141 
unmet need was Daytime activities. The area with the highest level of need was Welfare 
benefits with only seven participants not requiring any help in claiming them. The area with 
the least need was Caring for someone else with only one person (who was in the no ASD 
group) reporting this was a need (that was unmet). Table 9.6 shows the results for participants 
with and without ASD using the revised 21-item CANDID scale. 
 
Table 9.6: Revised 21-item CANDID results for participants with & without ASD 
 ASD (N =49) No ASD (N =44) 
Mean met needs 9.5 (2.4) 7.5 (2.9) 
Mean unmet needs 1.7 (1.6) 1.4 (2) 
Mean total needs 11.1 (2.4) 8.9 (2.9) 
Mean percentage of needs that were unmet 14.9 (15.7) 15.6 (19) 
 
 
Participants with ASD had significantly more needs and more of those needs were being met 
than those without ASD (F(1,92)=15.9, p<0.001; F(1,92)=12.3, p=0.001). There was no 
difference between those with and without ASD on participants‘ number of unmet needs or 
the proportion of their needs that were going unmet as demonstrated in Figure 9.2. 
 
 
Figure 9.2: Proportion of participants' needs that were met & unmet 
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Level of need was divided into high and low (high=total needs≥10). Participants with ASD 
were significantly more likely to have a high level of total needs compared to those without 




Higher numbers of total needs and met needs were significantly associated with moderate and 
severe intellectual disability, not living independently and absence of psychiatric disorder. 
The only factor associated with unmet needs was type of residence such that: 
 
 Participants in residential placements had a significantly lower number of unmet 
needs than those in other types of accommodation; they also had a significantly lower 
proportion of needs that were unmet. 
 
 Those living independently had a significantly higher proportion of their needs that 
were unmet compared with those in other types of residence. 
 
A linear regression analysis on predictors of total number of needs was carried out. The 
results are shown in Table 9.7. 
 




 B SE (B) 95% CI (B) β t p 
Presence/absence of ASD .80 .53 -0.25 to 1.9 .15 1.52 .13 
Moderate/severe intellectual disability 2.17 .51 1.2 to 3.2 .40 4.25 <.001 
Living independently -2.34 .67 -3.7 to -1 -.32 -3.51 .001 
Presence of psychiatric disorder .21 .55 -0.9 to 1.3 .04 .37 .71 
Constant 11.22 .61 10 to 21.4  18.40 <.001 
 
The model was statistically significant (F(1,91)=13.8, p<0.001) and accounted for 39% of the 
variance. Severity of intellectual disability and type of residence were significant predictors of 
total number of needs. Once these were taken into account there was no significant 
association between needs and presence of ASD. The factor with the highest standardised 
coefficient was having moderate to severe intellectual disability (β= 0.40). 
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Thus participants with ASD appeared to have higher levels of need but this was due to the higher 
rates of moderate and severe intellectual disability in this group. 
 
Informal assessment of need 
With regards to the informal identification of needs, 67 participants had at least one unmet 
need and the average number of unmet needs was 2.2 (slightly higher than that found by the 
CANDID). The number of unmet needs was very similar for those with and without ASD. 
 
The most commonly mentioned areas of unmet need were employment, college, activities and 
having more one-to-one support to enable access to the community. Many informants 
mentioned the need for more activities at weekends, during the evening and over the summer. 
A range of unmet physical and mental health needs were identified including input for 
behavioural problems, counselling, psychological therapy, exercise/weight loss and access to 
dental and chiropody services. 
 
Mental health and social functioning 
A snapshot of participants‘ mental health, behaviour and social functioning was taken using 
the Health of the Nation Outcome Scale for adult with Learning Disability (HoNOS-LD), 
Developmental Behaviour Checklist (DBC) and a specially devised social functioning scale 
for adults with developmental disabilities. 
 
Pattern of psychiatric disorder 
As shown earlier in Table 9.5 (page 137) there were 64 participants who were diagnosed with 
a psychiatric disorder. Table 9.8 shows the pattern of specific diagnoses for these participants. 
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Table 9.8: Pattern of diagnoses among participants with a psychiatric disorder 
Primary diagnosis ASD (N = 23) No ASD (N = 41) 
ADHD 3 (13%) 1 (2%) 
Anxiety disorder  4 (17%) 1 (2%) 
Bipolar disorder 5 (22%) 9 (22%) 
Depressive disorder  1 (4%) 14 (34%) 
Personality Disorder 0 1 (2%) 
Psychotic disorder 10 (44%) 13 (32%) 
Other* 0 2 (7%) 
* mixed anxiety & depression 
 
There was an overall significant difference between those with and without ASD on the 
primary diagnosis of psychiatric disorder (Fisher‘s exact test =14.3, p=0.01). Participants with 
ASD were less likely to have an additional diagnosis of depression (X
2
(1)=7.3, p=0.007) than 
those without ASD. 
 
Of the 64 participants with a psychiatric disorder, 25% had more than one diagnosis (16% of 
the 98 people with and without ASD). Table 9.9 shows the different diagnoses that these 
participants had. 
 
Table 9.9: Participants with more than one psychiatric diagnosis 











Affective disorder Borderline personality disorder 







Depression Catatonic schizophrenia (in 
remission) 
OCD Mental & 
behavioural 
disorder due to 
alcohol 
Depression Dissociative convulsions 
Depression Emotionally unstable 
personality disorder 
Depression Past history of psychotic 
disorder 







Past history of dysthymia 
PTSD Psychosis (in remission); 
Previous harmful use of alcohol 
Psychotic disorder Impulsive personality traits 
Schizoaffective disorder Hypomania 
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Two participants had three diagnoses (one in each group). It appeared that for participants 
without ASD it was quite common for depressive/mood disorders to be accompanied by an 
additional problem and for personality disorders to co-occur with other diagnoses. For those 
with ASD, it was ADHD and anxiety that were accompanied by other disorders. There was 
evidence of previous or current alcohol problems in both groups. 
 
HoNOS-LD 
The HoNOS-LD is a broad measure of health and social functioning focussing on a four week 
period. There were HoNOS-LD data from the informant interview for 93 participants. For the 
other five participants, data from a HoNOS-LD assessment carried out by a specialist mental 
health service clinician during the relevant time period were used. Total HoNOS-LD scores 
ranged from 2 to 42. One person had a total score higher than 40 (a participant with ASD). 
There was nothing unusual about this participant and they remained in the analyses. The 
internal consistency of the HoNOS-LD measured using Cronbach‘s alpha was acceptable 
(0.76). Table 9.10 shows the mean score for each group on the HoNOS-LD. 
 
Table 9.10: Mean total scores (& SDs) on the HoNOS-LD for participants with & without ASD 
 ASD No ASD  
Total HoNOS-LD 19.8 (8.2) 11 (6.1) F(1,97)=36.5, p<0.001 
HoNOS-LD 
Neuro-cognitive functioning 
4.3 (3.3) 1.8 (1.8) F(1,97)=21.9, p<0.001 
HoNOS-LD 
Mental/behaviour subscale 
9.1 (4.4) 4.5 (3.5) F(1,97)=33.5, p<0.001 
HoNOS-LD 
Health/social functioning 
6.3 (4.1) 4.7 (3.6) F(1,97)=4.4, p=0.039 
 
 
Participants with ASD had a significantly higher mean total HoNOS-LD score compared to 
those without ASD indicating lower health and social functioning. The mean difference in 
HoNOS-LD scores between those with and without ASD was 8.8 ‗points‘. Participants with 
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ASD had significantly higher scores on all three HoNOS-LD subscales than those without 
ASD. 
 
Cronbach‘s alpha for the subscale scores ranged from poor for Health/social functioning 
(0.596), to questionable for Mental/behavioural problems (0.65) and acceptable for Neuro-
cognitive functioning (0.73). 
 
Total HoNOS-LD score was significantly and positively correlated with number of unmet 
needs, number of met needs and total number of needs (r=0.51, p<0.001; r=0.25, p=0.015; 
r=0.56, p<0.001). It was also significantly, positively correlated with proportion of needs that 
were unmet (r=0.37, p<0.001). It appears that the more needs a person has the poorer their 
health and social functioning.  
 
Linear regression analyses found that ASD and severity of intellectual disability were 
independent significant predictors of HoNOS-LD score. Total number of needs, unmet needs 
and proportion of need that were unmet were also significant predictors when each was 
entered into the analysis. 
 
The model that included number of unmet needs accounted for the greatest variance (56%) 
and is shown in Table 9.11. The model was statistically significant (F(5,90)=21.7, p<0.001). 
The variable with the highest standardised coefficient was the presence of ASD. 
 




 B SE (B) 95% CI (B) β t p 
Presence/absence of ASD 7.14 1.43 4.3 to 10 .45 5 <.001 
Severity of intellectual disability 2.55 .93 0.7 to 4.4 .25 2.75 .007 
Presence of psychiatric disorder 1.14 1.51 -1.9 to 4.1 .07 0.75 .455 
Age 0.01 .05 - 0.1 to 0.1 .02 0.28 .783 
Number of unmet needs 1.95 .33 1.3 to 2.6 .44 5.86 <.001 
Constant 5.56 2.76   2.01 0.05 
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The maximum total score of the HoNOS-LD is 88 but participants‘ scores ranged from two to 
42. This indicates that most had good health and social functioning. The mean scores of 
participants with and without ASD fell within the range of none to mild problems (total score: 
1-22; see Figure 9.3). However some participants‘ scores (N=21; 20%) fell into the range of 







Participants with ASD were significantly more likely to fall within the range of mild to 
moderate problems (total score>22) than those without ASD (38% vs. 4%; X
2
(1)=16.7, 
p<0.001). As were those with severe intellectual disability compared to those with 
mild/moderate intellectual disability (47% vs. 16%; X
2
(1)=7.8, p=0.005).  
 
Binary logistic regression revealed that presence of ASD and number of unmet needs were 
significant predictors of having mild to moderate problems (HoNOS-LD score>22). The 
results are shown in Table 9.12. Presence of ASD and proportion of needs that were unmet 
were also significant predictors of having mild to moderate problems when this measure of 
need replaced number of unmet needs in the analysis. 
 
Table 9.12: Results of the logistic regression for total HoNOS-LD greater than 22 
 B SE (B) p Exp (B) 95% CI for Exp (B) 
Presence/absence of ASD 3.1 1 0.002 21.9 3 to 160.1 
Severe intellectual disability 0.29 0.7 0.664 1.3 0.4 to 5 
Number of unmet needs 0.56 0.2 0.001 1.7 1.2 to 2.4 
Constant -4.6 1.1 <0.001   
 
The factor with the highest odds ratio was presence/absence of ASD (OR= 21.9), the 
confidence intervals of which did not overlap with any of the other variables. 
Figure 9.3: Participants‟ range of scores on the HoNOS-LD 
0 22 44 66 88 
None to mild 
problems 
Mild to mod 
problems 





Severe to very 
severe problems 
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Developmental Behaviour Checklist for Adults (DBC) 
The DBC measures psychopathology over six months. The DBC was completed for 93 
participants: 49 with ASD and 44 without ASD. Total Problem Behaviour Scores (TPBS) 
ranged from 8 to 99. One participant with ASD appeared to be an outlier with a score of 99. 
Since the next lowest TPBS was much lower (85) this person was removed from the DBC 
analyses. TBPS scores were normally distributed.  
 
The internal consistency of the TBPS measured using Cronbach‘s alpha was good (0.899). 
HoNOS-LD total scores were significantly correlated with the DBC TPBS (r=0.69, p<0.001). 
Table 9.13 shows the DBC results for participants with and without ASD.  
 
Table 9.13: Developmental Behaviour Checklist results for participants with & without ASD 
 ASD (N = 48) No ASD (N = 44) 
Mean (SD) TPBS 54.2 (14.4) 29.2 (14.3) 
Psychiatric case (TBPS≥31) 45 (94%) 17 (39%) 
Psychiatric case (TBPS≥51) 29 (60%) 5 (11%) 
 
 
Participants with ASD had a significantly higher TPBS compared to those without ASD 
(F(1,91)=69.9, p<0.001); indicating poorer mental health. 
 
Participants with ASD were significantly more likely to exceed the cut-off scores for 
psychiatric caseness than those without ASD (TBPS≥31: X2(1)=31.7, p<0.001; TBPS≥51: 
X
2
(1)=23.7, p<0.001). The mean difference between the groups on TPBS was 25 points. This 
is greater than the level of clinical significance adapted from the DBC-P (TBPS of 19; see 
Chapter 10). 
 
Exploratory analyses found that TPBS was significantly associated with severity of 
intellectual disability, age, type of residence, presence of psychiatric disorder and total 
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number of needs (see Appendix VI). Therefore, five variables were entered in to a linear 
regression as predictors of TPBS (see Table 9.14)
3
. The model accounted for 51% of the 
variance and was statistically significant (F(5,91)=18.1, p<0.001).  
 




 B SE (B) 95% CI (B) β t p 
Presence/absence of ASD 21.02 3.6 13.9 to 28.1  0.56 5.9 <0.001 
Severity of intellectual disability -1.02 2.5 -5.9 to 3.9 -0.04 -0.4 0.68 
Presence of psychiatric disorder 2.99 3.6 -4.1 to 10.1 0.08 0.8 0.403 
Age -0.2 0.13 -0.5 to 0.05 -0.13 -1.6 0.114 
Total number of needs 1.99 0.6 0.8 to 3.2 0.3 3.3 0.001 
Constant 18.16 7.8   2.3 0.023 
 
 
The only significant predictors of TPBS were presence of ASD and total number of needs. 
Presence of ASD had the highest standardised coefficient (β=0.56). 
 
As with the HoNOS-LD results, participants‘ DBC scores were fairly low (range eight to 85) 






As this figure shows the mean TBPS of the group with ASD was above the 51-point cut-off 
score for psychiatric caseness. Whereas, the mean score for the group without ASD was 
below the lower (more sensitive) 31-point cut-off. None of the participants in the study scored 
above the high specificity cut-off of 96. 
                                               
3 Type of residence not entered due to the high correlation with age (see Exploratory data analysis) 
Figure 9.4: Participants' range of scores on the DBC 
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In addition to the presence of ASD, exceeding the cut-off score of 51 was significantly 
associated with having severe intellectual disability (X
2
(1)=4.3, p=0.039) and type of 
residence (X
2
(2)=14.4, p=0.001). None of the participants who lived independently exceeded 
the cut-off. However, 37% of those in residential placements and 57% of those living with 
family scored higher than 50. 
 
Binary logistic regression analysis revealed that presence of ASD, living with family and total 
number of needs were significant predictors of having a TBPS greater or equal to 51. The 
results are shown in Table 9.15. The odds ratio for ASD was 10.9. This was higher than the 
odds ratios for the other variables but confidence intervals overlapped with living with family. 
 
Table 9.15: Logistic regression results for psychiatric caseness on the DBC 
 B SE (B) p Exp (B) 95% CI Exp (B) 
Presence/absence of ASD 2.4 0.72 0.001 10.9 2.7 to 44.3 
Moderate/severe intellectual disability -1.2 0.72 0.098 0.3 0.1 to 1.3 
Living with family 1.3 0.6 0.035 3.6 1.1 to 11.5 
Total number of needs 0.5 0.2 0.001 1.7 1.2 to 2.3 
Constant -7.5 1.8 <0.001 0.001  
 
 
There was significant agreement (according to Cohen‘s kappa) between the DBC and 
HoNOS-LD on whether an individual had mild to moderate problems/exceeded the threshold 
for psychiatric caseness (κ=0.44, p<0.001). 
 
DBC subscales 
Participants scores on the DBC subscales described by Mohr et al (2004) are shown in Table 
9.16. Participants with ASD had significantly higher scores on the Self-absorbed, 
Communication disturbance and Social relating DBC subscales. Although they also had 
higher means scores on the Disruptive, Anxiety/anti-social and Depressive subscales these 
differences were not statistically significant. 
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Table 9.16: Mean (SD) DBC subscale scores for participants with & without ASD 
 
ASD 
N = 48 
No ASD 
N = 44 
 
Disruptive  11 (5.2) 9.5 (5.2) F(1,91)=2.03, p=0.158 
Self-absorbed  12.9 (6) 3.9 (3.4) F(1,91)=77.4, p<0.001 
Communication disturbance 5.7 (3.3) 4 (3) F(1,91)=6.2, p=0.014 
Anxiety/anti-social 2.7 (1.4) 2.1 (1.7) F(1,91)=3.3, p=0.073 
Social relating 5.8 (2.5) 1.7 (1.8) F(1,91)=81.3, p>0.001 
Depressive 3.2 (3.3) 2.6 (2.3) F(1,91)=1.1, p=0.305 
 
A subscale of 34 items relating to mental health rather than behavioural problems was derived 
from the DBC (see Appendix VI). The scale had acceptable internal consistency (Cronbach‘s 
alpha=0.74). Mean score on the DBC mental health subscale was significantly higher for 
participants with ASD (13.6, SD=6.5) than for participants without ASD (9.8, SD=5.5, 
F(1,91)=8.8, p=0.004). 
 
A higher DBC mental health subscale score was also significantly associated with having a 
diagnosis of psychiatric disorder, living with family, younger age and higher total number of 
needs. There was not a significant association between DBC mental health score and severity 
of intellectual disability. 
 
Five variables were entered in to a linear regression as predictors of DBC mental health 
subscale score (see Table 9.14)
4
. The model accounted for 34% of the variance and was 
statistically significant (F(5,91)=8.9, p<0.001). 
 




 B SE (B) 95% CI (B) β t p 
Presence/absence of ASD 4.1 1.4 1.3 to 6.8 0.33 2.97 0.004 
Severity of intellectual disability -1.42 1 -3.3 to 0.5 -0.17 -1.5 0.14 
Presence of psychiatric disorder 4.83 1.4 2.1 to 7.5 0.37 3.5 0.001 
Age -0.12 0.05 -0.2 to -0.02 -0.23 -2.4 0.018 
Total number of needs 0.73 0.2 0.3 to 1.2 0.33 3.2 0.002 
Constant 4.7 3 -1.2 to 10.7  1.6 0.119 
                                               
4 Type of residence not entered due to the high correlation with age (see Exploratory data analysis) 
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Presence of ASD, presence of psychiatric disorder, age and total number of needs were all 
significant predictors of mental health subscale score. Presence of psychiatric disorder had the 
highest standardised coefficients such that participants without a diagnosis had a higher 
mental health subscale score (β=0.37). 
 
The issues that participants had the most problems with on the DBC (items that had a mean 
score ≥ 1) were: poor attention span, impatience, impulsivity, poor sense of danger and being 
easily distracted. Three of these items were included in a hyperactivity subscale of the 
children‘s DBC (becomes overexcited, poor attention span, impatient, impulsive, 
noisy/boisterous and overactive; Einfeld & Tonge, 2002). 
 
Participants with ASD had a significantly higher total score for these six items compared to 
those without ASD (6.1 vs. 4; F(1,91)=17.2, p<0.001). However, there were no significant 
differences between those with and without ADHD
5
 on the total score of these items (6.7 vs. 




Problem behaviour was measured in two ways: by totalling the six behavioural items on the 
HoNOS-LD and totalling 72 items on the DBC that relate to problem behaviours (see 
Appendix VI). The results are shown in Table 9.18 below. 
 
Table 9.18: Problem behaviour scores of participants with and without ASD 
 ASD No ASD  
HoNOS-LD 
Behaviour subscale 
6.3 (3.6) 2.7 (2.7) F(1,97)=30.8, p<0.001 
DBC 
Behaviour subscale 
39.2 (10.6) 18.8 (10.3) F(1,91)=87, p<0.001 
                                               
5 The number of participants with ADHD and a DBC score was 3 (2 with ASD and 1 without ASD). 
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The HoNOS-LD problem behaviour subscale had questionable internal consistency 
(Cronbach‘s alpha=0.65). Participants with ASD had significantly higher levels of problem 
behaviour according to the HoNOS-LD. A higher HoNOS-LD problem behaviour score was 
also significantly associated with more severe intellectual disability, absence of a psychiatric 
disorder and total number of needs. 
 
The DCB behaviour subscale had good internal consistency (Cronbach‘s α=0.89). Participants 
with ASD had significantly higher levels of problem behaviour according to the DBC. A 
higher DBC problem behaviour score was also significantly associated with more severe 
intellectual disability, absence of a psychiatric disorder, not living independently, younger age 
and total number of needs. 
 
Many of the items included in the DBC behaviour subscale were related to ASD symptoms. 
The DBC for adults does not have an ASD subscale. However, it contains very similar items 
to the DBC-P (the children‘s version of the DBC) which has an item ASD subscale (Einfeld 
& Tonge, 2002; see Appendix VI). These items were removed from the total DBC behaviour 
score to explore whether the difference between participants with and without ASD remained. 
This subscale had acceptable internal consistency (Cronbach‘s α=0.78). 
 
Participants with ASD had a significantly higher mean DBC problem behaviour score when 
ASD items were removed than those without ASD (18.8, SD=6.8 vs. 11.4, SD=7; 
F(1,91)=26.2, p<0.001). Once these items had been removed there was no longer an 
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Linear regression found that DBC problem behaviour score (minus ASD items) was 
significantly predicted by ASD and total number of needs (see Table 9.19). The model 
accounted for 29% of the variance and was statistically significant (F(4,91)=8.8, p<0.001).  
 





 B SE (B) 95% CI (B) Β t p 
Presence/absence of ASD 5.6 1.6 2.5 to 8.8 0.36 3.6 0.001 
Mild intellectual disability 0.08 1.7 -3.2 to 3.4 0.005 0.05 0.962 
Living independently -0.86 2.1 -5.1 to 3.4 -0.041 -0.4 0.688 
Total number of needs 0.71 0.3 0.09 to 1.3 0.26 2.3 0.025 
Constant 5.3 3.8 -2.3 to 12.9  1.38 0.17 
 
 
Presence of ASD had the highest standardised coefficent (β=0.36).  
 
Social functioning 
This section explores associations between presence of ASD and measures of social 
functioning including communication, independence, employment, activities and 
relationships. These factors are then brought together using the composite social functioning 
scale for adults with developmental disabilities. 
 
Communication 
Participants with ASD were more likely to be non-verbal
6
 (28%) than those without ASD 
(2%; X
2
(1)=12.7, p<0.001). Among the 15 participants who were not able to express 
themselves verbally, 8 were able to use other means to express their basic needs to familiar 





                                               
6 Not able to talk in short phrases as sourced from SCQ or if unavailable by case note review. 
7 Information sourced from expressive communication item on HoNOS-LD 
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The majority of participants (93%) were able to understand words or signed communications 
about their needs
8
. The remaining participants were only able to understand single words and 
some signs for basic needs or had little understanding of others‘ attempts at communication. 
Only one of these participants did not have ASD; however this was confirmed by expert 
review not by ADOS assessment. 
 
Independence 
As described in Table 9.5, few participants lived independently and those with ASD were 
significantly less likely to do so. This group was also significantly younger than those without 
ASD, but the majority (over 75%) were over 25 years of age. Individuals living in residential 
placements or with family often have a high degree of independence with the ability to come 
and go as they please; others receive 24-hour supervision. The majority of participants (56%) 
were supervised by at least one other person whenever they were out in the community. 
Participants with ASD were significantly less likely to be able to leave their residence alone 





Table 9.20 shows employment rates among the participants. Only 26 (27%) had ever worked 
and even fewer (16%) were employed at the time of the informant interview. The number of 
hours that participants worked varied greatly from just two per week up to eight hours a day, 
five days a week. Only one participant worked full-time (more than 25 hours a week). 
 
Participants with ASD were less likely to have ever been employed than those without ASD 
(X
2
(1)=8.6, p=0.003). Participants with ASD were less likely to be currently employed than 
those without ASD (X
2
(1)=7.97, p=0.005). It appeared that among those with a job, 
                                               
8 Information sourced from receptive communication item on HoNOS-LD 
Chapter 9: Results 
156 
participants with ASD worked more hours per week than those without ASD but this 
difference was not statistically significant. 
 
Table 9.20: Employment status of participants with & without ASD 
 ASD No ASD 
Ever worked* 7 (14%) 19 (40%) 
Currently employed 3 (6%) 13 (27%) 
Full-time employed 0 1 
Part-time employed 1 8 
Supported/sheltered employment 1 1 
Voluntary work 1 3 
Mean (SD) hours spent working per week 
(Range) 
17 (13.5) 
3 to 30 
13.3 (11.3) 
2 to 40 




Table 9.21 shows the number of hours of activities that participants were taking part in each 
week at the time of their informant interview. These were made up of time spent at work, 
college, day centres, social clubs, one-to-one activities with a support worker or other 
activities (e.g. a music session or going to the gym). The number of participants who had no 
scheduled activities is also shown. The overall level of activity among participants was fairly 
low (16-17 hours per week on average). 
 
Table 9.21: Weekly scheduled activities of participants with & without ASD 
 ASD No ASD 
Mean (SD) hours per week 15.1 (13.3) 13.2 (9.8) 
No scheduled activities 10 (20%) 5 (10%) 
Mean (SD) hours per week for those 






There was not a significant difference between those with and without ASD on the mean 
number of hours of activities they took part in each week. There appeared to be more 
participants with ASD who did not take part in any activities. This difference was not 
significantly significant. When only participants who took part in activities were included 
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those with ASD appeared to have more hours of activity per week than those without ASD 
however this difference was not statistically significant. 
 
Relationships 
Most (93%) of the participants were not in a relationship at the time of the informant 
interview. One person with ASD was in a relationship. Among those without ASD, five were 
in a relationship and one was divorced. One participant without ASD had adult children who 
lived with her and two participants without ASD had children who had been taken into care. 
Many participants did not lead active social lives (see Table 9.22). Most had no particular 
friends and few met up with friends regularly. 
 
Table 9.22: Social life of participants with and without ASD 
 ASD (N = 49) No ASD (N = 44) 
Has friends 13 (27%) 24 (55%) 
Meets friends regularly 4 (9%) 15 (37%) 
 
 
Participants with ASD were less likely to have any friends than those without ASD 
(X
2
(1)=7.6, p=0.006). They were also less likely to meet up with friends regularly compared 




Social functioning scale 
Ratings for communication, community life, independence, social life and structured activity 
were combined to produce an overall composite score (as described in Chapter 8). 
Participants‘ social functioning was then categorised as shown in Table 9.23 and a total score 
calculated. A higher score indicated better social functioning. 
 
The internal consistency of the scale measured using Cronbach‘s alpha was 0.64. 
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Table 9.23: Results for the social functioning scale for participants with & without ASD 
Rating ASD (N = 50) No ASD (N = 44)  
Mean score (SD) 8.1 (2.9) 10.3 (2.3) F(1,93)=16.4, p<0.001 
Excellent 3 (6%) 8 (18%) 
Fisher‟s exact test= 
13.2, p=0.006 
Good 15 (30%) 24 (55%) 
Fair 24 (48%) 10 (23%) 
Poor 6 (12%) 2 (5%) 
Very poor 2 (4%) 0 
 
Most participants had a fair to good rating of social functioning. Few of those with ASD had 
an excellent rating and eight had a poor or very poor rating. By contrast few of those without 
ASD had a poor level of social functioning and eight had an excellent rating. There were 
significant differences between participants with and without ASD on their total score and 
which rating of social functioning they had. 
 
Social functioning was also significantly associated with severity of intellectual disability 
(decrease of around two points as severity increased), presence of psychiatric disorder (those 
with no diagnosis had poorer social functioning) and total number of needs (those with higher 
needs had poorer social functioning). These factors and ASD were entered into a linear 
regression with social functioning score as the dependent variable.  
 
Type of residence was not entered into the regression analyses as living independently was 
part of the formulation for social functioning score. There was not a significant difference in 
social functioning score between those living in residential placements and those living with 
their family.  
 
The regression model was statistically significant (F(4,91)=20.8, p<0.001) and accounted for 
49% of the variance in social functioning scores. The results are shown in Table 9.24. 
Presence of ASD was not a significant predictor of social functioning once severe intellectual 
disability, presence of a psychiatric disorder and total number of needs had been taken into 
account. 
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 B SE (B) 95% CI (B) β t p 
Presence/absence of ASD -.1 .49 -1.1 to 0.9 -.02 -.19 .848 
Severe intellectual disability -2.20 .66 -3.5 to -0.9 -.31 -3.35 .001 
Presence of psychiatric disorder 1.41 .52 0.4 to 2.4 .25 2.72 .008 
Total number of needs -.34 .08 -0.5 to -0.2 -.35 -4.11 <.001 
Constant 12.14 .94   12.97 <.001 
 
 
Further analyses found that total DBC and DBC behaviour scores were significantly 
correlated with social functioning (r=-.33,p=0.01 and r=-0.38, p<0.01). However, DBC 
mental health score was not significantly correlated with social functioning and neither was 
the DBC behaviour subscale once ASD items had been removed. Total DBC and DBC 
behaviour score were not significant predictors of social functioning when entered into the 
linear regression. 
 
Service use and intervention 
Data on participants‘ receipt of services and intervention were collected during the case note 
review and during the informant interview using the Client Service Receipt Inventory (CSRI). 
For both methods the period covered was the 12 months preceding the informant interview. 
 
Health service use 
Table 9.25 shows participants‘ health service use. The table shows the number of participants 
with at least one visit and the mean number of visits they had (i.e. those who did not have any 
visits were excluded from the mean calculations). 
 
There was no difference between participants with and without ASD on whether they had 
visited their general practitioner (GP). However, among those who visited their GP at least 
once, those with ASD had fewer appointments than those without ASD (F(1,75)=4.1, 
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p=0.048). There were some very high users of GP services among those without ASD: three 
had visited their GP on average more than once every two weeks. When these participants 
were removed the difference between those with and without ASD for GP visits was no 
longer statistically significant. 
 
 
Table 9.25: Health service use of participants with & without ASD 
  ASD (N=50) No ASD (N= 44) 
General 
Practitioner 
N (%) with ≥ 1 visit 








N (%) with ≥ 1 visit 






N (%) with ≥ 1 visit 







N (%) with ≥ 1 visit 






# N (%) with ≥ 1 visit 





Bold results indicate a statistically significant difference between those with and without ASD. 
$Includes 
primary care nurse, dentist, optician, chiropodist. *Includes alternative therapist, audiology, blood clinic, 
cardiology, colo-rectal clinic, dental hospital, dermatology, diabetes clinic, endoscopy, neurology, oncology, 
ophthalmology, rheumatism clinic, scans, X-ray & hospital department unclear. 
#Excludes days spent as a psychiatric inpatient. 
 
 
There was no difference between the groups on whether participants had visited other primary 
care clinicians or secondary care services in the last 12 months. There was no significant 
difference between those with and without ASD on the mean number of visits to any of these 
services. 
 
Participants with ASD were significantly less likely to have visited Accident and Emergency 
(A&E) (X
2
=(1)=7.6, p=0.006) or been admitted as an inpatient to hospital for medical reasons 






                                               
9 P value for Fisher‘s exact test 
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Physical health problems 
Participants‘ physical health was explored to establish whether differences in the needs of 
those with and without ASD could account for the above differences in service use. Table 
9.26 details the rates of epilepsy, visual/hearing impairments and physical disabilities/health 
problems among those in each group (as recorded in participants‘ mental health record). 
 
 
Table 9.26: Physical disability & health problems of participants with & without ASD 
 ASD No ASD 
Epilepsy 8 (16%) 6 (13%) 
Sensory impairment 6 (12%) 2 (4%) 
Other physical health problem or disability
# 
15 (30%) 26 (54%) 
Total number with any disability/health problem* 26 (52%) 30 (63%) 




Participants with ASD were significantly less likely to have a physical disability/health 





Items from the CANDID and HoNOS-LD relating to physical health were explored. Although 
a lower proportion of participants with ASD had physical health needs on the CANDID than 
those without ASD this difference was not significant (35% vs. 55%; X
2
(1)=3.7, p=0.054). 
Among those with a physical health need, around 80% of those with and without ASD were 
having those needs met. However, according to the HoNOS-LD, participants with ASD were 





It appeared that participants with ASD had fewer physical health needs than those without 
ASD. This could explain why they used fewer emergency and inpatient health services. 
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Social service use 
Participants‘ consumption of residential services was explored along with their support staff 
and day centre use. 
 
Residential service use 
As described in Table 9.5 on page 137, around half the participants lived in residential 
placements. More participants with ASD lived in a residential placement (54%) than those 
without ASD (44%) but this difference was not statistically significant. Some participants 
lived alone in these placements but most shared facilities with other service users. The 
majority of these placements had at least one member of staff on duty throughout the day and 
night (see Table 9.27). 
 
Participants with ASD lived in residential placements with significantly fewer service users 
than those without ASD (F(1,46)=4.09, p=0.049). Participants with ASD lived in placements 
with significantly more staff per service user: during the day, over night and over 24hours. 
 
Table 9.27: Staff provision in residential placements of participants with & without ASD 
Mean (SD) ASD (N=27) No ASD (N= 20*) 
Number of residents (incl. participant) 
Range 
3.9 (1.6) 
2 to 9 
5.2 (2.7) 
1 to 11 
Number of day staff/ 






Number of overnight staff 






Total number of staff/ 






*information unavailable for 1 participant without ASD 
# information unavailable for 1 participant with ASD 
 
 
Participants with ASD in residential placements appeared to need a higher level of staff 
input/supervision than those without ASD. It is important to note that participants lived in 
residential placements that served a mixture of individuals with or without ASD. Therefore, 
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although those with ASD appeared to live in households where residents needed a higher 
level of support this cannot be directly attributed to the participant or whether they had ASD. 
 
Support staff and day centre use 
Table 9.28 details participants‘ use of support staff. This does not include staff from 
residential placements unless the participant was specifically allocated a set number of one-to-
one support hours. Participants‘ use of day centres is also reported.  
 
Table 9.28: Support staff & day centre use of participants with & without ASD 
 ASD No ASD 
Receiving support 14 (28%) 18 (38%) 
Mean (SD) hours of support/week 13.7 (10.8) 8.7 (6) 
Attending a day centre 16 (32%) 15 (31%) 
Mean (SD) hours per week at day centre 18.9 (9.2) 10.6 (8) 
 
A smaller proportion of participants with ASD were receiving support compared to those 
without ASD however this difference was not statistically significant.  Although participants 
with ASD who received support had more hours per week on average than those without ASD 
this difference was not statistically significant. 
 
Almost a third of participants regularly attended a day centre for adults with intellectual 
disability. Those with ASD who attended a day centre did so for significantly more hours per 
week than those without ASD (F(1,30)=7.2, p=0.012). The difference in means between the 
groups was over 8 hours (the equivalent of about one day per week). 
 
Mental health service use 
Table 9.29 shows the specialist mental health service use of the participants. When a check 
was carried out in August 2011 a number of participants had been discharged but the majority 
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of participants (79%) were still receiving specialist mental health services for adults with 
intellectual disability. 
 
Table 9.29: Specialist mental health service characteristics of participants 
 ASD No ASD 
Current specialist mental health service user
# 
37 (74%) 40 (83%) 
Service user at time of informant interview
 
47 (94%) 42 (88%) 
Mean (SD) number of months between discharge 
& interview 
6 (6) 
1.5 to 13 
9.5 (11) 
1 to 26 
Mean (SD) number of months since referral to 
specialist mental health services
$ 
79 (64) 
4 to 284 
74 (59) 
4 to 271 
#on August 15th 2011. $measured at date of informant interview.  
 
Nine participants had been discharged before their informant interview took place (no 
significant difference in number who had been discharged in each group). There was no 
significant difference between the groups with and without ASD on the length of time 
between participants‘ discharge and their informant interview. 
 
The average length of time that had elapsed between participants‘ referral to specialist mental 
health services and their informant interview was similar in each group (around 6 to 6½ 
years). The majority (89%) of participants were referred at least 12 months prior to their 
informant interview. The most recent service user was referred in August 2010 (their 
informant interview took place four months later). The participant who had been a specialist 
mental health service user the longest was referred in 1986; a female with ASD she was 
discharged to her GP‘s care in December 2009 (two months after the informant interview). 
 
Specialist mental health service consumption 
Table 9.30 shows the specialist mental health service use of participants with and without 
ASD in the 12 months prior to their informant interview. Nine participants had no contact 
with specialist mental health services for people with intellectual disability during this time; 
Chapter 9: Results 
165 
six had been discharged from the service and three were current service users. Removing 
these participants had no effect on the results so they remained in the service use analyses. 
 
Table 9.30: Appointments with specialist mental health team members over 12 months 
 ASD No ASD 
On CPA 6 (12%) 15 (31%) 
No specialist mental health  
service use 
6 participants 
(2 current users) 
3 participants 
(1 current user) 
 




0 to 8 
2.7 (2) 
0 to 9 
CPN 
1.3 (4.3) 
0 to 21 
5.8 (9) 
0 to 31 
Total specialist mental health service 
appointments 
4 (5.3) 
0 to 26 
8.5 (9.7) 
0 to 40 
 
 
Participants with ASD were significantly less likely to be on the Care Programme Approach 
(CPA) than those without ASD (X
2
(1)=5.39, p=0.02).  
 
Participants with the highest levels of service use were those on CPA. In accordance with this 
participants with ASD had significantly fewer appointments (F(1,97)=9.9, p=0.002) with a 
CPN than those without ASD. As a result they also had fewer total number of appointments 
(F(1,97)=8, p=0.006). When those on CPA were removed from the analyses there were no 
significant differences between those with and without ASD. 
 
Other mental health service consumption 
Many participants received other mental health services. Table 9.31 shows participants‘ 
appointments with mental health staff outside of the specialist mental health service for adults 
with intellectual disability. 
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Table 9.31: Appointments with other mental health team members over 12 months 
  ASD No ASD 
ID Psychologist 
N (%) with ≥ 1 visit 







N (%) with ≥ 1 visit 









N (%) with ≥ 1 visit 







N (%) with ≥ 1 stay 





$Includes mainstream community mental health team psychiatrists, psychologists & social workers, Home 
Treatment Team and mental health Liaison Nurses/Psychiatrists 
 
 
Participants with ASD were significantly more likely to have seen an intellectual disability 
behaviour support worker than those without ASD (X
2
(1)=5.78, p=0.016). The proportions 
were reversed for those who saw a psychologist but the difference was not significant. 
Participants with ASD were significantly less likely to have had contact with another mental 
health service (X
2
(1)=5.3, p=0.021). Only four participants were admitted to a psychiatric 
inpatient service; there were no differences in inpatient service use between those with and 
without ASD. 
 
Less than half (41%) of the 34 participants with no diagnosis of psychiatric disorder were 
accessing behaviour support services. Only 21% were accessing psychology services and 44% 
were not accessing either of these services. 
 
Service consumption scores 
In total, the 98 participants had 1138 contacts with mental health services in the 12 months 
prior to their informant interview. This is the equivalent of almost one contact a month per 
participant; although the number of contacts ranged from zero to 106. Service consumption 
scores for specific subgroups were examined to explore the distribution of service resources 
among participants. This was to determine whether resources were evenly spread among 
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participants or whether some groups were consuming disproportionately more than others. It 
was found that although participants with ASD accounted for 51% of the sample they used 
only 30% of the services consumed. 
 
Two participants had much higher service use than any others with 106 and 100 contacts 
compared with the next lowest SCS of 40. Both of these participants were females in the no 
ASD group who had mild intellectual disability and lived independently. One had depressive 
disorder and dissociative convulsions while the other participant had bipolar disorder. The 
majority of their service use was from the mainstream Home Treatment Team and both were 
on CPA. These participants were removed from the rest of the analyses. 
 
The average number of contacts with mental health services per participant over 12 months is 
illustrated in Figure 9.5.  
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Some groups were consuming higher levels of mental health services; particularly participants 
without ASD, those with mild intellectual disability and those with a psychiatric disorder. 
 Participants with ASD had a significantly lower mean SCS compared to those without 
ASD (7.4 vs. 12.2; F(1,95)=4.8, p=0.031). 
 
The participants were divided into high and low service users according to whether they were 
in the top tertile of scorers (SCS>8). Low-level service users consumed 22% of the services; 
thus a third of participants consumed 78% of the services. 
 Significantly fewer participants with ASD were high-level service users (24%) than 




Participants who had been discharged from specialist mental health services at the time of 
their informant interview (N=9) were removed from these analyses but the results remained 
significant. However, when those with no service use over the 12 months prior to their 
informant interview were removed (N=7) the difference in mean SCS between those with and 
without ASD was no longer significant. Removing those on CPA also made the difference 
non-significant. 
 
Mental health service consumption score (SCS) was not significantly correlated with total 
number of needs, total HoNOS-LD score, TPBS on the DBC or total Social functioning score. 
Nor was SCS significantly correlated with the DBC mental health subscale, problem 
behaviour subscales or the HoNOS-LD behaviour subscale. 
 
In addition to presence of ASD, SCS was significantly associated with age, severity of 
intellectual disability, presence of psychiatric disorder and residence (highest among those 
living independently, lowest among those in residential placements) (see Appendix VI for 
data). 
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A linear regression was carried out with these factors entered as independent variables and 
SCS as the dependent variable. Table 9.32 shows the results. 
 




 B SE (B) 95% CI (B) β t p 
Presence/absence of ASD -4.2 2.2 -8.7 to 0.2 -0.2 -1.9 0.062 
Mild intellectual disability 5.4 2.2 1 to 9.7 0.26 2.4 0.016 
Presence of psychiatric disorder 2.8 2.3 -1.7 to 7.3 0.13 1.3 0.212 
Age -0.2 0.1 -0.4 to -0.05 -0.26 -2.6 0.012 
Constant 15.2 4.7   3.3 0.002 
 
The model was statistically significant (F(4,94)=7.7, p<0.001) and accounted for 26% of the 
variance (R
2
=0.256).  Mild intellectual disability and age were the only significant predictors 
of mental health service consumption. That is: participants with mild intellectual disability 
used a significantly greater amount of mental health services than those with moderate/severe 
intellectual disability and as age increased mental health service use decreased. Once these 
factors were taken into account, ASD was not significantly associated with mental health 
service consumption. 
 
In conclusion, participants with and without ASD had been using specialist mental health 
services for around the same length of time. They saw an intellectual disability psychiatrist on 
average once every four months regardless of whether they had ASD. Participants with ASD 
saw a CPN significantly less than those without ASD because they were less likely to be on 
CPA where fortnightly contact is standard. 
 
Participants with ASD used mental health services less than would be expected given the 
proportion of the sample that they represented. There was no evidence that they were 
accessing other types of health service more than those without ASD. However, those with 
ASD in residential placements had more staff per service user and those attending day centres 
spent more time there each week than those without ASD. 
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Psychotropic medication 
Most participants (86%) were prescribed at least one psychotropic medication. The proportion 
of participants prescribed any psychotropic medication was similar for those with (84%) and 
without (88%) ASD. A considerable number of participants (40%) were prescribed more than 
one psychotropic medication. Participants with ASD were not more or less likely to be 
receiving two or more psychotropic medications. The mean number of psychotropic 
medications (for participants with a prescription) was 1.6 for those with ASD and 1.8 for 
those without ASD (this difference was not statistically significant). 
 
The type of psychotropic medication prescribed to participants in each group is shown in 
Table 9.33. The most commonly prescribed psychotropic medication was antipsychotics but 
many participants were taking anticonvulsants and antidepressants. Other types of medication 
were rare but some participants were taking benzodiazepines; mainly only when required 
(PRN) rather than regularly. 
 
Table 9.33: Type of psychotropic medication prescribed to participants 
Type of medication ASD No ASD 
Antipsychotic 34 (68%) 26 (54%) 
Anticonvulsant  17 (34%) 14 (29%) 
Antidepressant 6 (12%) 20 (42%) 
Anxiolytic 0 1 (2%) 
Stimulant (ADHD)  2 (4%) 1 (2%) 
Mood stabiliser (Lithium)  1 (2%) 3 (6%) 
Benzodiazepine 11 (22%) 4 (8%) 
Benzodiazepine PRN 8 (16%) 3 (6%) 
See Appendix VI for a list of the medications included in each category. 
 
The only significant difference between those with and without ASD on psychotropic 
medication prescription overall was that those with ASD were less likely to be on 
antidepressants than those without ASD (X
2
(1)=11.1, p=0.001). This reflects the earlier 
finding that participants with ASD were less likely to have a diagnosis of depression than 
those without ASD. 
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A considerable proportion of participants (23%) were receiving psychotropic medication 
despite not having any psychiatric disorder. They were presumably being prescribed 
medication for challenging behaviour. However, participants with a diagnosis of psychiatric 
disorder were significantly more likely to be on psychotropic medication compared to those 




For those with a psychiatric disorder, there was no significant difference between those with 
and without ASD on whether a participant was receiving any medication. However, among 
those without a diagnosis of psychiatric disorder, participants with ASD were significantly 








As such it appears that participants with ASD were more likely to be prescribed medication 
for challenging behaviour than those without ASD. Table 9.34 shows the proportion of 
participants with and without a psychiatric diagnosis who were receiving medication. 
 
 
Table 9.34: Medication prescribed to participants with & without a psychiatric diagnosis 










No medication 22% 71% 9% 2% 
ADHD   9% 2% 
Anticonvulsant 37% 14% 30% 32% 
Antidepressant 7% 0% 17% 49% 
Antipsychotic 74% 29% 61% 59% 
Anxiolytic   0% 2% 
Benzodiazepine 26% 0% 17% 10% 
Mood stabiliser (lithium)   4% 7% 
 
 
                                               
10 P value for Fisher‘s exact test 
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It appeared that among participants with no psychiatric disorder, those with ASD were more 
likely to be receiving antipsychotic medication, benzodiazepines and anticonvulsants than 
those without ASD but these differences were not statistically significant according to 
Fisher‘s exact test. The only significant difference between those with and without ASD 
among those with a psychiatric disorder was for antidepressants, again reflecting the finding 
that those with ASD were less likely to have a diagnosis of depression. 
 
There were no significant differences in type of medication between participants with and 
without ASD among those specific psychiatric diagnoses (see Table 6, Appendix VI). This is 
likely to be because of the small number of participants in each comparison. The results did 
not appear to show that participants with ASD were particularly more or less likely to be 
receiving a treatment appropriate to their diagnosis than those without ASD. 
 
However, these analyses relied on recorded clinical diagnoses which may not accurately 
reflect the true levels of disorder among participants. Further analyses were carried out to 
explore whether participants with symptoms of different disorders were receiving appropriate 
treatment. Items on the HoNOS-LD were used to do this.  
 
There were 53 participants with moderate to very severe scores on either the anxiety or mood 
items of the HoNOS-LD. Among these participants, those with ASD (N=30) were 
significantly less likely to be receiving antidepressant or anxiolytic medication than those 
without ASD (17% vs. 61%; X
2
(1)=11.1, p=0.01). Among participants with psychotic 
symptoms, there were no differences in the prescription of antipsychotic medication between 
those with and without ASD. 
 
Whether or not a participant was prescribed psychotropic medication was not significantly 
associated with total HoNOS-LD score, TPBS on the DBC, total social functioning score or 
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service consumption score. None of these measures were associated with whether a 
participant was receiving more than one psychotropic medication. Neither were these were 
significantly associated with the DBC mental health subscale, problem behaviour subscales or 
the HoNOS-LD behaviour subscale. These results held regardless of whether participants did 
or did not have a diagnosis of psychiatric disorder. 
 
The only measures associated with the number of medications prescribed to participants were 
mental health service consumption score (r=0.26, p=0.018) and total number of needs (r=0.23, 
p=0.43). Therefore, it appeared that those with higher needs and those with more mental 
health service input were prescribed more psychotropic medications. 
 
However, with regards to specific medications the following results were found (see 
Appendix VI, table 7 for details): 
 
 Being prescribed an antidepressant was significantly associated with better social 
functioning and a lower DBC problem behaviour subscale although this association 
was no longer significant once ASD items were removed from the subscale. 
 
 Being prescribed an antipsychotic was significantly associated with poorer social 
functioning. 
 
 Being prescribed a benzodiazepine was significantly associated with higher total 
number of needs, higher total HoNOS-LD score, higher HoNOS-LD behaviour 
subscale score and poorer social functioning. It was also significantly associated with 
a higher DBC problem behaviour subscale score although this association was no 
longer significant once ASD items were removed from the subscale 
 
Being prescribed psychotropic medication was not significantly associated with any other 
variable apart from presence/absence of psychiatric disorder. However, among those with no 
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psychiatric disorder there was also a significant association between being prescribed a 





Presence of ASD, presence of psychiatric disorder and severity of intellectual disability were 
entered into a binary logistic regression (see Table 9.35). Having a psychiatric disorder and 
having moderate or severe intellectual disability were significantly associated with an 
increased likelihood of a participant being prescribed psychotropic medication. 
 
Table 9.35: Logistic regression on likelihood of receiving psychotropic medication 
 B SE (B) p Exp(B) 95% CI 
Presence/absence of ASD 0.56 0.8 0.49 1.8 0.36 to 8.5  
Moderate/severe intellectual disability 1.7 0.8 0.029 5.7 1.2 to 27.4 
Presence of psychiatric disorder 3.4 0.9 <0.001 30.1 5.1 to 178.6 
Constant -0.8 0.8 0.306 0.4  
 
The binary logistic regression was run again with presence of psychiatric disorder replaced 
each time with TPBS on the DBC, DBC mental health score, DBC behaviour subscale scores, 
total HoNOS-LD score, HoNOS-LD behaviour subscale score and social functioning score. 
None were significant predictors of whether or not a participant was prescribed psychiatric 
medication. 
 
Participants with globally poor mental health and social functioning 
There were 14 participants (14% of the sample) who had globally poor mental health and 
social functioning: 
 
1)  they had mild to moderate problems on the HoNOS-LD (total >22), 
 2) they met the criteria for psychiatric caseness (TPBS>50) 
and 3) they had a less than good rating of social functioning (total score<10). 
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All but one of these participants had ASD. The participant without ASD who had globally 
poor mental health and social functioning was the same person who had an SCQ score of 15 
(see Table 9.3). Five of those with globally poor mental health and social functioning had 
mild intellectual disability, three had moderate and six had severe intellectual disability. Five 
had a diagnosis of psychiatric disorder (psychotic, bipolar and anxiety disorders) and nine did 
not. Six lived in a residential placement, eight with family and none lived independently. 
 
The mean number of needs that these participants had was 12.4 and 21% of these needs were 
unmet. The areas in which these individuals had the most unmet need were daytime activities, 
social relationships, communication, basic education and transport. The items on the DBC 
that this group scored highly on were: poor sense of danger, poor attention span, impulsivity, 
arranging objects or routine in strict order and being aloof. The items they scored highly on 
the HoNOS-LD were occupation, attention, activities in the community, stereotyped 
behaviour and ‗other‘ behaviours. 
 
A binary logistic regression analysis was carried out to identify which factors were significant 
predictors of having globally poor mental health and social functioning. The results are shown 
in Table 9.36. Presence of ASD was the only significant predictor of having globally poor 
mental health and social functioning with an odds ratio of 11. 
 
Table 9.36: Results of the logistic regression for globally poor mental health & social functioning 
 B SE (B) p Exp (B) 95% CI 
Presence/absence of ASD 2.4 1.1 0.03 11 1.3 to 96.7 
Severe intellectual disability 0.6 0.7 0.423 1.8 0.4 to 7.6 
Presence of psychiatric disorder -0.5 0.7 0.487 0.6 0.1 to 2.5  





Chapter 9: Results 
176 
Post-hoc analyses 
In addition to the main variables used in the analyses, further checks were carried out to check 
for possible confounding factors. The length of time that participants had been using specialist 
mental health services for adults with intellectual disability, number of hours of activity, 
support and day centre hours were not significantly associated with any other measure. 
 
The reliability of the measures was assessed by examining their internal consistency 
(Cronbach‘s alpha). Overall, reliability was good (apart from the CANDID which was 
improved by removing four items). Table 9.37 examines whether the reliability of the 
measures was different for those with and without ASD.  
 
Table 9.37: Reliability of the measures for participants with & without ASD 
 Cronbach‟s alpha 
 ASD No ASD 
SCQ 0.665 0.586 
21-item CANDID 0.513 0.652 
HoNOS-LD 0.681 0.667 
HoNOS-LD behaviour scale 0.553 0.572 
DBC 0.786 0.881 
DBC mental health subscale 0.733 0.854 
DBC behaviour subscale 0.735 0.724 
DBC behaviour scale minus ASD items 0.653 0.802 
Social functioning scale 0.663 0.487 
 
 
The internal consistency of the scales did not appear to vary greatly between those with and 
without ASD. The SCQ, HoNOS-LD and Social functioning scale were slightly more reliable 
when used with people who have intellectual disability and ASD. The 21-item CANDID, 
HoNOS-Ld behaviour scale and all of the DBC scales were more reliable for those without 
ASD. The DBC had the highest level of Cronbach‘s alpha; it had good internal consistency 
for those without ASD and acceptable internal consistency for those with ASD (George & 
Mallery, 2010). 
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Conclusion 
Compared to those without ASD, participants with ASD had a lower level of mental health 
service use, a higher number of needs, poorer mental health, more problem behaviours and 
poorer social functioning. However, when other socio-demographic and clinical factors were 
taken into account the following results were found. 
 
Higher total number of needs (according to the CANDID) was significantly associated with: 
 Moderate and severe intellectual disability 
 Living with family or in a residential placement 
 
Poorer health and social functioning (as measured by total score on the HoNOS-LD) was 
significantly associated with: 
 Presence of ASD 
 Unmet needs and total number of needs 
 Moderate and severe intellectual disability 
 
Poorer mental health (as measured by the TPBS on the DBC) was significantly associated 
with: 
 Presence of ASD 
 Total number of needs 
 
More problem behaviours (as measured using behavioural items on the DBC) were 
significantly associated with: 
 Presence of ASD 
 Total number of needs 
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Poorer social functioning (as measured by the social functioning scale for adults with 
developmental disability) was significantly associated with: 
 Total number of needs 
 Severe intellectual disability 
 Not being diagnosed with a psychiatric disorder 
 
Higher levels of mental health service use were significantly associated with: 
 Mild intellectual disability 
 Younger age 
 
An increased likelihood of being prescribed psychotropic medication was significantly 
associated with 
 Being diagnosed with a psychiatric disorder (OR=30.1, 95% CI: 5.1 to 178.6) 
 Moderate and severe intellectual disability (OR=5.7, 95% CI: 1.2 to 27.4) 
 
An increased likelihood of having globally poor mental health and social functioning (defined 
as total HoNOS-LD score >22, TPBS>50 and social functioning scale score<10) was 
significantly associated with: 
 Presence of ASD (OR=11, 95% CI: 1.3 to 96.7) 
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Chapter 10: Clinic study 
 
A supplementary study used routinely collected, service-based data. The study aimed to 
investigate: 
 The rate of clinically diagnosed ASD among specialist mental health service users 
with intellectual disability. 
 Whether the participants included in the main study were representative of the wider 
clinical population from which they were sampled. 
 Whether differences in health and social functioning found in the main study 
replicated differences in the larger clinical sample. 
 
Method of the clinic study 
Participants 
The clinic study included the entire population of services users on the Mental Health in 
Intellectual Disability (MHID) caseload during 2010 (see Chapter 7 for a description of this 
service). All participants had a clinical diagnosis of intellectual disability (according to ICD-
10 criteria; WHO, 1992). 
 
Eligibility criteria 
The inclusion criteria for the clinic study were that participants were: 
1)  on the MHID service caseload between January 2010 and January 2011 (see 
Chapter 7 for the service‘s eligibility criteria) 
and 2)  had an mental health record that indicated they were an  
‗accepted‘ MHID service user 
 
The additional inclusion criterion for the ASD group was that participants had a clinical 
diagnosis of ASD documented in their mental health record. 
Chapter 10: Clinic study 
180 
The exclusion criteria for the clinical study were that: 
1)  a service user‘s mental health record indicated that subsequent to being 
accepted they were deemed ineligible to receive MHID services and were due 
to be discharged 
or 2) there was insufficient information available in their mental health  
record to determine whether an individual had ASD or the severity of their 
intellectual disability. 
 
The additional exclusion criteria for the group without ASD were that: 
1) the terms ‗autistic‘, ‗autistic traits‘, ‗autistic features‘ or ‗autistic behaviours‘ 
were specifically mentioned in an individual‘s mental health record 
or 2)  a service user‘s mental health record indicated that it was  
thought they might have ASD but further assessment was required. 
 
Measures 
Most of the data collected for the clinical study were routinely recorded socio-demographic 
and clinical characteristics. All clinical diagnoses were made or confirmed by an intellectual 
disability psychiatrist using ICD-10 criteria (WHO, 1992). In addition, health and social 
functioning data were available; the HoNOS-LD is completed by MHID clinicians during 
outpatient appointments and CPA reviews. 
 
Data collection 
Data were obtained from a database known as CRIS (Case Register Interactive Search); 
developed by the Biomedical Research Centre (BRC) at King‘s Health Partners (Stewart et 
al., 2009). It holds anonymised information sourced directly from the electronic Patient 
Journey System (ePJS) (see chapter 7). CRIS contains the records of over 150,000 past and 
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present mental health service users from South East London including all those on the MHID 
service caseload (Chang et al., 2010). 
 
CRIS domains and fields match the tabs and data entry fields in ePJS. In addition to directly 
entered data, CRIS can search and retrieve text from attachments such as letters, reports, 
forms, faxes and emails that are routinely uploaded into the correspondence section of ePJS. 
Where multiple entries have been made, for example several assessments using a specific 
measure over time, all data for each entry are retrieved. The system is updated daily. CRIS 
has been used to explore the characteristics of mental health service users (Stewart et al., 




The BRC has been granted ethical approval for the use of CRIS as an anonymised database 
for secondary analysis by the Oxfordshire Research Ethics Committee C (reference 
08/H0606/71). The system has also been approved by the South London and Maudsley NHS 
Foundation Trust Caldicott Guardian and the Trust Executive. An oversight committee led by 
the BRC Stakeholder Participation scheme reviews all requests to use CRIS. The clinical data 
study was approved by the CRIS oversight committee in November 2009 (see Appendix II for 
the CRIS approval). 
 
Procedure 
The CRIS searches, data extraction and analyses were carried out between January 2010 and 
March 2011. The first search of CRIS was carried out in January 2010 and included service 
users from Lambeth, Lewisham and Southwark. A subsequent search carried out in January 
2011 included service users from Croydon and new service users added to the other caseloads 
since the first search. 
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CRIS search 
The following strategy was used (See Appendix II for the full search strategy): 
 
Find:  all ‗active‘ service users on the MHID caseload 
Retrieve: BRC-ID
1




, ethnicity, ICD-10 diagnoses
2
, 
correspondence for 2009 and 2010 and all HoNOS-LD scores. 
 
The search results were exported from CRIS into MS Excel spreadsheets. Data were 












Identifying participants with ASD 
The diagnosis and correspondence information for each service user was systematically 
screened using Excel‘s find facility for any mention of the words: ‗autism‟, ‗ASD‟, 
‗Asperger‟, ‗autistic‟, ‗pervasive‟ and ‗PDD‟. Records that contained these terms were further 
reviewed to determine whether they indicated that the individual had a clinical diagnosis of 
ASD, had autistic traits, features or behaviours, were suspected of having an ASD or, 
                                               
1 These data are present for all individuals on ePJS/CRIS, other fields are optional and depend on clinicians 
entering and updating the information. 
2 See Chapter 7 for more details on how this information is recorded. 
Figure 10.1: Sources of data for the clinical study 
Direct from gender, date of birth & ethnicity CRIS 
fields 
Gender, date of birth 
Where available: ethnicity 
Most recent follow-up letter to participant‘s GP Ethnicity (if field blank) 
Type of residence 
Clinical diagnoses (ASD, ID & 
Psychiatric disorder) Direct from CRIS assessment/diagnosis & medication 
fields 
Most recent item of correspondence 
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alternatively, whether any of the terms used were not relevant to the service user themselves 
or stated they did not have ASD. If there was clinical diagnostic information in a participant‘s 
records but no mention of any of the above terms it was assumed that they did not have a 
clinical diagnosis of ASD or any recognised autistic traits/features/behaviours. 
 
Following this screening participants were put into three groups: 
1) Documented clinical diagnosis of ASD (ASD group) 
2) No diagnosis or mention of ASD (no ASD group) 
3) Presence of autistic traits/features/behaviours or ASD suspected 
 
The third group were participants who were eligible for the study but did not meet the 
additional criteria for the ASD or no ASD groups. This group will be referred to as having 
‗ASD traits‘. 
 
At the same time as the ASD screen, participants‘ severity of intellectual disability, type of 
residence and whether they had an additional psychiatric disorder were extracted. Information 
in most recent correspondence was cross-checked with past correspondence and diagnosis 
data to ensure it was consistent across sources. 
 
Analysis 
Participants‘ health and social functioning was measured using the total score on the HoNOS-
LD. Exploratory data analyses were carried out to check for homogeneity, normal distribution 
of continuous variables and outliers. The significance of differences between the groups was 
tested using analyses of variance (ANOVA) for continuous variables. Chi-squared tests were 
used for categorical variables except when the cell sizes were small. Fisher‘s exact test was 
used when more than 50% of cells had a count less than five. 
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Results of the clinic study 
A Case Register Interactive Search (CRIS) identified a total of 825 specialist mental health 
service users with intellectual disability. 
 
Participants 
Following a screen for eligibility, 37 people were excluded from the study because they did 
not have intellectual disability or because there was not enough information available to 
determine the severity of their intellectual disability or whether they had ASD (Figure 10.2 
shows the flow of participants through the study). Therefore, 788 participants were included 
in the study and allocated to one of three groups: 
 
1. ASD: participants who met the criteria for ASD. 
2. No ASD: participants who met the criteria for no ASD.  
3. ASD traits: participants who did not meet the criteria for ASD or no ASD. 
(Individuals who were described as having autistic traits/features/behaviours or who 
were thought to have ASD but had not received a clinical diagnosis) 
 
Figure 10.2: Flow of participants through the clinic study 
MHID service users
N = 825 Excluded (N=26):
Insufficient information to determine 
presence/absence of ASD (N=22)
Evidence of no ID (N=4)














Evidence of no ID (N=2)
Insufficient information to determine 
severity of ID (N=9)
 
There were 264 participants with a clinical diagnosis of ASD (33.5%), 460 participants with 
no ASD (58.4%) and 64 participants with ASD traits (8.1%) (see Figure 10.3 below). 
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Therefore, there was evidence of a clinical diagnosis of ASD (according to ICD-10 criteria) or 
that an intellectual disability psychiatrist had identified features suggestive of ASD for almost 
42% of the 788 participants. 
 
Figure 10.3: Rates of ASD and ASD traits among the 788 included participants 
 
It was not clear why participants with ASD traits had not received a clinical diagnosis. They 
appeared to be individuals who were awaiting further assessment and participants who had 
not been formally diagnosed because their symptoms did not reach diagnostic criteria. 
Participants with ASD traits were a difficult to define and heterogeneous group. Therefore, 
they were taken out of the dataset and analysed separately (see Chapter 11). The rest of the 




Table 10.1 shows the characteristics of the 724 included participants. An ANOVA and Chi-
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Table 10.1: Characteristics of the 724 participants with and without ASD 
  ASD 
N = 264 
No ASD 
N = 460 
 
Age Mean years (SD) 37.7 (13) 46.9 (14.1) F(1,723)=76.4, p<0.001 
Gender 
Males 206 (78%) 241 (52%) 
χ2(1)=46.68, p<0.001 
Females 58 (22%) 219 (48%) 
Ethnicity 
Afro-Caribbean 84 (32%) 100 (22%) 
χ2(3)=11.31, p=0.01 
Asian  16 (6%) 20 (4%) 
White 150 (57%) 306 (67%) 
Unclear or other 14 (5.3%) 34 (7.4%) 
Type of  
Residence
+ 
Family 92 (35%) 99 (22%) 
χ2(3)=43.16, p<0.001 
Independently  8 (3%) 86 (19%) 
Residential 156 (60%) 259 (57%) 
Other* 6 (2.3%) 10 (2%) 
+ 
Information unavailable for 2 people with ASD and 6 people with no ASD. * Includes inpatient units, secure 
units, hostels, prison and participants who were homeless 
 
 
There were significant differences between participants with and without a clinical diagnosis 
of ASD on all extracted socio-demographic variables: 
 Participants with ASD were younger than those with no ASD. 
 Participants with ASD were more likely to be male than those with no ASD. 
 Participants with ASD were more likely to be Afro-Caribbean (χ2(1)=9,p= 0.003) and 
less likely to be White (χ2(1)=6.8,p=0.009) than those with no ASD. 
 Participants with ASD were more likely to live with family (χ2 (1)=15.3, p<0.001) and 
less likely to live independently (χ2(1)=36.4,p<0.001) than those with no ASD. 
 
Table 10.2 shows the clinical characteristics of the participants and the prevalence of ASD 
among those with different severities of intellectual disability and with/without a diagnosis of 
psychiatric disorder. 
 
Most participants (55%) had mild intellectual disability; the rate of ASD among this group 
was 22%. Fewer participants had moderate and fewer still had severe intellectual disability 
but the rate of ASD increased with each level of severity. 
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Table 10.2: Clinical characteristics of the participants 
  Total N=724 Number (% with ASD) 
Severity 
of ID 
Mild 400 (55%) 87 (22%) 
Moderate 208 (29%) 95 (46%) 




Present 520 (73%) 137 (26%) 
Absent 193 (27%) 122 (63%) 
+Information was unavailable or unclear for 11 participants. 
 
Participants with ASD were less likely to have mild intellectual disability (33% vs. 68%; 
χ2(1)=83.5, p<0.001), more likely to have moderate intellectual disability (36% vs. 25%; χ2 
(1)=10.7, p=0.001) and more likely to have severe intellectual disability (31% vs. 7%; 
χ2(1)=69.8, p<0.001) than those without ASD. 
 
The rate of ASD was higher among those without a diagnosis of psychiatric disorder (63%) 
than it was among those with a disorder (26%). 
 Participants with ASD were less likely to have an additional psychiatric disorder than 
those without ASD (53% vs. 84%; χ2(2)=82.7, p<0.000). 
 
Pattern of psychiatric disorder 
Table 10.3 shows the pattern of diagnoses among the 520 participants who had a psychiatric 
disorder (i.e. participants who did not have a psychiatric diagnosis or had no information on 
presence/absence of psychiatric disorder were excluded).  
 
Table 10.3: Pattern of disorders among participants with a psychiatric diagnosis 
 ASD (N=137) No ASD (N=383)  
ADHD 6.6% 2.1% χ2(1)=6.4, p=0.011 
Anxiety disorder 13.1% 5.5% χ2(1)=8.5, p=0.004 
Bipolar disorder 15.3% 11.7% χ2(1)=1.2, p=0.28 
Dementia 0.7% 6% χ2(1)=6.4, p=0.012 
Depressive disorder 18.2% 20.6% χ2(1)=0.3, p=0.55 
Personality disorder 0 5% χ2(1)=7.1, p=0.008 
Psychotic disorder 35.8% 43.3% χ2(1)=2.2, p=0.137 
Other disorders* 10.2% 5.7% χ2(1)=7.8, p=0.005 
*included mixed anxiety & depression, adjustment disorder & gender identity disorder. See Appendix III for a 
list of the disorders included in each category. 
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Among participants with a psychiatric disorder, there was an overall statistically significant 
difference between the groups (χ2(7)=32.6, p<0.001). 
 
 Among participants diagnosed with a psychiatric disorder, those with ASD were more 
likely to have been diagnosed with anxiety than those with no ASD. 
 Among participants diagnosed with a psychiatric disorder, those with ASD were more 
likely to have been diagnosed with ADHD than those with no ASD. 
 Among participants diagnosed with a psychiatric disorder, those with ASD were less 
likely to have been diagnosed with dementia and personality disorder than those with no 
ASD.  
 
These findings were different from the main study in which there were significant differences 
between the groups on depression. Two factors could account for this: 1) the distribution of 
diagnoses among the sample of participants recruited into the main study was different to the 
clinic study sample and/or 2) the proportion of psychiatric diagnoses changed when 
participants‘ ASD diagnoses were assessed and those who did not meet the study criteria were 
excluded from the main study. 
 
It appears that both these suggestions are true to a certain extent. The proportion of 
participants with a psychiatric diagnosis was slightly lower among the 129 participants 
recruited into main study than it was in the clinical study. There were only two people with 
ASD and depression recruited and one of these was excluded from the ASD group leading to 
the difference between those with and without ASD. In addition, a high proportion of those 
who were excluded from the no ASD group of the main had psychotic disorder (56%) so the 
relative proportions of the different psychiatric diagnoses changed. 
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In conclusion, participants with ASD were significantly different from those without ASD on 
a number of socio-demographic and clinical characteristics. Individuals with ASD appear to 
form a distinct group among specialist mental health service users with intellectual disability. 
Although this could indicate a true difference in the prevalence of ASD among specific 
groups it could also be associated with disparities in referral to specialist mental health in 
intellectual disability services, access to other services and recognition. It is likely that many 
of the differences with regards to participants‘ clinical profiles reflect the difficulties of 
assessing adults with intellectual disability for ASD and mental health problems, particularly 
as severity of intellectual disability increases. Nonetheless, it is these clinical profiles that 
would have formed the basis of treatment decisions for this sample. 
 
Health and social functioning 
There were HoNOS-LD scores available for 618 participants; 78% of the sample. Of these 
618 participants, 32.5% had a clinical diagnosis of ASD, 59.1% had no ASD 8.4% had ASD 
traits. A slightly lower proportion of service users with ASD (76.1%) had been assessed using 
the HoNOS-LD compared to those no ASD (79.3%) and those with ASD traits (81.3%) but 
these differences were not significant.  
 
Significantly fewer male participants (76%) had a HoNOS-LD score compared with 82% of 
female participants (χ2(1)=4.1,p=0.043). Participants with a HoNOS-LD score were 
significantly younger (mean=42.4 years old) than those without a score (mean=45; 
F(1,787)=4.5, p=0.034). Indicating that perhaps older, male participants might be under-
represented among the sample with a HoNOS-LD assessment. Apart from this there were no 
statistically significant differences between those who had and had not been assessed using 
the HoNOS-LD according to ethnicity, severity of intellectual disability, presence/absence of 
psychiatric disorder or type of residence. As such, there did not appear to be any considerable 
selection bias. 
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The HoNOS-LD analyses included only those with a clinical diagnosis of ASD or no ASD 
(n=566). Data for participants with ASD traits are reported in Chapter 11. Some items in the 
HoNOS-LD were not completed resulting in missing data. There were five participants with 
more than four missing item scores. These participants were excluded from the analyses. 
Exploratory data analyses showed that the HoNOS-LD data was sufficiently normally 
distributed with acceptable distribution of outliers and equality of variance between the 
groups with and without ASD. Therefore, it was considered that the assumptions for 
parametric testing were met. 
 
Total HoNOS-LD scores 
Of the 561 participants included in the HoNOS-LD analyses, 200 had a clinical diagnosis of 
ASD (35.65%) and 361 had no ASD (64.35%). The internal consistency of the HoNOS-LD 
measured using Cronbach‘s alpha was 0.84. 
 
The mean total HoNOS-LD score for participants with a clinical diagnosis of ASD was 18.2 
(SD=9.5) compared with 13 (SD=9.1) for those without ASD. This difference of around five 
‗points‘ was statistically significant (F(1,560)=40.3, p<0.001). Thus, as in the main study, 
participants with ASD appeared to have lower health and social functioning than those 
without ASD. 
 
There were no a significant associations between age, gender, ethnicity and total HoNOS-LD 
score. Mean HoNOS-LD score was significantly lower for those living independently but 
similar for those in the other categories. As in the main study, mean total HoNOS-LD scores 
increased significantly with severity of intellectual disability (F(1,560)=57,p<0.001). 
Participants without an additional diagnosis of psychiatric disorder had significantly higher 
HoNOS-LD scores than those with a diagnosis of psychiatric disorder (F(1,560)=19, 
p<0.001). 
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HoNOS-LD subscales 
Using the item groupings identified by Tsakanikos et al. (In preparation), subscale scores 
were calculated and compared between those with and without a clinical diagnosis of ASD. 
Table 10.4 shows the mean scores for participants with and without ASD on the three 
HoNOS-LD subscales. 
 






Neuro-cognitive functioning 5.6 (4) 3.2 (3.4) F(1,560)=56.2, p<0.001 
Mental/behavioural problems 5.7 (4.4) 3.8 (3.6) F(1,560)=29.1, p<0.001 
Health/social functioning 7 (4.1) 6 (4.7) F(1,560)=5.68, p=0.017 
 
The results were similar to those found in the main study and appeared to show that 
participants with ASD have lower functioning in all three domains of the HoNOS-LD than 
those without ASD. 
 
HoNOS-LD ASD subscale 
It has been suggested that adults with ASD would be expected to score high on items relating 
to attention, communication and relationship problems. Therefore analyses of individual item 
scores were carried out. This was to determine whether there were any particular items that 
might have influenced the results of the total score analyses. 
 
Participants with ASD had a higher mean score than those without ASD on 14 items of the 
HoNOS-LD. An investigation was carried out to identify which five of these 14 items had the 
greatest difference in mean scores between those with and without ASD. These were found to 
be: Expressive communication, Stereotyped behaviour, Receptive communication, 
Attention/concentration and Anxiety. These items appear to be clinically meaningful with 
regards to the characteristics of people with ASD. It may be important to take them into 
account when looking at differences in the total HoNOS-LD scores between those with and 
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without ASD. They may provide a useful indicator that an individual who does not have a 
clinical diagnosis should be assessed for ASD. These items were said to form an ASD 
subscale within the HoNOS-LD. 
 
The mean total score for these five items was 6.4 (SD: 3.8) for participants with a clinical 
diagnosis of ASD and 3.2 (SD: 2.9) for those without ASD (F(1,560)=129.9, p<0.000). This 
ASD subscale had acceptable internal consistency (Cronbach‘s alpha was 0.74 for participants 
with ASD and 0.81 for those without ASD). 
 
When these items were removed from the total HoNOS-LD scores, the mean total scores for 
the remaining 17 items were 11.8 (SD: 6.7) for participants with ASD and 9.9 (SD: 7) for 
those without ASD (F(1, 560)=9.8, p=0.002). Thus, a significant difference remained even 
when items that appear to be ASD-specific were removed; although the magnitude of the 
difference was reduced to around two points. 
 
Further analyses of data from the main study were carried out to determine whether 
differences between participants on the HoNOS-LD remained when these ASD-type items 
were removed. The results are shown in Table 10.5. 
 
Table 10.5: HoNOS-LD results for main study participants with ASD items removed 
 ASD N=50 No ASD N=48  
HoNOS-LD 
ASD subscale 
6.4 (3) 2.4 (1.6) F(1,97)=69.3, p<0.001 
HoNOS-LD 
Total score excluding ASD items 
13.4 (6.8) 8.6 (5.6) F(1,97)=14.4, p<0.001 
 
 
Participants with ASD in the main study scored higher on the ASD subscale and a significant 
difference between those with and without ASD remained when these items were removed 
from the total HoNOS-LD score. 
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Among the sample from the main study, the internal consistency of the ASD subscale was 
questionable (0.64) but ASD score was significantly correlated with total SCQ score (r=0.72, 
p<0.001). Cronbach‘s alpha for the total HoNOS-LD score when the ASD items were 
removed was 0.7 which is acceptable. 
 
Quality of the anonymised clinical data 
The screening and extraction of the data for the clinical study using CRIS was very successful 
with few missing data. It was possible to ascertain both severity of intellectual disability and 
presence/absence of a clinical diagnosis of ASD for 88% of the entire sample of 825 
participants. For a further 8% it was possible to determine severity of intellectual disability 
and presence of ASD traits. Only 4.5% of the sample had to be excluded due to insufficient 
information. The amount of missing data for the 788 included participants was low. Data on 
gender, ethnicity and age were available for all participants. There were data on type of 
residence for 99% of participants and presence/absence of psychiatric disorder for 98%. 
 
Most of the data were sourced from reports and correspondence to participants‘ GPs. If data 
had been extracted directly from the fields for ethnicity, type of residence and ICD-10 
diagnoses there would have been much less data and the results might have been considerably 
different. For example, the prevalence of ASD if taken straight from the ICD-10 diagnoses 
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Conclusion 
In this descriptive study of routinely collected data from an entire clinic sample of specialist 
mental health service users with intellectual disability, individuals with a clinical diagnosis of 
ASD formed a distinct group with significantly different characteristics and health and social 
functioning compared to those without ASD.  
 
The rate of clinically diagnosed ASD was 33.5%. A further 8% of participants were described 
as having ASD traits but had not been given a formal diagnosis. The clinic study provided 
further evidence that specialist mental health services users with intellectual disability and 
ASD have poorer health and social functioning than those without ASD. 
 
Participants with and without ASD were broadly similar in each of the main and clinic study 
with regards to: 
 
 Age 
 Ratio of males to females 
 Distribution of ethnic groups 
 Type of residence (although a higher proportion of participants without ASD in the 
main study lived independently than did in the clinic study). 
 
Among participants with ASD, the main study included a slightly higher proportion of 
individuals with mild intellectual disability and a lower proportion of those with a diagnosis 
of psychiatric disorder than was found in the wider clinic population. The pattern of 
differences between participants with and without a clinical diagnosis of ASD was broadly 
similar to that found in the main study. The pattern of significant differences was the same for 
each study with the exception of ethnicity. 
Chapter 11: Participants with ASD traits 
195 
Chapter 11: Participants with ASD traits/behaviours 
 
Chapter 9 tested the main hypotheses for the thesis. Chapter 10 compared results from the 
main study with data from the wider clinic population. However, the studies produced some 
new questions. These concern the individuals who were excluded from the studies: those who 
did not meet the study criteria for ASD or no ASD. 
 
Main study 
As reported in Chapter 9, 28 participants who had no clinical diagnosis or mention of ASD in 
their mental health record were excluded from the main study because they exceeded the 
threshold for ASD on the ADOS or appeared to meet ICD-10 criteria for ASD. This group 
will be referred to as having ASD behaviours. 
 
The excluded participants with ASD behaviours had significantly higher scores on the SCQ 
(mean=13.6) than those without ASD included in the study (mean=5.5; F(1,69)=61.8, 
p<0.001). They were also significant more likely to have an SCQ score above 15; the cut-off 
point for ASD (46% vs. 2%; X
2
(1)=20.8, p<0.001). The excluded group with ASD behaviours 
had significantly lower SCQ scores than those with ASD (mean=16.2; F(1,74)=4.5, p=0.038). 
This could indicate that there is a threshold of ASD behaviours below which individuals with 
intellectual disability tend not to receive an ASD diagnosis or whose behaviours go 
undocumented as possibly being due to ASD. However there were many people in the ASD 
group who had low SCQ scores so this does not appear to be the case. 
 
The characteristics of participants with ASD behaviours compared with those included in the 
study are shown in Table 11.1. Participants with ASD behaviours
b
 appeared to be similar to 
those with ASD
a
, except that they were significantly older. There were no other significant 
differences between the excluded group and participants with ASD. 
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N=48 Significant differences 
Age Mean years (SD) 
Range 
36.4 (12.4) 
18 to 68 
42.8 (12.6) 
20 to 64 
43.7 (11.6) 
20 to 63 




Mild 20 (40%) 8 (29%) 35 (73%) 
b & c (χ2(2)=26.8, 
p<0.001) 
Moderate 14 (28%) 6 (21%) 12 (25%) 
Severe 16 (32%) 14 (50%) 1 (2%) 
Gender 
Males 40 (80%) 23 (82%) 29 (60%) b & c (χ2(1)=3.9, 
p=0.049) Females 10 (20%) 5 (18%) 19 (40%) 
Ethnicity 
Afro-Caribbean 19 (38%) 9 (32%) 15 (31%) 
None 
Asian 2 (4%) 2 (7%) 1 (2%) 
White  27 (54%) 17 (61%) 30 (63%) 
Unclear/other 2 (4%) 0 2 (4%) 
Type of 
residence 
With family 21 (42%) 5 (18%) 11 (23%) 
b & c (χ2(3)=11.04, 
p=0.012) 
Residential  27 (54%) 22 (78%) 23 (48%) 




Present 23 (46%) 18 (64%) 41 (85%) b & c (χ2(1)=4.55, 
p=0.033) Absent 27 (54%) 10 (36%) 7 (15%) 
 
 
The clinical profile of those excluded
b
 was considerably different from those without ASD
c 
who were included in the main study.  They were: less likely to have mild and more likely to 
have severe intellectual disability, more likely to be male, more likely to live in a residential 
placement, less likely to live independently and less likely to have been diagnosed with a 
psychiatric disorder. 
 
There were a number of features of the excluded group that may suggest why they did not 
meet the study criteria for ‗no ASD‘ or why their behaviours have not been recognised as 
being associated with ASD. A considerable number of those with no clinical diagnosis of 
ASD had epilepsy (N=19; 25%). The majority of this group (68%) were excluded. All of the 
participants who had no clinical diagnosis of ASD and were non-verbal were excluded. It is 
not clear whether this indicates a limitation of using the ADOS with non-verbal adults who 
have intellectual disability. 
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When compared to those with ASD, the group with ASD behaviours: 
 
 Were more likely to have epilepsy (46% vs. 16%; (X2(1)=8.14, p=0.004). 
 Had fewer staff per service user during the day (0.66 vs. 1; F(1,47)=10.5, p=0.002) 
and fewer staff over 24 hours (1 vs. 1.4; F(1,747)=9.1, p=0.004). 
 Were receiving more psychotropic medications (1.8 vs. 1.1; F(1,77)=8.8, p=0.004). 
 Had lower total HoNOS-LD scores (15.9 vs. 19.8; F(1,77)=4.2, p=0.044) and Mental 
health/behavioural subscale scores 6.4 vs. 9.1; F(1,77)=7.6, p=0.007). 
 Had lower Total Problem Behaviour Score (TPBS) on the DBC (42.7 vs. 53.7; 
F(1,74)=9.9, p=0.002). 
 
When compared to those without ASD, the group with ASD behaviours: 
 
 Were less likely to have capacity (39% vs. 85%; (X2(1)=17.4, p<0.001). 
 Were more like to have epilepsy (46% vs. 13%; (X2(1)=10.2, p=0.001). 
 Were less likely to be on CPA (11% vs. 33%; (X2(1)=4.5, p=0.033). 
 More likely to be on antipsychotic medication (86% vs. 54%; (X2(1)=7.82, p=0.005). 
 Had a higher total number of needs (12.8 vs. 10.7; F(1,71)=8.2, p=0.006) and more 
met needs (11 vs. 9; F(1,71)=7.2, p=0.009). 
 Were more likely to be supervised when in the community (68% vs. 36%; (X2(1)=7.1, 
p=0.008). 
 Had more hours of support per week (18.3 vs. 8.7; F(1,24)=6.4, p=0.019). 
 Were more likely to be non-verbal (29% vs. 0%; (X2(1)=15.3, p<0.001). 
 Less likely to have ever worked (15% vs. 40%; (X2(1)=5.04, p=0.025). 
 Less likely to currently work (7% vs. 29%; (X2(1)=4.7, p=0.03). 
 Had higher total HoNOS-LD scores (15.9 vs. 11; F(1,75)=9.4, p=0.003).  
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 Had higher Neurocognitive HoNOS-LD subscale scores (4 vs. 1.8; F(1,75)=19.8, 
p<0.001) and higher Mental health/behavioural HoNOS-LD subscale scores 6.4 vs. 
4.5; F(1,75)=4.9, p=0.029). 
 Had higher HoNOS-LD ASD subscale scores (5 vs. 2.4; F(1,75)=27.7, p<0.001). 
 Had higher TPBS on the DBC (42.7 vs. 29.2; F(1,69)=9.9, p<0.001). 
 
To summarise, participants with ASD behaviours excluded from the main study had a socio-
demographic and clinical profile that was similar to those with a confirmed diagnosis of ASD. 
This group‘s mental health and social functioning seemed to fall in the middle of those with 
and without ASD. Importantly, the only variable on which those with ASD and ASD 
behaviours significantly differed was age. Perhaps indicating that the likelihood of having 
undiagnosed ASD increases with age. This could help explain why studies consistently find 
that specialist mental health service users with intellectual disability and ASD are younger 
than those without ASD.  
 
Clinic study 
A small but significant number of participants in the clinic study were described as having 
ASD traits, features or behaviours but had not received a clinical diagnosis. These participants 
were removed from the main analyses in order to simplify what was already a large and 
complex sample. Table 11.2 shows the characteristics of the 64 participants with ASD traits 
and which group they significantly differed from.  
 
Ethnicity was the only variable for which participants with ASD traits were not significantly 
different from either those with or without a clinical diagnosis of ASD. 
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Table 11.2: Characteristics of participants with ASD traits in the clinical study 
  ASD traits 
N = 64 
Significant differences 
Age Mean years (SD) 35.97 (14.24) Significantly younger than group with no ASD 
Gender 
Males 38 (59.4%) Significantly fewer males than the group with 
ASD Females 26 (40.6%) 
Ethnicity 
Afro-Caribbean 20 (31.3%)  
Asian  0  
White 38 (59.4%)  
Unclear or other 6 (9.4%)  
Type of  
Residence
 
Family 23 (35.9%) 
Significantly more were living independently 
compared to group with ASD 
Independently  8 (12.5%) 
Residential 31 (48.4%) 
Other 2 (3.1%) 
Severity 
of ID 
Mild 38 (59.4%) Significantly more likely to have mild ID and 
less likely to have severe ID than group with 
ASD 
Moderate 20 (31.3%) 




Present 41 (64.1%) Significantly less likely to have a diagnosis than 
group with no ASD Absent 23 (35.9%) 
 
Participants with ASD traits were more like those with ASD for age, presence of psychiatric 
disorder and specific psychiatric diagnosis. Participants with ASD traits were more like those 
without ASD for gender, type of residence and severity of intellectual disability. Participants 
with ASD traits did not appear to be consistently similar to either those with or without a 
clinical diagnosis of ASD. They tended to fall somewhere in between the two groups. 
 
This reflects the heterogeneity among those with ASD traits. It could be assumed that if this 
group were formally assessed for ASD a significant proportion would receive a diagnosis. 
The main study provided evidence if all the participants without ASD in the clinical study 
were assessed it is likely that some would have traits suggestive of ASD, particularly among 
those with severe intellectual disability. 
 
Of the 64 participants with ASD traits, 52 had a HoNOS-LD assessment. The results of 
comparisons between the group with ASD traits and those with and without a clinical 
diagnosis of ASD were: 
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 Participants with ASD traits had a significantly lower mean total HoNOS-LD score 
compared to those with ASD (15.2 vs. 18.3, F(1, 252)=4.2, p=0.041). 
 Participants with ASD traits had significantly lower mean scores than those with ASD 
on the Neuro-cognitive functioning (3.7 vs. 5.6, F(1, 252)=10.5, p=0.001) and ASD 
subscales (4.3 vs. 6.4, F(1, 252)=14.1, p<0.001). 
 Participants with ASD traits had a higher mean total HoNOS-LD score than to those 
without ASD but the difference was not statistically significant. 
 Participants with ASD traits had significantly higher mean scores than those without 
ASD on the Mental/behavioural HoNOS-LD (mean=3.8, F(1,412)= 10.2, p=0.002) 
and ASD subscales (mean=3.2, F(1,412)=6.7, p=0.01). 
 
In conclusion, the participants with ASD traits seemed to occupy the middle ground between 
those with and without a clinical diagnosis of ASD on a range of socio-demographic and 
clinical variables including health and social functioning. 
 
Conclusion 
Rates based on clinical diagnoses are likely to underestimate the number of specialist mental 
health service users with intellectual disability who have ASD. In some cases the person‘s 
ASD traits may have been acknowledged. However, there is a group whose behaviour is 
consistent with a diagnosis of ASD (according to standardised diagnostic assessment) who 
have no mention of ASD in their mental health record. These service users have a similar 
socio-demographic and clinical profile to those with ASD, except that they are older.
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Chapter 12: Discussion and conclusion 
 
The aim of the thesis was to determine whether participants with ASD from a specialist 
mental health service for adults with intellectual disability have a different clinical and social 
functioning profile compared to those without ASD. That is: 
 
 Do those with ASD have distinct characteristics or needs? 
 Is their pattern of service use different? 
 Are these factors and/or the presence of ASD significantly associated with mental 
health, behaviour and social functioning? 
 
Summary of findings 
 
Hypothesis one (participants with ASD will have more needs) - partially accepted: 
Participants with ASD had a significantly greater number of needs (as measured by the 
CANDID) than those without ASD. However, there was no significant difference between 
those with and without ASD on number of unmet needs or the proportion of their needs that 
were unmet. When severity of intellectual disability and type of residence were taken into 
account ASD was not a significant predictor of participants‘ total number of needs.  
 
Hypothesis two (participants with ASD will have poorer health & social functioning) - 
accepted: Participants with ASD had significantly poorer health and social functioning than 
those without ASD (as measured by the HoNOS-LD). Health and social functioning was also 
independently associated with severity of intellectual disability and needs. 
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Hypothesis three (participants with ASD will have poorer mental health) - accepted: 
Participants with ASD had significantly poorer mental health than those without ASD (as 
measured by total score on the DBC). Mental health was also independently associated with 
total number of needs. 
 
Hypothesis four (participants with ASD will have poorer behaviour) - accepted: 
Participants with ASD had significantly higher levels of problem behaviour than those 
without ASD (as measured by a behaviour subscale of the DBC). Problem behaviour was also 
independently associated with total number of needs. 
 
Hypothesis five (participants with ASD will have poorer social functioning) - partially accepted: 
Participants with ASD had significantly poorer social functioning than those without ASD (as 
measured by a social functioning scale for adults with developmental disability). However, 
when severity of intellectual disability, absence of a psychiatric disorder and needs were taken 
into account, ASD was not a significant predictor of social functioning. 
 
Hypothesis six (participants with ASD will use more mental health services) - rejected: 
Participants with ASD had significantly lower levels of mental health service use than those 
without ASD. However when severity of intellectual disability and age were taken into 
account, ASD was not a significant predictor of mental health service consumption score. 
 
Hypothesis seven (participants with ASD will use more psychotropic medication) - rejected: 
There was no significant difference in the rate of psychotropic medication or number of 
psychotropic medications prescribed to participants with and without ASD. Whether or not a 
participant was prescribed a psychotropic medication was associated with severity of 
intellectual disability and presence of psychiatric disorder. 
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Hypothesis eight (mental health and social functioning will be associated with unmet needs, 
service use & intellectual disability severity - partially accepted: 
Total HoNOS-LD scores were significantly associated with unmet needs but total number of 
needs was a significant predictor of mental health and social functioning according to the 
DBC and social functioning scale. 
 
Measures of mental health, behaviour and social functioning were not significantly associated 
with mental health service consumption score. 
 
Mental health service use, psychotropic medication, needs and social functioning, were 
significantly associated with severity of intellectual disability. Mental health (according to a 
mental health subscale of the DBC) was not associated with severity of intellectual disability. 
 
Discussion 
The thesis successfully tested a number of hypotheses on the impact of ASD on specialist 
mental health service users with intellectual disability.  
 
Clinical and social implications of the findings 
A striking feature of the results was that mental health, problem behaviour, health and social 
functioning, mental health service use, medication use and needs tended to be significantly 
associated with clinical rather than socio-demographic factors. There was no evidence to 
suggest that these measures were affected by gender or ethnicity. Age and type of residence 
were significantly associated with some variables but usually not once other factors had been 
taken into account (apart from needs and mental health service use). 
 
Furthermore, perhaps with the exception of needs, these significant predictors are not 
characteristics that can be changed or improved. It appears that services (and research) should 
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focus on ways of improving provision to specific subgroups of people with intellectual 
disability who have mental health and behavioural problems. These subgroups should defined 
by clinical characteristics such as: additional comorbidities (e.g. ASD), severity of intellectual 
disability and presence/absence of psychiatric disorder. 
 
The study provided evidence that among specialist mental health service users with 
intellectual disability there appears to be: 
 
 High levels of undiagnosed ASD. 
 Undiagnosed mental health problems. 
 High rates of psychotropic medication in the absence of psychiatric disorder. 
 Inequalities in service provision and psychotropic medication use. 
 
The recent NICE guidelines make it clear that having unrecognised ASD, untreated mental 
health problems, inappropriately managed behaviour problems or receiving inadequate 
services can have considerable repercussions for adults on the autism spectrum and those 
around them (NICE, 2012). For individuals with intellectual disability, these circumstances 
may lead to increased difficulties with trying to live more independently, finding or 
maintaining employment, forming relationships and accessing community facilities. Thus 
leading to increased social exclusion. This study found that participants with intellectual 
disability and ASD had more problems with these aspects of their lives than those without 
ASD.  
 
Undiagnosed disorders and ineffective intervention may also increase the risk of an individual 
causing harm to themselves or others. There are also implications for services; they may end 
up attempting to manage patients without sufficient resources or expertise, treating 
individuals for longer than necessary and diverting resources away from other service users. 
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Further research is needed to establish whether improvements in ASD recognition, problem 
behaviour and mental health lead to better social functioning. Establishing the most effective 
ways of identifying and meeting the needs of adults who have intellectual disability, ASD and 
mental health problems is vital. 
 
There does not appear to be sufficient evidence on which to base the current assumption that 
specialist intellectual disability services are able to sufficiently recognise, assess and provide 
effective management of people with low-functioning ASD who have additional mental 
health needs. More research is needed on current pathways experienced by adults with 
intellectual disabilities who present to mental health services with symptoms of ASD and how 
these might be changed in order to improve diagnostic accuracy. Ideally this work would 
complement the work carried out by the National Audit Office which demonstrated that 
improved recognition of high-functioning ASD would lead to improved outcomes 
(Doctors.net.uk, 2008; National Audit Office, 2009a; National Audit Office, 2009b). 
 
The NICE guidelines also make it very clear that challenging behaviour in adults with ASD 
should be assessed using functional analysis. Furthermore, that psychosocial intervention, 
based on behavioural principles, should be offered for those with challenging behaviour 
before considering medication (NICE, 2012). Recommendations state that, when prescribed, 
antipsychotic medication should be offered in conjunction with a psychosocial intervention. 
The main study found that 74% of participants with ASD who had no diagnosis of psychiatric 
disorder were receiving antipsychotic medication. Only 35% of these participants had 
received behaviour support in the last 12 months. 
 
Specialist mental health services for adults with intellectual disability tend to focus on treating 
psychiatric disorders (mainly with medication). It may be that a more appropriate care 
pathway for those who do not have a diagnosis of psychiatric disorder would be a behavioural 
Chapter 12: Discussion 
206 
service that is more geared towards providing for individuals who have long-term, chronic 
and persistent problems (Royal College of Psychiatrists, 2001b). However, before individuals 
are diverted to this service they should receive comprehensive assessment to ensure that they 
do not have an undiagnosed psychiatric disorder. 
 
Undiagnosed ASD 
A significant finding of the study was the apparently high level of undiagnosed ASD among 
this sample of specialist mental health service users with intellectual disability. The study 
provided evidence that the routine assessment of ASD using a standardised screening tool 
would increase the recognition of ASD among specialist mental health services users with 
intellectual disability (provided this is followed up by a comprehensive diagnostic assessment 
where appropriate). 
 
National guidelines recommend clear pathways for the recognition, referral and assessment of 
ASD (Department of Health, 2010b; NICE, 2011; NICE, 2012). However these do not appear 
to be in place for adults with intellectual disability. That is, it is assumed that referral to a 
specialist intellectual disability service is sufficient. However, the thesis has demonstrated 
that even within a specialist mental health service, there are individuals with intellectual 
disability who have recognised ASD traits but have not been formally diagnosed and many 
whose ASD behaviours have gone unacknowledged. There was little evidence that the 
participants in the main study had undergone standardised ASD assessment (e.g. using the 
ADOS, ADI or DISCO) whilst receiving specialist intellectual disability services or that there 
was any policy of referral to specialist ASD assessment services. 
 
It is vital that intellectual disability services are able to adequately recognise signs and 
symptoms of ASD. Regardless of whether this triggers an assessment or referral to a specialist 
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ASD team, without that initial identification individuals will continue to go undiagnosed and 
their needs unmet (NICE, 2012). More awareness and training on ASD for people who work 
with individuals who have intellectual disability is needed. This should be implemented at all 
levels; from residential staff, general practitioners and social care staff to specialist 
intellectual disability psychiatrists and nurses (Department of Health, 2010c). 
 
Knowing that an individual has ASD can help those who work with or care for that person to 
better understand their behaviour. If an individual consistently behaves in a way that is 
challenging, knowing that they have ASD can provide a great deal of insight into why this 
might be. Perhaps they do not have enough routine; perhaps they do not understand what is 
being asked of them; perhaps they experience hypersensitivity and their environment is 
overwhelming. If it is known that a person has ASD or even just that they have a higher than 
usual number of ASD symptoms this can improve understanding of their behaviour in terms 
of impairments in social interaction, communication and the presence of restricted interests. 
 
Undiagnosed mental health problems 
There was some evidence from the main study that participants without a diagnosis of 
psychiatric disorder had high levels of mental health symptomatology; perhaps indicating 
undiagnosed psychiatric disorder. The DBC items that participants scored most highly on 
appeared to be related to ADHD despite there being low levels of diagnosed ADHD among 
the sample. This was particularly the case among participants with ASD. Rates of diagnosed 
depression were significantly lower among participants with ASD than those without ASD. 
However, analysis of HoNOS-LD data revealed that a similar proportion in each group had 
moderate to very severe problems with their mood. 
 
There is a great deal of literature on the difficulties of making a diagnosis of psychiatric 
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disorder in those with intellectual disability and the importance of carrying out a 
comprehensive and systematic assessment (e.g. Cooper & Simpson, 2006; Davis et al., 2008; 
Deb et al., 2001a; Kannabiran & McCarthy, 2009; O'Hara, 2007). A number of instruments 







& Costello, 2007; Royal College of Psychiatrists, 2001a). However, there is no evidence on 
whether these tools are being used by clinical services when they assess the mental health of 
adults with intellectual disability. 
 
By comparison, there is acknowledgement that the diagnostic assessment of ASD requires 
specialist training and should be assisted by standardised tools (Department of Health, 2010a; 
NICE, 2011; NICE, 2012). Specialist ASD services spend up to six hours with each 
individual and their family when carrying out an assessment (Murphy et al., 2011). It is not 
clear whether, in practice, the same level of rigour is considered when diagnosing mental 
health problems in adults who have intellectual disability (with or without ASD). The Green 
Light Toolkit states that assessment should be ‗skilled‘, ‗integrated‘ and ‗specialised‘ but 
offers no further details (Foundation for People with Learning Disabilities, 2004). Many 
experts question whether criteria developed for the general population, such as ICD-10 and 
DSM-IV, are appropriate for adults with developmental disorders (Bradley et al., In press; 
Einfeld & Aman, 1995). There is evidence that rates of psychiatric disorder appear lower 
when these criteria are applied (Cooper et al., 2007; Melville et al., 2008). 
 
Few recommendations on assessing mental health problems go as far as those for diagnosing 
ASD where the use of a standardised instrument is viewed as essential and assessors must 
demonstrate they have sufficient levels of reliability when using them. Formal methods of 
                                               
1 Diagnostic Criteria for adults with Learning Disability (Royal College of Psychiatrists, 2001a). 
2 Psychiatric Assessment Schedule for Adults with Developmental Disorders (Prosser et al., 1998). 
3 Diagnostic Assessment for the Severely Handicapped (Matson, 1995). 
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evaluating consensus and reliability are not routinely used to develop services‘ ability to carry 
out consistent assessment and diagnosis of mental health problems in adults with intellectual 
disability. A system such as that for the ADOS, where clinicians watch a video of an 
assessment or read a vignette and compare their formulation with a consensus diagnosis could 
improve the reliability of clinical assessments. 
 
Intervention and management 
The study provided evidence that despite receiving specialist mental health services, many 
individuals with intellectual disability continue to experience significant mental health and 
behaviour problems. The length of time that participants had been receiving specialist mental 
health services for adults with intellectual disability was not associated with mental health, 
problem behaviour or social functioning. Thus, although the study lacked longitudinal data, 
there was no evidence to suggest that participants‘ outcomes improved the longer they 
received specialist services. 
 
There appeared to be several differences in service provision for those with and without ASD. 
Participants with ASD had lower levels of mental health service use – despite a higher level 
of need – and were more likely to be prescribed psychotropic medication if they had no 
diagnosis of psychiatric disorder than those without ASD. 
 
Whether or not participants were prescribed medication did not appear to be related to the 
extent of their mental health or behavioural problems. Rather, it was associated with severity 
of intellectual disability or whether they had been given a diagnosis of psychiatric disorder. 
Furthermore, among those with no psychiatric diagnosis it was related to whether a person 
had ASD. Similar findings have emerged from previous studies despite the lack of evidence 
on using psychotropic medication to treat problem behaviour and concerns about adverse 
effects (Deb, 2009; de Bildt et al., 2006; Paton et al., 2011). 
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Inequalities in psychotropic medication use were found when specific symptoms were 
explored. Participants with ASD who had moderate to very severe symptoms of depression 
and anxiety were significantly less likely to be receiving antidepressant or anxiolytic 
medication than those without ASD. Lower levels of diagnosed depression were found among 
participants with ASD but more people in this group had moderate to very severe symptoms 
than among those without ASD. As described above, this could reflect an under-diagnosis but 
also an under-treatment of depression among those with ASD. 
 
The next sections of this chapter critically evaluate the methods and results of the thesis 
against previous research. The structure largely mirrors the literature review reported in 
Chapters 2 to 5. 
 
Assessment and diagnosis 
 
ASD assessment 
Few studies on adults with intellectual disability have used ‗gold standard‘ diagnostic 
assessments to reliably determine whether or not participants have ASD (Brugha et al., 2009a; 
Ecker et al., 2010). As such this study was a rare opportunity to explore the use of these 
methods in this population. The majority (86%) of participants were assessed using the 
Autism Diagnostic Observation Schedule (ADOS; Lord et al., 1989). Those who could not 
take part in an ADOS assessment had their records reviewed by an expert using ICD-10 
criteria for ASD. Agreement between routine clinical diagnoses according to ICD-10 criteria 
and the standardised assessments of ASD (ADOS or expert review) was significant (Cohen‘s 
kappa was 0.54, p<0.001). However, there was disagreement between the clinical diagnosis 
and the result of the ASD assessment for the study for 24% of participants. 
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Assessment of those with a clinical diagnosis of ASD was fairly consistent; there was 
disagreement on only three out of 53 participants. However, agreement on participants 
without a clinical diagnosis was low; there was disparity between the clinical diagnosis and 
standardised ASD assessment for 28 out of 76 participants. It was not clear whether this was 
because 1) the ADOS is not suitable or the specificity of the cut-off points of the ADOS 
algorithm is low for adults with intellectual disability who have mental health problems or 2) 
there was a high level of undiagnosed ASD among the participants. 
 
It is likely that both these factors contributed to the discrepancy between clinical diagnoses 
and standardised assessment of ASD. Previous studies have suggested that revised algorithms 
may improve the psychometric properties of the ADOS for children with low-functioning 
ASD (Gotham et al., 2007). A recent study found that module 4 of the ADOS was less 
specific when distinguishing between high-functioning adults with ASD and those with 
schizophrenia (Bastiaansen et al., 2011). There is evidence that clinical diagnoses of ASD 
have low reliability especially in people with comorbid intellectual disability and other mental 
disorders (Murphy et al., 2011). The review of the literature on the prevalence of ASD 
(Chapter 3) found that rates of ASD tend to be lower in studies that rely on clinical diagnoses.  
 
A further complication of using the ADOS with an adult population is that the modules for 
non-verbal individuals were designed for children. The responses of the participants may have 
been different if the materials and presses were more age-appropriate. On the other hand, 
ADOS codings are based on the participant‘s social interaction with the assessor and their 
general behaviour. Therefore, the content is largely irrelevant as long as the administration 
and coding of the assessments are consistent and adhere to the standard methods that are 
described in the manual. 
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Having said that, it is clear that the ADOS is not appropriate for all individuals with 
intellectual disability. The assessment is not suitable for people with profound intellectual 
disability, severe physical disabilities or sensory impairment. In children this may not be a 
barrier to assessment using other measures such as the Autism Diagnostic Interview (ADI; Le 
Couteur et al., 1989) since there will most likely be an available informant who is able to 
provide information on the individual‘s early life and development. With adults this becomes 
less likely. Older parents may find it difficult to remember details accurately. Many of the 
participants in the main study had no contact with any family members and the information 
available on their life before their current residential placement was limited or sometimes 
non-existent. This means while some ADI items can be administered, the scores which feed 
into the diagnostic algorithm cannot be calculated since they rely on information about the 
person‘s behaviour and development as a child (Lord et al., 1994). 
 
Further research is needed on participants with ASD traits/behaviours to determine whether 
they have undiagnosed ASD. This should include investigation into whether there might be 
alternative explanations for their ASD-type behaviours. It has been suggested that ASD traits 
may result from brain damage associated with intellectual disability rather the presence of 
ASD per se (Bhaumik et al., 2010). This is particularly the case among those with severe and 
profound intellectual disability. Among participants excluded from those without ASD in the 
main study for having ASD traits, there were three participants for whom assessors noted 
there may be other reasons for their lack of social reciprocity. These included antipsychotic 
medication, past history of alcohol abuse, severe epilepsy and frontal lobe damage. 
 
More studies are needed on other samples of adults who have intellectual disability (with and 
without mental health problems) to determine whether the current ADOS algorithms should 
be revised for this group. The ongoing development of adapted version of modules one and 
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two of the ADOS for non-verbal adults is much welcomed (Berument et al., 2005; Hus et al., 
2011). Though validated using pilot studies these versions have not yet been published. 
 
In addition to the standardised diagnostic assessment, continuous measures of ASD symptoms 
were used or developed: the Social Communication Questionnaire (SCQ; Berument et al., 
1999), a HoNOS-LD ASD subscale and a DBC ASD subscale. The psychometric properties 
of these scales were assessed against the standardised diagnostic measures. 
 
The SCQ is a well validated screening tool that, in this study, had good reliability and 
sensitivity compared with the other standardised assessments of ASD. Specificity however 
was low; therefore while it is likely that adults with intellectual disability scoring 15 or above 
on the SCQ have ASD, those scoring below 15 would require further assessment. This 
replicates findings from studies of children with intellectual disability (Witwer & Lecavalier, 
2007; NICE, 2011). 
 
The reliability (internal consistency) of the HoNOS-LD and DBC ASD subscales were good. 
More analyses are needed on these scales which are as yet unvalidated in adult populations 
with intellectual disability. This includes establishing cut-off scores for optimum specificity 
and sensitivity and testing on further samples of specialist mental health services users with 
intellectual disability. 
 
Using items from the HoNOS-LD could help to identify specialist mental health service users 
with intellectual disability who require further assessment for ASD. This would be of great 
use to services that already use the full scale as a routine outcome measure. The HoNOS-LD 
ASD subscale could act as the first stage in a screening process without clinicians having to 
obtain any additional data to that normally collected. The finding that individuals with ASD 
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tend to score higher on certain items may also help to inform the way that payment by results 
will work for adults with intellectual disability. It is anticipated that the current or a revised 
version of the HoNOS-LD will be used to collate data and categorise individuals into 
diagnosis-based clusters (Hillier et al., 2010). 
 
There was a great deal of ASD symptomatology among participants who did not have a 
clinical diagnosis of ASD. But there was also a considerable level among the 48 participants 
who met the study criteria for ‗no ASD‘. This group‘s average SCQ score was 5.5 with a 
range of zero to 15. The presence of ASD features in those with intellectual disability and 
overlap in symptoms is well established (Bhaumik et al., 1997). As discussed in the literature 
review, it makes assessing adults with intellectual disability for ASD, mental health or 
behavioural problems more of a challenge for researchers and clinicians (Hill & Furniss, 
2006). More research is needed on which specific symptoms or features are the best 
predictors of whether an individual with intellectual disability and mental health problems has 
ASD (Bhaumik et al., 2010; Bradley et al., 2011a). 
 
Assessment of psychiatric disorders 
The study relied on existing clinical diagnoses of psychiatric disorder made by specialist 
intellectual disability psychiatrists according to ICD-10 criteria. It was not possible to reassess 
these diagnoses since participants were receiving treatment and in many cases had been doing 
so for a number of years. Many participants‘ case records acknowledged that their mental 
health problem was currently in remission. Therefore a standardised diagnostic assessment 
would only have revealed whether any participants currently met the criteria for a psychiatric 
disorder; it would not have been able to validate their existing diagnoses. The high scores 
achieved by some participants on the DBC (including the depressive and anxiety subscales) 
and specific HoNOS-LD items may indicate a level of undiagnosed psychiatric disorder. 
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It is likely that there is not one ‗gold standard‘ diagnostic assessment for all individuals with 
intellectual disability (Deb et al., 2001a). Many of the tools reviewed in chapter 2 have been 
specifically developed for adults with severe and profound intellectual disability (e.g. DASH-
II); others are only suitable for those with mild to moderate impairment (e.g. PAS-ADD). 
Many researchers suggest that the assessment of psychiatric disorder among individuals with 
intellectual disability who have ASD requires measures designed especially for this group 
(Bradley et al., In press; Helverschou & Martinsen, 2011; Matson & Boisjoli, 2008). 
However, apart from those for children or adults with severe and profound intellectual 
disability, few have been developed (Underwood et al., 2011). 
 
Prevalence and comorbidity 
The study was designed to be exploratory and descriptive rather than epidemiological. As 
such the focus of the results was on participants‘ mental health and social functioning. 
However it is possible to use the results to make cautious inferences about the prevalence of 
ASD among specialist mental health service users with intellectual disability and differences 
in the comorbidity of mental health problems between those with and without ASD. It is also 
possible to compare the characteristics and patterns of psychiatric disorder found among 
participants to those in the general population and among other mental health service users. 
 
Prevalence of ASD 
The rate of clinically diagnosed ASD in the clinical study (33.5%) was consistent with 
previous research on ASD among adults with intellectual disability (Emerson & Baines, 
2010). The socio-demographic and clinical profile of those with ASD was also similar to 
previous studies on adults with intellectual disability with and without mental health problems 
(Lunsky et al., 2009; McCarthy et al., 2010; Melville et al., 2008; Morgan et al., 2003; 
Tsakanikos et al., 2006). 
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The study identified individuals with features consistent with ASD who had not received a 
diagnosis. If it is assumed that all of those with ASD traits in the clinic study actually had 
undiagnosed ASD this increases the rate to around 40% which is at the upper limit of most 
estimates (Matson & Shoemaker, 2009). Furthermore, if the assessments of ASD carried out 
for the main study were correct in their diagnosis, the estimated rate would be around 56%
1
. 
This is very high and could indicate that adults with ASD are over-represented among 







This could have considerable implications for specialist intellectual disability mental health 
services where current policy and practice is based on the premise that the majority of service 
users do not have ASD. Evidence suggesting that more than half of service users have ASD or 
significant ASD traits could have an impact on commissioning, planning, provision, staffing, 
training and measurement of outcomes. 
                                               
1 See Appendix VII for how this rate was calculated 
Figure 12.1: Estimated rate of ASD among specialist mental health service users with 
intellectual disability based on the thesis results 
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Characteristics of participants with and without ASD 
There was a lower rate of mild intellectual disability among the MHID clinic population 
compared with most estimates which are around 85% among adults (Bhate & Wilkinson, 
2006). Even among participants without ASD only 68% had mild intellectual disability. The 
rates of moderate and severe intellectual disability were around 2-3 times that usually found 
in the intellectual disability population (Bhate & Wilkinson, 2006; Maulik et al., 2011). This 
could explain why the rate of ASD was so high since it is more prevalent among those with 
more severe intellectual disability. It is likely that, as in the general population, many adults 
with mild intellectual disability receive primary care treatment for mental health problems and 
do not require referral to specialist services (Balogh et al., 2008). 
 
As a whole, the proportion of male service users was higher than among the general 
population and mental health service users of the South London and Maudsley NHS 
Foundation Trust (SLaM; Stewart et al., 2009). Participants were also younger than these 
populations. The ratio of males to females was slightly higher than other studies on adults 
with intellectual disability (Cooper et al., 2007; Emerson & Hatton, 2005b). This could 
suggest that young males with intellectual disability are more at risk of mental health 
problems (or more likely to be referred to specialist mental health services). It may also 
reflect the high number of people with ASD in the sample; who are more likely to be young 
and male. 
 
The distribution of ethnic groups within the clinic study was similar to the general population 
and mental health service users in South East London (Stewart et al., 2009). The type of 
residence that participants with ASD lived in was very similar to that found in an aggregate of 
data from studies on adults with intellectual disability and ASD. Knapp et al (2009) estimated 
that among those living in the community: 63% are in supported living/residential 
placements, 33% live with family and 4% independently. 
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In conclusion, participants in the study had similar characteristics to other samples of research 
participants with and without ASD. There was no evidence that they were not representative 
of the wider population of specialist mental health service users with intellectual disability in 
the UK. 
 
In common with previous research, the study demonstrated that there is a great deal of 
heterogeneity among individuals who have intellectual disability and among those with ASD 
(Carter et al., 1998; Deb et al., 2001a; de Bildt et al., 2004). The differences found between 
participants with and without ASD did not mean that it was necessarily feasible to 
characterise particular groups of individuals as more or less likely to have ASD. For example 
while those with ASD were more likely to be male, most males within the sample did not 
have ASD. While most participants without ASD had mild or moderate intellectual disability 
it could not be said that most of those with ASD had severe intellectual disability; there were 
roughly a third of participants with each severity. 
 
Nonetheless, it appeared that specialist mental health service users with intellectual disability 
who do not have a diagnosis should be assessed for ASD if they have severe intellectually or 
no diagnosis of psychiatric disorder. The prevalence of clinically diagnosed ASD was 
particularly high among these groups (71% and 63% respectfully). The study found that the 
vast majority of participants with severe intellectual disability had ASD, recognised ASD 
traits or behaviours consistent with a diagnosis of ASD. 
 
Psychiatric disorder 
As described above, rates of ASD among the sample were fairly high suggesting that perhaps 
individuals with intellectual disability and ASD are at increased risk of psychopathology (or 
at increased ‗risk‘ of being referred to a specialist mental health service). However, in the 
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clinic study almost half of those with ASD were receiving specialist mental health services for 
behavioural problems. The prevalence of ASD among those with a diagnosis of psychiatric 
disorder was actually about 26%; well within previous estimates. Conversely, the prevalence 
of ASD among those without a diagnosis of psychiatric disorder was 63%; a very high rate. 
 
This suggests that adults with intellectual disability and ASD are not at increased risk of 
psychiatric disorder but are at increased risk of challenging behaviour compared to those 
without ASD. This is consistent with previous studies on mental health problems in adults 
with ASD and intellectual disability (Melville et al., 2008; McCarthy et al., 2010). The 
finding that the more severe an individual‘s intellectual disability and less likely they are to be 
diagnosed with an additional mental health problem has been found elsewhere (Smith & 
Matson, 2010). 
  
The study found that participants with ASD were not accessing services as much as those 
without ASD. There may be strong referral and selection biases influencing the patterns of 
prevalence found in the study. More population-based studies such as those carried out in 
Scotland by Cooper et al. (2007; Melville et al., 2008; Smiley et al., 2007; Jones et al., 2008) 
are needed. However this group‘s method of recruiting via GPs may also contribute to 
selection bias. Research needs to recruit from wider, more comprehensive samples, focusing 
particularly on groups that appear to have least access to services. 
 
The pattern of psychiatric disorders found among the clinical study sample showed that if 
they are diagnosed at all, participants with ASD appear to have a narrower range of disorders 
than those without ASD. Both groups are likely to be diagnosed with psychotic disorder but 
otherwise those with ASD tend to be diagnosed with anxiety disorders where as those without 
ASD have depression. It is unclear whether this is related to actual differences in the 
prevalence of these disorders or whether difficulties in assessing psychopathology lead to 
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clinicians diagnosing fewer disorders in fewer individuals with ASD. The challenges of 
making a diagnosis could explain why so few of those with ASD had personality disorders 
and dementia. This highlights the importance of comprehensive assessments by experts with 
experience of diagnosing mental health problems both in individuals with intellectual 
disability and those with ASD. 
 
It was possible to compare the pattern of psychiatric disorder found among participants with 
intellectual disability in the clinical study to a wider population of mental health service users. 
Stewart et al. (2009) used the Case Register Interactive Search (CRIS) to explore the primary 
ICD-10 diagnosis assigned to past and present mental health service users in South London. 
The most common psychiatric diagnoses were mood (affective) disorders (prevalence of 
16%), followed by schizophrenia, schizotypal and delusional disorders (10%), substance 
abuse (9.7%), neurotic disorders (8.9%) and organic mental disorders (8%). A high proportion 
(30%) of these service users did not have a diagnosis of any ICD-10 mental and behavioural 
disorder (codes F0-F99; WHO, 1992). 
 
Comparing the clinic study results with this pattern, they would appear to confirm previous 
findings that adults with intellectual disability are at higher risk of psychotic disorders 
compared to the general population (Bouras et al., 2003; Deb et al., 2001b; Morgan et al., 
2008; Pridding & Tomasoni, 2006). However, it could also mean that adults with intellectual 
disability and psychotic disorder are more likely to be referred to specialist services than those 
with other types of mental health problem. Alternatively, it could indicate adults with 
intellectual disability are more likely to receive a diagnosis of psychotic disorder than adults 
in the general population. This could be because adults with intellectual disability often have 
an atypical presentation of disorders such as depression and anxiety (Deb et al., 2001a; Perry 
et al., 2001). 
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The rate of attention deficit hyperactivity disorder (ADHD) among participants in the clinical 
study was surprisingly low (2% overall and 3.4% among those with ASD) compared to 
previous estimates which range from 14% for those with intellectual disability and up to 45% 
for those with ASD (NICE, 2011; Ruedrich, 2010). Differentiating features of ADHD from 
symptoms of other psychiatric disorders, challenging behaviour, ASD and characteristics 
common among people with intellectual disability is a well-recognised challenge (Bradley et 
al., 2011b). Along with ASD, ADHD may be a condition that is currently under-recognised 
and under-diagnosed among specialist mental health service users with intellectual disability. 
 
Some evidence to support this was provided by the main study in which the DBC items that 
participants scored highest on were: poor attention span, impatience, impulsivity, poor sense 
of danger and being easily distracted. These appear to be related to ADHD or Hyperkinetic 
disorder; described in ICD-10 as: 
“...a combination of overactive, poorly modulated behaviour with marked inattention and 
lack of persistent task involvement...” (WHO, 1992; pp. 206). 
 
Needs, service use and intervention 
The Autism Strategy for England emphasised the importance of identifying and assessing the 
needs of adults with ASD within the framework of the Joint Strategic Needs Assessment 
(JSNA) (Department of Health, 2010b). At an individual level, assessments should be 
personalised with the person‘s needs clearly described. Services should be able to effectively 
recognise respond to those needs (Department of Health, 2010c). However, there appears to 
be a certain amount of assumption that once it is known that an individual has ASD, their 
needs have been identified and it is possible to base service and intervention provision around 
their diagnosis without further individualised assessment of their needs (Bennett et al., 2005). 
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Needs 
It was anticipated that participants with ASD would have greater needs than those without 
ASD. This was found to be the case; however, there was a lack of difference between the 
groups on level of unmet need. Participants appeared to have few unmet needs (an average of 
around two). This is lower than that found in other studies of specialist mental health service 
users with intellectual disability (Hall et al., 2006). Correspondingly the average level of met 
need was higher than in previous studies using the CANDID (Martin et al., 2005). 
 
The CANDID had the lowest internal consistency among the measures used in the study. 
Cronbach‘s alpha for the full 25-item scale was unacceptably low (George & Mallery, 2010). 
It was not clear whether this was because the scale is not reliable or whether participants had 
heterogeneous needs. The internal consistency of the CANDID has not been previously 
reported so it was not possible to compare the results with other samples. 
 
There was evidence that participants lacked constructive, daytime activity. This was the need 
that was most often unmet in the CANDID, it was highlighted in the informal assessment of 
need and Occupation was among the highest scoring HoNOS-LD items. Previous studies on 
adults with intellectual disability have pointed out the high level of unmet need in this area 
(Strydom et al., 2005). 
 
A lack of appropriate employment opportunities, education, training, day centres and social 
clubs can be a particular issue for individuals making the transition from adolescence to 
adulthood (Royal College of Psychiatrists, 2011). There is good evidence that individuals 
with intellectual disability and/or ASD find it difficult to adjust to the lack of structure and 
routine that they receiving from attending school or college (National Audit Office, 2009b; 
Shattuck et al., 2011). As adults, they also experience high levels of unemployment (Howlin, 
2000; Howlin et al., 2004). Participants spent an average of 16 hours a week taking part in 
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activities; compare this with children and adolescents who are provided with 25 to 35 hours a 
week of activity in educational settings (Ofsted, 2010). 
 
The number of hours of structured activity that participants were taking part in each week was 
not significantly associated with mental health although the trend of the relationship between 
the variables was that as activity increased, mental health improved. However, there was 
limited evidence that perceived level of activity was associated with mental health (TPBS was 
significantly correlated with the Occupation item on the HoNOS-LD). This is consistent with 
previous findings found quality of life is associated with perceived rather than actual levels of 
support (Renty & Roeyers, 2006). It may indicate that it is not the number of hours of activity 
that people take part in but whether they feel that they are adequately occupied. 
 
There was no evidence that individuals with physical health needs were more or less likely to 
have those needs met if they had ASD. It appeared that participants with ASD had fewer 
health needs than those without ASD; they had fewer recorded physical health problems and 
were less likely to have ‗increased incapacity due to physical problems‘ according to the 
HoNOS-LD. This raises the possibility that the health needs of people with intellectual 
disability and ASD are more likely to go unreported or unrecognised than those without ASD, 
particularly if they present with mental health or behavioural problems. It is known that there 
is an under-reporting of physical disorders among people with ASD (NICE, 2012). 
 
Service use 
Despite adults with ASD having an increased risk of developing mental health problems there 
is evidence they do not always have access to appropriate services (Higgins, 2009). A survey 
of adults with ASD in the UK found no evidence that they had increased mental health service 
use compared with the general population (Brugha et al., 2009b). The hypothesis on service 
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use assumed that once an individual with intellectual disability, ASD and mental health 
problems was receiving a specialist service their high levels of needs would mean that they 
had a high level of service consumption. This was not supported by the data. 
 
Participants with ASD used proportionally less specialist intellectual disability mental health 
services than those without ASD (as measured by the Service Consumption Score; SCS). 
However, this was not because they had less need or increased use of other health services. 
They lived in residential placements with a significantly higher ratio of staff to service users 
than those without ASD. Although the difference was not significant, participants with ASD 
received more hours of support staff per week than those without ASD. It is not clear whether 
this extra layer of support leads to lower mental health service use. There is some evidence 
that different models of residential care impact on challenging behaviour which in turn 
influences quality of life (Gerber et al., 2011). 
 
A study of the costs of ASD to the economy estimated that the amount spent on community 
health and social care
1
 for each adult with intellectual disability and ASD per year was just 
£581 (Knapp et al., 2009). This contrasts greatly with the amount spent on residential (£36 
233) and hospital services (£4 588). The National Audit Office (2009a) suggested that 
improving access to effective specialist services for people with ASD would significantly 
reduce overall costs to the economy, particularly with regards to local authority spending
2
 
whilst improving outcomes for individuals. However, the report acknowledged that this 
would only be possible if identification rates increase. 
 
It was not clear why participants with ASD used fewer mental health services than those 
without ASD. It was not because their mental health or behaviour was better and therefore 
                                               
1 Not including respite care, day services, education, employment support or benefits 
2 On supported accommodation/residential care homes, day services, employment service & education 
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they required less intervention. The main factors driving this difference were that some 
participants with ASD did not use any mental health services for 12 months and they were 
less likely to be on the Care Programme Approach (CPA). The number of participants without 
ASD who were on the CPA was similar to that found in other mental health services (Stewart 
et al., 2009). 
 
The Department of Health (2006a) has previously stated that individuals with intellectual 
disability, ASD and “…significant mental health needs will almost certainly require 
enhanced CPA.” (pp. 21). Significant mental health needs are not explicitly defined but even 
among those with ASD and a psychiatric diagnosis only four participants (17%) were on the 
CPA. 
 
Bhaumik et al. (2008a) argued that service users with intellectual disability should be 
categorised according their level of need and developed a three level criteria. People with 
high needs would be on the Care Programme Approach (CPA) and receiving multi-
professional care at least once a fortnight; those with medium needs would have fortnightly to 
three monthly input from one or two professionals; and those with low needs would receive 
input once every three months in the form of an outpatient review with one professional. The 
importance of identifying the characteristics of those with a high level of need was 
highlighted (Bhaumik et al., 2008a).  
 
Despite have higher levels of need, it appeared that those with ASD tended to receive a less 
enhanced service and were more likely to not receive any mental health service over 12 
months. There was no evidence that participants with ASD were more likely to drop out of 
specialist mental health services. Service users are discharged if they do not attend three 
consecutive appointments. So it is likely that participants who had no mental health service 
use but remained on the caseload had not been offered an appointment for over a year. 






An explanation for the disparity in service use between those with and without ASD is that 
the poorer mental health and behaviour of those with ASD is chronic but fairly stable over 
time. This means they do not have as many episodes where they require an increased level of 
service input. By contrast, those without ASD have periods when their mental health and 
behaviour fluctuates. This leads them to access services to seek adjustments in their 
medication or treatment. This could also explain why service users tend to use specialist 
mental health services for so long. Their mental health either fluctuates necessitating longer 
term follow-up and monitoring (service users without ASD/with a psychiatric disorder) or 
their mental health and behaviour is always poor and they require continuous treatment 








An unpublished audit of specialist mental health service users with intellectual disability 
found that the majority of those with ASD had little change in mental health symptoms over 
time (McCarthy & Kannabiran, 2010). Furthermore there were few changes to their 
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medication following their second mental health appointment. Unfortunately, the same 
information for those without ASD was not collected.  Further longitudinal studies are needed 
to examine whether there is any evidence for this. These should compare matched groups of 
those with and without ASD. 
 
A small proportion of participants (33%) were using a very large amount (80%) of the mental 
health services consumed by participants over 12 months. Briefly, this group were more likely 
to have mild intellectual disability, a psychiatric disorder, live with family or independently 
than those with lower levels of mental health service use. More research is needed on who 
these individuals are and why they consume such a high proportion of services. 
 
A previous study on consumption of specialist mental health services by those with 
intellectual disability also found that a small number of service users were consuming a large 
number of services (Spiller et al., 2007). The only significant predictor of SCS was diagnosis 
of psychotic disorder. However, this study found no significant relationship between any 
specific psychiatric disorder and service consumption. Participants with psychotic disorder 
comprised 23% of the sample and used 24% of the services consumed. 
 
There is much debate about whether challenging behaviour should be viewed as a mental 
health issue and whether individuals with challenging behaviour should be receiving mental 
health services (Baker & Daynes, 2010). Lower level challenging behaviour is likely to be 
seen as a psychosocial problem and the point at which it becomes a psychiatric problem is 
unclear and undefined. Slater & Baillie‘s (2008) audit of referrals to an intellectual disability 
psychology service indicated that challenging behaviour accounted for more than 42% of 
referrals. It would appear from the clinical study that probably most of these individuals 
would have ASD. 
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It was clear from the data that when adults with intellectual disability suffer from mental 
health problems they require specialist treatment over a long period of time. Those who used 
specialist mental health services for a shorter amount of time did not appear to have any 
different characteristics from those who were longer term service users. Length of service use 
was not significantly associated with participants‘ mental health or social functioning. 
 
Mental health and social functioning 
Most participants had fairly low scores on the HoNOS-LD and DBC. Mean scores were lower 
than those found at the baseline or endpoint of previous intervention studies (Dowling et al., 
2006; Hall et al., 2006; Pridding & Tomasoni, 2006). Furthermore, 51% of participants in the 
main study had a good to excellent rating of social functioning and most of those with ASD 
had a fair to excellent rating. However, there was evidence that particular subgroups did not 
have as positive outcomes as others. These included individuals with ASD, those with severe 
intellectual disability and those with no diagnosis of psychiatric disorder. 
 
The study found that severity of intellectual disability was a significant predictor of total 
number of needs, mental health service consumption score, psychotropic medication use and 
social functioning. Previous studies on adults with ASD found strong relationships between 
low IQ/intellectual disability and poor social functioning (Beadle-Brown et al., 2009; Billstedt 
et al., 2005; Eaves & Ho, 2007; Howlin et al., 2004; Lockyer & Rutter, 1969; Lotter, 1974; 
Rutter et al., 1967). 
 
There was consistent evidence that participants with ASD had higher needs, lower mental 
health service use, poorer mental health and social functioning than those without ASD. 
However, for mental health service use, needs and social functioning; ASD was not a 
significant predictor once severity of intellectual disability was taken into account. Few 
studies have considered whether IQ or cognitive functioning are more important predictors of 
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social functioning than ASD itself. This is largely because they have not included matched 
comparison groups of people without ASD. 
 
It was not possible to compare the results for participants with ASD with previous studies on 
social functioning because of the different methods used to measure and define this outcome. 
The finding that severity of intellectual disability and having challenging behaviour were 
important predictors of social functioning replicates earlier results (Beadle-Brown et al., 
2009; Felce et al., 2011; Totsika et al., 2010). 
 
Only one previous study could be found that was specifically designed to compare the social 
functioning of adults who had intellectual disability with and without ASD (Esbensen et al., 
2010). Those with ASD had significantly poorer social functioning than those with Down 
syndrome (DS). Most of the participants with ASD had moderate to low social functioning 
whereas most of those with DS had moderate social functioning. There was a much higher 
proportion of participants with severe intellectual disability among those with ASD, however 
in regression analyses severity of intellectual disability was not a significant predictor of 
social functioning (Esbensen et al., 2010). 
 
Levels of independent living and employment were much lower among participants in the 
study than other studies of adults with ASD (Cederlund et al., 2008; Howlin et al., 2000; 
Farley et al., 2009; Mawhood et al., 2000; Renty & Roeyers, 2006). It is not clear whether this 
reflects participants‘ lower levels of functioning compared with those in previous studies. It 
could relate to the difficulties that people with additional mental health or behavioural 
problems have finding and maintaining employment. The overall rate of employment among 
participants (16%) was similar to previous estimates by the Foundation for People with 
Learning Disability (2007). However, 27% of those without ASD had a job suggesting that 
this group were achieving better levels of employment than expected. Although all but one of 
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these participants were in part-time, supported or voluntary employment rather than full-time 
jobs. Around a fifth of participants were not engaging in any scheduled activities, a result 
similar to the findings of a survey by the National Autistic Society (Barnard et al., 2001) and 
a Spanish study on quality of life (Saldana et al., 2009). 
 
The original hypotheses for the thesis were based on the literature and followed the premise 
that: adults with intellectual disability and ASD have higher levels of need; this would lead to 
higher levels of mental health service use; but despite this, and because many of their needs 
remained unmet, they would have poorer mental health, and social functioning compared to 
those without ASD. This model was not confirmed by the results of the study. 
 
Total level of need and met need were higher among those with ASD and were also 
associated with mental health, behaviour and social functioning. However, those with higher 
levels of need had significantly poorer mental health, behaviour and social functioning 
regardless of whether those needs are being met. This could indicate that poorer mental health 
and social functioning are characteristic of adults with intellectual disability and ASD and 
cannot be improved even with increased attempts to meet their needs. 
 
Alternatively instead of trying to meet a need, perhaps services and interventions should aim 
for the person to have no need in the first place. For example, enabling someone to 
independently buy and prepare their own meals rather than having them provided. Esbensen 
et al. (2010) found that those with intellectual disability and ASD had poorer life skills than 
those Down Syndrome and suggested that improving skills and activities should be a key goal 
of services and may lead to improved outcomes. It is not clear how many of the items in the 
CANDID could feasibly be eliminated so that an individual went from having a met or unmet 
need to no need.  
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Further research is needed to determine the exact nature of the needs that most predict mental 
health and social functioning. This could be achieved by identifying subdomains within the 
CANDID through factor analysis or exploring which specific items appear to be related to 
social functioning. It will be important to establish whether the needs that predict social 
functioning are the same for individuals with and without ASD or at different levels of 
intellectual disability severity. Given the low internal consistency of the CANDID it may be 
that an alternative measure of need should be developed. 
 
Based on the results of the study, a revised model of the relationships between variables is 
shown in Figure 12.3. The higher an individual‘s needs the less able they are to access 










The study provides limited evidence for this model as it did not establish a direct link between 
service use and needs or mental health and social functioning but it may help to explain why 
some service users have poorer mental health and social functioning. It could be a useful 
theoretical starting point for future research. 
 
An explanation for this hypothesis could be that current mental health services for adults with 
intellectual disability are not well equipped to deal with those who have ASD and/or very 
Figure 12.3: Model of relationships between needs, service use and outcome 
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high levels of need. As a result they are either not providing an effective service for these 
individuals or when they are it does not matter how much input an individual has their mental 
health and social functioning does not improve. 
 
In any case, within this service model for adults with intellectual disability who have mental 
health problems there was a small but significant number of individuals whose mental health 
and social functioning was poorer. The following strategies could be considered to improve 
this situation: 
 
Develop distinct care pathways and protocols within specialist mental health services for 
adults with intellectual disabilities based on individuals‘ levels of need. Needs should be 
assessed at an individual level but it should be recognised that at a group level those with the 
highest needs are likely to have moderate/severe intellectual disability and/or ASD. This 
approach is supported by advocates of personalised health and social care including the 
Department of Health (2006b; 2007b; 2010b). 
 
Further differentiation could be achieved by improving access to mainstream mental health 
services for those who have mild intellectual disability, psychiatric disorder and low levels of 
need. If these people were not consuming as many specialist mental health services there 
would be more resources available and the service could be better tailored to serve those with 
higher levels of need including people with moderate/severe intellectual disability and ASD. 
This would bring services more into line with national policy that states individuals with 
intellectual disability should be accessing mainstream mental health services where possible 
(Department of Health, 2001b). 
 
Alternative, the provision of specialist mental health services for adults with intellectual 
disability should be focussed on those with psychiatric disorder. Individuals with higher 
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levels of need and behaviour problems would access a specialist behavioural service that may 
better serve their needs. 
 
It is likely that these options would require additional resources or a reconfiguration of 
existing resources. However as described earlier, there is evidence that improving access to 
specialist services and enhancing current assessment and intervention for ASD would lead to 
savings in the long term (National Audit Office, 2009a). 
 
An alternative explanation for the results is that the tools used by the study (HoNOS-LD, 
DBC and social functioning scale) measured ASD and cognitive functioning more than they 
assessed mental health and social functioning. Although the HoNOS-LD and DBC both 
contain items that are related to features of ASD they also contain many that are unrelated. 
Furthermore, significant differences between those with and without ASD remained when 
these ASD-specific items were removed. Although the difference between the mean scores 
became smaller it was clear that participants with ASD had higher scores over a wide range of 
mental health and behavioural problems than those without ASD. 
 
The study found that participants with ASD had poorer scores across all three HoNOS-LD 
subdomains – neuro-cognitive functioning, mental health/behaviour and health/social 
functioning. However, in the clinical study the items that participants with ASD scored higher 
than those without ASD on were all ASD-type features. Similarly, those with ASD scored 
higher than those without ASD on the DBC self-absorbed, communication disturbance and 
social relating subscales. All these DBC subscales could be said to relate to characteristics of 
ASD whereas there was no difference between the groups for the subscales that relate more to 
mental health: anxiety/anti-social and depressive. 
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The degree of overlap between features of intellectual disability or ASD and psychopathology 
is such that for many symptoms it is very difficult to determine whether someone is 
experiencing a problem because of their developmental disability or because they have a 
mental health problem. Establishing the onset of an individual‘s problems can help to 
overcome this; any that have been present over a long period of time or since early childhood 
are more likely to be related to ASD or intellectual disability rather than psychopathology 
(Deb et al., 2001a). Finding out more about the nature of an individual‘s symptoms can also 
help to determine their origin. A commonly cited example is obsessions and compulsions; 
common features of ASD but more likely to be an indicator of OCD if there is evidence that 
the individual finds them distressing and attempts to resist them (WHO, 1992). 
 
These overlaps cause difficulties when carrying out diagnostic assessments and should be 
taken into consideration when making a diagnosis and treatment plan. However, in many 
respects when it is general ‗mental health‘ that is being measured (as represented by the 
DBC); the source of an individual‘s problems is not as salient. The important issue is that they 
are experiencing a problem that is having a negative impact on their life or the lives of those 
around them. The aim of the thesis was to determine whether adults with intellectual 
disability and ASD had poorer mental health and social functioning compared to those 
without ASD rather than explore the cause of their problems. 
 
As described in Chapter 11, there were 14 participants in the main study with globally poor 
mental health and social functioning. Despite receiving specialist mental health services for 
an average of 5½ years this group had the highest HoNOS-LD and DBC scores and the lowest 
social functioning scale scores. It is not possible to ascertain what the scores of these 
individuals were when they were referred to specialist mental health services but it does not 
appear that the treatment they have received has resulted in a positive outcome. Almost 30% 
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were not receiving any psychotropic medication at the time of their informant interview (none 
of these individuals had been diagnosed with a psychiatric disorder); the rest were all on 
antipsychotics. Five participants had no contact with specialist mental health services for 12 
months and only three were on CPA. However, nine were receiving behavioural or 
psychological input (including two of those with no specialist mental health service contact). 
 
Further research would be needed to explore why these participants‘ mental health and social 
functioning was not as good as the rest of the sample.  Specifically, it would be useful to 
comprehensively reassess their mental health to find out whether there was any evidence that 
they: 
 
 were receiving treatment for a psychiatric disorder but in fact did not have one and 
required more behavioural intervention, or 
 had an undiagnosed psychiatric disorder for which they were not receiving effective 
treatment (e.g. medication). 
 
 
As discussed earlier, there was some evidence that ADHD, in particular, appeared to be 
under-diagnosed in this group of service users who exhibited high levels of inattention and 
hyperactivity. 
 
Previous research has found that the misdiagnosis of psychiatric disorder is common among 
mental health service users with intellectual disability and/or ASD (Bradley et al., 2011a). 
Further evidence that this is a significant determinant of outcome would lend weight to the 
argument that services should be taking steps to ensure that the way in which service users are 
assessed results in consistent and reliable diagnoses. 
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Participants with ASD traits and behaviours 
The study identified some noteworthy features of participants who had no clinical diagnosis 
of ASD but were excluded because they exceeded the ADOS threshold or appeared to meet 
ICD-10 criteria for ASD. These could be useful indicators that an individual should be further 
assessed for ASD. They may also be part of the reason that ASD has gone unrecognised. For 
example, a high proportion (25%) of those with no clinical diagnosis of ASD had epilepsy 
and most of these participants (13 out of 19) were excluded. 
 
This could be because: 
 
 Diagnostic overshadowing of behaviours relating to epilepsy and ASD symptoms 
means that ASD symptoms are overlooked in those with epilepsy. 
 Treatment with anticonvulsant medication reduces ASD-type behaviours and therefore 
individuals go undiagnosed. 
 Individuals with epilepsy have reduced social communication skills that limit their 
ability to take part in the ADOS assessment. 
 
Other characteristics that this may apply to include people with an identifiable cause of their 
intellectual disability and those who are non-verbal (see Chapter 11). 
It may be the case that individuals with undiagnosed or unrecognised ASD have different 
patterns of ASD symptoms compared to those who receive a clinical diagnosis. There may be 
a threshold of certain ASD behaviours above which a diagnosis is triggered; while other 
behaviours cause problems for an individual but do not lead to formal, clinical diagnosis of 
ASD. Participants with ASD traits/behaviours had poorer mental health and social functioning 
than those without ASD therefore it is important that they are effectively identified and have 
their needs assessed. 
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Reliability and validity 
The methods chosen for the study performed satisfactorily and the results did not appear to 
have been unduly influenced by measurement bias. There were few problems administering 
the chosen measures to adults with intellectual disability and their informants. The validity of 
the social functioning scale was enhanced by developing it in consultation with an expert 
service user who had intellectual disability. 
 
Comparing the main study sample to the wider clinic population 
Potential participants approached to take part in the main study were not randomly sampled. 
As a result there was an increased possibility of selection bias. There was an additional 
element to consider since many of those approached were unable to consent for themselves 
and a consultee was appointed to decide on their behalf. Families and support staff often acted 
as influential barriers or facilitators of access to potential participants regardless of whether 
they had capacity. 
 
To check for any selection bias, the results of the main study were compared to results from 
the supplementary clinic study determine how representative participants were of the wider 
specialist mental health service user population. A comparison of participants with ASD 
included in the clinic study and the 53 recruited into the main study revealed no significant 
differences between the samples. Participants in the main study without a clinical diagnosis of 
ASD were significantly different to the clinic study participants without ASD. It is likely that 
this was partly due to initial attempts to recruit matching groups of participants with and 
without ASD. Those with no ASD in the main study were younger, more likely to be male 
and have severe intellectual disability than those with no ASD in the clinical study. 
 
The pattern of differences between participants with and without ASD in each study was 
broadly similar. The only noteworthy disparity was that the pattern of psychiatric disorder 
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was slightly different. There were fewer participants with ASD and depression and more 
participants without ASD who had depression in the main study leading to a significant 
difference between the ASD groups. 
 
The internal consistency of the HoNOS-LD was lower for the main study than it was for the 
clinical study but this could be because of the much larger dataset used in the latter. The size 
of the difference in total HoNOS-LD scores between the ASD groups in the main study (mean 
difference of nine) was greater than that found between those with and without ASD in the 
clinic study (mean difference of five). This was because the mean score of those with ASD in 
the main study was higher than those with ASD in the clinical study (19.8 vs. 18.2). Plus the 
mean score of those without ASD was lower than those without ASD in the clinical study (11 
vs. 13). The clinic study included participants subsequently excluded from the main study. It 
is possible that these individuals were contributing to an inflated mean HoNOS-LD score. The 
mean HoNOS-LD score of the 76 participants in the main study with no clinical diagnosis of 
ASD was 12.7, closer to the mean score in the clinic study, which appears to support this 
argument. 
 
In conclusion, participants with ASD in the main study were not significantly different from 
those in the clinic study. Therefore it appears reasonable to generalise the results for those 
with a confirmed diagnosis of ASD included in the main study to those with a clinical 




The study aimed to assess participants using the most suitable measures available. However, 
it should be noted that the measures selected have some limitations. For example, social 
functioning was measured using a scale especially constructed for the study that relied on data 
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collected using other tools. As such, this measure has not been validated nor have its 
psychometric properties been evaluated beyond internal consistency. The method of 
developing the scale was based on previous studies on the social functioning of adults with 
ASD (Howlin et al., 2000; Howlin et al., 2004; Lotter, 1974; Marriage et al., 2009; Mawhood 
et al., 2000). However, it is acknowledged that this did not follow standard methods of scale 
development. Further testing of this scale among wider groups of adults with intellectual 
disability is needed. Further development of the scale may benefit from clinician and carer 
input. 
 
The study did not use a standardised measure of problem behaviour. Instead, a subscale was 
derived from the DBC. Again, this was developed following a review of existing scales and 
has not been validated. Therefore, the results of analyses that included this measure should be 
interpreted with caution. 
 
The study used the HoNOS-LD as a measure of health and social functioning. This is used as 
an outcome measure within clinical services but has not been extensively used in research. 
Many items relate to functioning and as such there may be a ceiling effect whereby 
participants with more severe intellectual disability will tend to score highly because of 
deficits in their memory, attention, and ability to communicate. Therefore, it may be more 
useful to look at differences between those with and without ASD on the three HoNOS-LD 
subscales (neuro-cognitive functioning, mental health/behaviour and health/social 
functioning) rather than the total score. 
 
Limitations and strengths 
When evaluating the limitations and strengths of the studies it is important to consider that 
they aimed to provide a snapshot of the mental health and social functioning of specialist 
mental health service users with intellectual disability and ASD.  They were not designed to 
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measure the prevalence of mental health problems in adults with intellectual disability or 
evaluate the effectiveness of specialist mental health services for adults with intellectual 
disability. Other key issues that should be taken into account when assessing the studies 
include the well known difficulties when recruiting people with intellectual disability, ASD 
and mental health problems into research and lack of evidence-based tools available for this 
service user group. 
 
Limitations of the study 
Aside from issues of relying on clinical diagnoses which were discussed earlier, the main 
limitations of the studies for the thesis were: 
 Use of a single, specialist mental health service in a geographical area not 
representative of the UK 
 Inability to recruit matched samples 
 Reliance on informants for collection of data on participants 
 Lack of test re-test or inter-rater reliability data for informant interviews 
 Use of assessors who were not always blind to participants‘ ASD status  
 
Use of a single service 
The participants were all sourced from a single community mental health service for adults 
with intellectual disability. As such, the participants are not representative of the national 
intellectual disability population within the UK. It is therefore not possible to generalise the 
findings beyond their relevance to the provision of mental health services to adults with 
intellectual disability. 
 
As discussed in Chapter 5 this type of specialist service – provided separately from local 
community intellectual disability services – is unusual within the UK (Chaplin et al., 2009). It 
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is also located in a part of London that is quite different from the rest of the country with 
regards population density and socio-economic demographics (Stewart et al., 2009). As such 
these service users may not be representative of the wider population of adults with 
intellectual disability who have mental health problems. There are several groups of 
individuals that this study did not include: 
 
 Adults with intellectual disability and mental health/behaviour problems who are placed 
out of area or admitted to an inpatient unit. 
 Adults with intellectual disability and mental health/behaviour problems who are not 
referred to/accepted to the specialist mental health service but receive 
psychological/behavioural input from a community intellectual disability team. 
 Adults with intellectual disability and mental health/behaviour problems who are not 
referred to or accepted in to either of these services. 
 
That is, those with the most and least severe problems may not have been included. The 
pattern of differences between those with and without ASD may be different among people in 
these groups. More research is needed on broader populations. 
 
However, the service user group included provided an excellent opportunity to access a 
clearly defined sample of individuals (the service has stringent eligibility criteria) and explore 
the service model that has developed in this area (the service also has well-defined operational 
criteria). The results of the thesis provide a useful evidence-base on which to design further 
research on wider samples. 
 
Matching 
When designing the study, it was thought that matching participants with and without ASD 
would be vital and that disentangling the effects of intellectual disability severity and ASD 
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would be very difficult. It emerged that this was the case for the HoNOS-LD and social 
functioning scale, but not the DBC. Although severity of intellectual disability was associated 
with differences in DBC score it did not exert as high an influence as anticipated. In the 
regression analyses, it was not a significant predictor of DBC score. This is most likely 
because the DBC contains mainly mental health and behavioural items compared with the 
more health and social functioning focus of the HoNOS-LD. 
 
Every attempt was made to recruit samples with and without ASD that were well-matched on 
severity of intellectual disability. Ultimately, this was not possible because of the high 
proportion of participants with moderate and severe intellectual disability who failed to meet 
the study criteria for ‗no ASD‘. These participants were also more likely to be male and have 
no additional psychiatric disorder therefore it was not possible to match on these variables 
because there were no service users among the remaining sample who had the necessary 
characteristics. Of 15 recruited participants with severe intellectual disability and no clinical 
diagnosis of ASD only one was included in the study. This level of undiagnosed ASD was not 
anticipated in such a specialist service. More research is needed to explore why so many 
individuals exceeded the ADOS thresholds for ASD. 
 
The high level of undiagnosed ASD and inability to match groups with and without ASD 
throws into question the reliability of previous studies; especially those that relied on clinical 
diagnoses of ASD. It seems likely that many of the participants in the no ASD comparison 
groups of these studies in fact have ASD; particularly those with severe intellectual disability.  
 
Informant-based data 
A concern for studies that include individuals with a range of intellectual disability severities 
is that it becomes necessary to rely on informant-based data. This can introduce measurement 
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bias (Rojahn et al., 1994). It could be argued that there is a qualitative difference in the 
information provided by a family carer who has looked after someone 24 hours a day for their 
whole life compared with a paid carer who works with the person for a limited amount of 
time each week and may not have known them long. There is some evidence that type of 
informant can affect ratings of mental health (Kanne et al., 2009a). However the use of 
informants is standard practice in intellectual disability and ASD research (Hutton et al., 
2008).  
 
Furthermore, studies have found little difference between results from informant and self-
rating scales (Gordon et al., 2007). The accuracy of the service use data provided by 
informants is unclear. In some cases it was possible to look back through well-kept diaries 
and obtain information on participants‘ appointments in the previous 12 months. At other 
times the memory of the informant was relied on. However, the Client Service Receipt 
Inventory was designed for use with an informant and has been found to have good agreement 
with case records (Patel et al., 2005). 
 
Lack of inter-rater reliability data and assessor blinding 
All the informant interviews were carried out by a single researcher. As such there were no 
inter-rater reliability data to assess the measures used. It was also not possible to re-administer 
the measures to obtain test-retest data. However, the advantage of using one researcher is that 
bias introduced by multiple raters is eliminated. An alternative measure of reliability – 
internal consistency – was calculated for the CANDID, DBC, HoNOS-LD and SCQ. 
 
Another disadvantage of using one researcher was that this was the same person who 
recruited participants. As such the informant interviews were not carried out by a researcher 
who was blind to whether the participant did or did not have ASD. This was also the case for 
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many of the ADOS assessments. A consultant psychiatrist carried out the review using ICD-
10 criteria of those who did not take part in an ADOS assessment. It was not revealed whether 
or not the participants had a clinical diagnosis of ASD but this may have been obvious from 
their mental health record. 
 
None of these limitations hindered the ability of the study to address the key aims of the 
thesis. Any difficulties interpreting the results were related more to the heterogeneity of the 
participants and complexity of the relationships between the variables that were explored. 
 
Strengths of the study 
The main strengths of the studies for the thesis were: 
 
 Good sample sizes 
 Inclusion of adults with a range of intellectual disability severity 
 Inclusion of well-defined comparison groups of those without ASD 
 Standardised assessment of ASD using the ADOS and expert review 
 Standardised measures used to collect data on a wide range of variables 
 A social functioning scale specifically for adults with intellectual disability developed 
in consultation with an expert who has intellectual disability 
 
Studies on the characteristics and differences in the prevalence of mental health problems 
between those with and without ASD have ranged in sample size from 24 to 752. The main 
study‘s sample size of 98 participants provided sufficient power to detect significant 
differences between those with and without ASD. The clinical study included 788 participants 
in the main analyses. This compares well with previous studies on the prevalence of ASD 
among adults with intellectual disability (see Table 3.2). 
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Studies that have measured the mental health of adults with ASD compared to those without 
ASD rarely used a standardised diagnostic assessment of ASD. Furthermore, few previous 
studies on the social functioning of adults with ASD included any comparison group (see 
Table 4.2). Therefore, the inclusion of participants without ASD and confirmation of 
presence/absence of ASD using the ADOS were major advances on earlier work. 
 
The main strength of the thesis was the use of a ‗gold standard‘ ASD assessment, in addition 
to clinical diagnosis. The decision to include this safeguard was supported by the high number 
of participants who were excluded from the no ASD group because they exceeded the 
threshold for ASD. It is not clear whether these individuals had undiagnosed ASD. Their 
characteristics were more similar to those with ASD and their mental health and social 
functioning was different from those without ASD; justifying their exclusion from the main 
analyses. 
 
It should be noted that the ADOS alone is not sufficient to make a diagnosis of ASD in an 
adult. It is for this reason that those with no clinical diagnosis who exceeded the ADOS 
threshold were excluded from the study rather than transferred into the ASD group. It was not 
possible to carry out standardised assessment based on participants‘ developmental history; 
using the ADI-R for example. However, all participants in the ASD group had a clinical 
diagnosis made by a specialist intellectual disability psychiatrist using ICD-10 criteria. This 
assessment would have included an investigation into the individual‘s developmental history 
where possible. 
 
The breadth of the data collected made it possible to build up a detailed description of 
relationships between participant characteristics, service use, mental health and social 
functioning. It also allowed the analyses to take a wide range of variables into account when 
comparing participants with and without ASD. The use of three measures presented the 
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opportunity to explore participants‘ mental health, behaviour and social functioning from 
different angles: 
 
 A short-term look at health and social functioning over a broad range of domains for 
the last four weeks plus exploration of subscales including behavioural items 
(HoNOS-LD), 
 a longer-term measure of mental health and behavioural symptoms over six months 
plus exploration of subscales (DBC), 
 and a composite measure of current independence, communication, social interaction, 
community involvement and structured activity (social functioning scale). 
 
The results were fairly consistent: participants with ASD had poorer scores on all of these 
measures. 
 
The inclusion of the specially devised social functioning scale was particularly important 
because the choice of domains was made from the perspective of someone with intellectual 
disability. None of the previous studies on the social functioning of adults with ASD included 
any input from individuals with ASD or intellectual disability in the development of their 
measures. The involvement of a service user expert influenced what was included in each 
domain, the way each level of the items were scored and how the overall rating of social 
functioning was calculated. The design of the social functioning scale meant that participants 
with and without ASD could be meaningfully compared. If measures from previous studies 
had been used most of the participants would have had a poor or very poor social functioning. 
The data would have been skewed and it would have been more difficult to assess whether 
there were differences between those with and without ASD. 
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Previous studies have often found contradictory results when comparing adults who have 
intellectual disability with and without ASD. When they are examined more closely it 
emerges that there are questions about whether those in each group really did or did not have 
ASD, how they measured prevalence of psychiatric disorder, how they assessed mental health 
and social functioning, and whether the results can be generalised to the full spectrum of 
adults with intellectual disability. The strengths described above, acknowledgement of 
limitations and explicitly stated, standardised methods used in the studies for the thesis 
increase confidence in their findings. 
 
How the study adds to the evidence-base 
The literature review for the thesis revealed that there has been a lack of high-quality research 
on the impact of ASD on the mental health and social functioning of adults with intellectual 
disability. The study was designed to build on previous work and add to the current evidence 
base on whether there are differences between specialist mental health service users who have 
intellectual disability with and without ASD. 
 
Assessment and diagnosis 
Current evidence 
There are a wide range of assessment tools for ASD but few are suitable for adults with 
intellectual disability. There is a lack of evidence on whether mental health assessment tools 
for adults with intellectual disability have different psychometric properties when used with 
those who also have ASD. 
 
What the study adds 
The ADOS was found to be a useful tool for adults with intellectual disability. It enabled the 
study to successfully establish two groups of participants who, it could be reliably said, did 
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and did not have ASD. However, the high number of participants who exceeded the threshold 
for ASD indicates that its sensitivity and specificity needs further investigation. 
 
The low sensitivity of the SCQ means that it probably should not be used to screen for ASD 
as this would results in a high number of false negatives. However, an indicator that an 
individual does not require a full diagnostic assessment would be if they meet clinical criteria 
for ASD and have an SCQ score higher than 15. A five-item subscale within the HoNOS-LD 
could flag up those with unrecognised ASD traits/behaviours. More research is needed to 
develop this scale. 
 
The measures used to assess participants needs, mental health and social functioning did not 
appear to have significantly different psychometric properties when used with people who 
have ASD. The DBC appeared to be a reliable measure of mental health for individuals who 
have intellectual disability with and without ASD. 
 
Prevalence and comorbidity 
Current evidence 
The estimated rate of ASD among adults with intellectual disability ranges from 8 to 40%. 
Studies on mental health service users with intellectual disability have found rates of around 
20%. High quality studies on the prevalence of psychiatric disorder have found limited 
evidence for similar or slightly lower rates of psychotic disorder, and higher rates of 
depression, bipolar and anxiety disorders among those with ASD. 
 
What the study adds 
Among specialist mental health service users with intellectual disability, the rate of clinically 
diagnosed ASD was around 34%. However, a further 22% may have undiagnosed ASD. The 
clinical study provided further evidence that adults with intellectual disability and ASD are 
not more vulnerable to psychotic disorders. There was some indication that they are more 
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likely to have anxiety and ADHD than those without ASD although the rate of these disorders 
was not particularly high. 
 
Needs, service use and medication 
Current evidence 
It is known that adults with intellectual disability and ASD require high levels of support but 
there is evidence that they do not get the help they need for mental health problems. The care 
pathway for this group usually leads to specialist intellectual disability services. 
 
What the study adds 
Even when the mental health problems of adults with intellectual disability and ASD are 
recognised and they are referred to specialist services, they do not have the same level of 
access to these services as those without ASD, despite having higher needs. 
 
Mental health and social functioning 
Current evidence 
There is limited evidence that adults with intellectual disability and ASD have higher levels of 
mental health and behavioural problems and poorer social functioning than those without 
ASD. However, severity of intellectual disability and challenging behaviours may be more 
important predictors of these factors than ASD. 
 
What the study adds 
Previous findings on non-clinic populations appear to hold true for adults with intellectual 
disability who receive specialist mental health services. For this group, number of needs is a 
more important predictor of mental health and social functioning than either of ASD, 
intellectual disability severity or presence/absence of a psychiatric diagnosis. The results also 
provided some evidence that the relationship between intellectual functioning and social 
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functioning among those with ASD persists as IQ drops below 50 (moderate to severe 
intellectual disability). 
 
Recommendations for policy, practice and future research 
The focus of the thesis was whether specialist mental health service users with intellectual 
disability and ASD have different characteristics, needs, service use, mental health, behaviour 
and social functioning to those without ASD. Therefore, the results primarily have 
implications for specialist mental health services for adults with intellectual disability in the 
UK. It is vital that these services better understand their users. This includes recognising the 
importance of characteristics that group individuals together and impact on their needs and 
outcomes. Evidence from the thesis indicates that these characteristics include the presence of 
ASD, moderate to severe intellectual disability and presence/absence of a psychiatric 
disorder. 
 
Once recognised and better understood these characteristics (either at a group or individual 
level) should inform: 
 
 The delineation of assessment and care pathways. 
 The identification of people that services should be prioritising for improved access to 
assessment, services and monitoring. 
 Choice of evidence-based intervention. 
 
The areas highlighted by the thesis that could lead to better outcomes for specialist mental 
health service users with intellectual disability include: 
 
1. Efforts to identify groups and individuals who are not effectively accessing services and 
increase equity of access, particularly among those with high needs. 
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2. Better assessment and monitoring of needs using standardised methods plus proactive 
intervention to meet or eliminate specific needs. 
3. Improved assessment and monitoring of outcomes, ensuring that action is taken when 
outcomes do not improve. This includes proactively identifying factors that may be 
limiting an individual‘s opportunity for a better outcome. 
4. Improved awareness and understanding of ASD. Among support staff and carers but also 
health and social care staff including providers of specialist mental health services for 
adults with intellectual disability. 
5.  Improved diagnostic assessment. Both for ASD in order to better understand an 
individual‘s presentation and for psychiatric disorders to better inform treatment and care 
decisions. This should include comprehensive and consistent reassessment of new service 
users (whether they have existing diagnoses or not), service users whose symptoms have 
not responded to treatment, and those who have persistent and chronic symptoms or 
whose outcomes are poor. 
6. Better established assessment and care pathways for ASD, service users with severe 
intellectual disability, those with and without a psychiatric disorder and those with high 
levels of need. 
7. Less fragmented assessment of need and implementation of care packages across the 
range of health and social services that adults with intellectual disability use. 
 
Future research 
Areas in which more research is needed have been highlighted throughout the thesis. These 
include further collection and analysis of data from specialist mental health services with 
intellectual disability to: 
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 Develop and test the five-item HoNOS-LD subscale identified by the clinical study as 
a first-line screening measure for ASD among adults with intellectual disability who 
have mental health problems. 
 Determine the level of undiagnosed ASD among specialist mental health service users 
with intellectual disability. Specifically by determining whether those with ASD 
traits/behaviours meet the criteria for a diagnosis. 
 
Further studies from wider samples are needed to find out: 
 
 Building on the recommendations made by the NICE guideline for ASD in adults 
(2012). What are the key symptoms or behaviours that should prompt an assessment 
for ASD in adults with intellectual disability? 
 Whether using current algorithms of the ADOS for adults with intellectual disability 
and mental health problems results in too many false positives? 
 What steps can be taken to better equip services and clinicians to carry out more 
consistent diagnostic assessments of mental health problems in adults with intellectual 
disability and/or ASD? 
 What factors determine whether adults with intellectual disability who have mental 
health problems get referred to specialist services? 
 Among adults with intellectual disability, which individuals are using high levels of 
mental health services and why? 
 Which specific needs are the strongest predictors of social functioning among those 
using specialist mental health services for adults with intellectual disability? 
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In addition to these specific questions, a range of other points on health services research on 
adults with intellectual disability and/or ASD were raised. Few studies of adults with 
intellectual disability report the number of participants with ASD or investigate whether 
presence of ASD has any impact on their findings. The situation is similar for research on 
adults with ASD which does not always take intellectual disability into account unless it is 
specifically on those with low-functioning ASD.  
 
The current study found that: 
 
 The rate of ASD among adults with intellectual disability who use specialist mental 
health services could be as high as 56%. 
 Those with ASD form a distinct group among adults with intellectual disability. 
 Adults with ASD and intellectual disability have different patterns of mental health, 
problem behaviour and social functioning to those without ASD.  
 
This has considerable implications for the reliability and validity of studies which fail to take 
into account the impact of ASD on participants‘ outcome. 
 
A number of issues undermine epidemiological research on intellectual disability, ASD and 
comorbid mental health problems. Many studies that purported to measure prevalence of 
psychopathology were actually designed to test the psychometric properties of an assessment 
tool. Furthermore, scale and screening tools often were used in place of proper diagnostic 
assessment. Many instruments include subscales with cut-off points for particular types of 
symptoms but these do not always match diagnostic criteria or are not adequately validated 
against standardised diagnoses. 
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Research on adults with intellectual and ASD often blurs the boundaries between problem 
behaviours and psychiatric disorder; grouping them together or using behavioural measures to 
ascertain prevalence of psychopathology. This makes it hard to estimate the prevalence of 
comorbid psychiatric disorder among people with intellectual disability and ASD. This 
crossover is one of the key areas of difficulty when evaluating the evidence for or against a 
relationship between challenging behaviour and mental health problems. As discussed in 
Chapter 2, these challenges are difficult to avoid since the assessment and diagnosis of 
intellectual disability, ASD and comorbid mental health problems is largely based on 
behavioural symptomatology but studies need to be clearer in their methods and analysis. 
 
In summary, mental health services users with intellectual disability and/or ASD are 
heterogeneous populations with complex needs. Research needs to more clearly define, assess 
and differentiate between severities of intellectual disability, high- and low-functioning ASD, 
mental health problems and challenging behaviour. Studies on the prevalence of intellectual 
disability, ASD or psychiatric disorder need to ensure that data on multiple diagnoses are 
accurately captured.  
 
Conclusion 
A significant proportion of specialist mental health service users with intellectual disability 
have ASD. Although it appears that individuals with ASD are overrepresented in these 
services there does not appear to be evidence that they are more vulnerable to psychiatric 
disorder than those without ASD. Many individuals with intellectual disability and ASD 
receiving mental health services do not have a diagnosis of psychiatric disorder but are 
receiving treatment for challenging behaviour. 
 
Currently, most adults who have intellectual disability with and without ASD share a common 
care pathway. Once they reach specialist services there are few assessment or care protocols 
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in place to meet the specific needs of those with ASD. There appears to be an assumption that 
specialist mental health services for adults with intellectual disability have sufficient expertise 
and resources to effectively recognise ASD and provide effective evidence-based 
intervention. 
 
The thesis found evidence that ASD goes unrecognised or undiagnosed in a considerable 
number of specialist mental health service users with intellectual disability. Data from 
participants with and without a confirmed diagnosis of ASD indicated that those with high 
levels of need, moderate and severe intellectual disability and no diagnosed psychiatric 
disorder were receiving lower levels of service and had poorer mental health, behaviour and 
social functioning. In some cases, these clinical factors were more significant predictors of 
mental health, behaviour and social functioning than ASD itself but most of the service users 
who fitted these profiles had ASD. 
 
There will always be some service users whose outcomes are less positive than others. 
However, within this sample these individuals formed a consistently distinct group and were 
consuming the least amount of services. The results suggest that the current model does not 
provide fully accessible and effective services for individuals with high needs such as those 
with ASD, severe intellectual disability and challenging behaviour that requires specialist 
assessment and intervention. 
 
Proposals to improve this include: 
 Specialist assessment and intervention services for adults with ASD (including those 
who are low-functioning). This may not help those without ASD who have high needs 
who would continue to receive services according to the current model (e.g. those with 
severe intellectual disability). 
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 Greater access to mainstream services for those with low levels of need. 
 Separate specialist services for adults with intellectual disability who have a 
psychiatric disorder and those who have challenging behaviour. 
 One ‗neurodevelopmental‘ service for all those with intellectual disability and/or 
ASD. Such a service could incorporate different pathways for those with and without 
additional psychiatric disorder. 
 
The recent NICE guidelines have highlighted the current lack of evidence on the best ways of 
recognising and managing ASD among adults (NICE, 2012). The recommendations made 
particular reference to the need for more research on what structure and organisation of 
specialist teams are associated with improved outcomes for adults with ASD. The thesis has 
provided some evidence that there is a need for intellectual disability services to rethink their 
approach to assessing and managing ASD. However, this should be evaluated within the 
context of the study‘s limitations. These include the way in which mental health, problem 
behaviour and social functioning were measured; the highly selected nature of the sample and 
the number of participants included. 
 
Nonetheless the thesis provides a platform on which to build further research as described 
above. It may also serve as a baseline comparison for futures studies on whether recent 
initiatives such as the Autism Strategy and recommendations by NICE on setting up local 
autism strategy multi-agency groups do in fact lead to an increase in ASD recognition among 
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Tsakanikos et al., in preparation 
To be submitted as:  
Tsakanikos, E., Underwood, L., McCarthy, J. & Arshad, S. Psychometric properties of the 
Health of the Nation Outcome Scale for people with Learning Disabilities (HoNOS-LD). 
Research in Developmental Disabilities. 
 
Aim: To identify domains within the HoNOS-LD using statistical factor analysis. 
 
Method: Data were sourced from the anonymised case records of past and present mental health 
services users in South East London. A search was carried out to identify all service users who had 
received a HoNOS-LD assessment since electronic records were implemented in 2006. Individual item 
and total scores were obtained for participants‘ most recent HoNOS-LD assessment. 
 
Results: The search identified 2032 mental health service users with HoNOS-LD assessments carried 
out between April 2005 and December 2010. The mean age of participants was 43 (SD=14; range 18-
91) and 45% were female. HoNOS-LD scores ranged from zero to 75 with a mean of 14.1 (SD=10.4). 
 
A principal axis factoring analysis with Promax rotation was carried out. There were five factors with 
Eigenvalues greater than one. However, an examination of the Scree plot indicated a three factor 
solution (Figure 0.1). 
 
 
Figure 0.1: Scree plot for the factor analysis of 2032 HoNOS-LD assessments 
 
The factor analysis was rerun with three factors extracted. The pattern matrix showed that the first 
factor contained five items relating to memory, attention, expressive and receptive communication, 
and seizures (see Table 1). The second factor contained the behavioural items of the HoNOS-LD plus 




The remaining items related to participants‘ physical health, access to the community, 
activities/occupation, self-care and relationships. 
 
These items appeared to fit well together in a way that was clinically meaningful. The three factors 
were labelled ‗Neuro-cognitive functioning‘, ‗Mental & behavioural problems‘ and ‗Health & social 
functioning‘. 
 
Table 1: Three factor pattern matrix for the HoNOS-LD 
HoNOS-LD Items 
Factor 
1 2 3 
Receptive com .918 .029 -.156 
Expressive com .872 .016 -.071 
Memory .616 -.011 .124 
Attention .553 .136 .181 
Seizures .204 .015 .058 
Destructive beh .041 .722 -.085 
Personal habits .084 .631 -.036 
Stereotypy .246 .617 -.101 
Beh to others .037 .540 .017 
Other beh .022 .488 .023 
Mood changes -.219 .469 .330 
Anxiety -.043 .437 .166 
Beh to self .070 .420 .062 
Hallucinations -.120 .278 .167 
Occupation .024 .022 .600 
Daily living at home .353 -.083 .597 
Activities outside home .361 -.135 .590 
Self-care .191 .074 .475 
Eating probs -.100 .130 .386 
Relationships -.098 .290 .374 
Sleeping probs -.128 .228 .374 
Physical probs .130 -.083 .300 
Extraction Method: Principal Axis Factoring.  
 Rotation Method: Promax with Kaiser Normalization. 
a. Rotation converged in 9 iterations. 
 
 
The reliability of these groupings was explored. The Internal consistency (Cronbach‘s alpha) of the 
subscales is shown in Table 2. 
 
Table 2: Internal consistency of the HoNOS-LD subscales 
HoNOS-LD Subscale α 
Neuro-cognitive functioning 0.804 
Mental health/behavioural problems 0.779 
Health & social functioning 0.759 
 
 
Conclusion: Three HoNOS-LD subscales were identified by factor analysis. The items within these 
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CRIS confirmation of approval 
 







(Referrals_Episodes.Team_episode.Referral_Admin_Status_ID="Accepted")) OR  
((Referrals_Episodes.Team_episode.Site_Code="02300") AND 









































Appendix III:  Clinic study results 
 
Table III.1: Diagnoses included in each category of psychiatric disorder in Table 10.3 
Type of disorder Diagnostic label as entered into mental health record 
ADHD ADHD, hyperkinetic conduct disorder, hyperkinetic disorder 
Anxiety disorder Agoraphobia, Anxiety disorder, Generalised Anxiety Disorder, Mixed anxiety disorder, 
Obsessive Compulsive Disorder, Other anxiety disorder, Other neurotic disorders, Post-
Traumatic Stress Disorder, Specific phobia 
Bipolar disorder Bipolar affective disorder, Bipolar disorder, Hypomania, Manic episode with psychotic 
symptoms 
Dementia Alzheimer's dementia, Cognitive decline, Vascular Dementia 
Depression Depressive episode, Depressive disorder, Depressive disorder with psychotic symptoms, 
Depressive Illness, Mood disorder, Psychotic depression, Recurrent depression/depressive 
disorder/depressive episode 
Personality disorder Borderline personality disorder, Dependent personality disorder, Emotionally unstable 
personality disorder, Emotionally unstable Personality disorder (Borderline type), 
Emotionally unstable personality disorder (impulsive type), Paranoid Personality Disorder, 
Personality disorder, unspecified                                 
Psychotic disorder Acute & transient psychotic disorder, Catatonic schizophrenia , Delusional disorder, 
Organic delusional disorder, Organic Psychotic disorder, Other non-organic psychotic 
disorder, Paranoid schizophrenia, Persistent Delusional Disorder, Psychosis unspecified, 
Psychotic & affective disorder, Psychotic episode, Residual Schizophrenia , 
Schizoaffective disorder, Schizophrenia, Simple schizophrenia, Unspecified non organic 
psychosis, Unspecified psychotic illness 
Other Acute Stress Reaction, Adjustment disorder, Affective and anxiety disorder, Eating 
disorder, Gender identity disorder, unspecified, mixed affective disorder, Mixed anxiety 
and depression, Oppositional Defiant Disorder 
 
Table III.2: Total HoNOS-LD scores for those with & without ASD by other variables 


































Living with family 
Independently 
Residential placement 































Table III.3: Correlations between age and HoNOS-LD subscales 
 CogincEpi MHBeh HSFunc 
Age Pearson Correlation .090* -.125** .049 




Table III.4: ANOVA results for HoNOS-LD subscales 
 N Mean SD Df F p 
CogincEpi Female 228 3.64 3.642 1 3.927 .05 
Male 333 4.28 3.837 559     
     560     
MHBeh Female 228 4.48 4.125 1 .020 .888 
Male 333 4.53 3.972 559     
     560     
HSFunc Female 228 6.23 4.309 1 .231 .631 
Male 333 6.42 4.592 559     
CogincEpi Asian 30 4.37 3.222 3 .128 .943 
Black 142 4.08 3.730 557   
White 353 3.96 3.864 560   
Unclear or other 36 4.06 3.513    
MHBeh Asian 30 4.43 4.232 3 .165 .920 
Black 142 4.32 4.042 557   
White 353 4.57 4.082 560   
Unclear or other 36 4.72 3.403    
HSFunc Asian 30 6.97 4.916 3 .218 .884 
Black 142 6.31 4.368 557   
White 353 6.32 4.552 560   
Unclear or other 36 6.17 3.866    
CogincEpi Family 152 3.78 3.523 3 16.974 .000 
Placement 315 4.80 3.952 551   
Other 12 2.83 2.588 554   
Independent 76 1.58 2.311    
MHBeh Family 152 5.00 3.932 3 2.918 .034 
Placement 315 4.51 4.204 551   
Other 12 5.33 4.250 554   
Independent 76 3.38 3.302    
HSFunc Family 152 6.48 4.308 3 1.185 .315 
Placement 315 6.54 4.539 551   
Other 12 6.17 3.070 554   
Independent 76 5.49 4.675    
CogincEpi Psych Disorder 404 3.49 3.564 F (1, 551)=31.6, 
p<0.001 No Psych Disorder 148 5.47 3.944 
MHBeh Psych Disorder 404 4.15 3.923 F (1, 551)=11.2, 
p<0.001 No Psych Disorder 148 5.44 4.183 
HSFunc Psych Disorder 404 6.17 4.524 
F (1, 551)=, p=0.113 
No Psych Disorder 148 6.85 4.362 
CogincEpi Mild ID 319 2.07 2.322 2 200.919 .000 
Moderate ID 156 5.49 3.680 558     
Severe ID 86 8.57 3.089 560     
MHBeh Mild ID 319 3.81 3.663 2 18.159 .000 
Moderate ID 156 4.79 4.184 558     
Severe ID 86 6.63 4.290 560     
HSFunc Mild ID 319 5.47 4.273 2 17.748 .000 
Moderate ID 156 6.98 4.499 558     
Severe ID 86 8.41 4.348 560     
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Appendix IV:  Ethical approval 
 
 
Confirmation of ethical approval from St Thomas‟ REC 
Original application 
[Documents removed from pdf version to reduce file size] 
 
Amendment one 
[Documents removed from pdf version to reduce file size] 
 
Amendment two 
[Documents removed from pdf version to reduce file size] 
 
Confirmation of approval from the Institute of Psychiatry R&D Office 
 
[Documents removed from pdf version to reduce file size]
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Go through each question. If the service user is unable to give an adequate answer, do not 
tick the ―Yes‖ box, explain the answer & move on to the next question.  
 
1. Does the person understand the information?   Yes: ⁪ 
 Do you think you understand what the research is about? 
 Do you understand what will happen if you agree to take part? 
 Do you understand what will happen if you don‘t agree to take part? 
 
2. Can the person retain the information?    Yes: ⁪ 
 Can you tell me what you understand about the research? 
 Can you tell me what you think will happen if you agree to take part? 
 Can you tell me what you think will happen if you don‘t agree to take part? 
 
3. Can the person use or weigh the information?   Yes: ⁪ 
 What do you think about taking part? 
 What do you think will be good about taking part? 
 Do you think there might be anything bad about taking part? 
 
 
4. Can the person communicate the decision (by any means)?  Yes: ⁪ 
 Do you understand that you can say yes or no to taking part? 
 Have you decided whether you will say yes or no to taking part? 
 Would you like to take part in the research? (tick ―Yes‖ above regardless of  
 whether they do or do not want to take part, so long as they can give an answer) 
 
If you have been unable to tick “Yes” for all four conditions, go through the information 
sheet with the service user again. Then go through the questions they were unable to 
answer first time around. 
 
Has the service user demonstrated capacity to consent to take part in the study?  
I.e. Have you ticked “Yes” for all four conditions above? 
Yes     ⁪  No   ⁪ 
 
If ―Yes‖, detail why you think the person If ―No‖, detail why you think the person 
has capacity to consent does not have capacity to consent 
__________________________ _________________________ 
__________________________ _________________________ 
__________________________  _________________________ 
__________________________ _________________________ 
 
Please sign to confirm that you have carried out the above procedure 
 





Service user consent form 
 
 
Research project on Mental Health of  
People with Learning Disability 
Service User Consent Form 
 
Principal investigator: Dr Jane McCarthy, Estia Centre 
Name of service user:  
 





The purpose of the research has been explained 
to me. 
 
I have been given an information sheet about the 
research.  
 
I have been given the chance to ask questions 
about the research. 
 
I understand that the researcher will need to get 
some information from my records 
Estia Centre 
Munro - Guy's Hospital 
66 Snowfields 
London SE1 3SS 






















I understand the researcher will need to get 
some information from someone who knows me 
well. 
 
I understand that the researcher will need to 
speak to my carer. 
 
I understand that I might get invited to an 
assessment at the outpatient clinic 
 
I understand that I can take a break if I need to.   
 
I understand that if I say yes and then change 
my mind, that is ok.  
 
I understand that what I say will be kept strictly 
private.   
 
I understand that if the researcher is worried 
about me, he/she will talk to my carers or doctor. 
 
I understand that people from the Department of 
Health may want to look at my records to check 




If you agree with what has been said, please sign this form. 
 
    I agree to take part in this research 
    I do not agree to take part in this research 
If you agree to take part please tick one of these boxes: 
    I agree to come to a meeting with my carer 
    I do not want to go to the meeting with the  
  researchers but I agree that my carer can go. 
 
Print name       
Sign name       Date: ___/___/___ 
 
Person taking consent 
I have discussed the research with the participant, and (tick either box (a) or box (b)) 
(a) I have answered questions that were asked about the research   
    
(b) The participant had no questions to ask about the research. 
Researcher‘s signature………………………………………………………….. 
Researcher‘s name in block letters……………………………..………………. 
 
This study is funded by the Baily Thomas Trust, sponsored by the Institute of Psychiatry & 









Research study on 
Mental Health Problems of People with Learning Disability 
 
Consultee Assent Form 
 
Principal investigator: Dr Jane McCarthy, Estia Centre 
 
 
Name of service user: [Participant’s name] 
 
 













The purpose of the research has been explained to me. 
 
I have been given an information sheet about the research.  
 
I have been given the chance to ask questions about the research. 
 
I understand that I am agreeing that [Participant’s name] can 
participate in this research study. 
 
I understand that I am free to withdraw my agreement at any time, 
Estia Centre 
Munro - Guy's Hospital 
66 Snowfields 
London SE1 3SS 
























and do not have to give any reason for this. 
 
I understand that [Participant’s name] can take a break if he needs 
to. 
 
I understand that all information obtained in the study will be kept 
strictly confidential, although any information which causes the 
researcher concern will be passed on to [Participant’s name]’s care 
team. 
 
I have considered what the wishes and feeling’s of [Participant’s 
name] would be if she[he] had capacity to decide whether to take 
part. 
 
If you agree with all of the above, please sign your name and write the date 
below. 
 
Sign your name_______________________ Date____________ 
Print your name_______________________ 
 
This study is funded by the Baily Thomas Trust, sponsored by the Institute of 
Psychiatry and has received ethical approval from St Thomas' Hospital Research 
Ethics Committee 




Participant information sheet 
 
 
Research project on Mental Health of  
People with Learning Disability 
Service User Information Sheet 






Who are we? 
 
We work for the Estia Centre  
 
We help people with learning disability who have mental 
health problems.  
 
We are doing a research project. 
 
The project is about the mental health of people with 
learning disability. 
 
What do we want to know? 
 
If you have mental health problems, you might feel sad 
or hear voices. 
 
We want to know: 
 
1.  Do mental health problems get better, get worse or 
stay the same?  
 
2.  Do you get the help you want?  
 
Once we know this, we can help you and other people 
better.  
Estia Centre 
Munro - Guy's Hospital 
66 Snowfields 
London SE1 3SS 





































What do we want to do? 
 
There are three parts to the study. 
 
We will ask everyone to do part one and part two. 
 
 
We will only ask some people to do part three. We will 
tell you if we would like you to do part three. 
 
PART ONE 
We would like to meet with someone who knows you 
well. 
We want to talk about – 
 you and your problems  
 what help you get, your medication and how people 
look after you 
 if you need help with anything else 
You can decide: 
 if we meet you and your carer 
 if we meet just your carer 
 
We will only talk to your carer if you agree. 
 
How long will it take? 
The meeting will take about 2 hours. 
 
PART TWO 

















     
PART THREE 
 
We will ask some people to come to the outpatient clinic 
for a meeting. 
 
A researcher will ask you to do some activities (for 
example: describe a picture). 
 
The researcher will write down what you do or say. The 
activities will take about 45 minutes. 
  
You can take a break at any time. If you get upset in the 
meeting please tell the researcher.  
 
If you get upset, we can stop. 
If you are upset, we will talk to your carers. 
 
If you get upset after the meeting please tell your 







You can choose: 
 if you want to help us  
 if you don‘t want to help us   
 
You can take 14 days to think about it.   
 
You do not have to take part if you do not want to. 
 
If you say yes and then change your mind, that is ok. 
 
You do not have to give us a reason why you have 
changed your mind. 
 







If you say yes - 
We will talk to your carer.  
We will look at your file. 
We might invite you to do some activities. 
        
 
Do you get paid? 
 
Sorry, we cannot pay you to help us  
















Will anyone find out what you and your carer have 
said? 
 
Everything you say will be private. 
Your information will be kept safely. 
Your name will not be on any letters or reports. 
If we are worried about you, we will talk to your carers 
or your doctor. 
 
People from the Department of Health may want to look 
at our information to check our work. 
 
What if you are not able to understand the study 
(lack capacity)? 
 
If this happens before the study, we will ask someone 
who knows you well to decide whether you should take 
part. 
 
If this happens after the study we will still keep a record 
of your information and use it in our research. 
What happens after our study? 











We will then write a report. 
We will send you a copy of the report, if you would like 
one.   
 
What if I have a concern or complaint? 
If you have any questions, concerns or complaints please 
telephone 
Doctor Jane McCarthy on 0203 228 9738. 
 
You can write to her at: The Estia Centre, 66 
Snowsfields, London, SE1 3SS. 
 
If you are still unhappy you can make a complaint 
through the NHS Complaints Procedure. Ask your GP or 
the team that is responsible for your care and treatment. 




What happens now? 
There is a form with this information. Please send this 
back to us. 
 
Please fill out the form if you think you would like to 
help. Tick the Yes box. 
This study is funded by the Baily Thomas Trust, sponsored by the Institute of Psychiatry and 
has received ethical approval from St Thomas' Hospital Research Ethics Committee  
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Service user profile 
 
Age last birthday   ⁪⁪ 
 
Ethnicity  
White British    ⁪1  Indian    ⁪9  
White Irish    ⁪2  Pakistani   ⁪10  
Other White    ⁪3  Bangladeshi   ⁪11  
Mixed White and Black Caribbean ⁪4  Other Asian   ⁪12  
Mixed White and Black African ⁪5  Black Caribbean  ⁪13  
Mixed White and Asian  ⁪6  Black African   ⁪14  
Other Mixed    ⁪7  Other Black   ⁪15  
Chinese    ⁪8  Other Ethnic Group  ⁪16  
      (please specify)__________________ 
 
Nationality 
British     ⁪1   Other (please specify)   ⁪2  
      ______________________________ 
 
First language   ____________________________________ 
 
Relationship status 
Married/civil partnership ⁪1  Divorced/dissolved civil partnership ⁪3  
Single    ⁪2  Widowed    ⁪4  
Other (please specify)  ⁪5  Not known    ⁪6  
______________________________ 
 
Level of educational 
No education   ⁪1  Community college   ⁪5  
Primary education or less ⁪2  Tertiary/further education  ⁪6  
Secondary education  ⁪3  Other (please specify)   ⁪7   
Special education  ⁪4  ______________________________ 
 




Mental Health Outcomes in Adults with LD 
 
Data Collection Pack – Informant Interview 
 
1. Relationship of informant to service user: ______________________________ 
_________________________________________________ 
 
2. Approx. length of time informant has known service user:  
⁪⁪years, ⁪⁪months Or tick here if informant has known service user all their life 
(e.g. for a family member) ⁪ 
 
3. Number of contacts per week with service user:        ⁪⁪ 
Or tick here if service user lives with the informant so there‘s contact every day ⁪ 
 
Circle the appropriate box for each item. 
 
4. Age group of informant 
16 - 24    ⁪1   45 – 54   ⁪4  
25 – 34   ⁪2   55-64    ⁪5  
35 – 44   ⁪3   Over 65   ⁪6  
 
5. Gender of informant 
Male    ⁪1   Female   ⁪2  
 
6. Ethnicity of informant 
White British    ⁪1   Indian   ⁪9  
White Irish    ⁪2   Pakistani  ⁪10  
Other White    ⁪3   Bangladeshi  ⁪11  
Mixed White & Black Caribbean ⁪4   Other Asian  ⁪12  
Mixed White & Black African ⁪5   Black Caribbean ⁪13  
Mixed White & Asian  ⁪6   Black African  ⁪14  
Other Mixed    ⁪7   Other Black  ⁪15  
Chinese    ⁪8   Other Ethnic Group ⁪16   
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Case note review schedule 
Mental Health Outcomes in Adults with LD 
 
Data Collection Pack – Case note review 
 
Please take care to note the period of time that should be rated. 
 
Service user ID:   
 
 
Period of rating: from ⁪⁪/⁪⁪/⁪2 ⁪0 ⁪⁪ = interview minus 1 year 
     To   ⁪⁪/⁪⁪/⁪2 ⁪0 ⁪⁪ = date of interview 
 
 
Date of rating :   ⁪⁪/⁪⁪/⁪2 ⁪0 ⁪⁪ 
 
Name of Rater:  ____________________________________________ 
 
Is this person on the current MHiLD caseload? Yes ⁪2  No ⁪1  
 
Are there any existing measures on ePJS?  Yes ⁪2  No ⁪1  
 
If “Yes”, which measures have been taken, when and what was the result? 
 
HoNOS-LD ⁪1  Date: ⁪⁪/⁪⁪/⁪⁪⁪⁪  Score: ⁪⁪ 
 
HoNOS ⁪2  Date: ⁪⁪/⁪⁪/⁪⁪⁪⁪  Score: ⁪⁪ 
 
CANDID ⁪3  Date: ⁪⁪/⁪⁪/⁪⁪⁪⁪  Met needs:  ⁪⁪ 
        Unmet needs: ⁪⁪ 
        Total  needs:  ⁪⁪ 
Other  ⁪4  
Name:____________ Date : ⁪⁪/⁪⁪/⁪⁪⁪⁪  Score: ⁪⁪ 
Name:____________ Date : ⁪⁪/⁪⁪/⁪⁪⁪⁪  Score: ⁪⁪ 





SERVICE USER PROFILE 
 
N.B. For severity of learning disability, psychiatric diagnosis and current 
medication, priority should be given to the last follow-up letter to the service 
user‟s GP as this is likely to be the most accurate and up to date information. 
 
Date of birth:    ⁪⁪/⁪⁪/⁪1 ⁪9 ⁪⁪ 
 
Gender: Male   ⁪1  Female   ⁪2   
 
Current MHiLD team: 
Lambeth   ⁪1  Lewisham    ⁪2  
Southwark   ⁪3  Other (please specify)   ⁪4  
      ______________________________ 
 
What is the service user‟s degree of learning disability? 
 
If different severities are mentioned in different sources of information, make a note of these 
in the margin then circle the answer that seems most consistent in the service user‘s notes. Try 
to give a definitive severity (e.g. mild) unless it is always stated to be something else (e.g. 
mild/moderate). 
Borderline   ⁪1  Severe     ⁪4  
Mild    ⁪2  Profound    ⁪5  
Moderate   ⁪3  Other (e.g. mild to moderate)  ⁪6   
      Please specify:___________________ 
Unclear   ⁪7  _______________________________ 
  
Does the service user currently have a psychiatric diagnosis? 
Yes  ⁪2  No  ⁪1  
 
Write the diagnosis/es as worded on ePJS, make a note if there are any differences in the 











Does the service user currently have a diagnosis of PDD/ASD? 
Yes  ⁪2  No  ⁪1  
 
If “Yes”, how is this recorded? Write the diagnosis/es as worded on ePJS, make a note if 
there are any differences in the diagnosis given in different sources of information. 
 
⁪1  Definite diagnosis Where on ePJS?_____________________________ 
 Classification/details?_________________________________ 
 
⁪2  Suspected  Where on ePJS?_______________________________ 
 Details?_____________________________________________ 
 
⁪3  Other   Where on ePJS?_______________________________ 
 Details?_____________________________________________ 
 
⁪4  Cannot find any mention of ASD, autism, Asperger‘s or PDD 
    
Does the service user have epilepsy? Yes ⁪2  No  ⁪1  
 
Does the service user have any physical disabilities, illnesses or problems (including 
sensory impairment)?   Yes ⁪2 No/unclear ⁪1  




Current CPA status      
No CPA   ⁪1   
Standard CPA   ⁪2  Enhanced CPA   ⁪3  
 
 
Current legal status 
Informal   ⁪1   Other Section MHA   ⁪3  
Guardianship   ⁪2  Other, please specify   ⁪4  
      ______________________________ 
 
Occupation of care co-ordinator 
Psychiatrist   ⁪1   Psychologist    ⁪3  
Nurse    ⁪2  Other, please specify   ⁪4  




INITIAL INVOLVEMENT WITH MHiLD 
 
Date of referral to MHiLD:  ⁪⁪/⁪⁪/⁪⁪⁪⁪ 
Tick here if the date is unclear from current records: ⁪ 
 
Reason for referral to MHiLD:_________________________________________ 
____________________________________________________________________ 
Tick here if the reason is unclear from the records: ⁪ 
 
Source of referral to MHiLD: 
GP    ⁪1  Hospital or other doctor  ⁪4  
Residential Support staff ⁪2  Voluntary services   ⁪5  
Social Services staff  ⁪3  Other (please specify)   ⁪6  
      ______________________________ 
Unclear   ⁪7  
 
Borough of MHiLD team at referral: 
Lambeth   ⁪1  Lewisham    ⁪2  
Southwark   ⁪3  Other (please specify)   ⁪4  
      ______________________________ 
Unclear   ⁪5  
 
Legal status referral: 
Informal   ⁪1   Other Section MHA   ⁪3  
Guardianship   ⁪2  Other, please specify   ⁪4  
      ______________________________ 
Unclear   ⁪5  
 
Type of residence at referral to MHiLD: 
Family home   ⁪1  Independently    ⁪4  
Hospital   ⁪2  Some other place (please specify)  ⁪5  
Supported home  ⁪3  ______________________________ 




On assessment, was the service user diagnosed with a psychiatric disorder? Yes 
 ⁪2  No  ⁪1  Unclear ⁪3  
 




On initial assessment, was the service user diagnosed with a PDD? 
Yes  ⁪2  No  ⁪1  Unclear ⁪3  
 





Following referral what clinical management action decision was taken? 
 
Further involvement from MHiLD?   Yes ⁪2  No ⁪1  
Admission to Weston Unit?    Yes ⁪2  No ⁪1  
Recommended pharmacotherapy?   Yes ⁪2  No ⁪1  
Referral to Psychology/Challenging Needs?  Yes ⁪2  No ⁪1  
Referral to Social Services?    Yes ⁪2  No ⁪1  
Referral to OT?     Yes ⁪2  No ⁪1  
Referral to Speech and Language Therapy?  Yes ⁪2  No ⁪1  
Referral to Physiotherapy?    Yes ⁪2  No ⁪1  
Admission to Adult Psychiatric Unit?  Yes ⁪2  No ⁪1  
Referral to General Hospital Physician/Surgeon? Yes ⁪2  No ⁪1  
Discharged to GP's care?    Yes ⁪2  No ⁪1  
Other? Please specify:    Yes ⁪2  No ⁪1  
__________________________________________________ 






SUMMARY OF THE RATING PERIOD 
 
Please write in all the things that happened to the service user during the rating period. 
Include life events, appointments and all contacts with health or social care services, 
changes in care/treatment/medication. DO NOT USE THE SERVICE USER‟S NAME. 
 


























Date of most recent Date previous to that 
When was the 
service user last seen 




Details of contact: 
 ⁪⁪/⁪⁪/⁪⁪ 
Details of contact: 
Care or care plan 
review Yes No ⁪⁪/⁪⁪/⁪⁪ ⁪⁪/⁪⁪/⁪⁪ 
Risk assessment Yes No ⁪⁪/⁪⁪/⁪⁪ ⁪⁪/⁪⁪/⁪⁪ 
 
List of current medication Dose Started on Started by (name) 
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Antipsychotics Yes No   
Mood stabilisers Yes No   
Antidepressants Yes No   
Benzodiazepines Yes No   
Antiepileptic medication Yes No   









During the rating 
period 
If YES - 
No. of 
sessions 
Behaviour therapy/intervention Yes No   
Cognitive or cognitive behavioural therapy (CBT) Yes No   
Individual therapy Yes No   
Group therapy Yes No   
Parental/ intervention Yes No   
Staff training Yes No   




Family intervention Yes No   
Consultation with other agencies – please specify: Yes No   










No. of home 
visits 















Community psychiatric nurse Yes No    
Community Learning Disability Team Yes No   
Community psychiatrist. Outpatient appointments Yes No   
Community psychiatrist - excluding outpatient visits Yes No   
Learning disability nurse Yes No   
Psychologist Yes No   
Behaviour support worker or behavioural therapist Yes No   
Physiotherapist Yes No    
Occupational therapist Yes No   
Social worker/Approved social worker Yes No   
Speech and language therapist Yes No   








No. of home 
visits 





General Adult Mental Health Services Yes No   
Community psychiatrist - other than from MHiLD 




Community psychiatrist - other than from MHiLD 




Community psychiatric nurse Yes No   





Other community services Yes No    
General Practitioner Yes No   
Other community nurse (e.g. district nurse, health 




Dentist Yes No   
Optician Yes No   
Chiropodist Yes No   
Alternative therapist (e.g. reflexologist) Yes No   
Advocate/counsellor Yes No   
Home help/home care worker Yes No   
Employment services/job centre Yes No   










 Yes No   
 
Hospital-based services 
In last 12 
months? 
If YES - No. of 
inpatient days or 
appointments 
Learning disability psychiatric ward  Yes No  
Psychiatric intensive care ward Yes No  
Acute psychiatric ward Yes No  
Psychiatric rehabilitation ward Yes No  
General medical ward Yes No  
Long stay ward Yes No  




Day hospital Yes No  












Note here any referrals made by MHiLD or any other agency in the last 12 months and the 
results of the referral. 
 
Date of referral Referral by: Referral to: Result 
⁪⁪/⁪⁪/⁪⁪    
⁪⁪/⁪⁪/⁪⁪    
⁪⁪/⁪⁪/⁪⁪    
⁪⁪/⁪⁪/⁪⁪    
⁪⁪/⁪⁪/⁪⁪    
 
Is there anything else you feel it‟s important to mention that has not already been 
covered in the case note review? Include here anything major that has happened to the 










Table V.1: Measures reviewed during the development of the social functioning scale 
Howlin et al., 2000; Mawhood et al., 2000 
 
Four composite measures: 
Language, Friendship, Independence & Autistic-type stereotyped behaviours. 
Each rated 0 (normal/near-normal), 1 (moderate/fair) or 2 (poor/very poor). 
 
Composite score (sum of above) comprising 3 levels: 
0-1 = near normal functioning. 
2-4 = moderate difficulties. 
5-8 = considerable levels of difficulty 
 
Language: Good (uses sentences with mature grammar, understands 2/3-step instructions, talks with others so 
that conversation flows, able to build on other person's dialogue) = 0. 
Fair (scores positively on 2 of the above) = 1. 
Poor (scores on only 1) = 2. 
Very poor (scores on none) = 2. 
Friendships: Good (normal relationship) = 0, 
Fair (some limited friendships) = 1, 
Poor (no friends, has acquaintances who are met in a group situation, such as work or a club) = 2, 
Very poor (no friendships involving selectivity & sharing) = 2. 
Independence: Full (able to cope with all self-care activities, travel independently & manage own finances 
without help) = 0, 
Moderate (requires some help in these areas) = 1, 
Little (significant help required) = 2. 
Autistic behaviours: ADI scores for unusual preoccupations; rituals/compulsions, resistance to change & unusual 
attachments to objects. 
Total score of 0/1 (None /minimal problems) = 0 
Total score of 2-5 (Moderate problems) = 1 
Total score of 6 (severe problems) = 2 
 
Also measured was Education: university = 0, mainstream college = 1, special college = 2, no further education 
= 3; and Occupation: Regular paid work = 0, voluntary/special job arrangements = 1, day or residential centre = 
2, no daytime placement = 3. 
Howlin et al., 2004; Eaves & Ho, 2007; Farley et al., 2009 
 
3 composite measures: Occupation, Friendships & Independent Living. Each rated 0, 1 or 2. 
 
Composite score (sum of above) comprising 5 levels: 
0-2 = Very Good (achieving a high level of independence).  
3-4 = Good (generally in work but requiring some degree of support in daily living). 
5-7 = Fair (some degree of independence, although requires support & supervision does not need specialist 
residential provision) 
8-10 = Poor (requiring special residential provision/high level of support). 
11 = Very Poor (needing high-level hospital care). 
 
Occupation: employed or self-employed = 0, voluntary work/job training or low-pay scheme = 1, 
supported/sheltered employment = 2, in special centre/no occupation = 3. 
Friendships: range of scores from >1 close friendships involving sharing & exchange of confidences & range of 
different activities together = 0 to no friends, no joint activities = 3. 
Living independently = 0, in semi-sheltered accommodation (or still at home) but with high degree of autonomy 
= 1, living with parents, some limited autonomy = 2, in residential accommodation with some limited autonomy 
= 3, specialist autistic or other residential accommodation with little or no autonomy = 4, in hospital care or at 
home because nowhere else would accept the individual = 5. 
 
Support required: see Engstrom et al., 2003 
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Marriage et al., 2009 
 
5 composite measures: Education, Vocation, Independence, Friendships & Intimate relationships. Each rated 1 
(poor functioning) to 5 (age appropriate attainment). 
 
Composite score (sum of above). 
 
Education: Did not graduate from high school = 1, Graduated from an adapted program in high school = 2, 
Graduated from regular high school = 3, Attended college/university: If < 25 years, in college = 5, If > 25 years, 
attending college = 4, Graduated from college/university = 5. 
Employment: Disability pension, never employed, not in educational program = 1, Employed briefly, 
unemployed now = 2, Series of jobs, briefly in or out of work now, or in school part-time, no job = 3, Stable 
employment or in school full-time, if >25 years = 4, Employed at potential or, if <25 & in school full-time = 5. 
Living Arrangements/Independence: Lives with parents, needs support in activities of daily living & routine = 1, 
Lives with parents, needs some support to manage in community = 2, Lives with parents, self sufficient 
managing life otherwise, if >25 years = 3, Lives independently, needs some support to manage finances, etc. = 4, 
Living independently, manages affairs alone, or, < 25, lives with parents, manages affairs alone = 5. 
Social Relationships (outside the family): Isolated, lives in own world, no friends = 1, Somewhat isolated, has 
some acquaintances–not necessarily any shared interests = 2, Some acquaintances around shared interests = 3, 
Has 1 or more friendships–only short term = 4, Has 1 or more close & enduring friendships = 5. 
Intimate Relationships: No partner–ever, no interest = 1, Some attempt at finding partner, brief relationships, 
unsatisfactory to subject = 2, Relationships of a few months or more = 3, 1 or more long term (>6/12) 
relationships, or divorced = 4, Married/living common-law, satisfactory to both partners = 5. 
Billstedt et al., 2005; Engstrom et al., 2003 (Lotter (1978) criteria). 
Composite score comprising 5 levels:  
Good outcome: a) employed or in education or training plus 
b) living independently (for those aged 23 & over) 
>2 friends or steady relationship (for those aged under 23).  
Fair outcome: a) or b). 
Restricted outcome (neither a) nor b) + no mental health problem). 
Poor outcome (obvious severe handicap, no independent social progress, some clear verbal or non-verbal 
communicative skills).  
Very poor outcome (obvious very severe handicap, unable to lead any kind of independent existence, no clear 
verbal or non-verbal communication). 
Engstrom et al., 2003 Criteria for level of support 
 
Public: None (no public support). 
Low (advice & support from habilitation, regular home-help service).  
Moderate (continuous home support, sheltered job, job assistant, regular support from psychiatry and/or 
habilitation. 
High (supported living, group home or institution, daycentre, personal assistant). 
 
Private: None (no contact with family). 
Low (normal or near normal contact with parents, siblings & other relatives; support & practical assistance from 
time to time). 
Moderate (regular practical assistance at home; daily contact by phone or physically; help with local authorities). 
High (extensive help with social contacts & employment sites; total control of economic affairs; lives with 





Appendix VI:  Main study results  
 
Results for 129 participants with and without a clinical diagnosis of ASD 
 




N = 53 
Clinical no ASD 




Mean SCQ score (SD) 
Range 
16.1 (4.7) 
4 to 26 
8.49 (5.8) 
0 to 24 
F(1,120)=60.4, p<0.001 
Exceeding cut-off for ASD (≥15) 32 (63%) 13 (19%) χ2(1)=24.6, p<0.001 
Age 
Mean years (SD) 
Range 
36.2 (12.2) 
18 to 68 
43.3 (11.9) 




Mild 23 (43%) 43 (57%) 
χ2(2)=2.57, p=0.276 Moderate 14 (26%) 18 (24%) 
Severe 16 (30%) 15 (20%) 
Gender 
Males 42 (79%) 52 (68%) 
χ2(1)=1.85, p=0.174 
Females 11 (21%) 24 (32%) 
Ethnicity 
Afro-Caribbean 20 (38%) 24 (32%) 
χ2(3)=1.53, p=0.677 
Asian 2 (4%) 3 (4%) 
White  28 (53%) 47 (62%) 
Unclear or other 3 (6%) 2 (3%) 
Type of 
residence 
With family 22 (42%) 16 (21%) 
χ2(2)=8, p=0.019 Residential  27 (51%) 45 (59%) 
Independently 4 (8%) 15 (20%) 
Psychiatric 
disorder 
Present 25 (47%) 59 (78%) 
χ2(1)=12.76, p<0.000 
Absent 28 (53%) 17 (22%) 
 
 
Participants with and without a clinical diagnosis of ASD were sufficiently matched (there 
were no statistically significant differences between the groups) on severity of intellectual 
disability, gender and ethnicity. However, there were some significant differences between 
those with and without ASD: 
 
 Participants with a clinical diagnosis of ASD were younger, more likely to live with 




Results for variables entered into the regression analyses 
 
 








Age Pearson Correlation -.210 .065 -.215* -.274** .089 
Sig. (2-tailed) 0.04 .533 .033 .008 .396 
N 96 93 98 92 94 
 
 
Table VI.3: ANOVAs of continuous dependent variables & socio-demographic/clinical variables 
 Dependent variable Level of variable N Mean SD df F Sig 
Mental health service 
consumption score 
Female 27 11.11 11.7 1 5.039 . 632 
Male 69 9.16 10.5 94     




Female 29 9.41 2.8 1 2.379 .126 
Male 64 10.39 2.8 91     
        92     
HoNOSLDTotal 
  
Female 29 15.34 8.5 1 .007 .931 
Male 69 15.51 8.5 96     
        97     
DBC 
  
Female 29 38.41 17.1 1 1.729 .192 
Male 63 44.00 19.7 90     
        91     
IndexOutcomeScore Female 29 9.76 3.1 1 2.139 .147 
Male 65 8.83 2.7 92     
    
93     
Mental health service 
consumption score 
Afro-Caribbean 33 10.79 12.3 2 .495 .611 
White 56 8.80 9.9 93     
Other/unclear 7 11.86 10.7 95     
CANDID21Total 
Need 
Afro-Caribbean 30 9.83 3.1 2 .330 .720 
White 57 10.14 2.8 90     
Other/unclear 6 10.83 1.7 92     
HoNOSLDTotal Afro-Caribbean 34 16.00 10.4 2 .234 .792 
White 57 14.98 7.1 95     
Other/unclear 7 16.71 8.9 97     
DBC Afro-Caribbean 30 43.00 19.4 2 .143 .867 
White 56 41.50 19.4 89     
Other/unclear 6 45.33 15.8 91     
IndexOutcomeScore Afro-Caribbean 31 8.39 3.2 2 2.468 .090 
White 57 9.63 2.6 91     
Other/unclear 6 8.00 2.3 93     
Mental health service 
consumption score 
Inde 14 14.86 12.8 2 5.809 .004 
Resid 50 6.34 8.4 93     
Family 32 12.72 11.6 95     
CANDID21Total Need Inde 16 7.50 2.5 2 11.053 .000 
Resid 46 11.02 2.3 90     
Family 31 10.03 3.0 92     
HoNOSLDTotal Inde 16 12.56 6.4 2 3.245 .043 
Resid 50 14.54 8.6 95     
Family 32 18.34 8.5 97     
DBC Inde 16 28.00 9.5 2 9.390 .000 
Resid 46 41.30 18.6 89     
Family 30 51.27 18.7 91     
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 Dependent variable Level of variable N Mean SD df F Sig 
IndexOutcomeScore Inde 16 12.19 1.4 2 14.317 .000 
Resid 47 8.47 2.5 91     
Family 31 8.52 2.9 93     
Mental health service 
consumption score 
Mild 53 13.26 11.8 2 7.460 .001 
Moderate 26 4.62 5.5 93     
Severe 17 6.41 9.8 95     
CANDID21Total Need Mild 51 8.78 2.8 2 16.510 .000 
Moderate 25 11.28 2.2 90     
Severe 17 12.24 1.4 92     
HoNOSLDTotal Mild 55 12.85 7.3 2 11.788 .000 
Moderate 26 15.96 8.3 95     
Severe  17 23.12 7.8 97     
DBC Mild 50 37.84 19.7 2 3.893 .024 
Moderate 25 44.56 19.7 89     
Severe 17 51.76 11.0 91     
IndexOutcomeScore Mild 52 10.27 2.3 2 20.519 .000 
Moderate 25 8.84 2.7 91     
Severe 17 6.00 2.4 93     
Mental health service 
consumption score 
No diagnosis 34 6.35 9.3 1 5.322 .023 
Psychiatric disorder 62 11.55 11.2 94     
Total 96 9.71 10.791 95     
CANDID21Total Need No diagnosis 32 11.16 2.7 1 7.354 .008 
Psychiatric disorder 61 9.52 2.8 91     
Total 93 10.09 2.9 92     
HoNOSLDTotal No diagnosis 34 18.38 8.6 1 6.591 .012 
Psychiatric disorder 64 13.91 8.0 96     
Total 98 15.46 8.4 97     
DBC No diagnosis 32 48.16 13.9 1 4.962 .028 
Psychiatric disorder 60 39.08 20.6 90     
Total 92 42.24 19.0 91     
IndexOutcomeScore No diagnosis 32 7.34 2.8 1 23.117 .000 
Psychiatric disorder 62 10.03 2.4 92     










CANDID21TotalNeed Pearson Correlation .564** .463** -.545** 
Sig. (2-tailed) .000 .000 .000 
CANDID21MetNeeds Pearson Correlation .251* .361** -.401** 
Sig. (2-tailed) .015 .000 .000 
CANDID21UnmetNeeds Pearson Correlation .507** .168 -.236* 
Sig. (2-tailed) .000 .110 .023 
CANDID21PropNeedsUnmet Pearson Correlation .366** .033 -.077 













medication Value Df p 
Female Count 1 28 3.951
a
 1 .05 
% within Gender 3.4% 96.6% 
Male Count 13 56 
% within Gender 18.8% 81.2% 
A/C Count 6 28 1.483a 2 .476 
% within Ethnicity 17.6% 82.4% 
White Count 8 49 
% within Ethnicity 14.0% 86.0% 
Other Count 0 7 
% within Ethnicity .0% 100.0% 
Inde Count 1 15 2.562a 2 .278 
% within Residence 6.3% 93.8% 
Resid Count 6 44 
% within Residence 12.0% 88.0% 
Family Count 7 25 
% within Residence 21.9% 78.1% 
Mild Count 9 46 .442a 2 .802 
% within SevID 16.4% 83.6% 
Moderate Count 3 23 
% within SevID 11.5% 88.5% 
Severe Count 2 15 
% within SevID 11.8% 88.2% 
No disorder Count 11 23 13.879a 1 .000 
% within Psych dis 32.4% 67.6% 
Psychiatric 
disorder 
Count 3 61 
% within Psych dis 4.7% 95.3% 
  HoNOS-LD<22 
HoNOS-LD 
Value Df p 
Female Count 24 5 .429a 1 .513 
% within Gender 82.8% 17.2% 
Male Count 53 16 
% within Gender 76.8% 23.2% 
A/C Count 25 9 1.236a 2 .539 
% within Ethnicity 73.5% 26.5% 
White Count 47 10 
% within Ethnicity 82.5% 17.5% 
Other Count 5 2 
% within Ethnicity 71.4% 28.6% 
Inde Count 15 1 5.724a 2 .057 
% within Residence 93.8% 6.3% 
Resid Count 41 9 
% within Res 82.0% 18.0% 
Family Count 21 11 
% within Residence 65.6% 34.4% 
Mild Count 47 8 8.255a   2 .016 
% within SevID 85.5% 14.5% 
Moderate Count 21 5 
% within SevID 80.8% 19.2% 
Severe Count 9 8 
% within SevID 52.9% 47.1% 
No disorder Count 24 10 1.971a 1 .160 
% within psych dis 70.6% 29.4% 
Psychiatric 
disorder 
Count 53 11 




DBC<51 DBC≥51 Value Df p 
Female Count 22 7 2.987a 1 .084 
% within Gender 75.9% 24.1% 
Male Count 36 27 
% within Gender 57.1% 42.9% 
A/C Count 17 13 .778a 2 .678 
% within Ethnicity 56.7% 43.3% 
White Count 37 19 
% within Ethnicity 66.1% 33.9% 
Other Count 4 2 
% within Ethnicity 66.7% 33.3% 
Inde Count 16 0 14.382a 2 .001 
% within Residence 100.0% .0% 
Resid Count 29 17 
% within Residence 63.0% 37.0% 
Family Count 13 17 
% within Residence 43.3% 56.7% 
Mild Count 35 15 4.537a 2 .103 
% within SevID 70.0% 30.0% 
Moderate Count 16 9 
% within SevID 64.0% 36.0% 
Severe Count 7 10 
% within SevID 41.2% 58.8% 
No disorder Count 17 15 2.072a 1 .150 
% within psych dis 53.1% 46.9% 
Psychiatric 
disorder 
Count 41 19 
% within Psych dis 68.3% 31.7% 
  Ok outcome Poor outcome Value Df p 
Female Count 27 2 1.837a 1 .175 
% within Gender 93.1% 6.9% 
Male Count 57 12 
% within Gender 82.6% 17.4% 
A/C Count 27 7 1.761a 2 .415 
% within Ethnicity 79.4% 20.6% 
White Count 51 6 
% within Ethnicity 89.5% 10.5% 
Other Count 6 1 
% within Ethnicity 85.7% 14.3% 
Inde Count 16 0 5.880
a
 2 .053 
% within Residence 100.0% .0% 
Resid Count 44 6 
% within Residence 88.0% 12.0% 
Family Count 24 8 
% within Residence 75.0% 25.0% 
Mild Count 50 5 7.500a 2 .024 
% within SevID 90.9% 9.1% 
Moderate Count 23 3 
% within SevID 88.5% 11.5% 
Severe Count 11 6 
% within SevID 64.7% 35.3% 
No disorder Count 25 9 6.313a 1 .012 
% within Psych dis 73.5% 26.5% 
Psychiatric 
disorder 
Count 59 5 





TableVI.6: proportion of participants with specific psychiatric diagnoses receiving different 
medication 
Psychiatric diagnosis/medication ASD No ASD 
ADHD N=3 N=1 
ADHD 67% 100% 
Anticonvulsant 33% 100% 
Antipsychotic 67% 0% 
Anxiety disorder  N=4 N=1 
Antidepressant 50% 100% 
Antipsychotic 50% 100% 
Benzodiazepine 50% 0% 
Bipolar disorder N=5 N=9 
No medication 0% 11% 
Anticonvulsant 100% 67% 
Antidepressant 0% 11% 
Antipsychotic 40% 78% 
Benzodiazepine 20% 0% 
Mood stabiliser (lithium) 0% 33% 
Depressive disorder  N=1 N=14 
Anticonvulsant 14% 0% 
Antidepressant 100% 100% 
Antipsychotic 0% 21% 
Anxiolytic 0% 7% 
Benzodiazepine 0% 14% 
Personality Disorder N=0 N=1 
Antidepressant  100% 
Psychotic disorder N=10 N=13 
No medication 20% 0% 
Anticonvulsant 10% 31% 
Antipsychotic 80% 100% 
Antidepressant 10% 8% 
Benzodiazepine 10% 15% 
Mood stabiliser (lithium) 10% 0% 
Mixed anxiety & depression N=0 N=2 
Antidepressant  100% 
 
Table VI.7: Associations between specific medication and measures 
Measure Medication 




Square F Sig. 
CANDID21 
TotalNeed 
Benzodiazepine 15 11.60 2.23 Between Groups 40.99 1 40.99 5.28 .024 
No benzodiazepine 78 9.79 2.88 Within Groups 706.32 91 7.76     
HoNOSLD 
Total 
Benzodiazepine 15 19.93 10.13 Between Groups 354.54 1 354.54 5.18 .025 
No benzodiazepine 83 14.65 7.91 Within Groups 6569.80 96 68.44     
HoNBeh 
Subsc 
Benzodiazepine 15 6.27 4.23 Between Groups 52.13 1 52.13 4.06 .047 
No benzodiazepine 83 4.24 3.46 Within Groups 1234.11 96 12.86     
DBCBeh Benzodiazepine 15 36.40 10.35 Between Groups 864.06 1 864.06 4.19 .044 





Benzodiazepine 15 18.87 5.32 Between Groups 230.22 1 230.22 3.90 .051 




Benzodiazepine 15 7.60 3.02 Between Groups 41.07 1 41.07 5.26 .024 




Antipsychotic 58 8.59 2.80 Between Groups 42.67 1 42.67 5.47 .021 




Antidepressant 25 10.36 2.72 Between Groups 52.62 1 52.62 6.85 .010 
No antidepressant 69 8.67 2.79 Within Groups 707.09 92 7.69     
DBCBeh Antidepressant 25 24.56 14.54 Between Groups 823.05 1 823.05 3.98 .049 
No antidepressant 67 31.28 14.31 Within Groups 18597.77 90 206.64     
DBCBeh 
MinASD 
Antidepressant 25 14.52 7.63 Between Groups 19.96 1 19.96 .33 .570 




Histograms and P-P plots for linear regression analyses 
Total HoNOS-LD scores 
Figure VI.1: Histogram of standardised residuals for total HoNOS-LD score linear regression 
 






TPBS on the Developmental Behaviour Checklist 
Figure VI.3: Histogram of standardised residuals for TPBS linear regression 
 
Figure VI.4: Normal P-P plot of standardised residuals for TPBS linear regression 
 
Problem behaviour 





Figure VI.4: Normal P-P plot of standardised residuals for DBC behaviour subscale linear 
regression 
 
Figure  VI.5: Histogram of standardised residuals for DBC behaviour subscale minus ASD items 
linear regression 
 
Figure VI.6: Normal P-P plot of standardised residuals for DBC behaviour subscale minus ASD 




Social functioning scale 
Figure VI.9: Histogram of standardised residuals for the Social functioning scale linear 
regression 
 
Figure VI.10: Normal P-P plot of standardised residuals for Social functioning scale linear 
regression 
 
Developmental Behaviour Checklist subscales 
 
Table VI.8: Items included in the DBC mental health subscale 
Appears depressed, downcast or unhappy. 
Bizarre speech. Please describe:  
Cries easily for no reason, or over small upsets.  
Delusions: has a firmly held belief or idea that can't 
possibly be true. Please describe: 
Distressed about being alone.  
Easily distracted from his/her task, e.g. By noises.  
Excessively distressed if separated from a familiar person.  
Fears particular things or situations, e.g. The dark, insects 
or crowds. Please describe: 
Has become confused or forgetful. 
Has become more withdrawn. 
Has nightmares, night terrors or walks in sleep 
Increase in appetite. 
Irritable.  
Lacks self-confidence, poor self-esteem. 
Loss of appetite. 
Loss of enjoyment or interest in usual activities. 
Loss of self-care skills. 
Makes gloomy statements.  
Mood changes rapidly for no apparent reason.  
Moves slowly, underactive, does little, e.g. Only sits 
and watches others. 
Not communicating as much as usual.  
Overactive, restless, unable to sit still.  
Panics. Sweats, flushes, trembles. 
Sleeps too little. Disrupted sleep. 
Sleeps too much or overly drowsy. 
Shy.  
Says he/she can do things that he/she is not capable 
of. 
Sees, hears, something which isn‘t there. 
Hallucinations. Please describe:  
Talks about or attempts suicide. 
Talks too much or too fast.  
Talks to self or imaginary people or objects.  
Thoughts are unconnected. Different ideas are 
jumbled together with meaning difficult to follow. 
Tense, anxious, worried. 
Unrealistically happy or elated. 
Appendices 
319 
Table VI.9: Items included in the DBC behaviour subscale 
Avoids eye contact. Won't look you straight in the eye.  
[ASD] 
Aloof, in her/his own world.  [ASD] 
Abusive. Swears at others.  
Arranges objects or routine in a strict order. Please 
describe: [ASD] 
Bangs head.  
Becomes over-excited.  
Bites others.  
Cannot attend to one activity for any length of time, poor 
attention span. [ASD] 
Chews or mouths objects, or body parts.  
Covers ears or is distressed when hears particular sounds. 
Please describe:   
Confuses the use of pronouns, e.g. Uses ‗you‘ instead of 
‗I‘.  
Deliberately runs away. [ASD] 
Doesn't show affection.   
Doesn't respond to others' feelings, e.g. Shows no 
response if a close friend or family member is crying. 
[ASD] 
Easily led into trouble by others.  
Eats non-food items, e.g. Dirt, grass, soap.  
Facial twitches or grimaces.  
Flicks, taps, twirls objects repeatedly. [ASD] 
Fussy eater or has food fads.  
Gorges food. Will do anything to get food, e.g. Takes 
food out of bins or steals food.  
Gets obsessed with an idea or activity.  Please describe: 
[ASD] 
Grinds teeth.  
Has temper tantrums, e.g. Stamps feet, slams doors. 
[ASD] 
Hides things.  
Hits, bites or injures self.  
Hums, whines, grunts, squeals, or makes other non-speech 
noises. [ASD] 
Impatient. [ASD] 
Inappropriate sexual activity with another.  
Impulsive, acts before thinking.  
Jealous.  
Kicks, hits or injures others.  
Laughs or giggles for no obvious reason. [ASD] 
Lights fires. [ASD] 
Likes to hold or play with an unusual object, e.g. String, 
twigs, overly fascinated with something, e.g. Water. 
[ASD] 
Masturbates, or exposes self, in public.  
Noisy or boisterous.  
Overaffectionate.   
Overbreathes, vomits, has headaches or complains of 
being sick for no physical reason.  
Overly attention-seeking.  
Overly interested in looking at, listening to or 
dismantling mechanical things, e.g. Lawnmower, 
vacuum cleaner.  
Poor sense of danger.  [ASD] 
Prefers to do things on his/her own. Tends to be a 
loner. [ASD] 
Preoccupied with only one or two particular interests.  
Please describe: [ASD] 
Problems with cigarettes, alcohol or caffeine.   
Problems with the illegal use of drugs.   
Refuses to go to college, activity centre or workplace.  
Repeated movements of hands, body, head or face, 
e.g. Handflapping or rocking. [ASD] 
Resists being cuddled, touched, or held by close 
friends or family.  [ASD] 
Repeats back what others say like an echo.   
Repeats the same word or phrase over and over. 
[ASD] 
Smells, tastes, or licks objects. [ASD] 
Scratches or picks her/his skin.  
Screams a lot. [ASD] 
Stares at lights or spinning objects. [ASD] 
Soils outside toilet though toilet trained, smears or 
plays with faeces.  
Speaks in whispers, high pitched voice, or other 
unusual tone or rhythm.   
Spits.  
Switches lights on and off, pours water over and 
over; or similar repetitive activity.  Please describe:   
Steals.  
Stubborn, disobedient or uncooperative.  
Strips off clothes or throws away clothes.  
Stands too close to others.   
Tells lies.  
Throws or breaks objects. [ASD] 
Tries to manipulate or provoke others.  
Underreacts to pain.   
Unusual body movements, posture or way of 
walking.  Please describe:  
Upset or distressed over small changes in routine or 
environment.  Please describe:  [ASD] 
Urinates outside toilet, although toilet trained.  
Very bossy.   
Wanders aimlessly.  [ASD] 
Whines or complains a lot. 
[ASD] = items included in the DBC-P ASD subscale and removed from the behaviour 






Psychotropic medication, psychiatric disorders and physical health problems 
 
 
Table VI.10: psychotropic medication included in Tables 9.33, 9.45, VI.6 and VI.7 
Type of medication Name of medication 
Antipsychotic Amisulpride, Aripiprazole, Benperidol, Chlorpromazine, Clopixol, Clozapine, 
Flupentixol, Haloperidol, Olanzapine, Quetiapine, Risperdone, Trifluoperazine, 
Zuclopenthixol 
Anticonvulsant  Buccal Midazolam, Carbamazepine, Clobazam, Clonazepam, Depakote, Gabapentin, 
Lamotrigine, Rufinamide, Sodium Valproate, Topiramate 
Antidepressant Amitriptyline, Citalopram, Clomipramine, Escitalopram,,Fluoxetine, Fluvoxamine, 
Mirtazapine, Paroxetine, Sertraline, Trazodone 
Anxiolytic Zopiclone 
Stimulant (ADHD)  Atomoxetine, Equasym XL, Methylphenidate 
Mood stabiliser Lithium Carbonate   
Benzodiazepine Diazepam, Lorazapam, Temazepam 
 
 
Table VI.11: diagnoses included in each category of psychiatric disorder in Table 9.8 
Type of disorder Diagnostic label as entered into mental health record 
ADHD ADHD  
Anxiety disorder Anxiety disorder, Generalised Anxiety Disorder, OCD, Other anxiety disorder, PTSD 
Bipolar disorder Bipolar affective disorder, Bipolar disorder 
Depression Depressive episode, Mild depressive disorder, Moderate depressive episode, Persistent 
mood (affective) disorder, Recurrent depression, Recurrent depressive disorder, Recurrent 
depressive episode 
Personality disorder Emotionally unstable Personality disorder (Borderline type)                                   
Psychotic disorder Organic delusional disorder, Organic Psychotic disorder, Paranoid schizophrenia, 
Psychotic disorder, Psychotic episode, Schizoaffective disorder, Schizophrenia, 
Unspecified psychotic illness 
Other Affective & anxiety disorder, Mixed anxiety & depression, Oppositional Defiant Disorder 
 
 
Table VI.12: physical health problems and disabilities included in Table 9.26 















Irritable bowel syndrome 
Multiple sclerosis 
Pulmonary embolism 




















































Appendix VII:  Additional calculations 
 
 
Estimated rate of ASD 
Rates of clinically diagnosed ASD=33.5%: 20% of those with mild ID, 42% of those with 
moderate ID and 67% of those with severe ID. 
 
Proportion of service users with mild ID=56%, moderate ID=29%, severe ID=15%. 
Overall rate of those with ASD and each severity: 11%, 12.1% and 10.4% 
 
Rate of ASD traits=8.7% of those with mild ID, 8.8% of those with mod ID & 4.9% of those 
with severe ID. Overall rates of 4.8%, 2.5% & 0.8%=8.1%; revised ASD prevalence=41.6% 
 
Standardised data suggested that: 13% of those with mild ID & a clinical diagnosis of ASD 
don‘t have ASD => rates of ASD & mild ID =11% – 0.13x11=9.6%; revised 
prevalence=40.2% 
 
Rate of ASD behaviours among those with no clinical diagnosis of ASD: 18.6% of those with 
mild ID, 33.3% of those with moderate ID & 93.3% of those with severe ID => overall rates 
of 7.4%, 4.8%, 4% = 16.2% => overall prevalence of ASD = 40.2 + 16.2 = 56.4%. 
